,data,description,cluster
5431,cell cytoplasm,cell cytoplasm,0
5283,newly emerging strains,newly emerging strains,0
5284,h3n2 virusthatwerecollectedacrosssixcontinentsfrom2002to2007bythewho sglobalinfluenzasurveillancenetworkshowedthenewlyemergingstrainsofh3n2appearedin east southeast asian countries,subtype,0
5285,additional months,additional months,0
5288,swine populations,swine disease,0
5295,swine farms,swine disease,0
5298,strong serologic crossreactions,strong serologic crossreactions,0
5303,closeness,closeness,0
5312,graphic,graphic,0
5323,h3n2 subtype,subtype,0
5326,2004–05 trivalent,2004–05 trivalent,0
5333,related biological products advisory committee,related biological products advisory committee,0
5341,2009–2010 season,2009–2010 season,0
5359,mules,mules,0
5360,zebras,zebras,0
5363,north south america,north south america,0
5364,massive outbreaks,massive outbreaks,0
5375,quarter,quarter,0
5436,necrosis,necrosis,0
5434,hyperemia,hyperemia,0
10861,2013 genes,2013 genes,0
5427,binding,binding,0
5424,infecting dose,infecting dose,0
5423,mucus,mucus,0
5276,b. measured resistance,b. measured resistance,0
5422,mucopolysaccharides,mucopolysaccharides,0
5418,embeds,embeds,0
5411,7 days,7 days,0
5410,typically 1–3 days,typically 1–3 days,0
5395,epithelial cells,epithelial cells,0
5387,direct contact,direct contact,0
5380,h2n2 subtype,wikimedia disambiguation page,0
5421,glycoproteins,structural class chemical compounds,0
5260,isolatefujian flustrains,isolatefujian flustrains,0
5254,nonimmune partially immune population,nonimmune partially immune population,0
5252,threat,threat,0
5163,smithsonian magazine,smithsonian magazine,0
5158,variant,variant,0
5155,european centre,european centre,0
5153,20.5%,20.5%,0
5152,chinese ministry,chinese ministry,0
5150,nasal swabs,nasal swabs,0
5166,pig populations,pig populations,0
5144,chinese cdc,chinese cdc,0
5139,close monitoring,close monitoring,0
5134,national academy,national academy,0
5131,variant genotype,variant genotype,0
5114,lahore,city big city city millions inhabitants administrative territorial entity,0
5112,multan,city big city city millions inhabitants,0
5108,help,help,0
5140,swine working populations,swine disease,0
5439,basement membrane,basement membrane,0
5171,oman,emoji regional indicator sequence,0
5188,coastal cities,coastal cities,0
5250,potential marker,potential marker,0
5249,increased il6 levels,increased il6 levels,0
5246,interferongamma,interferongamma,0
5241,nasal oral swabs,nasal oral swabs,0
5230,cynomolgus macaques,cynomolgus macaques,0
5226,particular humans,infectious disease france,0
5172,malaysia,emoji regional indicator sequence,0
5224,mammalian receptor,mammalian receptor,0
5221,transmits,transmits,0
5220,prior adaptation,prior adaptation,0
5216,national institutes,national institutes,0
5208,vials,vials,0
5207,u.s. government,u.s. government,0
5204,cincinnati,big city city united states county seat,0
5222,adaptation,adaptation,0
5443,102.5 105.0 f frequent dry cough,102.5 105.0 f frequent dry cough,0
5450,equine1,equine1,0
5451,2 serum,2 serum,0
5677,inactivated h5n2,inactivated h5n2,0
5667,uninfected ones,uninfected ones,0
5660,ron fouchier,ron fouchier,0
5657,arctic temperatures,arctic temperatures,0
5655,6 days,6 days,0
5653,bodily fluids,bodily fluids,0
5681,ibaraki prefecture,ibaraki prefecture,0
5650,longer periods,longer periods,0
5644,wild aquatic birds,wild aquatic birds,0
5639,bird population,taxon,0
5630,antigenic drift,antigenic drift,0
5627,specific known genetic variation,specific known genetic variation,0
5618,infected poultry manure,organisms known particular common,0
5616,domestic poultry,organisms known particular common,0
5648,bird populations,taxon,0
5607,contagiousness,contagiousness,0
5684,ibaraki prefectural government,ibaraki prefectural government,0
5690,central federal district,central federal district,0
5721,south african commercial ostrich industry,south african commercial ostrich industry,0
5719,south africa ostriches,continent,0
5718,destruction,destruction,0
5712,sri lanka outbreak,sri lanka outbreak,0
5709,h5n2 outbreaks,h5n2 outbreaks,0
5708,ibaraki,ibaraki,0
5689,kostroma oblast,kostroma oblast,0
5705,saitama prefecture,saitama prefecture,0
5696,dispersion,dispersion,0
5695,forage wasn tthermallydisinfectedbefore dispersion,forage wasn tthermallydisinfectedbefore dispersion,0
5694,forage,forage,0
5693,factory,factory,0
5692,chickens combs,chicken gallus gallus domesticus common,0
5691,owners,owners,0
5699,quarantine officials,quarantine officials,0
5107,official request,official request,0
5604,animal,taxon,0
5601,federal government.together steps,federal government.together steps,0
5531,intervention,intervention,0
5527,international herald tribune,international herald tribune,0
5519,united nations,united nations,0
5514,poultry sales,organisms known particular common,0
5511,u.s. dollars,u.s. dollars,0
5507,significant effect,significant effect,0
5532,shuangqing district,shuangqing district,0
5505,entire domestic poultry population,organisms known particular common,0
5496,focus,focus,0
5494,flocks,flocks,0
5485,key events,key events,0
5483,adequate resources,adequate resources,0
5468,fao,fao,0
5453,serous light mucoid nasal discharge,serous light mucoid nasal discharge,0
5497,roche ag,roche ag,0
5602,animal populations,taxon,0
5535,hubei province,hubei province,0
5542,noticeable sign,noticeable sign,0
5600,agencies,agencies,0
5595,containment measures,containment measures,0
5593,global efforts,global efforts,0
5589,greater monitoring,greater monitoring,0
5588,88 foreign governments,88 foreign governments,0
5586,food agriculture organization,food agriculture organization,0
5541,nasal discharge,nasal discharge,0
5585,international organizations,international organizations,0
5576,biohazardous threats emerging diseases graduate program,biohazardous threats emerging diseases graduate program,0
5572,best protection,best protection,0
5570,crossprotection,crossprotection,0
5561,noticeable signs,noticeable signs,0
5550,negative sense,negative sense,0
5549,segmented genome,scientific model natural environment,0
5577,georgetown university,georgetown university,0
5104,27 july,27 july,0
5103,late july,late july,0
5100,trip,trip,0
4703,extensive outbreaks,extensive outbreaks,0
4702,outbreaks areas,outbreaks areas,0
4699,retrospective analysis,retrospective analysis,0
4698,cultural revolution,cultural revolution,0
4697,reported data,reported data,0
4695,july–september,july–september,0
4704,lethality,lethality,0
4694,waves,waves,0
4687,13 july,13 july,0
4672,queen mary hospital,queen mary hospital,0
4655,24%,24%,0
4652,1987 boca acre study,1987 boca acre study,0
4651,macrophages,macrophages,0
4649,infiltration,infiltration,0
4689,population density,population density,0
4648,particular type,particular type,0
4713,mao tsetung,mao tsetung,0
4718,corpses,corpses,0
4772,key point,key point,0
4768,probably half dozen,probably half dozen,0
4767,spokeswoman,spokeswoman,0
4766,maria cheng,maria cheng,0
4764,united states centers,united states centers,0
4757,ontario,ontario,0
4716,berlin,berlin,0
4743,100 confirmed cases,100 confirmed cases,0
4734,smoldering pattern,smoldering pattern,0
4730,key role,key role,0
4728,maurice hilleman team,maurice hilleman team,0
4727,american microbiologist maurice hilleman,american microbiologist maurice hilleman,0
4721,garbage collectors,garbage collectors,0
4720,west germany,historical period germany historical country,0
4735,united states health authorities,united states health authorities,0
4774,difficulties,difficulties,0
4646,liver tissue,organ type,0
4638,hbv association,hbv association,0
4571,stop,stop,0
4570,cellular enzyme adenosine,cellular enzyme adenosine,0
4568,reading frame,reading frame,0
4563,nterminals,nterminals,0
4558,significant difference,significant difference,0
4555,iii,iii,0
4572,ugg,ugg,0
4551,hdv genome,scientific model natural environment,0
4547,hepatocyte,hepatocyte,0
4541,hdv receptor,hdv receptor,0
4537,nucleotide sequence,nucleotide sequence,0
4531,200 molecules,200 molecules,0
4530,ribonucleoprotein particle,ribonucleoprotein particle,0
4529,kinds,kinds,0
4549,nucleus,nucleus,0
4645,extensive destruction,extensive destruction,0
4579,later stages,later stages,0
4587,hbv surface proteins,group class chemical substances second-order class,0
4634,39 patients,39 patients,0
4632,boca acre,boca acre,0
4631,males,males,0
4624,anorexia,anorexia,0
4618,colombia,sovereign state republic secular state country,0
4615,acre,acre,0
4585,antigenic loop infectivity,antigenic loop infectivity,0
4614,amazon river,amazon river,0
4604,virion surface,virion surface,0
4602,antigenic loop,antigenic loop,0
4600,georges abou jaoudé,georges abou jaoudé,0
4599,cellular receptor,cellular receptor,0
4592,ribonucleoprotein,ribonucleoprotein,0
4589,genome main function,scientific model natural environment,0
4609,host cell,host cell,0
5725,pennsylvania,pennsylvania,0
4776,quantities,quantities,0
4786,efforts,efforts,0
5015,ismaillia,ismaillia,0
5014,oneyearold infants,oneyearold infants,0
5012,imidazopyridines,imidazopyridines,0
5006,antiinflammatories,antiinflammatories,0
5000,nonbenzodiazepines,nonbenzodiazepines,0
4998,pyrazolopyrimidines,pyrazolopyrimidines,0
5017,minnesota,minnesota,0
4997,gabaaagonizing imidazopyridines,gabaaagonizing imidazopyridines,0
4988,potentially useful activity,potentially useful activity,0
4980,secretary,secretary,0
4978,sufficient herd immunity,sufficient herd immunity,0
4972,production facilities,production facilities,0
4968,passage,passage,0
4963,probable lethality,probable lethality,0
4992,nitrogen,nitrogen,0
4960,greater lesser likelihood,greater lesser likelihood,0
5018,turkey farms,sovereign state transcontinental country mediterranean country country social state regional power secular state,0
5022,pond,pond,0
5096,holidays,holidays,0
5091,midmarch,midmarch,0
5081,unusually mongrelised mix,unusually mongrelised mix,0
5068,230 soldiers,230 soldiers,0
5067,retrospective serologic testing,retrospective serologic testing,0
5063,13 soldiers,13 soldiers,0
5019,31%,31%,0
5040,size,size,0
5037,glycoside hydrolase enzyme,glycoside hydrolase enzyme,0
5036,infected cell,infected cell,0
5033,n,n,0
5026,local harbour seal population,local harbour seal population,0
5024,harbour seals,harbour seals,0
5023,increased mortality,increased mortality,0
5038,host cells,host cells,0
4784,technologies,technologies,0
4945,genetic properties,genetic properties,0
4939,haemagglutinin gene,haemagglutinin gene,0
4832,older victims,older victims,0
4823,largest number,largest number,0
4822,poultry handlers,organisms known particular common,0
4818,problem,problem,0
4816,unavoidable limitations,unavoidable limitations,0
4814,national governments,national governments,0
4833,milder attacks,milder attacks,0
4812,global extent,global extent,0
4808,fatality ratio,fatality ratio,0
4807,existing prepandemic global case fatality ratio,existing prepandemic global case fatality ratio,0
4802,little attention,little attention,0
4800,guangdong,province china,0
4797,mortality incidence,mortality incidence,0
4791,h5 surface proteins,group class chemical substances second-order class,0
4809,official tally,official tally,0
4941,humantype receptor,humantype receptor,0
4838,agefatality curve,agefatality curve,0
4848,n1 group,n1 group,0
4936,independent virulence factors,independent virulence factors,0
4935,intervention measures,intervention measures,0
4917,adaptations,adaptations,0
4900,organizations,organizations,0
4892,over50% case fatality ratio,over50% case fatality ratio,0
4891,lethal waves,lethal waves,0
4842,mortality curve,mortality curve,0
4883,certain genetic similarities,certain genetic similarities,0
4878,advance,advance,0
4875,unrelated maladies survival chances,unrelated maladies survival chances,0
4870,poorer chances,poorer chances,0
4865,significant familial pattern,significant familial pattern,0
4854,flumist inoculation,brand,0
4851,inoculation,inoculation,0
4880,prepandemic case fatality ratio,prepandemic case fatality ratio,0
5727,affected flock,affected flock,0
5731,routine testing,routine testing,0
5738,15 states,15 states,0
6500,processes,processes,0
6499,type undergoes antigenic shift,type undergoes antigenic shift,0
6497,host cell receptors,host cell receptors,0
6496,enzyme neuraminidase,group class enzymes,0
6493,hemagglutininesterase fusion,hemagglutininesterase fusion,0
6491,transcription,transcription,0
6513,animal reservoir,taxon,0
6487,antigens,antigens,0
6480,prior exposure,prior exposure,0
6475,infectious agent,infectious agent,0
6471,rhinorrhea,rhinorrhea,0
6460,animal reservoirs,taxon,0
6454,greater level,greater level,0
6451,divergence,divergence,0
6484,structure variation,structure variation,0
6446,antigenic types,antigenic types,0
6529,estimated occurrence,estimated occurrence,0
6537,normal lung temperature,normal lung temperature,0
6593,comets,comets,0
6586,agency,agency,0
6584,affiliations,affiliations,0
6582,mid2008,mid2008,0
6581,international nihfunded searchable online database,international nihfunded searchable online database,0
6580,genbank,sequence database data library,0
6530,1.3%,1.3%,0
6579,sequence data,sequence data,0
6564,steven salzberg,steven salzberg,0
6563,david lipman,david lipman,0
6553,william b. epperson,william b. epperson,0
6551,alicia k. olivier,alicia k. olivier,0
6549,challenge experiments,challenge experiments,0
6548,partial protection,partial protection,0
6574,elodie ghedin,elodie ghedin,0
6594,earthquakes,earthquakes,0
6439,linear negativesense,linear negativesense,0
6436,500 surface projections,500 surface projections,0
6357,peruvian bat,peruvian bat,0
6355,h17n10,h17n10,0
6354,11 different known n antigens,11 different known n antigens,0
6353,18 different known h antigens,18 different known h antigens,0
6350,negativesense,negativesense,0
6346,better characterization studies,better characterization studies,0
6363,toll,toll,0
6342,continuous evolution,continuous evolution,0
6339,computational molecular analysis,computational molecular analysis,0
6338,tong y,tong y,0
6325,h9 antigenic sites,h9 antigenic sites,0
6320,antigenicity,antigenicity,0
6312,air droplet,air droplet,0
6308,a/quail/hong kong/g1/97like,a/quail/hong kong/g1/97like,0
6340,phylogenetic characterization,phylogenetic characterization,0
6437,genome structure,scientific model natural environment,0
6366,structure genetics,structure genetics,0
6375,micrometers,micrometers,0
6421,subtype list,subtype list,0
6414,essential gene,essential gene,0
6410,radiation,radiation,0
6409,uv radiation,uv radiation,0
6408,inactivation,inactivation,0
6406,gene product,gene product,0
6368,80–120 nanometers,80–120 nanometers,0
6404,segmented pieces,segmented pieces,0
6390,progeny virions,progeny virions,0
6388,target cell,target cell,0
6384,central core,central core,0
6382,virions,virions,0
6380,electron microscopy,electron microscopy,0
6376,filamentous virions,filamentous virions,0
6398,organisms,organisms,0
6307,a/chicken/beijing/1/94like,a/chicken/beijing/1/94like,0
6597,setting,setting,0
6604,different type,different type,0
6807,policies,policies,0
6802,emerging pandemic.each state,emerging pandemic.each state,0
6792,federal government,federal government,0
6790,actions,actions,0
6789,responsibilities,responsibilities,0
6775,alum,structural class chemical compounds,0
6816,growing concern,growing concern,0
6770,acceptable level,acceptable level,0
6761,lessdeveloped countries,lessdeveloped countries,0
6758,assurances,assurances,0
6751,welldeveloped plans,welldeveloped plans,0
6749,best scenario situation,best scenario situation,0
6747,19 countries,19 countries,0
6742,commonly sought drug,commonly sought drug,0
6766,large multicentre trial,large multicentre trial,0
6739,adamantanes,adamantanes,0
6817,hazards,hazards,0
6821,malaysian population,malaysian population,0
6883,flumist,brand,0
6869,poultry farming protection funds,organisms known particular common,0
6866,dollars,dollars,0
6861,domestic birds,domestic birds,0
6859,domestic flock,domestic flock,0
6857,domesticated poultry,organisms known particular common,0
6820,place processes,place processes,0
6850,kobasa et al,kobasa et al,0
6844,genetic mechanisms,genetic mechanisms,0
6836,federal government goal,federal government goal,0
6832,$1 billion drug manufacturers,$1 billion drug manufacturers,0
6831,fiveyear contracts,fiveyear contracts,0
6828,therapies,therapies,0
6823,molecular virology,molecular virology,0
6848,genetic sequence,genetic sequence,0
6598,sun,sun,0
6737,national surveys,national surveys,0
6727,following shortterm strategies,following shortterm strategies,0
6659,horrific disconnect,horrific disconnect,0
6658,ignorance,ignorance,0
6649,hospital rooms,hospital rooms,0
6628,practice,practice,0
6625,mild illness,mild illness,0
6622,soldiers,soldiers,0
6660,reassurances,reassurances,0
6621,wwi practice,wwi practice,0
6617,detergents,detergents,0
6615,human body temperature,organisms known particular common homo sapiens homo sapiens sapiens homo,0
6611,feces,biogenic substance type,0
6609,droppings,droppings,0
6608,sneezes,sneezes,0
6605,unrelated gastroenteritis,unrelated gastroenteritis,0
6618,appearance,appearance,0
6732,attitudes,attitudes,0
6662,credibility,credibility,0
6665,u.s. army camp,u.s. army camp,0
6725,animal problem,taxon,0
6724,foreign relations panel,foreign relations panel,0
6723,section,section,0
6713,capacity development,capacity development,0
6710,grouping,grouping,0
6708,existing national preparedness,existing national preparedness,0
6664,trust.a letter,trust.a letter,0
6704,sixphase approach,sixphase approach,0
6702,2009 revision,2009 revision,0
6696,seven ill patients,seven ill patients,0
6694,24 april,24 april,0
6692,unknown causation,unknown causation,0
6680,variable mortality,variable mortality,0
6677,wave nature,wave nature,0
6703,phase descriptions,phase descriptions,0
4528,host phospholipids,host phospholipids,0
6303,extensive gene reassortment,extensive gene reassortment,0
6300,crucial role,crucial role,0
5948,h7 subtype,h7 subtype,0
5947,h7n9 identifies,taxon,0
5938,poultry production,organisms known particular common,0
5916,h7n4,h7n4,0
5910,h7n3,h7n3,0
5903,japan ground selfdefense force,sovereign state island nation country,0
5949,n9 subtype,n9 subtype,0
5898,regional official,regional official,0
5894,state animal husbandry officials,taxon,0
5888,kerala officials,state india start time 1 november 1956,0
5880,16 places,16 places,0
5876,official confirmed reports,official confirmed reports,0
5866,alquaiyat,alquaiyat,0
5863,riyadh,riyadh,0
5897,genetic test,genetic test,0
5862,poultry market,organisms known particular common,0
5950,group,group,0
5956,genetic characterisation,genetic characterisation,0
6025,april 30 report,april 30 report,0
6024,veterinary services,veterinary services,0
6023,overall level,overall level,0
6021,live bird markets,taxon,0
6020,contaminated environment,contaminated environment,0
6018,hypothesis,hypothesis,0
5952,subgroup,subgroup,0
6005,live poultry markets,organisms known particular common,0
5991,genetic modification work,genetic modification work,0
5983,lot,lot,0
5980,thing,thing,0
5977,genetic makeup,genetic makeup,0
5967,migration,migration,0
5961,origins,origins,0
6003,chinese scientists,chinese scientists,0
6026,assessment,assessment,0
5859,south african poultry association,organisms known particular common,0
5856,standerton,standerton,0
5777,1 840 2 497 birds,1 840 2 497 birds,0
5774,pampanga,pampanga,0
5770,highest level,highest level,0
5768,bird droppings,taxon,0
5763,central northern southern parts,central northern southern parts,0
5762,locations,locations,0
5780,7 mile zone,7 mile zone,0
5759,moca,moca,0
5756,2 hens,2 hens,0
5745,abbottsford,abbottsford,0
5744,commercial turkey farm,sovereign state transcontinental country mediterranean country country social state regional power secular state,0
5743,montana,montana,0
5742,fergus county,fergus county,0
5741,duck,duck,0
5757,visible sign,visible sign,0
5857,mpumalanga,mpumalanga,0
5781,poultry movement,organisms known particular common,0
5787,75 percent,75 percent,0
5850,major poultry producers,organisms known particular common,0
5845,poultry flocks,organisms known particular common,0
5844,restrictions,restrictions,0
5842,striking domestic birds,striking domestic birds,0
5840,slovenia,slovenia,0
5832,turkey farm,sovereign state transcontinental country mediterranean country country social state regional power secular state,0
5785,dead animals,dead animals,0
5827,rural,rural,0
5815,seven additional european countries,seven additional european countries,0
5803,lab,lab,0
5801,28 020 chickens,chicken gallus gallus domesticus common,0
5798,nervousness,nervousness,0
5796,farms,farms,0
5792,conserved amino acids,conserved amino acids,0
5823,louth,louth,0
6302,wide host range,wide host range,0
6027,poultry vaccination,organisms known particular common,0
6031,chinese authorities,chinese authorities,0
6219,52yearold woman,52yearold woman,0
6211,wuxi,wuxi,0
6210,suzhou,suzhou,0
6203,travel,travel,0
6200,minds,minds,0
6196,intense relevancy,intense relevancy,0
6221,huzhou,prefecture-level city big city city millions inhabitants,0
6195,internet surveys,internet surveys,0
6188,hangzhou,hangzhou,0
6187,38%,38%,0
6181,university,university,0
6170,chinese veterinary technicians,chinese veterinary technicians,0
6166,vaccination ofpoultryagainsttheh5n1avianinfluenzavirusoverthelastdecademighthavemadetheh5n1avianinfluenzavirusharderforchineseveterinarytechnicianstospottherecentspreadoftheh7n9viruschina sagricultureministrydefendedchina sagricultureministrypolicyoflargescalevaccinationof poultry,organisms known particular common,0
6164,gisaid sharing mechanism,gisaid sharing mechanism,0
6190,nanjing,nanjing,0
6163,spirit,spirit,0
6226,7.on april,7.on april,0
6239,sevenyearold girl,sevenyearold girl,0
6299,gene donor,gene donor,0
6295,chinese chickens,chicken gallus gallus domesticus common,0
6294,common subtype,common subtype,0
6288,songjiang district,songjiang district,0
6282,unprotected exposure,unprotected exposure,0
6277,genome sequence,scientific model natural environment,0
6231,25yearold pregnant woman,25yearold pregnant woman,0
6276,may. 60yearold man daughter,may. 60yearold man daughter,0
6271,british medical journal,british medical journal,0
6261,yoshihiro kawaoka,yoshihiro kawaoka,0
6255,cumulative total,cumulative total,0
6245,31yearold thoracic surgeon,31yearold thoracic surgeon,0
6243,central henan,central henan,0
6242,xinhua chinese state media,xinhua chinese state media,0
6275,may. 60yearold man,may. 60yearold man,0
6028,control option,control option,0
6160,chinese team,chinese team,0
6151,credit,credit,0
6104,zhejiang university,zhejiang university,0
6093,great difficulty,great difficulty,0
6089,complexes,complexes,0
6083,lifetime exposure,lifetime exposure,0
6082,older chinese men,older chinese men,0
6081,british columbia centre,british columbia centre,0
6105,hong kong university,hong kong university,0
6076,greater exposure,greater exposure,0
6073,poultry exposure,organisms known particular common,0
6072,yuzo arima colleagues,yuzo arima colleagues,0
6070,3.6:1.dr,3.6:1.dr,0
6069,female ratio,female ratio,0
6065,male,male,0
6061,older males,older males,0
6074,common risk factor,common risk factor,0
6153,china early openness,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",0
6106,chinese center,chinese center,0
6110,chinese academy,chinese academy,0
6146,novartis,business multinational corporation,0
6145,inc.,inc.,0
6141,china cdc,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",0
6137,shanghai,city direct-controlled municipality national central city big city city millions inhabitants,0
6135,adjuvants,adjuvants,0
6126,routine procedure,routine procedure,0
6109,food drug control,food drug control,0
6125,randomized observerblinded placebocontrolled clinical trial,randomized observerblinded placebocontrolled clinical trial,0
6120,insect cells,insect cells,0
6118,manufacture,manufacture,0
6117,novavax,novavax,0
6116,april 3.on,april 3.on,0
6114,throat swab,throat swab,0
6112,chinese national influenza center director shu yuelong,infectious disease,0
6123,a/indonesia/5/05,a/indonesia/5/05,0
4524,structure genome,scientific model natural environment,0
4521,hdvspecific cd8+ t cells,hdvspecific cd8+ t cells,0
4519,exception,exception,0
3005,unpublished phase iii trials,unpublished phase iii trials,0
3003,accelerated clearance,accelerated clearance,0
3000,fda phase ii phase iii clinical trials,fda phase ii phase iii clinical trials,0
2998,medivector inc.,medivector inc.,0
2997,partnership,partnership,0
2987,actions actions,actions actions,0
3010,animal experiments,taxon,0
2981,generic drug,generic drug,0
2964,eicar,eicar,0
2960,experimental drug,experimental drug,0
2959,deleobuvir,chemical compound,0
2951,tablets,tablets,0
2950,administration storage,administration storage,0
2946,u.s. fda,u.s. fda,0
2966,nucleoside derivative,nucleoside derivative,0
2940,dasabuvir works,scholarly article,0
3012,labor,labor,0
3014,production condition,production condition,0
3050,hamsters,hamsters,0
3049,encephalitis,encephalitis,0
3046,aspects,aspects,0
3041,saliva,mixture body fluids,0
3037,philippines,philippines,0
3036,slaughterhouses,slaughterhouses,0
3013,welfare,welfare,0
3035,malaysiasingapore,malaysiasingapore,0
3026,retroviruses,retroviruses,0
3025,conference,conference,0
3023,guinea,guinea,0
3022,guéckédou,guéckédou,0
3018,conclusions,conclusions,0
3015,emergency,emergency,0
3030,trial design,trial design,0
3051,lethal dose,lethal dose,0
2939,greater times upper limit,greater times upper limit,0
2933,insomnia,insomnia,0
2878,oral dose,oral dose,0
2877,distribution,distribution,0
2872,pgp substrate,pgp substrate,0
2867,administration,administration,0
2866,peak dose,peak dose,0
2865,oncedaily 60 mg oral administration,oncedaily 60 mg oral administration,0
2881,100 μg,100 μg,0
2864,4 days,4 days,0
2852,specificity,specificity,0
2848,huh7 cells,cell line cancer cell line,0
2847,gt1b replicon,gt1b replicon,0
2835,required dosage adjustments,required dosage adjustments,0
2833,antifungals,antifungals,0
2831,nonnucleoside reverse transcriptase inhibitors,nonnucleoside reverse transcriptase inhibitors,0
2855,pegylated interferon,group class proteins,0
2935,increases,increases,0
2882,economics,economics,0
2884,different prices,different prices,0
2929,1a,1a,0
2922,unknown subtype,unknown subtype,0
2921,genotype,genotype,0
2920,genotype 1a,genotype 1a,0
2916,food drug administration,food drug administration,0
2913,ethinylestradiol,ethinylestradiol,0
2883,sale,sale,0
2911,harm,harm,0
2908,trouble,trouble,0
2903,ascletis,ascletis,0
2893,fluoroisoindole tertbutyl carbamate moieties,fluoroisoindole tertbutyl carbamate moieties,0
2890,danoprevir,chemical compound,0
2887,generics manufacturers,generics manufacturers,0
2886,economic development,economic development,0
2909,liver failure,organ type,0
2827,daclatasvir levels,scholarly article review article,0
3056,14 days,14 days,0
3067,rabies,infectious disease switzerland disease,0
3314,germany,historical period germany historical country,0
3309,openness,openness,0
3294,genetic level,genetic level,0
3290,jakarta,city capital province indonesia big city city millions inhabitants human settlement,0
3289,greater frequency,greater frequency,0
3285,extensive experience,extensive experience,0
3328,foxes,foxes,0
3283,institutes,institutes,0
3273,severely affected country,severely affected country,0
3264,2 april,2 april,0
3259,official confirmation,official confirmation,0
3251,nearly 1.2 million poultry,organisms known particular common,0
3237,arenaviruses,arenaviruses,0
3230,niaid,niaid,0
3282,team members,team members,0
3225,adenosine analog,adenosine analog,0
3329,seals,seals,0
3335,subsequent seroconversion,subsequent seroconversion,0
3392,central hunan province,central hunan province,0
3391,22yearold man,22yearold man,0
3388,myanmar,sovereign state country,0
3381,wild migratory bird populations,taxon,0
3380,asian countries,asian countries,0
3376,romania,sovereign state start time 10 1877julian country,0
3331,dr. osterhaus,dr. osterhaus,0
3372,newly appointed senior united nations coordinator,newly appointed senior united nations coordinator,0
3364,2005,2005,0
3360,point,point,0
3347,z genotype,z genotype,0
3346,evolution,evolution,0
3342,numerous farms,numerous farms,0
3336,calf,calf,0
3367,qinghai lake,qinghai lake,0
3059,lethal niv challenge,lethal niv challenge,0
3220,aggressive antibiotic therapy,aggressive antibiotic therapy,0
3216,variety,variety,0
3134,measured resistance,measured resistance,0
3122,different times,different times,0
3114,tropics,tropics,0
3112,southern hemisphere winters,southern hemisphere winters,0
3109,south latitudes,south latitudes,0
3108,tropical climate,tropical climate,0
3146,earnings,earnings,0
3106,brazil,brazil,0
3094,influenzavirus,influenzavirus,0
3092,location,location,0
3088,cold half,cold half,0
3085,strategic reasons,strategic reasons,0
3080,genotype 1 polymerases,genotype 1 polymerases,0
3075,noncatalytic thumb ii allosteric pocket,noncatalytic thumb ii allosteric pocket,0
3104,southern hemisphere countries,southern hemisphere countries,0
3218,viral bacterial fungal protozoa disorders,viral bacterial fungal protozoa disorders,0
3158,274 304 hospitalizations,274 304 hospitalizations,0
3161,notable occurrences,notable occurrences,0
3214,cancer suspect,constellation zodiacal constellation,0
3213,cancer doctor,constellation zodiacal constellation,0
3205,lung cancer patients,constellation zodiacal constellation,0
3200,radiation therapy,radiation therapy,0
3199,cancer patients,constellation zodiacal constellation,0
3197,cancer,constellation zodiacal constellation,0
3160,ph1n1,ph1n1,0
3184,common cold,common cold,0
3179,environment,environment,0
3177,wide range,wide range,0
3176,diabetics,diabetics,0
3173,extensive text,extensive text,0
3170,weekly updates,weekly updates,0
3165,influenzalike illness,influenzalike illness,0
3180,bacteria,taxon,0
3396,25yearold female,25yearold female,0
2821,decreased therapeutic effect,decreased therapeutic effect,0
2819,strong inducers,strong inducers,0
2481,2006 state,2006 state,0
2477,final conclusion,final conclusion,0
2467,modafinil,chemical compound medication,0
2462,m2 resistance testing,m2 resistance testing,0
2455,cdc cdc,cdc cdc,0
2453,neuraminidase inhibitors,group class enzymes,0
2483,subjective fatigue,symptom,0
2452,cdc guidelines,cdc guidelines,0
2439,barrel,barrel,0
2437,function,function,0
2435,protein synthesis,protein synthesis,0
2418,nmdatype glutamate receptor,structural class chemical compounds,0
2415,mechanism,mechanism,0
2413,u.s. national library,u.s. national library,0
2441,pore function,pore function,0
2407,oseltamivir resistance,chemical compound neuraminidase inhibitor medication essential medicine,0
2484,problem solving,problem solving,0
2488,msrelated fatigue,symptom,0
2551,cardiovascular,cardiovascular,0
2544,depression,depression,0
2537,light headedness,light headedness,0
2530,longterm outcomes,longterm outcomes,0
2527,direct dopamine stimulation,chemical compound medication neurotransmitter,0
2525,functional gains,functional gains,0
2485,memory,memory,0
2516,capacity,capacity,0
2513,neuroplasticity overall functional recovery patients brain injury,neuroplasticity overall functional recovery patients brain injury,0
2503,injury,injury,0
2500,traumatic brain injury patients,traumatic brain injury patients,0
2496,mcs,mcs,0
2494,minimally conscious state,minimally conscious state,0
2489,awareness patients disorders consciousness,awareness patients disorders consciousness,0
2515,neuroplasticity,neuroplasticity,0
2553,syncope,syncope,0
2406,increasing incidence,increasing incidence,0
2401,choice,choice,0
2348,chemical structure,chemical structure,0
2346,arousal,arousal,0
2340,levodopainduced dyskinesia,levodopainduced dyskinesia,0
2338,fda,fda,0
2337,amantadine resistance,chemical compound medication,0
2332,prophylaxis,prophylaxis,0
2349,adamantane backbone,chemical compound,0
2331,approval,approval,0
2318,adamantane solid allow incorporation,chemical compound,0
2315,homologues,homologues,0
2313,touchscreens,touchscreens,0
2312,coatings,coatings,0
2309,hydraulic systems,hydraulic systems,0
2307,potential technological applications,potential technological applications,0
2328,endosomal escape,endosomal escape,0
2404,surface,surface,0
2350,amino group,amino group,0
2356,dyskinesia,dyskinesia,0
2399,southeast asia,continent continental area surrounding islands,0
2398,estimated 2.6 billion doses,estimated 2.6 billion doses,0
2395,chinese poultry farmers,organisms known particular common,0
2394,veterinary misuse,veterinary misuse,0
2371,central nervous,central nervous,0
2370,interactions,interactions,0
2355,parkinsonian syndromes,parkinsonian syndromes,0
2369,mild sideeffect profile,mild sideeffect profile,0
2364,small extent,small extent,0
2363,hemodialysis,hemodialysis,0
2361,halflife elimination,halflife elimination,0
2359,greater risk,greater risk,0
2358,amantadine increase,chemical compound medication,0
2357,plasma concentrations,plasma concentrations,0
2366,urine,urine,0
2820,cytochrome p450 cyp3a,gene,0
2558,skin,skin,0
2564,food drug administration category c,food drug administration category c,0
2737,brand hepcludex,brand hepcludex,0
2736,bulevirtide,medication synthetic peptide,0
2734,il28b genotype,il28b genotype,0
2733,noncirrhotic patients,noncirrhotic patients,0
2729,hcv genotype 1infected patients,hcv genotype 1infected patients,0
2724,hiv,organisms known particular common,0
2739,raised levels,raised levels,0
2722,phase,phase,0
2718,postmarketing trial,postmarketing trial,0
2708,phase iii trial,phase iii trial,0
2706,phase ii trial,phase ii trial,0
2703,granules,granules,0
2699,published evidence,published evidence,0
2696,names,names,0
2721,liver function,organ type,0
2690,publications,publications,0
2742,receptor,receptor,0
2747,cells,cells,0
2815,european medicines agency,european medicines agency,0
2808,single agent,single agent,0
2804,interferon,group class proteins,0
2799,bristol myers squibb,bristol myers squibb,0
2794,rifampin,rifampin,0
2791,cirrhosis,cirrhosis,0
2745,liver cells,organ type,0
2788,nucleoside analogue,nucleoside analogue,0
2782,norovirus,taxon,0
2780,cmx521,chemical compound,0
2766,biln,biln,0
2764,boehringer ingelheim,boehringer ingelheim,0
2751,hdvrna positive adult patients,hdvrna positive adult patients,0
2750,european union,european union,0
2785,sapoviruses,sapoviruses,0
2562,livedo reticularis,livedo reticularis,0
2686,insight,insight,0
2678,substituted pyridone derivative,substituted pyridone derivative,0
2606,subjective objective reduction,subjective objective reduction,0
2605,66%,66%,0
2603,163 patients,163 patients,0
2599,seven patients,seven patients,0
2595,group oftenpatientswithparkinson sdiseaseandgaveagroupof patients,group oftenpatientswithparkinson sdiseaseandgaveagroupof patients,0
2594,researchers lookedatagroupoftenpatientswithparkinson sdiseaseandgave group,researchers lookedatagroupoftenpatientswithparkinson sdiseaseandgave group,0
2611,greater lengths,greater lengths,0
2593,manufacturer data,manufacturer data,0
2576,incidental finding,incidental finding,0
2573,benefits,benefits,0
2572,infant exposure,infant exposure,0
2571,amantadine therapy,chemical compound medication,0
2569,breast milk production,breast milk production,0
2568,breast milk,breast milk,0
2582,woman,woman,0
2680,chemical synthesis,chemical synthesis,0
2614,safe drug,safe drug,0
2621,experimental drug candidate,experimental drug candidate,0
2677,chemistry,chemistry,0
2673,host premrnasattheir5,host premrnasattheir5,0
2666,activities,activities,0
2663,mechanism action,mechanism action,0
2662,21%,21%,0
2660,single dose administration,single dose administration,0
2618,adamas pharma,adamas pharma,0
2655,dairy products,dairy products,0
2637,active agent,active agent,0
2634,resistant mutants,resistant mutants,0
2632,mouth,mouth,0
2631,single dose,single dose,0
2628,brand xofluza,brand xofluza,0
2623,bristolmyers squibb,bristolmyers squibb,0
2654,postexposure prevention,postexposure prevention,0
6886,rapid generation,rapid generation,0
3397,sennoris district,sennoris district,0
3403,local government,local government,0
4197,lichen planus,lichen planus,0
4191,common problem,common problem,0
4189,stage,stage,0
4186,varices,varices,0
4185,bleeding,bleeding,0
4182,liver cirrhosis,organ type,0
4199,porphyria cutanea tarda,porphyria cutanea tarda,0
4181,1–3%,1–3%,0
4178,developing cirrhosis,developing cirrhosis,0
4171,25%,25%,0
4154,acute phase,acute phase,0
4150,liver injury,organ type,0
4149,acute liver failure,organ type,0
4139,hcv recurrence,hcv recurrence,0
4179,20fold greater risk,20fold greater risk,0
4136,velpatasvir,chemical compound medication,0
4200,necrolytic acral erythema,necrolytic acral erythema,0
4206,associated abnormal heart rhythms,associated abnormal heart rhythms,0
4252,puncture wound,puncture wound,0
4251,needle,needle,0
4249,needle stick injury,needle stick injury,0
4246,11–70 days,11–70 days,0
4245,unit,unit,0
4242,significant risks,significant risks,0
4201,insulin resistance,insulin resistance,0
4241,hcv screening,hcv screening,0
4230,general population,general population,0
4225,drug use,drug use,0
4217,liver biopsies,organ type,0
4215,original method,original method,0
4211,crusted lesions,crusted lesions,0
4207,central nervous disorders,central nervous disorders,0
4234,nonsterile equipment,nonsterile equipment,0
4256,hospital equipment,hospital equipment,0
4135,better understanding,better understanding,0
4129,275 patients,275 patients,0
4047,improved screening,improved screening,0
4042,difference,difference,0
4036,andean,andean,0
4022,sustained responses,sustained responses,0
4020,pegylated interferon ribavirin results,group class proteinschemical compound medication essential medicine 1 april 1990,0
4019,hcv genotypes,hcv genotypes,0
4048,north america,north america,0
4018,70–80%,70–80%,0
4001,accompanying cirrhosis,accompanying cirrhosis,0
3991,sterile syringes,sterile syringes,0
3987,national level,national level,0
3985,screening,screening,0
3982,infant,infant,0
3980,highrisk individuals,highrisk individuals,0
4016,48 weeks,48 weeks,0
4130,needles,needles,0
4052,hcv testing,hcv testing,0
4056,needle exchange,needle exchange,0
4127,2010–2012 data,2010–2012 data,0
4122,1998 usd,1998 usd,0
4121,united states costs,united states costs,0
4113,physiology,physiology,0
4112,nobel prize,nobel prize,0
4107,royalty income,royalty income,0
4054,3%,3%,0
4095,panel,panel,0
4084,decade,decade,0
4070,8–12 weeks,8–12 weeks,0
4067,schistosomiasis,schistosomiasis,0
4066,nowdiscontinued masstreatment campaign,nowdiscontinued masstreatment campaign,0
4062,abbvie,abbvie,0
4061,dohme,dohme,0
4091,unknown organism,unknown organism,0
3979,routine screening,routine screening,0
4258,syringes,syringes,0
4260,infusion bags,infusion bags,0
4439,opportunities,opportunities,0
4435,xenotransplantation,xenotransplantation,0
4433,liver tissues,organ type,0
4432,mammalian models,mammalian models,0
4426,human cell culture systems,organisms known particular common homo sapiens homo sapiens sapiens homo,0
4425,regulatory restrictions,regulatory restrictions,0
4448,virusoid,virusoid,0
4420,mammalian systems,mammalian systems,0
4409,immunosuppressed,immunosuppressed,0
4408,subsequent pregnancy,physiological condition,0
4405,membrane rupture,membrane rupture,0
4403,factors,factors,0
4398,spontaneous clearance,spontaneous clearance,0
4391,genetic factors,genetic factors,0
4419,preclinical testing,preclinical testing,0
4385,ginseng,ginseng,0
4451,hbv,hbv,0
4461,intravenous drug use,intravenous drug use,0
4518,9.5x10×10−3 1.2x10×10−3 substitutions/site/year,9.5x10×10−3 1.2x10×10−3 substitutions/site/year,0
4512,early 1950s,early 1950s,0
4506,okinawa islands,okinawa islands,0
4504,genotype iii,genotype iii,0
4502,genotype ii,genotype ii,0
4495,subsequent experiments,subsequent experiments,0
4458,drug users,drug users,0
4491,improved measures,improved measures,0
4483,b. bulevirtide,medication synthetic peptide,0
4480,medicinal products,medicinal products,0
4477,late relapse,late relapse,0
4475,efficiency,efficiency,0
4473,pegylated interferon alpha,group class proteins,0
4471,interferon alpha therapy,group class proteins,0
4488,globe,globe,0
4259,multipleuse medication vials,multipleuse medication vials,0
4384,alternative therapies proponents,alternative therapies proponents,0
4380,2013 review,2013 review,0
4307,toothbrushes,toothbrushes,0
4302,unsterilized tattooing equipment,unsterilized tattooing equipment,0
4301,prison,prison,0
4297,sterile techniques,sterile techniques,0
4296,particular concern,particular concern,0
4289,body modification,body modification,0
4309,equipment,equipment,0
4284,condom use,condom use,0
4282,united states department,united states department,0
4277,anogenital mucosa,anogenital mucosa,0
4272,heterosexual partners,heterosexual partners,0
4269,sexual intercourse,sexual intercourse,0
4265,stringent standard precautions,stringent standard precautions,0
4262,limitations,limitations,0
4283,veterans affairs,veterans affairs,0
4383,alternative therapies,alternative therapies,0
4313,cuts,cuts,0
4338,6–8 weeks,6–8 weeks,0
4379,recurrence,recurrence,0
4377,common reason,common reason,0
4375,elbasvir/grazoprevir,combination drug,0
4365,single screening test,single screening test,0
4363,sign,sign,0
4362,long term hemodialysis,long term hemodialysis,0
4326,serology,academic discipline academic major,0
4361,jail,jail,0
4357,routine,routine,0
4355,5–50%,5–50%,0
4345,liver damage,organ type,0
4342,elevation,elevation,0
4341,seven weeks,seven weeks,0
4339,care testing,care testing,0
4358,united states preventive services task force,united states preventive services task force,0
3398,fayum governorate,fayum governorate,0
3978,elevated liver enzyme levels,organ type,0
3970,diagnosing patients,diagnosing patients,0
3593,manufacturers,manufacturers,0
3577,oral dosage form,oral dosage form,0
3574,nucleotide analogue,nucleotide analogue,0
3573,gs6620,gs6620,0
3569,50%,50%,0
3568,active metabolite,active metabolite,0
3597,cidrap article novavax,cidrap article novavax,0
3566,nonhuman primates,nonhuman primates,0
3563,clinical preclinical data,clinical preclinical data,0
3559,science,science,0
3557,preclinical data,preclinical data,0
3554,cynomolgus nonhuman primates,cynomolgus nonhuman primates,0
3550,experiments,experiments,0
3542,dephosphorylation,biological process,0
3564,nucleoside analogues,nucleoside analogues,0
3537,nucleoside,nucleoside,0
3598,good preliminary phase 1 findings,good preliminary phase 1 findings,0
3611,hemagglutination inhibition,hemagglutination inhibition,0
3662,lancet,lancet,0
3661,gsk spokeswoman,gsk spokeswoman,0
3656,big breakthrough,big breakthrough,0
3651,given,given,0
3649,gsk chief executive officer j.p. garnier,gsk chief executive officer j.p. garnier,0
3644,80%,80%,0
3608,42 days,42 days,0
3635,francebased sanofi aventis,francebased sanofi aventis,0
3633,sanofi pasteur,sanofi pasteur,0
3624,modestly better performance,modestly better performance,0
3621,testing.cidrap article sanofi,testing.cidrap article sanofi,0
3620,chief medical officer,chief medical officer,0
3614,signs,signs,0
3612,82% seroconversion,82% seroconversion,0
3634,subsidiary,subsidiary,0
3665,volunteers,volunteers,0
3536,active nucleotide triphosphate form,active nucleotide triphosphate form,0
3532,gs441524 nucleoside,gs441524 nucleoside,0
3451,severe pulmonary lesions,severe pulmonary lesions,0
3446,weakness,psychopathological symptom symptom,0
3445,11 october,11 october,0
3441,infected poultry,organisms known particular common,0
3438,reservoir,reservoir,0
3430,domestic cats,domestic cats,0
3456,agriculture official,agriculture official,0
3423,—the standard mammalian model,—the standard mammalian model,0
3415,fao avian influenza disease emergency situation update,infectious disease,0
3412,live poultry,organisms known particular common,0
3409,hong kong poultry wholesalers association,organisms known particular common,0
3408,chairman ofthehongkongpoultrywholesalersassociationsaidthelocalgovernment sdecisionmakesthegovernment sdecisionverydifficultfor hong kong poultry wholesalers association,organisms known particular common,0
3407,chairman,chairman,0
3405,live chickens,chicken gallus gallus domesticus common,0
3422,thanh hóa,thanh hóa,0
3533,nucleoside kinases,nucleoside kinases,0
3457,southern state,southern state,0
3467,500 stray cats,500 stray cats,0
3523,sales,sales,0
3519,suppliers,suppliers,0
3514,deuterium modified version,deuterium modified version,0
3512,longer intellectual property lifespan,longer intellectual property lifespan,0
3493,pet owners,pet owners,0
3489,veterinary use,veterinary use,0
3461,august 2006 cdc eid journal,august 2006 cdc eid journal,0
3487,official fda approval,official fda approval,0
3479,halflife,halflife,0
3477,main plasma metabolite,main plasma metabolite,0
3475,nucleoside analogue antiviral drug,nucleoside analogue antiviral drug,0
3471,resulting illness,resulting illness,0
3470,sumatra,island,0
3468,poultry markets,organisms known particular common,0
3483,cell culture,cell culture,0
3972,acute illness,acute illness,0
3668,aluminum,aluminum,0
3682,bethesda,bethesda,0
3904,doi:10.1371/journal.pmed.1000049. pmc,doi:10.1371/journal.pmed.1000049. pmc,0
3898,antigenic fingerprinting,antigenic fingerprinting,0
3892,lanzavecchia,lanzavecchia,0
3890,rivera y,rivera y,0
3882,polymerase encoding gene segments,group class enzymes,0
3879,nucleoprotein encoding gene segments.,group class proteins,0
3906,liver,organ type,0
3874,surface proteins,group class chemical substances second-order class,0
3861,gene segments,gene segments,0
3859,internal encoding gene segments,internal encoding gene segments,0
3857,loop,loop,0
3853,n2 n9 proteins,group class chemical substances second-order class,0
3852,hollow pocket,hollow pocket,0
3849,n9,n9,0
3871,matrix encoding gene segments,matrix encoding gene segments,0
3843,antigenic glycoprotein enzyme,antigenic glycoprotein enzyme,0
3907,dark urine,dark urine,0
3914,liver cancer,organ typeconstellation zodiacal constellation,0
3969,pcr,pcr,0
3967,elisa,female given,0
3960,method,method,0
3954,45 minutes,45 minutes,0
3949,seven major genotypes,seven major genotypes,0
3942,central,central,0
3913,occasionally cirrhosis,occasionally cirrhosis,0
3937,liver transplantation,organ type,0
3935,liver transplant,organ type,0
3933,access,access,0
3927,95%,95%,0
3926,harm reduction efforts,harm reduction efforts,0
3922,birth,birth,0
3916,esophagus,esophagus,0
3936,leading reason,leading reason,0
3671,sinovac biotech,sinovac biotech,0
3842,neuraminidase,group class enzymes,0
3836,gene,gene,0
3752,1.9 mcg.the glaxosmithklinebacked team,1.9 mcg.the glaxosmithklinebacked team,0
3748,press release,press release,0
3746,trial,trial,0
3736,2006 trial,2006 trial,0
3733,15mcg dose,15mcg dose,0
3725,manufacturer sanofi pasteur,manufacturer sanofi pasteur,0
3764,regulatory authorities,regulatory authorities,0
3718,1 year,1 year,0
3714,45 volunteers,45 volunteers,0
3705,colleagues,colleagues,0
3698,ph.d.,ph.d.,0
3692,portions,portions,0
3690,sanofi pasteur inhenseggsandthenadministeredasaweakenedorkilledformofanh5n1vaccinedevelopedbysanofipasteur,sanofi pasteur inhenseggsandthenadministeredasaweakenedorkilledformofanh5n1vaccinedevelopedbysanofipasteur,0
3688,hens eggs andthenadministeredas,hens eggs andthenadministeredas,0
3715,placebo injections,placebo injections,0
3839,receptor specificity,receptor specificity,0
3767,safety data,safety data,0
3779,molecular structure,molecular structure,0
3835,places,places,0
3822,receptor binding pocket,receptor binding pocket,0
3821,positions,positions,0
3819,poultry receptors,organisms known particular common,0
3810,haemoagglutinin receptor protein,haemoagglutinin receptor protein,0
3808,sample,sample,0
3773,h5 healthy adults november 2006,h5 healthy adults november 2006,0
3804,types,types,0
3795,antigenic glycoprotein,antigenic glycoprotein,0
3792,surface antigen encoding gene segments,group class chemical substances,0
3791,surface encoding gene segments,surface encoding gene segments,0
3787,context,context,0
3786,thogotovirus,taxon,0
3782,5 genera,5 genera,0
3802,ha bind alpha,ha bind alpha,0
2303,fuel,fuel,0
6892,cell cultures,cell cultures,0
6902,multiple strains.avi bio pharma inc.,multiple strains.avi bio pharma inc.,0
9458,methyl rimant,methyl rimant,0
9459,enamine005755,enamine005755,0
9469,chembl1201272,chembl1201272,0
9472,bcp12269,bcp12269,0
9474,zxan012619,zxan012619,0
9475,anw72018,anw72018,0
9476,bbl013215,bbl013215,0
9486,db00478,db00478,0
9489,u.s. fda press release,u.s. fda press release,0
9494,uncoating,uncoating,0
9512,r enantiomer,r enantiomer,0
9513,stronger binding affinity,stronger binding affinity,0
9519,binding affinity,binding affinity,0
9532,good results,good results,0
9547,purified surface fragments,purified surface fragments,0
9556,eastern european,eastern european,0
9557,middle eastern,middle eastern,0
9611,medivir ab,medivir ab,0
9605,sunlight,sunlight,0
9592,vaxigrip,vaxigrip,0
9587,normal aging,normal aging,0
9585,times strength,times strength,0
9576,dosage storage,dosage storage,0
9448,rimantadina,rimantadina,0
9575,chemical disruption,chemical disruption,0
9569,construction costs,construction costs,0
9568,united states government,united states government,0
9566,mammalian cell line,mammalian cell line,0
9565,european union approval,european union approval,0
9564,positive opinion,positive opinion,0
9560,2009.in february,2009.in february,0
9573,flublok,flublok,0
9447,remantadine,scholarly article,0
9446,rimantadinum,rimantadinum,0
9439,synthesis ofrimantadinefromthecorrespondingketoneoximewerebasedonprichard smethodsofsynthesisof rimantadine,chemical compound medication,0
9372,amino group results,amino group results,0
9369,oh results,oh results,0
9368,5 carbon,5 carbon,0
9367,imidazole riboside structure,imidazole riboside structure,0
9366,natural products,natural products,0
9360,great effect,great effect,0
9374,native nucleoside drug resemble adenosine,native nucleoside drug resemble adenosine,0
9357,2 nitrogen,2 nitrogen,0
9353,ribosyl purine analogue,ribosyl purine analogue,0
9351,cancer chemotherapies,constellation zodiacal constellation,0
9346,ribavirin mechanism,chemical compound medication essential medicine 1 april 1990,0
9338,zidovudine,chemical compound medication essential medicine carcinogen,0
9337,birth defects,birth defects,0
9335,fda black box warnings,fda black box warnings,0
9354,incomplete purine 6membered ring,incomplete purine 6membered ring,0
9613,simeprevir component,chemical compound medication essential medicine,0
9379,rnadependent replication,rnadependent replication,0
9390,cellular inosine monophosphate dehydrogenase,cellular inosine monophosphate dehydrogenase,0
9434,methyl ketones,methyl ketones,0
9433,excess methyllithium,excess methyllithium,0
9431,sodium borohydride,sodium borohydride,0
9422,drug interactions,drug interactions,0
9417,orally administered antiviral drug,orally administered antiviral drug,0
9416,amidine,amidine,0
9386,drug functions,drug functions,0
9414,increased concentration,increased concentration,0
9407,useful properties,useful properties,0
9401,taribavirin,chemical compound,0
9398,brand names,brand names,0
9397,tribavirin,tribavirin,0
9395,inn,inn,0
9391,intracellular pools,intracellular pools,0
9408,erythrocytetrapping,erythrocytetrapping,0
9622,sickle cell anemia,sickle cell anemia,0
9626,female partners,female partners,0
9629,difficulty breathing,difficulty breathing,0
9807,u.s. infected population,u.s. infected population,0
9793,fixed dose combination drug sofosbuvir/ledipasvir,fixed dose combination drug sofosbuvir/ledipasvir,0
9789,michael sofia,michael sofia,0
9787,ns5b protein,ns5b protein,0
9786,negative charges,negative charges,0
9785,phosphorus,phosphorus,0
9818,nucleotide reversetranscriptase inhibitor,nucleotide reversetranscriptase inhibitor,0
9783,phosphate group,phosphate group,0
9781,protide approach,protide approach,0
9778,enzymatic addition,enzymatic addition,0
9770,emtricitabine,chemical compound medication essential medicine,0
9769,efavirenz,chemical compound medication alkyne essential medicine,0
9762,anticonvulsants,anticonvulsants,0
9760,intestinal pglycoprotein,intestinal pglycoprotein,0
9782,slow step,slow step,0
9754,substrate,substrate,0
9825,liver diseases,organ type,0
9842,injectable drug,injectable drug,0
9878,2 methyl group,2 methyl group,0
9876,2 deoxy2 αfluoroβcmethylcytidine,2 deoxy2 αfluoroβcmethylcytidine,0
9875,2 deoxy2 αfluoroβcmethylcytidine],2 deoxy2 αfluoroβcmethylcytidine],0
9874,similar nucleotide analogue,similar nucleotide analogue,0
9873,incoming ntp,incoming ntp,0
9871,3 hydroxyl group toactas,3 hydroxyl group toactas,0
9835,liver transplant patients,organ type,0
9869,defective substrate,defective substrate,0
9865,active phosphorylated nucleotide,active phosphorylated nucleotide,0
9864,protide type,protide type,0
9861,fetal harm,fetal harm,0
9857,harmful fetal defects,harmful fetal defects,0
9856,pregnant females sofosbuvir/ribarivin combinations male sexual partners,pregnant females sofosbuvir/ribarivin combinations male sexual partners,0
9844,older drug combinations,older drug combinations,0
9866,cell permeability,cell permeability,0
9329,herpes outbreaks,herpes outbreaks,0
9750,16–18%,16–18%,0
9745,good safety profile,good safety profile,0
9692,combinations aren trecommendedand product labels,combinations aren trecommendedand product labels,0
9686,negative pregnancy test,physiological condition,0
9683,patient populations,patient populations,0
9679,kidney function,kidney function,0
9674,nbk385156,nbk385156,0
9671,national center,national center,0
9693,government preparation,government preparation,0
9667,ifnl3 genotype,ifnl3 genotype,0
9660,fda fda,fda fda,0
9649,ns3 q80k polymorphism,ns3 q80k polymorphism,0
9644,cyp2c8 peak effect,gene,0
9642,cyp2c8 halflife,gene,0
9634,capsule,capsule,0
9630,increased bilirubin,increased bilirubin,0
9665,underrepresented populations,underrepresented populations,0
9747,interferonfree ones,interferonfree ones,0
9695,billion dollars,billion dollars,0
9699,national strategy,national strategy,0
9743,30 weeks,30 weeks,0
9740,nucleotide analog family,nucleotide analog family,0
9739,abnormally slow heartbeat,abnormally slow heartbeat,0
9737,ledipasvir,chemical compound carbocyclic compound heterocyclic compound essential medicine medication,0
9736,brand sovaldi,brand sovaldi,0
9732,tickin,tickin,0
9698,2005 president george w. bush,2005 president george w. bush,0
9730,lines,lines,0
9716,hhs secretary michael o. leavitt,hhs secretary michael o. leavitt,0
9714,hopes,hopes,0
9709,stocks,stocks,0
9708,dollars worth,dollars worth,0
9704,h5n1.according,h5n1.according,0
9701,donor nations,donor nations,0
9727,evaluations,evaluations,0
9323,experimental data,experimental data,0
9322,weak.this,weak.this,0
9317,crimeancongo hemorrhagic fever,crimeancongo hemorrhagic fever,0
9047,generic drug companies,generic drug companies,0
9046,nonexclusive voluntary licenses,nonexclusive voluntary licenses,0
9045,500 metric tons,500 metric tons,0
9044,captisol annual manufacturing capacity,captisol annual manufacturing capacity,0
9041,ligand pharmaceuticals,ligand pharmaceuticals,0
9032,100 kilograms,100 kilograms,0
9048,127 countries,127 countries,0
9030,alberta,alberta,0
9027,glasslined steel chemical reactors,glasslined steel chemical reactors,0
9026,remdesivir production,chemical compound prodrug antiviral drug,0
9024,contract manufacturers,contract manufacturers,0
9022,9 12 months,9 12 months,0
9020,reagents,reagents,0
9018,pediatric patient population,pediatric patient population,0
9029,edmonton,edmonton,0
9017,continued access,continued access,0
9049,agreements,agreements,0
9054,emergency marketing approval,emergency marketing approval,0
9100,nucleoside gs441524,nucleoside gs441524,0
9096,additional nucleotides,additional nucleotides,0
9091,additional bases,additional bases,0
9090,immediately subsequent nucleotide,immediately subsequent nucleotide,0
9082,remdesivir interferes,chemical compound prodrug antiviral drug,0
9081,adenosine nucleoside triphosphate analog,adenosine nucleoside triphosphate analog,0
9052,covid‑19 emergency,covid‑19 emergency,0
9079,major metabolite,major metabolite,0
9075,active metabolite triphosphate,active metabolite triphosphate,0
9073,protide,protide,0
9069,funds,funds,0
9067,hospital stay,hospital stay,0
9066,little effect,little effect,0
9064,repurposed drug,repurposed drug,0
9076,nucleosidephosphate kinases,nucleosidephosphate kinases,0
9101,active nucleotide triphosphate,active nucleotide triphosphate,0
9016,1,1,0
9012,filoviruses,filoviruses,0
8969,excess trimethylsilyl chloride,excess trimethylsilyl chloride,0
8968,amine group,amine group,0
8956,chun,chun,0
8955,synthesis routes,synthesis routes,0
8949,vitro data,vitro data,0
8947,remdesivir chloroquine phosphate,chemical compound prodrug antiviral drugchemical compound medication essential medicine,0
8970,nbutyllithium,nbutyllithium,0
8945,hydroxychloroquine,chemical compound medication essential medicine,0
8943,rifampicin,rifampicin,0
8942,cytochrome p450 inducers,cytochrome p450 inducers,0
8940,cyp2c8,gene,0
8939,cytochrome p450,cytochrome p450,0
8937,shivering,shivering,0
8932,gastrointestinal distress,gastrointestinal distress,0
8944,phenobarbital,phenobarbital,0
9015,entire population,entire population,0
8974,intermediate c.,intermediate c.,0
8980,trimethylsilyl cyanide,trimethylsilyl cyanide,0
9011,9 april,9 april,0
9009,united states patent trademark office,united states patent trademark office,0
9008,patent applications,patent applications,0
9006,mid2010s,mid2010s,0
9004,government agencies,government agencies,0
8998,czech news agency,czech news agency,0
8979,1: 1 anomers,1: 1 anomers,0
8994,diastereomer mixture,diastereomer mixture,0
8987,boron,boron,0
8986,benzyl,benzyl,0
8985,protective group,protective group,0
8984,aqueous sodium hydrogen carbonate,aqueous sodium hydrogen carbonate,0
8983,additional hour,additional hour,0
8982,trimethylsilyl triflate,trimethylsilyl triflate,0
8993,trimethyl phosphate,trimethyl phosphate,0
9879,steric clash,steric clash,0
9103,intracellular levels,intracellular levels,0
9107,united states army medical research institute,united states army medical research institute,0
9267,american patients,american patients,0
9257,state local government authorities,state local government authorities,0
9256,government agency,government agency,0
9255,authorized distributors,authorized distributors,0
9253,extracorporeal membrane oxygenation,extracorporeal membrane oxygenation,0
9251,oxygen saturation,oxygen saturation,0
9268,highest caseloads,highest caseloads,0
9249,agent,agent,0
9243,united states president donald trump,united states president donald trump,0
9237,news conference,news conference,0
9235,emergency authorization,emergency authorization,0
9234,fasttracked process,fasttracked process,0
9222,contract,contract,0
9220,2 070 euros,2 070 euros,0
9246,press conference,press conference,0
9215,north macedonia,north macedonia,0
9272,wrong hospitals,wrong hospitals,0
9277,approximately 70 countries,approximately 70 countries,0
9313,pediatric population,pediatric population,0
9309,seven months,seven months,0
9308,effective birth control,effective birth control,0
9306,allergic reactions,allergic reactions,0
9302,ebola marburg infections,infectious diseaselocation identifier q28791882 masculine plural 8 november 1919gregorian,0
9296,\ tribavirin,\ tribavirin,0
9275,discussion,discussion,0
9294,ribavirin],ribavirin],0
9290,face,face,0
9289,veklury,veklury,0
9288,sole distributor,sole distributor,0
9286,domestic demand,domestic demand,0
9283,fact sheet,fact sheet,0
9281,suspected laboratoryconfirmed covid‑19,suspected laboratoryconfirmed covid‑19,0
9291,emerging sales,emerging sales,0
9106,partial resistance,partial resistance,0
9212,iceland,iceland,0
9205,joint procurement framework contract,joint procurement framework contract,0
9154,fiveday remdesivir group,chemical compound prodrug antiviral drug,0
9148,odds,odds,0
9147,statistically significant difference,statistically significant difference,0
9146,15 days,15 days,0
9145,remdesivir group,chemical compound prodrug antiviral drug,0
9142,1 062 hospitalized participants,1 062 hospitalized participants,0
9155,standard,standard,0
9141,29 days,29 days,0
9138,226 sites,226 sites,0
9131,direct administration,direct administration,0
9124,veterinary uses,veterinary uses,0
9114,usamriid,usamriid,0
9113,continuing collaboration,continuing collaboration,0
9108,preclinical results,preclinical results,0
9140,randomized doubleblind placebocontrolled clinical trial,randomized doubleblind placebocontrolled clinical trial,0
9207,37 european countries,37 european countries,0
9157,separate randomized openlabel multicenter clinical trial,separate randomized openlabel multicenter clinical trial,0
9160,statistically significant differences,statistically significant differences,0
9201,3 july,3 july,0
9200,additional days,additional days,0
9199,fiveday treatment course,fiveday treatment course,0
9197,beneficial effect,beneficial effect,0
9190,invasive mechanical ventilation,invasive mechanical ventilation,0
9186,covid‑19 patients,covid‑19 patients,0
9159,10day remdesivir group,chemical compound prodrug antiviral drug,0
9184,czech republic,czech republic,0
9176,22 september,22 september,0
9173,sap,sap,0
9167,remdesivir/interferon beta1a,remdesivir/interferon beta1a,0
9166,eli lilly,eli lilly,0
9164,drug baricitinib,chemical compound medication,0
9163,remdesivir/baricitinib,remdesivir/baricitinib,0
9182,formulary review,formulary review,0
9881,peak concentration,peak concentration,0
9882,oral administration,oral administration,0
9884,peak plasma concentration,peak plasma concentration,0
10514,smaller apartments,smaller apartments,0
10505,times higher mortality,times higher mortality,0
10503,lower ones,lower ones,0
10496,historian john m. barry,historian john m. barry,0
10489,saint helena,saint helena,0
10484,iceland population,iceland population,0
10519,recently arrived group,recently arrived group,0
10480,french colony,french colony,0
10476,community elders,community elders,0
10473,oral tradition,oral tradition,0
10468,governor john martin poyer,governor john martin poyer,0
10466,22%,22%,0
10464,german samoa,german samoa,0
10460,tonga,tonga,0
10477,persian famine,persian famine,0
10458,talune,talune,0
10527,chances,chances,0
10537,sick analysis,sick analysis,0
10590,encephalitis lethargica,encephalitis lethargica,0
10583,utero,utero,0
10579,longterm effects,longterm effects,0
10577,early extensive nonmedical measures,early extensive nonmedical measures,0
10570,historian nancy bristow,historian nancy bristow,0
10563,theories,theories,0
10531,et al,et al,0
10560,oxford university computing services,oxford university computing services,0
10555,central powers,central powers,0
10551,argument,argument,0
10547,factors modeling results,factors modeling results,0
10542,biologically plausible values,biologically plausible values,0
10541,variation,variation,0
10540,best explanation,best explanation,0
10557,2006 lancet study,2006 lancet study,0
10591,elevated mortality risk,elevated mortality risk,0
10456,villages,villages,0
10454,40 percent,40 percent,0
10385,extremely cold temperatures,extremely cold temperatures,0
10380,cold marine air,cold marine air,0
10379,sixyear climate anomaly,sixyear climate anomaly,0
10374,ideal conditions,ideal conditions,0
10373,increased precipitation,increased precipitation,0
10370,concurrent increase,concurrent increase,0
10386,normally mediterranean climate,normally mediterranean climate,0
10364,maine,maine,0
10362,harvard university,harvard university,0
10360,ultrahighresolution climate data,ultrahighresolution climate data,0
10359,conflict,conflict,0
10358,lowerthanaverage temperatures,lowerthanaverage temperatures,0
10352,role climate conditions,role climate conditions,0
10348,assumption,assumption,0
10363,climate change institute,climate change institute,0
10455,total population,total population,0
10388,atmospheric dust,atmospheric dust,0
10397,islands,islands,0
10451,bristol bay,bristol bay,0
10448,required customers,required customers,0
10444,1 6 percent,1 6 percent,0
10441,2005 estimate,2005 estimate,0
10438,global mortality,global mortality,0
10435,uboats,uboats,0
10396,maritime quarantines,maritime quarantines,0
10429,winds,winds,0
10422,kampo,traditional medicine,0
10416,strychnine,chemical compound flammable solid alkaloid heterocyclic compound neurotoxin,0
10410,50 percent,50 percent,0
10409,wearing,wearing,0
10407,subways,subways,0
10406,staggered shifts,staggered shifts,0
10423,information dissemination,information dissemination,0
10344,october revolution,october revolution,0
10592,physiological condition,physiological condition,0
10596,comparison pandemics,comparison pandemics,0
10814,1.5 days,1.5 days,0
10813,symptom,symptom,0
10806,zanamivir package insert,chemical compound neuraminidase inhibitor medication,0
10801,small benefits,small benefits,0
10795,australian biotech firm biota holdings,australian biotech firm biota holdings,0
10793,vosevi,vosevi,0
10824,rational drug design,rational drug design,0
10786,uprifosbuvir,uprifosbuvir,0
10781,mammalian cell cultures,mammalian cell cultures,0
10775,phagocytic function,phagocytic function,0
10767,membrane fusion,membrane fusion,0
10757,4 g/kg,4 g/kg,0
10751,darunavir,darunavir,0
10749,16 percent share,16 percent share,0
10785,mammalian cells,mammalian cells,0
10748,highest sales volume,highest sales volume,0
10826,computational chemistry techniques,computational chemistry techniques,0
10831,grid software,grid software,0
10859,zanamivir resistance,chemical compound neuraminidase inhibitor medication,0
10855,proof,proof,0
10851,clear effect,clear effect,0
10849,7% royalty,7% royalty,0
10846,resources,resources,0
10844,basic guanidine functional group,basic guanidine functional group,0
10827,dana,dana,0
10843,conserved pocket,conserved pocket,0
10840,salt bridge,salt bridge,0
10839,positively charged amino group,positively charged amino group,0
10838,c4 hydroxyl group,c4 hydroxyl group,0
10837,neuraminidase active site,group class enzymes,0
10834,residues,residues,0
10832,energetically favourable interactions,energetically favourable interactions,0
10842,glu,glu,0
10594,numerous works,numerous works,0
10747,drug brand,drug brand,0
10740,target cells,target cells,0
10650,immunocompromised patients,immunocompromised patients,0
10647,broadspectrum antibiotic,broadspectrum antibiotic,0
10645,overgrowth,overgrowth,0
10644,bacteriology,bacteriology,0
10643,examples,examples,0
10641,different microbial agent,different microbial agent,0
10653,later point,later point,0
10638,transportation,transportation,0
10625,enlistment,enlistment,0
10619,female population,female population,0
10616,major role,major role,0
10612,diverse labor,diverse labor,0
10606,nutritional deficiency,nutritional deficiency,0
10602,major cause,major cause,0
10636,wars,wars,0
10744,direct comparison,direct comparison,0
10657,colonization,colonization,0
10671,freezing,freezing,0
10738,pharmstandard,pharmstandard,0
10737,umifenovir,chemical compound,0
10734,modern pharmaceutical enterprise llc plant medsintez,modern pharmaceutical enterprise llc plant medsintez,0
10724,purine nucleosides,purine nucleosides,0
10712,ural center,ural center,0
10710,ural federal university,ural federal university,0
10665,tmc647055,tmc647055,0
10709,joint effort,joint effort,0
10690,domestic possibly resident bird populations,taxon,0
10682,united nations fao,united nations fao,0
10680,local authorities,local authorities,0
10679,dealing outbreaks,dealing outbreaks,0
10677,poultry farming practices,organisms known particular common,0
10674,timm c. harder,timm c. harder,0
10705,laboratoryconfirmed case,laboratoryconfirmed case,0
8929,thrombocytes,thrombocytes,0
10342,common misdiagnosis,common misdiagnosis,0
10339,haemophilus influenzae,haemophilus influenzae,0
10053,historians,historians,0
10051,news,news,0
10048,legacy,legacy,0
10042,forgetting,forgetting,0
10041,song,song,0
10037,senegal itwasnamedthebrazilianflu andinbrazilthegermanflu whileinpoland,senegal itwasnamedthebrazilianflu andinbrazilthegermanflu whileinpoland,0
10054,nearsimultaneous outbreaks,nearsimultaneous outbreaks,0
10034,alternative names,alternative names,0
10025,2007 analysis,2007 analysis,0
10024,stronger immune,stronger immune,0
10012,stories,stories,0
10010,grave illness,grave illness,0
10007,newspapers,newspapers,0
9995,chinese,chinese,0
10033,widelyspread stories,widelyspread stories,0
9988,innovative step,innovative step,0
10055,similarities,similarities,0
10076,bells,bells,0
10120,french recruits,french recruits,0
10105,brestlitovsk,brestlitovsk,0
10101,breslau,breslau,0
10100,great britain,great britain,0
10097,army camps,army camps,0
10093,march/april,march/april,0
10060,deadliest diseases,deadliest diseases,0
10092,preventive measures,preventive measures,0
10087,522 men,522 men,0
10086,local doctor loring miner,local doctor loring miner,0
10085,haskell county,haskell county,0
10083,army cook,army cook,0
10081,recording,recording,0
10079,wave early 1918,wave early 1918,0
10090,queens,queens,0
10124,u.s. military sites,u.s. military sites,0
9984,cardiff university,cardiff university,0
9969,pricing manufacturing distribution category,pricing manufacturing distribution category,0
9913,gilead sciences inc. ceo john martin,gilead sciences inc. ceo john martin,0
9911,gilead sciences inc.,gilead sciences inc.,0
9909,frank pallone jr.,frank pallone jr.,0
9908,u.s. house democrats henry waxman,u.s. house democrats henry waxman,0
9905,brand version,brand version,0
9904,91 developing countries,91 developing countries,0
9914,discounts,discounts,0
9903,generic manufacturers,generic manufacturers,0
9898,14%,14%,0
9894,inactive metabolite,inactive metabolite,0
9893,subsequent repeated phosphorylation,subsequent repeated phosphorylation,0
9889,minimal binding,minimal binding,0
9888,61–65%,61–65%,0
9886,pharmacologically inactive nucleoside,pharmacologically inactive nucleoside,0
9900,expired air recovery,expired air recovery,0
9982,protide technology,academic discipline,0
9915,lowincome patients,lowincome patients,0
9920,japan south korea,sovereign state island nation country,0
9966,egyptian government,egyptian government,0
9964,highest incidence,highest incidence,0
9962,indian activist group,indian activist group,0
9961,leader,leader,0
9959,minimum achievable cost,minimum achievable cost,0
9957,gilead announcedthatgileadwouldseekgenericlicensingagreementswithmanufacturerstoproducesofosbuvirin91developingcountriescontaining54%oftheworld shcvinfectedpopulationandthatgileadwouldsell brand version,gilead announcedthatgileadwouldseekgenericlicensingagreementswithmanufacturerstoproducesofosbuvirin91developingcountriescontaining54%oftheworld shcvinfectedpopulationandthatgileadwouldsell brand version,0
9917,insurers,insurers,0
9955,generic licensing agreements,generic licensing agreements,0
9950,agreement,agreement,0
9943,controller general,controller general,0
9940,manufacturer,manufacturer,0
9939,negotiations,negotiations,0
9925,additional discounts,additional discounts,0
9922,germany negotiations,historical period germany historical country,0
9951,7%,7%,0
10340,bacillus,bacillus,0
10126,central south america,central south america,0
10134,ethiopia,ethiopia,0
10273,ill lives,ill lives,0
10266,civilian travelers,civilian travelers,0
10265,modern transportation systems,modern transportation systems,0
10261,combat chemical attacks,combat chemical attacks,0
10257,probably increased transmission augmented mutation,probably increased transmission augmented mutation,0
10251,chinese workers,chinese workers,0
10283,0.29%,0.29%,0
10249,chinese southeast asian workers,chinese southeast asian workers,0
10246,chinese southeast asian soldiers,chinese southeast asian soldiers,0
10241,modern comparison,modern comparison,0
10233,st. john,st. john,0
10229,british french lines,british french lines,0
10227,mobilization,mobilization,0
10226,historian mark humphries,historian mark humphries,0
10247,chinese medical association circulation,chinese medical association circulation,0
10225,alternative hypotheses,alternative hypotheses,0
10290,john barry,john barry,0
10295,common occurrence,common occurrence,0
10337,misdiagnosis,misdiagnosis,0
10332,transfected animals,transfected animals,0
10331,frozen victims,frozen victims,0
10330,modern analysis,modern analysis,0
10327,common upper respiratorytract bacteria,taxon,0
10325,cytokine storms,cytokine storms,0
10293,deadliest plague,deadliest plague,0
10313,teeth,teeth,0
10310,spontaneous mouth,spontaneous mouth,0
10309,fluids,fluids,0
10308,torso,torso,0
10305,black coloration,black coloration,0
10303,mahogany spots,mahogany spots,0
10301,1919 stanley cup finals,1919 stanley cup finals,0
10311,nosebleeds,nosebleeds,0
10132,south african native labour corps,south african native labour corps,0
10224,hannoun,hannoun,0
10218,pasteur institute,pasteur institute,0
10174,late peak,late peak,0
10170,milwaukee,milwaukee,0
10168,twice number,twice number,0
10158,nashville,nashville,0
10156,los angeles,los angeles,0
10155,isolated outbreaks,isolated outbreaks,0
10176,potential origins,potential origins,0
10153,maritime quarantine,maritime quarantine,0
10151,wave 1919,wave 1919,0
10150,nairobi,capital administrative territorial entity kenya big city city millions inhabitants,0
10147,armistice,armistice,0
10142,southwest–northeast diagonal,southwest–northeast diagonal,0
10140,government bonds,government bonds,0
10138,philadelphia,philadelphia,0
10152,lifting,lifting,0
10222,allied soldiers,allied soldiers,0
10178,historian alfred w. crosby,historian alfred w. crosby,0
10184,evolutionary biology professor michael worobey,evolutionary biology professor michael worobey,0
10217,leading expert,leading expert,0
10215,austrian archives,austrian archives,0
10212,european armies,european armies,0
10211,chinese medical association,chinese medical association,0
10210,virologist john oxford team,virologist john oxford team,0
10204,poison gas attacks,poison gas attacks,0
10179,popular author john m. barry,popular author john m. barry,0
10202,ideal environment,ideal environment,0
10197,aldershot,aldershot,0
10196,army barracks,army barracks,0
10192,étaples camp,commune france,0
10190,virologist john oxford,virologist john oxford,0
10189,étaples,commune france,0
10188,major uk troop staging hospital camp,major uk troop staging hospital camp,0
10198,military pathologists,military pathologists,0
8920,40 kilograms,40 kilograms,0
8919,authorization,authorization,0
8916,solidarity trial,solidarity trial,0
7688,university texas medical branch,state united states,0
7685,mastocytosis,mastocytosis,0
7683,follicular lymphoma,follicular lymphoma,0
7678,hairy cell leukemia,hairy cell leukemia,0
7673,biogen,biogen,0
7663,flock,flock,0
7690,direct antiviral effect,direct antiviral effect,0
7646,chickens aresmallerandyouonlyneedtoprotecthumanvaccines].chickensforsixweeksbecausethat showlonghumanvaccines].chickenslivetill,chicken gallus gallus domesticus common,0
7641,useavaccinethat sonly85percentrelatedyou llget protection,useavaccinethat sonly85percentrelatedyou llget protection,0
7635,painful swollen fingers,painful swollen fingers,0
7632,mineral oil,mineral oil,0
7627,6–12 month intervals,6–12 month intervals,0
7614,placebo group,placebo group,0
7612,data analysis,data analysis,0
7643,single point mutation,single point mutation,0
7608,conclusion,conclusion,0
7691,interferon alpha,group class proteins,0
7698,universities,universities,0
7740,ifn type,ifn type,0
7737,transcription factors,transcription factors,0
7733,ifns,ifns,0
7729,membrane,membrane,0
7728,pattern recognition receptors,pattern recognition receptors,0
7725,bacteria products,taxon,0
7694,texas medical branch,state united states,0
7719,ifn,ifn,0
7715,types interferon,group class proteins,0
7713,nearby cells,nearby cells,0
7708,foreign protein,foreign protein,0
7707,usefulness,usefulness,0
7706,nonhuman animals,nonhuman animals,0
7701,significant reduction,significant reduction,0
7717,major types,major types,0
7745,ifn receptors,ifn receptors,0
7601,internal protein domains,internal protein domains,0
7598,tcells,tcells,0
7526,influenzarelated respiratory illness,influenzarelated respiratory illness,0
7525,reductions,reductions,0
7522,acceptance,acceptance,0
7510,1940s,1940s,0
7503,vanderbilt university,vanderbilt university,0
7501,embryonated hens eggs wasreportedby,embryonated hens eggs wasreportedby,0
7527,physician visits,physician visits,0
7498,hint,hint,0
7490,origins development,origins development,0
7471,2nd bstrain,2nd bstrain,0
7461,resident physicians,resident physicians,0
7459,reasons,reasons,0
7457,42%,42%,0
7453,reasons healthcare workers decisions,reasons healthcare workers decisions,0
7495,serums,serums,0
7599,epitopes,epitopes,0
7530,needed.the eggbased technology,academic discipline,0
7537,maximum military containment efforts,maximum military containment efforts,0
7597,better outcomes,better outcomes,0
7593,different antigens,different antigens,0
7591,conserved domains,conserved domains,0
7590,approach,approach,0
7589,domains,domains,0
7581,promising approach,promising approach,0
7532,president gerald ford,president gerald ford,0
7577,error,error,0
7567,low moderateincome countries,low moderateincome countries,0
7566,better realtime access,better realtime access,0
7563,short time frame,short time frame,0
7561,rapid development,rapid development,0
7549,nasal mist,nasal mist,0
7538,single army base,single army base,0
7571,following month,following month,0
7452,reasons healthcare workers,reasons healthcare workers,0
7748,ifnstimulated gene factor,ifnstimulated gene factor,0
7751,transcription factor,transcription factor,0
7896,ii ifn gene,ii ifn gene,0
7894,gene cloning,gene cloning,0
7893,definitive proof,definitive proof,0
7889,chemical verification,chemical verification,0
7888,vessel,vessel,0
7887,tube,tube,0
7899,recombinant mammalian cells,recombinant mammalian cells,0
7886,test tube,test tube,0
7877,active site,active site,0
7874,interferon gene,group class proteins,0
7869,purification,purification,0
7868,interferon action gene,group class proteins,0
7863,human amniotic cell cultures,organisms known particular common homo sapiens homo sapiens sapiens homo,0
7859,tissue homogenates,tissue homogenates,0
7878,tyrosine residues,chemical compound medication amino acid l-amino acid proteinogenic amino acid dl-tyrosine conditionally essential amino acids cargo cargo monophenol monooxygenase activity,0
7858,tissues,tissues,0
7900,interferon beta1a,group class proteins,0
7906,hematological malignancy,hematological malignancy,0
7939,advanced development,advanced development,0
7935,estimated u$231m,estimated u$231m,0
7934,barda,barda,0
7933,1 april,1 april,0
7932,laninamivir,chemical compound,0
7931,nasal inhalation,nasal inhalation,0
7902,attacks,attacks,0
7929,influenzavirus b. laninamivir,chemical compound,0
7919,interferon molecule,group class proteins,0
7918,polyethylene glycol,polyethylene glycol,0
7913,drug formulations,drug formulations,0
7912,recombinant ifnα2b,recombinant ifnα2b,0
7909,nodular lymphoma,nodular lymphoma,0
7907,lymphomas,lymphomas,0
7927,telaprevir,chemical compound medication,0
7750,stat2,stat2,0
7855,japanese virologists,japanese virologists,0
7853,yasuichi nagano,yasuichi nagano,0
7787,highly conserved multiprotein complex,highly conserved multiprotein complex,0
7783,phosphorylates,phosphorylates,0
7782,cell proliferation,cell proliferation,0
7778,p38 mitogenactivated protein kinase,p38 mitogenactivated protein kinase,0
7777,stat5,protein family,0
7770,type ifn,type ifn,0
7790,phosphorylation,phosphorylation,0
7769,gene induction,gene induction,0
7766,gene promoters,gene promoters,0
7764,gene transcription,gene transcription,0
7760,isgs,armed organization,0
7759,curated online database,curated online database,0
7754,transcriptional complexes,transcriptional complexes,0
7752,cell nucleus,cell nucleus,0
7767,type ifns,type ifns,0
7854,yasuhiko kojima—,yasuhiko kojima—,0
7792,stat3,stat3,0
7796,ifn response,ifn response,0
7847,heatinactivated influenza virustreated membranes,infectious disease,0
7836,jean lindenmann,jean lindenmann,0
7833,precise mechanism,precise mechanism,0
7830,jev,jev,0
7829,protein kinase r,protein kinase r,0
7828,interferon stimulated genes,group class proteins,0
7793,lung cancer cells,constellation zodiacal constellation,0
7823,rnadependent protein kinases,rnadependent protein kinases,0
7820,cytokine,cytokine,0
7818,ifn cellular receptor,ifn cellular receptor,0
7816,soluble ifn receptor,soluble ifn receptor,0
7800,functions,functions,0
7799,ifn production,ifn production,0
7798,cytokine receptor,cytokine receptor,0
7821,ifn target cells,ifn target cells,0
7941,nasal spray,nasal spray,0
7449,healthcare workers patients,healthcare workers patients,0
7444,direct patient contact,direct patient contact,0
7092,control group,control group,0
7090,1.2 grams,1.2 grams,0
7087,medical profession,medical profession,0
7086,interferon use,group class proteins,0
7085,interferon manufacturers,group class proteins,0
7084,emergency prevention,emergency prevention,0
7095,oral supplementation,oral supplementation,0
7083,nasal drops,nasal drops,0
7079,elderly patients,elderly patients,0
7076,phase iii trials,phase iii trials,0
7073,subsequent studies,subsequent studies,0
7069,interferon therapies,group class proteins,0
7061,cellular signalling factors,cellular signalling factors,0
7058,products,products,0
7081,interferon alfa2b medicine,group class proteins,0
7057,available data,available data,0
7096,gram,gram,0
7103,influenzainfected macrophages,influenzainfected macrophages,0
7145,procedural refinements,procedural refinements,0
7142,recovered patients,recovered patients,0
7141,plasma,plasma,0
7125,1.2 milligrams,1.2 milligrams,0
7124,ethanol extract,ethanol extract,0
7122,chinese medicinal herbs,chinese medicinal herbs,0
7098,body weight,body weight,0
7121,extract,extract,0
7118,mixture,mixture,0
7117,kan jang,kan jang,0
7115,labels,labels,0
7109,elderberry,elderberry,0
7107,cultured airway cells,cultured airway cells,0
7105,equine influenzainfected canine kidney cells,equine influenzainfected canine kidney cells,0
7119,eleutherococcus senticosus,eleutherococcus senticosus,0
7149,bovine colostrum,bovine colostrum,0
7056,compelling evidence,compelling evidence,0
7048,panax quinquefolium,panax quinquefolium,0
6969,180 micrograms,180 micrograms,0
6966,april 17 2007 approval,april 17 2007 approval,0
6959,45 percent,45 percent,0
6949,marburg,location identifier q28791882 masculine plural 8 november 1919gregorian,0
6948,novartis cellbased vaccine production facility isin,business multinational corporation,0
6926,fda approval,fda approval,0
6970,piece,piece,0
6923,p. fluorescens,p. fluorescens,0
6920,dow chemical,dow chemical,0
6909,morpholinos,morpholinos,0
6908,neugene therapeutics,neugene therapeutics,0
6907,key finding,key finding,0
6906,independent research laboratories,independent research laboratories,0
6905,multiple strains.avi bio pharma inc. labs,multiple strains.avi bio pharma inc. labs,0
6921,different bacteria,taxon,0
7054,quality,quality,0
6973,15 micrograms,15 micrograms,0
6980,panel members,panel members,0
7043,herbal alternative medicines,herbal alternative medicines,0
7037,metaanalysis,metaanalysis,0
7035,vitamin d synthesis,vitamin d synthesis,0
7034,sunlight exposure,sunlight exposure,0
7031,anemia,anemia,0
7030,zinc,zinc,0
6979,fda advisory panel,fda advisory panel,0
7022,common cause,common cause,0
6998,bacterial antibiotic resistance,bacterial antibiotic resistance,0
6997,oseltamivir phosphate,chemical compound neuraminidase inhibitor medication essential medicine,0
6996,uninfected individuals,uninfected individuals,0
6994,united states authority,united states authority,0
6990,acidic endonuclease inhibitors,acidic endonuclease inhibitors,0
6987,hhs,hhs,0
7020,nutritional supplements herbal medicines,nutritional supplements herbal medicines,0
7447,nurse practitioners,nurse practitioners,0
7159,vaccinating children,vaccinating children,0
7179,1930s,1930s,0
7382,zero systemic allergic reactions,zero systemic allergic reactions,0
7380,nearly 800 children,nearly 800 children,0
7377,anaphylaxis,anaphylaxis,0
7371,incidence,incidence,0
7370,guillain–barré,guillain–barré,0
7369,link,link,0
7384,increased incidence,increased incidence,0
7364,allergic reaction,allergic reaction,0
7361,trivalent,trivalent,0
7359,pregnant women chances,pregnant women chances,0
7354,vaccinating healthcare workers,vaccinating healthcare workers,0
7351,vulnerable population,vulnerable population,0
7347,advisory committee,advisory committee,0
7338,younger person,younger person,0
7363,redness,redness,0
7336,nonpandemic year,nonpandemic year,0
7385,narcolepsy,narcolepsy,0
7392,mercurybased preservative,mercurybased preservative,0
7441,61.9%,61.9%,0
7440,2010–11 season,2010–11 season,0
7438,united states healthcare workers,united states healthcare workers,0
7436,greece,greece,0
7430,group vaccinations,group vaccinations,0
7425,leaflets,leaflets,0
7388,hypocretin,hypocretin,0
7423,beliefs,beliefs,0
7419,personal factors,personal factors,0
7410,united states routine influenza vaccination,infectious disease,0
7407,polio,infectious disease sweden norway united states america france,0
7399,age household contacts,age household contacts,0
7398,national advisory committee,national advisory committee,0
7397,moreexpensive singledose administration,moreexpensive singledose administration,0
7421,ethnicity,ethnicity,0
7164,percent,percent,0
7333,declining immunological function,declining immunological function,0
7324,systematic reviews,systematic reviews,0
7267,michael osterholm,michael osterholm,0
7266,anthony fauci,anthony fauci,0
7249,reduction,reduction,0
7238,observed reduction,observed reduction,0
7230,genetic determinants,genetic determinants,0
7229,researchers understanding ofwhatmakesonestrainmorelethalthananother,researchers understanding ofwhatmakesonestrainmorelethalthananother,0
7274,vaccination campaigns,vaccination campaigns,0
7226,molecular evolution,molecular evolution,0
7220,suitability,suitability,0
7214,complexities,complexities,0
7208,different settings,different settings,0
7191,15 45%,15 45%,0
7190,myocardial infarction,myocardial infarction,0
7186,2012 metaanalysis,2012 metaanalysis,0
7221,willingness,willingness,0
7327,reviews,reviews,0
7275,special attention,special attention,0
7281,cdc director,cdc director,0
7323,elderly,elderly,0
7322,comparison patients,comparison patients,0
7311,2006 review,2006 review,0
7306,working days,working days,0
7305,modest decrease,modest decrease,0
7303,1.1%,1.1%,0
7279,possibly influenzalike illness,possibly influenzalike illness,0
7302,2.4%,2.4%,0
7297,immunosuppressed pediatric patients,immunosuppressed pediatric patients,0
7292,afluria tetra,afluria tetra,0
7288,0.5 milliliters,0.5 milliliters,0
7287,36 months,36 months,0
7286,age group,age group,0
7282,85 percent,85 percent,0
7299,unvaccinated adults,unvaccinated adults,0
6893,genetically engineering baculovirus,genetically engineering baculovirus,0
7944,recommendation,recommendation,0
7949,medimmune,business,0
8630,proprietary immunologic adjuvant,proprietary immunologic adjuvant,0
8627,4fold increased risk,4fold increased risk,0
8624,thadreceived pandemrix vaccination,influenza vaccine,0
8621,developing narcolepsy,developing narcolepsy,0
8618,pandemrix vaccination campaign,influenza vaccine,0
8608,figure,figure,0
8638,alpha interferon family,group class proteins,0
8607,recently vaccinated children,recently vaccinated children,0
8600,consultation,consultation,0
8598,pandemrix vaccination,influenza vaccine,0
8596,swedish finnish healthcare professionals,swedish finnish healthcare professionals,0
8590,swedish medical products agency,swedish medical products agency,0
8589,nurse,nurse,0
8587,clack,clack,0
8603,reported reactions,reported reactions,0
8583,irish parliament,irish parliament,0
8639,breakdown,breakdown,0
8643,potential harm,potential harm,0
8682,cell cycle control,cell cycle control,0
8681,interferon stimulate transcription factor3,group class proteins,0
8679,interferon transcription factor,group class proteins,0
8678,receptor heterodimer,receptor heterodimer,0
8677,phosphorylated stats,phosphorylated stats,0
8672,ifnar1,gene,0
8642,improved visual acuity,improved visual acuity,0
8670,ligand,ligand,0
8655,natural clearance,natural clearance,0
8652,il28b gene,il28b gene,0
8651,certain genetic variant alleles,certain genetic variant alleles,0
8648,interferon lambda,group class proteins,0
8646,genetic polymorphisms,genetic polymorphisms,0
8644,host genetic factors,host genetic factors,0
8667,basic mechanism,basic mechanism,0
8683,cell differentiation,cell differentiation,0
8582,gsk h1n1 vaccines,virus,0
8578,1 incident,1 incident,0
8506,resistance development,resistance development,0
8504,drug labels,drug labels,0
8497,decreased risk,decreased risk,0
8496,2013 metaanalyses,2013 metaanalyses,0
8493,cdc states,cdc states,0
8489,2015 systematic review,2015 systematic review,0
8510,systematic review,systematic review,0
8488,pcr testing,pcr testing,0
8483,ema,ema,0
8482,aap,aap,0
8476,cdc.a systematic review,cdc.a systematic review,0
8474,indigenous peoples,indigenous peoples,0
8468,toxin production,toxin production,0
8467,gastrointestinal bacterial colonization,gastrointestinal bacterial colonization,0
8484,ema labeling,ema labeling,0
8581,gsk,gsk,0
8512,1 12%,1 12%,0
8518,community specimens,community specimens,0
8577,adolescents,adolescents,0
8576,27 times,27 times,0
8575,514 times,514 times,0
8570,chmp assessment report,chmp assessment report,0
8566,gsk biologicals,gsk biologicals,0
8562,immunocompromised adults,immunocompromised adults,0
8517,immunosuppressed patients,immunosuppressed patients,0
8559,subsequent testing,subsequent testing,0
8556,separate vials,separate vials,0
8555,dosage,dosage,0
8541,1.7%,1.7%,0
8531,european cdcs,european cdcs,0
8529,99.8%,99.8%,0
8519,haematologic malignancies,haematologic malignancies,0
8558,21 days,21 days,0
8465,crypt cells,crypt cells,0
8684,apoptosis,biological process,0
8686,t helper cells,t helper cells,0
8860,cellular mrnas,cellular mrnas,0
8852,laboratories cell surface,laboratories cell surface,0
8849,primate species,primate species,0
8844,cell surface receptors,cell surface receptors,0
8842,messenger,messenger,0
8836,ncr,ncr,0
8864,hydroxyl group,hydroxyl group,0
8835,positive—strand synthesis,positive—strand synthesis,0
8825,negative plus strand rna synthesis,structural class chemical compounds,0
8820,negative strand synthesis,negative strand synthesis,0
8819,translation andthe3in negative strand synthesis,translation andthe3in negative strand synthesis,0
8814,5 utr isusuallylongerbeingaround,5 utr isusuallylongerbeingaround,0
8810,mrna,transcript,0
8809,virally encoded protein,virally encoded protein,0
8826,cis acting replication element,cis acting replication element,0
8808,5 cap,5 cap,0
8865,vpg primer mechanism,wikimedia disambiguation page,0
8876,ravidasvir,ravidasvir,0
8915,therapeutics,therapeutics,0
8913,development code,development code,0
8911,rna.the u.s. food drug administration,rna.the u.s. food drug administration,0
8908,covid19.the common effect,covid19.the common effect,0
8902,50 countries,50 countries,0
8900,emergency use,emergency use,0
8871,pimodivir,group stereoisomers,0
8898,animation,animation,0
8895,nonhereditary genetic change,nonhereditary genetic change,0
8894,genome segments,scientific model natural environment,0
8893,uv irradiation,uv irradiation,0
8888,particular reassortment occurs,particular reassortment occurs,0
8887,cell exchange genetic material,cell exchange genetic material,0
8883,different processes,different processes,0
8897,bionyt,magazine,0
8685,multifunctional immunoregulatory cytokine,multifunctional immunoregulatory cytokine,0
8807,mammalian mrna picornaviruses,transcript,0
8803,–oh source,–oh source,0
8734,47 genera,47 genera,0
8721,alleviation,alleviation,0
8718,intravenous option,intravenous option,0
8716,rapiacta,rapiacta,0
8714,limited phase iii trial data,limited phase iii trial data,0
8712,intravenous administration,intravenous administration,0
8735,notable examples,notable examples,0
8708,later report,later report,0
8701,mitochondrial membrane potential,mitochondrial membrane potential,0
8693,caspases,caspases,0
8692,u266 daudi rhek1 cell lines,u266 daudi rhek1 cell lines,0
8691,cell cycle arrest,cell cycle arrest,0
8688,stimulation,stimulation,0
8687,type 2 helper t cells,type 2 helper t cells,0
8707,brand,brand,0
8805,rna.the genome,scientific model natural environment,0
8737,aphthovirus,taxon,0
8741,dual etymology,dual etymology,0
8802,tyrosine,chemical compound medication amino acid l-amino acid proteinogenic amino acid dl-tyrosine conditionally essential amino acids cargo cargo monophenol monooxygenase activity,0
8800,tyrosine residue,chemical compound medication amino acid l-amino acid proteinogenic amino acid dl-tyrosine conditionally essential amino acids cargo cargo monophenol monooxygenase activity,0
8799,vpg,wikimedia disambiguation page,0
8789,3 little triangles,3 little triangles,0
8787,icosahedral structure,icosahedral structure,0
8781,vp2 vp4 polypeptides,vp2 vp4 polypeptides,0
8739,hepatovirus,taxon,0
8779,4 polypeptides,4 polypeptides,0
8763,poliovirus clone,taxon,0
8761,uncapped mrna,transcript,0
8759,polyprotein synthesis,polyprotein synthesis,0
8756,culture,culture,0
8748,pico,pico,0
8742,acronym,acronym,0
8778,tightly packed icosahedral structure,tightly packed icosahedral structure,0
7946,season.this recommendation,season.this recommendation,0
8462,prequalified medicinal products,prequalified medicinal products,0
8459,cheaper generic version,cheaper generic version,0
8131,largescale phase iii multicenter pioneer study,largescale phase iii multicenter pioneer study,0
8115,arlansa,arlansa,0
8106,hospitalized patients,hospitalized patients,0
8105,stage 2/3 trial,stage 2/3 trial,0
8103,medical data,medical data,0
8102,hospitalized nonhospitalized patients,hospitalized nonhospitalized patients,0
8135,treatmentexperienced patients,treatmentexperienced patients,0
8092,drive,drive,0
8085,mutagenic properties,mutagenic properties,0
8083,rick bright,rick bright,0
8082,whistleblower complaint,whistleblower complaint,0
8079,emory,emory,0
8078,drug innovation ventures,drug innovation ventures,0
8076,emory university,emory university,0
8091,ceo,ceo,0
8070,synthetic nucleoside derivative n4hydroxycytidine,synthetic nucleoside derivative n4hydroxycytidine,0
8136,dual therapy,dual therapy,0
8144,moscow government healthcare department,moscow government healthcare department,0
8197,70 kda cleavage product,70 kda cleavage product,0
8193,covid19 patients,covid19 patients,0
8190,preclinical animal testing,taxon,0
8171,symptomatic illness,symptomatic illness,0
8170,low fatality record,low fatality record,0
8162,neuraminidase enzyme,group class enzymes,0
8137,pegylated interferon alfa,group class proteins,0
8161,yaroslavl,yaroslavl,0
8155,russian government,russian government,0
8154,120 million rubles,120 million rubles,0
8151,pharmaceutical medical industry,pharmaceutical medical industry,0
8150,federal target program development,federal target program development,0
8149,texas liver institute,state united statesorgan type,0
8146,major milestone,major milestone,0
8158,russia.the drug,russia.the drug,0
8202,nucleoside triphosphatase,nucleoside triphosphatase,0
8067,mk608 mk608,mk608 mk608,0
8060,phase 2 clinical trial,phase 2 clinical trial,0
7995,biodiem,biodiem,0
7993,quadrivalent version,quadrivalent version,0
7987,ann arbor,ann arbor,0
7985,professor,professor,0
7984,hunein john maassab,hunein john maassab,0
7982,vaccinated person,vaccinated person,0
8000,bcht plans,bcht plans,0
7970,refrigerated version,refrigerated version,0
7967,coming months,coming months,0
7965,body temperature,body temperature,0
7964,relatively cold temperatures,relatively cold temperatures,0
7958,cdc advisory committee,cdc advisory committee,0
7957,younger children,younger children,0
7950,astrazeneca,astrazeneca,0
7969,chick kidney cells,chick kidney cells,0
8061,viralclear pharmaceuticals,viralclear pharmaceuticals,0
8006,chinese market priorities,chinese market priorities,0
8013,nepal,nepal,0
8059,merimepodib,chemical compound,0
8056,modest benefits,modest benefits,0
8051,nucleotide bases,nucleotide bases,0
8049,clinically useful drug treatment program,clinically useful drug treatment program,0
8046,mericitabine,chemical compound,0
8045,following populations,following populations,0
8012,bhutan,bhutan,0
8038,laivs,laivs,0
8030,early work,early work,0
8025,broad protection,broad protection,0
8019,modifying flumist,brand,0
8018,h5n1 advance preparation,subtype,0
8015,surface antigens,surface antigens,0
8014,government pharmaceutical organization,government pharmaceutical organization,0
8032,cdc team,cdc team,0
8460,cipla drug,business enterprise,0
8203,180 aminoacids,180 aminoacids,0
8205,additional role,additional role,0
8416,2.6%,2.6%,0
8413,2011 metaanalysis,2011 metaanalysis,0
8411,vast majority,vast majority,0
8403,causative role,causative role,0
8396,aggravation,aggravation,0
8392,rash allergic reactions,rash allergic reactions,0
8418,especially h1n1 subtype,virus,0
8391,liver inflammation,organ type,0
8381,oseltamivir therapy,chemical compound neuraminidase inhibitor medication essential medicine,0
8375,critically ill hospitalized patients,critically ill hospitalized patients,0
8366,inclusion,inclusion,0
8364,deletion,deletion,0
8363,expert committee,expert committee,0
8353,generic version,generic version,0
8384,19 children,19 children,0
8347,seizures,seizures,0
8420,oseltamivir use,chemical compound neuraminidase inhibitor medication essential medicine,0
8426,23–26 litres,23–26 litres,0
8458,indian drug company ciplawonacaseinindia scourtsystemallowingtheindiandrugcompanyciplatomanufacture cheaper generic version,indian drug company ciplawonacaseinindia scourtsystemallowingtheindiandrugcompanyciplatomanufacture cheaper generic version,0
8456,indian drug company ciplawonacaseinindia scourtsystemallowingtheindiandrugcompany cipla,business enterprise,0
8455,december 2008theindiandrugcompanyciplawonacaseinindia scourtsystemallowing indian drug company,december 2008theindiandrugcompanyciplawonacaseinindia scourtsystemallowing indian drug company,0
8451,government decisions,government decisions,0
8450,recused defense secretary donald rumsfeld,recused defense secretary donald rumsfeld,0
8449,past chairman,past chairman,0
8421,severely immunocompromised patients,severely immunocompromised patients,0
8448,defense secretary donald rumsfeld,defense secretary donald rumsfeld,0
8444,stockpiling,stockpiling,0
8442,worldwide shortages,worldwide shortages,0
8440,hospital admissions,hospital admissions,0
8439,antibiotic use,antibiotic use,0
8436,pooled analysis,pooled analysis,0
8431,starting point,starting point,0
8447,military use,military use,0
8204,ns3,ns3,0
8345,individual household levels,individual household levels,0
8337,discretion,discretion,0
8267,cell surface,cell surface,0
8264,cytoplasm,cytoplasm,0
8257,lung,lung,0
8246,lectin,lectin,0
8241,pieces,pieces,0
8237,lipid bilayer membrane,lipid bilayer membrane,0
8271,cellular mrna,transcript,0
8235,clusters,clusters,0
8232,approximately 500 distinct spikelike surface projections,approximately 500 distinct spikelike surface projections,0
8231,spherical filamentous forms,spherical filamentous forms,0
8224,gammainfluenzavirus,gammainfluenzavirus,0
8221,alphainfluenzavirus,alphainfluenzavirus,0
8215,interferonresistance,interferonresistance,0
8209,odalasvir,chemical compound,0
8234,major glycoprotein,major glycoprotein,0
8340,criticisms,criticisms,0
8275,negativesense vrnas,negativesense vrnas,0
8280,cell membrane,cell membrane,0
8336,clinicians,clinicians,0
8327,antigenic change,antigenic change,0
8323,antigenic diversity,antigenic diversity,0
8312,vaccination prophylaxis,vaccination prophylaxis,0
8309,minimum,minimum,0
8303,2 weeks,2 weeks,0
8278,neuraminidase molecules,group class enzymes,0
8300,200 days,200 days,0
8298,100 days,100 days,0
8296,viability disinfection,viability disinfection,0
8294,following table,following table,0
8284,membrane coat,membrane coat,0
8283,host phospholipid membrane,host phospholipid membrane,0
8281,membrane protrusion,membrane protrusion,0
8299,distilled water,distilled water,0
2301,spacecraft fuel,spacecraft fuel,0
10862,chinese patients,chinese patients,0
1953,14 april,14 april,0
699,edinburgh,capital scotland city college town lieutenancy area scotland big city,0
704,chicago,chicago,0
710,month,month,0
719,singapore,emoji regional indicator sequence,0
721,japan,sovereign state island nation country,0
722,australia,continent,0
724,april,april,0
726,original starting point,original starting point,0
727,central asia,continent continental area surrounding islands,0
1982,cdc illness,cdc illness,0
730,united states,united states,0
734,reported case,reported case,0
735,peak mortality,peak mortality,0
737,4%,4%,0
1985,poultry farms,organisms known particular common,0
738,resurgence,resurgence,0
1975,1.5%,1.5%,0
746,carbolic smoke ball company – case,carbolic smoke ball company – case,0
748,advertisement,advertisement,0
753,ueber,ueber,0
1969,journal,journal,0
760,strychnine larger ones,chemical compound flammable solid alkaloid heterocyclic compound neurotoxin,0
764,salt,salt,0
765,warm water,warm water,0
1963,texas children shospitalinhoustontexaswasof toddler,state united states,0
767,belief,belief,0
768,body,body,0
1962,texas,state united states,0
769,heat,heat,0
770,fact,fact,0
1977,30 days,30 days,0
698,glasgow,city big city lieutenancy area scotland,0
1986,wild bird populations,taxon,0
1987,subsequent cullings,subsequent cullings,0
599,severity,severity,0
2027,gifu prefecture,gifu prefecture,0
603,region s physicians oftendistinguishedtheregion sphysiciansfrom contagious seasonal pneumonias,region s physicians oftendistinguishedtheregion sphysiciansfrom contagious seasonal pneumonias,0
611,valencia,valencia,0
616,abyssinian empire habesh eyalet,abyssinian empire habesh eyalet,0
619,habesh eyalet,habesh eyalet,0
621,emperor,emperor,0
2021,49 places poultry farms,organisms known particular common,0
622,team,team,0
624,events,events,0
2018,official confirmed report,official confirmed report,0
633,medri bahri,medri bahri,0
2015,duck farm,duck farm,0
2012,countermeasure,countermeasure,0
642,deadliest pandemics,deadliest pandemics,0
643,history,history,0
646,recurrences,recurrences,0
1988,millions,millions,0
1991,russian authorities,russian authorities,0
1992,poultry farm workers,organisms known particular common,0
688,vienna,federal capital statutory city austria metropolis city millions inhabitants enclave city-state municipality austria,0
684,norway,emoji regional indicator sequence,0
679,vaxholm,urban area sweden,0
780,work,work,0
1999,poultry farm,organisms known particular common,0
667,krasnovodsk,krasnovodsk,0
663,samarkand,samarkand,0
660,central asian city,central asian city,0
656,transatlantic travel,transatlantic travel,0
652,19 largest european countries,19 largest european countries,0
2010,agriculture minister carola schouten,agriculture minister carola schouten,0
671,moscow,moscow,0
2029,local official confirmed report,local official confirmed report,0
788,subtype h3,subtype h3,0
795,exhumed corpses,exhumed corpses,0
916,destroyers,destroyers,0
920,microbiologist maurice hilleman,microbiologist maurice hilleman,0
1921,antivirals effectiveness questioned healthy adults,chebi ontology term,0
924,navy doctor,navy doctor,0
931,26 july,26 july,0
932,lowry air force base,lowry air force base,0
933,29 july,29 july,0
934,wales,wales,0
935,limited quantities,limited quantities,0
1915,resistance,resistance,0
938,hundreds thousands,hundreds thousands,0
939,lives,lives,0
942,cdc,cdc,0
945,soviet union,soviet union,0
907,hong kong residents,hong kong residents,0
1909,trouble breathing,trouble breathing,0
957,liaoning,province china,0
958,jilin,province china,0
960,chinese researchers,chinese researchers,0
964,british hong kong,british hong kong,0
1900,animal husbandry products,taxon,0
976,reappearance,reappearance,0
977,1950s,1950s,0
1897,food products,food products,0
978,younger population,younger population,0
1895,agriculture,agriculture,0
1894,united states secretary,united states secretary,0
997,functioning,functioning,0
998,poultry industry,organisms known particular common,0
1001,income,income,0
952,genetic analysis,genetic analysis,0
905,times,times,0
904,17 april,17 april,0
900,chinese government,chinese government,0
797,seroarcheological data,seroarcheological data,0
798,h3,h3,0
802,virologists,virologists,0
804,comparison,comparison,0
1951,california,state united states start time 9 september 1850gregorian,0
1950,san diego county,san diego county,0
808,authors,authors,0
812,lone simonsen,lone simonsen,0
815,genetic comparisons,genetic comparisons,0
1945,midst,midst,0
1943,hundreds,hundreds,0
831,hong kong,hong kong,0
833,virology,virology,0
1939,flights,flights,0
843,0.2%,0.2%,0
1935,u.s. children,u.s. children,0
854,antibiotics,scientific journal academic journal 2012,0
895,united states cdc,united states cdc,0
889,yunnan,yunnan,0
885,chile,chile,0
1928,mild benefits,mild benefits,0
876,rodrigo,rodrigo,0
1929,finding,finding,0
790,subtype h1,subtype h1,0
873,simonsen,simonsen,0
866,united kingdom,united kingdom,0
1931,useful drug,useful drug,0
1932,duration,duration,0
1933,paucity,paucity,0
859,preexisting heart lung disease,preexisting heart lung disease,0
1934,good data,good data,0
1930,role,role,0
1004,nandurbar district,nandurbar district,0
597,spanish population,spanish population,0
592,country,country,0
2105,spatial arrangement,spatial arrangement,0
388,contemporary physicians,contemporary physicians,0
2104,c10h16,c10h16,0
2102,cyclohexane rings,cyclohexane rings,0
2100,adamantane molecules,chemical compound,0
390,ingrassia,ingrassia,0
2099,formula c10h16,formula c10h16,0
2097,adamantane,chemical compound,0
2095,7 farm workers,7 farm workers,0
396,days,days,0
400,observers,observers,0
401,reoccurring pattern,reoccurring pattern,0
2091,chiba prefecture,chiba prefecture,0
403,greater research,greater research,0
2106,carbon atoms,carbon atoms,0
2090,narita,narita,0
2089,yokoshibahikari,municipality japan town japan,0
2087,weaken bodies condition,weaken bodies condition,0
409,pseudomembranes,pseudomembranes,0
2085,fishers,fishers,0
2084,forestry,forestry,0
413,illnesses,illnesses,0
2082,63 700 birds,63 700 birds,0
427,ottoman empire territory,ottoman empire territory,0
430,unrestricted access,unrestricted access,0
431,athens,athens,0
433,sarajevo,sarajevo,0
2078,iraq,emoji regional indicator sequence,0
434,sail,sail,0
2077,european countries,european countries,0
406,diphtheria,diphtheria,0
2107,molecule,molecule,0
2108,diamond crystal,diamond crystal,0
382,common ways,common ways,0
309,outbreaks,outbreaks,0
312,measles,infectious disease france,0
313,mediterranean sea,mediterranean sea,0
2147,systematic nomenclature,systematic nomenclature,0
317,conditions,conditions,0
2142,camphene,analytical technique toxaphene,0
2139,melting point,melting point,0
326,entire populations,entire populations,0
327,mass outbreaks,mass outbreaks,0
2136,unusually high melting point,unusually high melting point,0
329,stars,stars,0
333,air,air,0
337,highest levels,highest levels,0
339,sailors,sailors,0
340,central america,central america,0
343,year,year,0
344,south atlantic states,south atlantic states,0
381,good governance,good governance,0
376,gentle bleeding,gentle bleeding,0
375,sealed earth,sealed earth,0
2113,history synthesis,history synthesis,0
371,dr. thomas short,dr. thomas short,0
370,illness,illness,0
435,capital,capital,0
365,climate,climate,0
2120,diethyl malonate,diethyl malonate,0
354,access point,access point,0
353,continent,continent,0
2123,synthesis,synthesis,0
2124,adamantane adamantane derivatives,chemical compoundchemical compound,0
346,southwest,southwest,0
358,ottoman army,ottoman army,0
593,luis mercado,luis mercado,0
436,recently conquered north african territories,recently conquered north african territories,0
2075,namibia,emoji regional indicator sequence,0
521,british isles,british isles,0
526,unsound viscera,unsound viscera,0
527,army,army,0
528,mary,mary,0
529,mary government,mary government,0
532,rutland,rutland,0
533,calais,calais,0
536,duke,duke,0
538,underprotected city,underprotected city,0
541,dutch historian petrus forestus,dutch historian petrus forestus,0
2044,shanxi province,shanxi province,0
545,common catarrh,common catarrh,0
546,dutch historian petrus forestus great malignancy,dutch historian petrus forestus great malignancy,0
552,patients,patients,0
519,medical historian charlesjacques saillant,medical historian charlesjacques saillant,0
553,paroxysm,paroxysm,0
555,tight convulsive cough,tight convulsive cough,0
560,thousands,thousands,0
562,hunger,hunger,0
2040,central west ofsouthkorea sandissuedthehighlypathogenich5n8strainofbirdfluinsamplesfromwildbirdsinthecentralwestof country bird flu warning,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,0
2038,central west,central west,0
564,authorities,authorities,0
2037,wild birds inthecentralwestofsouthkorea sandissuedthehighlypathogenich5n8strainofbirdfluinsamplesfromwildbirdsin central west,wild birds inthecentralwestofsouthkorea sandissuedthehighlypathogenich5n8strainofbirdfluinsamplesfromwildbirdsin central west,0
572,chroniclers,chroniclers,0
575,mantua carpentaria,mantua carpentaria,0
577,jaws,jaws,0
582,sweat,sweat,0
584,pleurisy,pleurisy,0
587,mortality,mortality,0
590,parts,parts,0
554,complaint,complaint,0
2050,regional ban,regional ban,0
515,paris judiciary,paris judiciary,0
510,7 14 days,7 14 days,0
439,land,land,0
2074,seven states,seven states,0
2073,9 january,9 january,0
440,poland,poland,0
441,grand duchy,grand duchy,0
442,lithuania,lithuania,0
2071,middecember,middecember,0
444,sicily italian states holy roman empire,autonomous region special statute cultural region region italy,0
2070,poultry belt,organisms known particular common,0
450,advisory capacity,advisory capacity,0
451,collaboration,collaboration,0
453,government officials,government officials,0
459,italian peninsula,italian peninsula,0
460,coastline,coastline,0
464,bernardo,bernardo,0
2068,raipur rani,raipur rani,0
466,lombardy,lombardy,0
506,breath,breath,0
2054,north jeolla province,north jeolla province,0
2056,2021 outbreaks,2021 outbreaks,0
501,françois valleriola,françois valleriola,0
483,doctorate,doctorate,0
480,swiss physician felix plater,swiss physician felix plater,0
438,habesh,habesh,0
478,swiss plateaus,swiss plateaus,0
2064,states,states,0
2067,panchkula,panchkula,0
471,young population,young population,0
469,padua,comune italy big city city college town capital,0
468,members,members,0
467,catarrh,catarrh,0
475,extreme cough,extreme cough,0
1005,maharashtra,state india,0
1007,numerous birds,numerous birds,0
1884,u.s. national pork board,u.s. national pork board,0
1380,confirmed diagnosis,activity,0
1382,testing,testing,0
1383,nasopharyngeal nasal oropharyngeal tissue swab,nasopharyngeal nasal oropharyngeal tissue swab,0
1720,accusations conflict,accusations conflict,0
1386,recommended test,recommended test,0
1718,safety profile,safety profile,0
1389,test,test,0
1716,u.s. national institutes,u.s. national institutes,0
1390,test results,test results,0
1391,recommended course,recommended course,0
1714,16 countries,16 countries,0
1395,results,results,0
1400,u.s. cdc,u.s. cdc,0
1402,ridts,ridts,0
1379,diagnosis,activity,0
1709,waivers,waivers,0
1707,u.s. president obama,u.s. president obama,0
1409,h1n1 test results,virus,0
1415,molecular biology technique,molecular biology technique,0
1418,emergency use authorization,emergency use authorization,0
1419,u.s. food drug administration,u.s. food drug administration,0
1423,little protection,little protection,0
1698,gaps,gaps,0
1426,prevention,prevention,0
1697,united states response,united states response,0
1432,older adults,older adults,0
1694,u.s. governmental agencies,u.s. governmental agencies,0
1435,previous exposure,previous exposure,0
1438,rural unvaccinated population,rural unvaccinated population,0
1441,exposure,exposure,0
1708,national emergency,national emergency,0
1377,277 children,277 children,0
1729,beginning,beginning,0
1373,developmental delays,developmental delays,0
1769,organization,organization,0
1767,directorgeneral margaret chan,directorgeneral margaret chan,0
1764,regard,regard,0
1293,bird,taxon,0
1297,term swine,swine disease,0
1759,keiji fukuda,keiji fukuda,0
1758,12 april 2010keijifukudathewho stopinfluenzaexpertstatedthatthesystemleadingtothedeclarationofapandemicledtoconfusionabouth1n1circulatingaroundtheworldand keiji fukuda,12 april 2010keijifukudathewho stopinfluenzaexpertstatedthatthesystemleadingtothedeclarationofapandemicledtoconfusionabouth1n1circulatingaroundtheworldand keiji fukuda,0
1756,preparation,preparation,0
1752,enquiry,enquiry,0
1318,increased breathing difficulty,increased breathing difficulty,0
1322,warning sign,warning sign,0
1323,child,child,0
1324,relapse,relapse,0
1327,wide assortment,wide assortment,0
1745,spokeswoman fadela chaib,spokeswoman fadela chaib,0
1331,genetic divergence,genetic divergence,0
1743,review,review,0
1372,muscular dystrophy,muscular dystrophy,0
1365,u.s.,u.s.,0
1364,hospitalizations,hospitalizations,0
1355,neurological problems,neurological problems,0
1354,vomiting,vomiting,0
1737,enormous,enormous,0
1442,older u.s. population,older u.s. population,0
1739,borders,borders,0
1343,subsequent report,subsequent report,0
1342,factory farms,factory farms,0
1338,u.s. agricultural officials,u.s. agricultural officials,0
1741,interference,interference,0
1337,future outbreaks,future outbreaks,0
1335,need,need,0
1347,central mexico,state mexico,0
1284,highest population density,highest population density,0
1446,gisaid database,gisaid database,0
1689,u.s. officials,u.s. officials,0
1641,documented chest xrays,documented chest xrays,0
1545,indiscriminate use,indiscriminate use,0
1638,45%,45%,0
1549,addition,addition,0
1636,5%,5%,0
1559,5–15%,5–15%,0
1560,global population,global population,0
1631,631 patients,631 patients,0
1565,influenzarelated illnesses,influenzarelated illnesses,0
1566,data,data,0
1567,industrialised countries,industrialised countries,0
1568,highrisk populations,highrisk populations,0
1569,infants,infants,0
1574,major genetic changes,major genetic changes,0
1642,29%,29%,0
1578,genetic segments,genetic segments,0
1581,factory farm,factory farm,0
1626,united kingdom investigation,united kingdom investigation,0
1582,north carolina,north carolina,0
1589,lining,lining,0
1592,common bacteria,taxon,0
1594,nose throat lungs,nose throat lungs,0
1595,subsequent pandemics,subsequent pandemics,0
1597,development,development,0
1598,antibiotic medicines,antibiotic medicines,0
1604,certain underlying medical conditions,certain underlying medical conditions,0
1605,increased risk,increased risk,0
1606,symptom onset,symptom onset,0
1611,intensive care unit,intensive care unit,0
1619,lung injury,lung injury,0
1627,risk factors,risk factors,0
1540,shortages,shortages,0
1534,oseltamivir,chemical compound neuraminidase inhibitor medication essential medicine,0
1533,hospitalised patients,hospitalised patients,0
1688,general practitioners,general practitioners,0
1459,1 100 children,1 100 children,0
1460,7 500 adults,7 500 adults,0
1463,discovery,discovery,0
1470,nancy cox,nancy cox,0
1472,particular paper,particular paper,0
1477,situation,situation,0
1486,households,households,0
1679,genetic code,genetic code,0
1488,injections,injections,0
1673,nonessential travel,nonessential travel,0
1494,officials,officials,0
1496,contingency plans,contingency plans,0
1670,27 april,27 april,0
1499,surges,surges,0
1668,cheetah,cheetah,0
1501,potentially widespread outbreaks,potentially widespread outbreaks,0
1531,start,start,0
1652,h1n1associated myocarditis,h1n1associated myocarditis,0
1528,h1n1caused illness,h1n1caused illness,0
1523,preexisting underlying medical conditions,preexisting underlying medical conditions,0
1522,ones,ones,0
1521,medical attention,medical attention,0
1447,nature,nature,0
1517,ibuprofen,ibuprofen,0
1514,thecounter,thecounter,0
1513,adequate liquid intake,adequate liquid intake,0
1662,transmissions,transmissions,0
1664,animals,animals,0
1666,household cats,household cats,0
1503,direct relief,direct relief,0
1516,thecounter pain medications,thecounter pain medications,0
1771,frank critical transparent credible independent review,frank critical transparent credible independent review,0
1282,moist cold climate,moist cold climate,0
1278,blanket ban,blanket ban,0
1099,veterinary laboratories agency,veterinary laboratories agency,0
1102,1 500 birds,1 500 birds,0
1105,3 protection zone,3 protection zone,0
1107,restricted zone,restricted zone,0
1851,quarantine,quarantine,0
1849,disagreement,disagreement,0
1112,nearby farmers,nearby farmers,0
1119,hospital,hospital,0
1843,face masks,face masks,0
1124,permission,permission,0
1125,production,production,0
1132,turkey waste,sovereign state transcontinental country mediterranean country country social state regional power secular state,0
1133,roosts,roosts,0
1136,turkey houses,sovereign state transcontinental country mediterranean country country social state regional power secular state,0
1096,farm,farm,0
1138,defra minister jeff rooker,defra minister jeff rooker,0
1838,persons,persons,0
1142,hungarian connection,hungarian connection,0
1144,semiprocessed turkey meat,sovereign state transcontinental country mediterranean country country social state regional power secular state,0
1145,hungary,sovereign state country,0
1149,hungarian connection.bernard matthews,hungarian connection.bernard matthews,0
1835,peak,peak,0
1151,partly processed turkey meat,sovereign state transcontinental country mediterranean country country social state regional power secular state,0
1152,weekly basis,weekly basis,0
1153,hungarian connection.bernard matthews saga foods company,hungarian connection.bernard matthews saga foods company,0
1154,sárvár,town hungary,0
1159,whitehall,whitehall,0
1829,plans,plans,0
1161,biosecurity,type security,0
1164,britain,britain,0
1839,seven days,seven days,0
1095,defra,defra,0
1088,turkeys,turkeys,0
1857,teachers,teachers,0
1017,indian population,indian population,0
1020,villagers,villagers,0
1022,maharashtra state animal husbandry ministry authorities,state indiataxon,0
1024,lab analysis,lab analysis,0
1025,poultry,organisms known particular common,0
1879,term,term,0
1877,common,common,0
1030,observation,observation,0
1032,150 persons,150 persons,0
1033,national institute,national institute,0
1034,analysis,analysis,0
1035,movement,movement,0
1036,passenger trains,passenger trains,0
1037,state governments,state governments,0
1039,jammu,jammu,0
1045,indian army,indian army,0
1870,47 airline passengers,47 airline passengers,0
1858,teachers hotel rooms,teachers hotel rooms,0
1069,centre,centre,0
1068,state central governments,state central governments,0
1065,kingfisher airlines,kingfisher airlines,0
1064,indian airlines,indian airlines,0
1863,240 guests,240 guests,0
1165,9 february,9 february,0
1063,jet airways,jet airways,0
1061,airlines,airlines,0
1059,hundreds millions,hundreds millions,0
1057,mutton,mutton,0
1867,egyptian muslims,egyptian muslims,0
1054,prices,prices,0
1048,drugdistribution measures,drugdistribution measures,0
1062,air india,dominion british empire sovereign state historical country,0
1827,video,video,0
1166,hungarian authorities,hungarian authorities,0
1169,suffolk hungarian outbreaks,suffolk hungarian outbreaks,0
1797,major changes,major changes,0
1796,u.s. airlines,u.s. airlines,0
1232,union members,union members,0
1233,state benefits,state benefits,0
1793,closing borders,closing borders,0
1792,effect,effect,0
1234,laidoff workers,laidoff workers,0
1791,containment,containment,0
1235,row,row,0
1238,hens,hens,0
1239,toms,toms,0
1789,travel precautions,travel precautions,0
1786,decisions,decisions,0
1241,event,event,0
1244,subtype,subtype,0
1248,type,type,0
1249,causative agent,causative agent,0
1276,imposition,imposition,0
1275,poultry birds,organisms known particular common,0
1773,fiona godlee,fiona godlee,0
1774,margaret chan,margaret chan,0
1274,eggs,eggs,0
1269,bankura,municipality west bengal big city,0
1231,union funds,union funds,0
1267,cooch behar,cooch behar,0
1265,burdwan,municipality west bengal big city,0
1264,murshidabad,municipality west bengal,0
1262,birbhum,district india,0
1259,southeastern hungary,sovereign state country,0
1258,corresponding incidence,corresponding incidence,0
1254,privately owned quarantine facility,privately owned quarantine facility,0
1266,hooghly,hooghly,0
308,1557 parts,1557 parts,0
1799,passengers,passengers,0
1229,general workers union general workers union paidout,general workers union general workers union paidout,0
1170,turkey products,sovereign state transcontinental country mediterranean country country social state regional power secular state,0
1174,hungary link,sovereign state country,0
1177,99.96%,99.96%,0
1179,leak,leak,0
1187,contaminated poultry farming tools,organisms known particular common,0
1189,product,product,0
1195,information,information,0
1200,hungarian turkey products,sovereign state transcontinental country mediterranean country country social state regional power secular state,0
1815,u.s. government officials,u.s. government officials,0
1203,lengthening list,lengthening list,0
1205,poultry products,organisms known particular common,0
1207,spokesman,spokesman,0
1813,effective method,effective method,0
1811,airports,airports,0
1209,british poultry council,organisms known particular common,0
1210,exports,exports,0
1212,level,level,0
1801,airline crews,airline crews,0
1802,nonu.s. airlines,nonu.s. airlines,0
1803,singapore airlines,emoji regional indicator sequence,0
1804,china eastern airlines,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",0
1225,product sales,product sales,0
1223,130 workers,130 workers,0
1800,masks,masks,0
1222,company,company,0
1219,consumer confidence,consumer confidence,0
1806,cathay pacific,cathay pacific,0
1218,biggest ongoing surveys,biggest ongoing surveys,0
1214,supermarket sales,supermarket sales,0
1808,measures,measures,0
1213,domestic sales,domestic sales,0
1221,respected trusted brand,respected trusted brand,0
2148,iupac,learned society publisher,0
1617,strongest risk factors,strongest risk factors,0
167,ottoman empire,ottoman empire,0
226,french physicians,french physicians,0
2234,3coordinated carbon sites,3coordinated carbon sites,0
117,antigenic shift,antigenic shift,0
176,merchant ships,merchant ships,0
2279,adamantane derivative,chemical compound,0
2210,1.756 ppm,1.756 ppm,0
227,historian françois eudes mézeray,historian françois eudes mézeray,0
285,eventually americas,eventually americas,0
104,oily lintus,oily lintus,0
2176,cell,cell,0
174,italy,italy,0
106,decoctions,decoctions,0
2197,corresponding values,corresponding values,0
108,justus hecker,justus hecker,0
126,modern epidemiologists,modern epidemiologists,0
287,thomas short,thomas short,0
2183,properties,properties,0
2164,electron diffraction,electron diffraction,0
274,gastrodynia,gastrodynia,0
62,voice,voice,0
2154,adamantane analogues,chemical compound,0
2277,pure adamantane,chemical compound,0
205,louis xii,louis xii,0
180,holy roman empire,holy roman empire,0
2161,naturally occurring organoarsenic analogue,naturally occurring organoarsenic analogue,0
2256,hydrolysis,hydrolysis,0
46,mediterranean,mediterranean,0
2155,molecules,molecules,0
161,cities,cities,0
192,holy roman empire upper kingdoms,holy roman empire upper kingdoms,0
132,tommasino bianchi,tommasino bianchi,0
2232,bridgehead atoms,bridgehead atoms,0
77,ships,ships,0
2175,ordered primitive tetragonal phase,ordered primitive tetragonal phase,0
225,cephalie catarrhal,cephalie catarrhal,0
202,royal assembly,royal assembly,0
34,operum medicorum tombus primus,operum medicorum tombus primus,0
239,historian jean bouchet,historian jean bouchet,0
125,1510 coqueluche,1510 coqueluche,0
61,hoarseness,hoarseness,0
109,john parkin,john parkin,0
2209,13c nmr chemical shifts,13c nmr chemical shifts,0
2271,nitrogensubstituted drug amantadine,chemical compound medication,0
56,church services,church services,0
272,previous medical historians data hasfound,previous medical historians data hasfound,0
2185,density,density,0
293,populations,populations,0
2199,1123 gpa,1123 gpa,0
2166,td symmetry,td symmetry,0
81,santo domingo,santo domingo,0
292,modern physicians,modern physicians,0
173,mediterranean coasts,mediterranean coasts,0
2178,0.5 gpa,0.5 gpa,0
2266,normal conditions,normal conditions,0
2165,xray crystallography,xray crystallography,0
2184,cubic phase,cubic phase,0
2216,nodal carbon sites,nodal carbon sites,0
230,french surgeon ambroise paré,french surgeon ambroise paré,0
2158,tetramine,tetramine,0
2282,adapalene,chemical compound medication carboxylic acid,0
2281,adamantane derivatives,chemical compound,0
2160,silaadamantane,silaadamantane,0
264,countries,countries,0
2264,particular reaction,particular reaction,0
24,government,government,0
2218,values,values,0
2217,hydrogen bromine methyl carboxyl group,hydrogen bromine methyl carboxyl group,0
80,isle,isle,0
2290,vildagliptin,medication heterocyclic compound group stereoisomers,0
2283,carmantadine,chemical compound,0
265,england ireland,nation uk cultural area countryemoji regional indicator sequence éire (irish),0
123,europeeurope,europeeurope,0
58,turin professor francisco vallerioli,turin professor francisco vallerioli,0
266,british medical historian charles creighton,british medical historian charles creighton,0
2157,adamantanelike cage structures,adamantanelike cage structures,0
2177,208 k,208 k,0
231,rheumatic affliction,rheumatic affliction,0
2174,orientationally disordered adamantane molecules,chemical compound,0
76,fleets,fleets,0
2182,heat capacity,heat capacity,0
2221,adamantane cation,chemical compound,0
278,spain portugal,sovereign state start time 1415 country,0
2202,weak van der waals forces,weak van der waals forces,0
94,bloodletting,treatment,0
2192,ultrasonic echo technique,ultrasonic echo technique,0
2252,carboxylating agent,carboxylating agent,0
86,smallpox,eradicated disease start time 1980,0
183,germanspeaking europeans,germanspeaking europeans,0
37,german medical writer justus hecker,german medical writer justus hecker,0
84,1490s,1490s,0
3,north africa,continent,0
72,americas,americas,0
140,delirium,disease,0
2244,catalysts,catalysts,0
2171,1.112 å.at ambient conditions,1.112 å.at ambient conditions,0
234,tours,tours,0
306,flulike illness,flulike illness,0
170,july,july,0
277,ireland,emoji regional indicator sequence éire (irish),0
149,weeks,weeks,0
172,infected merchant ships,infected merchant ships,0
148,pertussis,pertussis,0
185,canton,canton,0
2203,adamantane crystals,chemical compound,0
144,lung congestion,lung congestion,0
2150,applications,applications,0
47,malta,religious minority major religious group,0
39,influenzas,influenzas,0
143,10th days,10th days,0
2286,memantine,chemical compound medication,0
68,lawyer francesco muralto,lawyer francesco muralto,0
2204,spectroscopy,spectroscopy,0
2181,anomaly,anomaly,0
212,kingdom,kingdom,0
38,historical nature,historical nature,0
2236,bromination,bromination,0
2190,elastic constants,elastic constants,0
7,epidemiologists,epidemiologists,0
2163,structure,structure,0
2275,acetamide,acetamide,0
190,german physician achilles gasser,german physician achilles gasser,0
2294,amantadine,chemical compound medication,0
13,printing press,printing press,0
15,coqueluche,coqueluche,0
2153,polymer formulations,polymer formulations,0
2152,dry etching masks,dry etching masks,0
2259,ozonation,scholarly article review article,0
2293,drug resistance,drug resistance,0
2173,facecentered cubic structure,facecentered cubic structure,0
208,baltic states,baltic states,0
253,henry iii,henry iii,0
121,european chroniclers,european chroniclers,0
48,british medical historian thomas short,british medical historian thomas short,0
2276,medical applications,medical applications,0
92,paré,paré,0
134,3 days,3 days,0
2206,poorly resolved signals,poorly resolved signals,0
2189,hardness,hardness,0
2172,adamantane crystallizes,chemical compound,0
25,church,church,0
135,headache,headache,0
2231,electrons,electrons,0
281,portugal,sovereign state start time 1415 country,0
2200,arrangement,arrangement,0
189,fatigue,symptom,0
65,physicians,physicians,0
303,repeated waves,repeated waves,0
2220,adamantane cations,chemical compound,0
188,population,population,0
6554,david r. smith,david r. smith,1
6552,suzanne genova,suzanne genova,1
6558,richard j. webby,richard j. webby,1
10534,temporal patterns,temporal patterns,1
6555,liesel schneider,liesel schneider,1
10536,morbidity,morbidity,1
88,head,head,1
6559,xiufeng wan,xiufeng wan,1
10535,sick correlation,sick correlation,1
10532,mechanistic modeling approach,mechanistic modeling approach,1
6556,kathleen barton,kathleen barton,1
10533,underlie variability,underlie variability,1
6557,katlin mccuan,katlin mccuan,1
2300,sdb001,sdb001,1
10529,poorer nutrition,poorer nutrition,1
6610,nasal secretions,nasal secretions,1
1216,shoppers,shoppers,1
6613,virusladen aerosol,virusladen aerosol,1
6614,aforementioned bodily fluids,aforementioned bodily fluids,1
10502,30 times higher death rates,stock character psychopomp literary character,1
10501,geographic patterns,geographic patterns,1
6620,epidemiological factors,epidemiological factors,1
10498,hospitalized women,hospitalized women,1
1211,9%,9%,1
6627,important determinant,important determinant,1
10493,92%,92%,1
6629,deadly avian strain,deadly avian strain,1
6632,highrisk humans,infectious disease france,1
6640,following year,following year,1
6642,variants subtypes influenzavirus,variants subtypes influenzavirus,1
6644,lineage,lineage,1
6648,upheaval psychological damage,upheaval psychological damage,1
10490,patterns fatality,patterns fatality,1
1208,bans,bans,1
6651,living,living,1
6652,dead bodies,dead bodies,1
1217,alternatives,alternatives,1
6606,infected mammals,infected mammals,1
10506,times higher chance,times higher chance,1
10507,extremes,extremes,1
10528,indian women,indian women,1
6572,igsp,igsp,1
89,shoulders,shoulders,1
6575,tigr,tigr,1
6576,publication,publication,1
1230,hardship monies,hardship monies,1
10526,preexisting tuberculosis,notifiable disease valid place switzerland endemic disease,1
10524,african americans,african americans,1
10523,crowded living conditions,crowded living conditions,1
10522,worse diets,worse diets,1
6570,handful,handful,1
1228,workers,workers,1
10518,italian americans,italian americans,1
6583,3000 isolates,3000 isolates,1
1226,transport,transport,1
10515,social status,social status,1
10512,apartment size,apartment size,1
10511,oslo,capital big city city administrative centre,1
6595,volcanoes,volcanoes,1
6596,cosmic dust,cosmic dust,1
10510,social classes,social classes,1
10508,differences,differences,1
10520,average americans,average americans,1
10538,temporal variations,temporal variations,1
9803,fda availability,fda availability,1
6544,shift,shift,1
6313,dust,dust,1
6314,feathers,feathers,1
6315,trachea,trachea,1
6317,especially escherichia coli infections,especially escherichia coli infections,1
6318,bronchi,bronchi,1
6319,ventilation,ventilation,1
6322,immunization failure,immunization failure,1
6330,distal head,distal head,1
6331,ha trimer,ha trimer,1
6335,butt,butt,1
10586,lower income,lower income,1
6337,idrees m,idrees m,1
1290,pandemics,pandemics,1
1287,districts,districts,1
10582,cohorts,cohorts,1
6345,effective surveillance,effective surveillance,1
10581,political economy,political economy,1
6351,h number,h number,1
6352,n number,n number,1
6359,variants subtypes,variants subtypes,1
6362,total cost,total cost,1
1277,disinfection programme,disinfection programme,1
10574,nursing staff,nursing staff,1
6369,smallest virions,smallest virions,1
10571,increasing number,increasing number,1
6370,elliptical shape,elliptical shape,1
10584,reduced educational attainment increased rates,reduced educational attainment increased rates,1
6309,a/duck/hong kong/y439/97,a/duck/hong kong/y439/97,1
1292,previous triple reassortment,previous triple reassortment,1
6305,eurasian avian lineage,eurasian avian lineage,1
6248,reported cases 2015,reported cases 2015,1
10601,island newfoundland,island newfoundland,1
6249,canadian visitor,canadian visitor,1
6250,15 cases,15 cases,1
6252,reported cases late 2016 2017 (5th epidemic),reported cases late 2016 2017 (5th epidemic),1
6253,5th epidemic,5th epidemic,1
6256,laboratoryconfirmed cases,laboratoryconfirmed cases,1
6258,281 deaths,281 deaths,1
6260,international team,international team,1
6268,kawaoka,kawaoka,1
6272,epidemiological investigations,epidemiological investigations,1
6274,avian h7n9,taxon,1
1303,higher proportion,higher proportion,1
10599,115 million cases,115 million cases,1
1301,lower value,lower value,1
6278,phylogenetic trees,phylogenetic trees,1
6279,fortythree close contacts,fortythree close contacts,1
1300,asymptomatic mild cases,asymptomatic mild cases,1
6287,huhuai wholesale agricultural products market,huhuai wholesale agricultural products market,1
10597,lower percentage,lower percentage,1
1299,actual number,actual number,1
6291,latest occurring,latest occurring,1
6293,h9n2,h9n2,1
6297,longterm vaccination programs,longterm vaccination programs,1
1294,swine,swine disease,1
10589,birth cohorts,birth cohorts,1
10588,higher transfer payments,higher transfer payments,1
6371,length,length,1
6550,lucas ferguson,lucas ferguson,1
6372,particle,particle,1
10569,profit gains,profit gains,1
6478,young children,young children,1
6483,highest preventable mortalities,highest preventable mortalities,1
10553,allied cause,allied cause,1
10552,power,power,1
6488,d.,d.,1
6492,glycoprotein,glycoprotein,1
1246,birdadapted strain,birdadapted strain,1
10550,academic andrew pricesmith,academic andrew pricesmith,1
1242,actual compensation,actual compensation,1
6504,techniques,techniques,1
6505,color change,color change,1
6507,hef,hef,1
1251,recent outbreaks uk rest eu,recent outbreaks uk rest eu,1
6508,hi test,hi test,1
10545,temperature changes,temperature changes,1
6515,seasonal epidemics,seasonal epidemics,1
10544,school opening,school opening,1
6521,wagaman pc,wagaman pc,1
6522,spence ha,spence ha,1
6523,o callaghan rj],o callaghan rj],1
6527,serum samples,serum samples,1
6528,hemagglutinationinhibiting antibodies,family protein complexes,1
1240,payout,payout,1
6539,genetic changes,genetic changes,1
6540,lower lung,lower lung,1
6543,c d growth requirements,c d growth requirements,1
6511,quick inexpensive method,quick inexpensive method,1
6472,muscle pain,muscle pain,1
6469,coldlike symptoms,coldlike symptoms,1
1255,essex,essex,1
1272,west midnapore,west midnapore,1
6381,varied shapes,varied shapes,1
6383,main types,main types,1
1270,purulia,municipality west bengal,1
6387,virion,virion,1
10568,healthcare industry,healthcare industry,1
6389,abundant nonproductive attachment sites,abundant nonproductive attachment sites,1
6391,targets,targets,1
6392,antigen proteins,group class chemical substancesgroup class chemical substances second-order class,1
6394,16 subtypes,16 subtypes,1
6395,ha 9 subtypes,ha 9 subtypes,1
6397,genetic material,genetic material,1
10566,losses,losses,1
10565,entertainment service industries,entertainment service industries,1
78,atlantic,atlantic,1
10562,home computers,home computers,1
10558,higher excess mortality rates,higher excess mortality rates,1
1261,thirteen districts,thirteen districts,1
6422,following subtypes,following subtypes,1
6423,fi6 antibody,family protein complexes,1
6424,fi6,fi6,1
6429,morphology,morphology,1
6434,nucleoprotein complex,group class proteins,1
10556,allied powers,allied powers,1
1257,cellardyke,village,1
6444,genus gammainfluenzavirus,genus gammainfluenzavirus,1
1256,dead whooper swan,dead whooper swan,1
6373,excess,excess,1
6657,illegal behavior,illegal behavior,1
6773,15 μg,15 μg,1
10486,isolated island,isolated island,1
7110,cytokines,cytokines,1
7116,antioxidant food supplement,antioxidant food supplement,1
1089,segregation zones,segregation zones,1
10382,instrumental records,instrumental records,1
1084,h5n1subtype,h5n1subtype,1
1083,instance,instance,1
7126,liter,liter,1
7127,green tea,green tea,1
7129,reduced risk,reduced risk,1
7131,epigallocatechin gallate,epigallocatechin gallate,1
7132,topical application,topical application,1
7133,mild disinfectant,mild disinfectant,1
7108,18%,18%,1
7135,stronger immune response,stronger immune response,1
7140,direct transfusion,direct transfusion,1
1082,suffolk,suffolk,1
7144,era,era,1
7146,hospitalized severe cases,hospitalized severe cases,1
7148,37%,37%,1
7153,vaccines effectiveness,vaccines effectiveness,1
7165,temporary muscle pains,temporary muscle pains,1
7170,guillain–barré syndrome,guillain–barré syndrome,1
7181,u.s centers,u.s centers,1
7185,protective antibodies,family protein complexes,1
7189,24 months,24 months,1
1074,west bengal,west bengal,1
7138,transfused antibodies,family protein complexes,1
1093,55 turkey poults,sovereign state transcontinental country mediterranean country country social state regional power secular state,1
7099,survival,survival,1
10387,anthropogenic increase,anthropogenic increase,1
1117,vet fromthesitewasadmittedintohospitalsufferingfromamildrespiratoryillnessduringtheeveningof6februaryavetfrom site,vet fromthesitewasadmittedintohospitalsufferingfromamildrespiratoryillnessduringtheeveningof6februaryavetfrom site,1
7038,13 studies,13 studies,1
7039,support,support,1
7041,rigorous clinical trials,rigorous clinical trials,1
7042,recent review,recent review,1
1116,vet,vet,1
7044,vitro studies,vitro studies,1
7046,dhea,chemical compound steroid,1
7049,larix occidentalis arabinogalactans,larix occidentalis arabinogalactans,1
7051,astragalus membranaceus,astragalus membranaceus,1
7052,isatis tinctoria,isatis tinctoria,1
7053,isatis indigotica,isatis indigotica,1
1114,320 workers,320 workers,1
10399,debates,debates,1
1111,criticism,criticism,1
7060,interferons,interferons,1
7066,donated blood,biogenic substance type,1
7071,1969 study,1969 study,1
7075,low concentrations,low concentrations,1
10395,delayed response,delayed response,1
10391,dust particles,dust particles,1
7080,interferonalpha actually reduced interferonalpha immune response,interferonalpha actually reduced interferonalpha immune response,1
10390,nucleation,nucleation,1
10389,incessant bombardment,incessant bombardment,1
1100,weybridge,town,1
7089,randomized clinical trial,randomized clinical trial,1
1097,tests,tests,1
7196,fertilized chicken eggs,fertilized chicken eggs,1
7200,chicken eggs,chicken eggs,1
7201,monovalent harvests,monovalent harvests,1
1072,worry,worry,1
1047,evacuation operations,evacuation operations,1
10345,view,view,1
7310,healthcare workers,healthcare workers,1
1046,alert,alert,1
7313,eighteen studies,eighteen studies,1
7315,patient mortality,patient mortality,1
7317,healthcare worker vaccination,healthcare worker vaccination,1
7318,reduced patient deaths,reduced patient deaths,1
10343,aftermath,aftermath,1
7325,randomized controlled case–control studies,randomized controlled case–control studies,1
1042,pharmaceutical companies,pharmaceutical companies,1
7328,case–control studies,case–control studies,1
7332,steep decline,steep decline,1
1040,kashmir,kashmir,1
7337,influenzaassociated death,stock character psychopomp literary character,1
142,5th,5th,1
7344,fluad,fluad,1
1038,tamil nadu,tamil nadu,1
7348,immunization practices guidelines,immunization practices guidelines,1
10341,deadly second wave,deadly second wave,1
7356,fluad quad,fluad quad,1
7357,fluad quadrivalent,fluad quadrivalent,1
7358,fluad tetra,fluad tetra,1
7360,successful fullterm pregnancy,physiological condition,1
146,second week,second week,1
10329,massive hemorrhages,massive hemorrhages,1
7367,complication,complication,1
1049,grievances locals,grievances locals,1
7036,seasonality,seasonality,1
7295,pediatric fluad,pediatric fluad,1
1055,chicken products,chicken products,1
7209,published studies,published studies,1
7212,uncertainty,uncertainty,1
1071,tamiflu,chemical compound neuraminidase inhibitor medication essential medicine,1
7216,seasonal variability,seasonal variability,1
1070,supplies,supplies,1
10368,precipitation,precipitation,1
7223,productivity gains,productivity gains,1
10366,environmental indicators,environmental indicators,1
1067,official response,official response,1
1066,chicken,chicken,1
7233,following objectives,following objectives,1
7235,immunization series,immunization series,1
7245,good match,good match,1
7247,slight mutation,slight mutation,1
7256,overall effectiveness,overall effectiveness,1
7261,rubbish,rubbish,1
7263,rubbish views,rubbish views,1
136,prostration,prostration,1
138,sleep,sleep,1
10357,incessant rains,incessant rains,1
10356,especially wwi troops,especially wwi troops,1
1058,fish,fish,1
139,appetite,appetite,1
7283,preference,preference,1
10350,mismanaged response,mismanaged response,1
7284,dose volume,dose volume,1
1056,steep rise,steep rise,1
10349,poor hygiene,poor hygiene,1
10400,japan efficacy,sovereign state island nation country,1
7033,seasonal variation,seasonal variation,1
7025,micronutrient deficiencies,micronutrient deficiencies,1
6772,strength,strength,1
6244,reported cases 2014,reported cases 2014,1
6777,as04,as04,1
6778,mf59,immunologic adjuvant,1
6779,second problem,second problem,1
6780,circulating clades,circulating clades,1
6781,clade,clade,1
6788,guidance,guidance,1
10470,blockade,blockade,1
1173,transport ban,transport ban,1
1172,eu regulations,eu regulations,1
6795,office,office,1
6798,critical pilot test,critical pilot test,1
6799,immunogenicity,immunogenicity,1
10467,adult women,adult women,1
6808,current portal,current portal,1
6815,document,document,1
10465,adult men,adult men,1
103,bole armoniac,bole armoniac,1
10457,pacific island territories,pacific island territories,1
6825,genomics,branch biology genome omics academic discipline,1
10452,alaska,alaska,1
6838,specialized chicken eggs,specialized chicken eggs,1
6840,companies,companies,1
6843,fort riley,fort riley,1
6845,fort,fort,1
6846,local consumption,local consumption,1
10471,higher social classes,higher social classes,1
6847,recent reconstruction,recent reconstruction,1
10472,custom,custom,1
1181,investigator,investigator,1
10485,main road,main road,1
6661,reality,reality,1
1204,importation,importation,1
96,supraorbital pain vision problems,supraorbital pain vision problems,1
10478,lessaffected areas,lessaffected areas,1
6675,eu response,eu response,1
1201,plausible cause,plausible cause,1
6679,increasing lethality,increasing lethality,1
99,hoods,hoods,1
1198,uk,uk,1
6699,787 confirmed cases,787 confirmed cases,1
6700,stages,stages,1
10475,deathbeds,deathbeds,1
6705,easy incorporation,easy incorporation,1
6707,approaches,approaches,1
6709,response plans,response plans,1
6712,observable phenomena,observable phenomena,1
1191,allegations,allegations,1
6714,response planning activities,response planning activities,1
6715,mitigation efforts,mitigation efforts,1
1190,bernard matthews owned subsidiary,bernard matthews owned subsidiary,1
10474,chiefs,chiefs,1
100,light sensitivity,light sensitivity,1
6728,public response measures,public response measures,1
6735,uk department,uk department,1
6736,set,set,1
6744,initial stages,initial stages,1
6755,considerations,considerations,1
10487,marajó,marajó,1
1158,revelation,revelation,1
6852,classic symptoms,classic symptoms,1
6944,annual output,annual output,1
10417,epsom salts,epsom salts,1
6955,sanofiaventis,sanofiaventis,1
6956,swiftwater,swiftwater,1
6958,better vaccines,better vaccines,1
10415,digitalis,taxon,1
6965,general ill feeling,general ill feeling,1
6967,recipient,recipient,1
10412,random assortment,random assortment,1
6976,vietnamese patient,vietnamese patient,1
1131,gulls,gulls,1
6985,protective immune response,protective immune response,1
6989,main classes,main classes,1
1128,biosecurity failings,type security,1
1127,series,series,1
6995,certain drugs,certain drugs,1
10403,actual enforcement,actual enforcement,1
6999,overuse,overuse,1
7007,performance,performance,1
10401,antimask league,antimask league,1
7010,tamifluresistance mutation,tamifluresistance mutation,1
7014,offlabel uses drugs,offlabel uses drugs,1
7015,generic prescription medications,generic prescription medications,1
7017,statins,drug class group class molecular entities,1
7018,fibrates,scholarly article review article,1
7021,malnutrition,malnutrition,1
7023,immunodeficiency,organisms known particular common,1
6941,holly springs,holly springs,1
6851,infected monkeys,infected monkeys,1
6934,optaflu,optaflu,1
6928,pitfalls,pitfalls,1
6853,distributed computing,distributed computing,1
6854,distributed research projects,distributed research projects,1
6855,global alliance,global alliance,1
1157,company director,company director,1
10447,stores,stores,1
10442,2018 reassessment,2018 reassessment,1
6872,wild bird migration patterns,taxon,1
6880,participants,participants,1
113,massive migrations,massive migrations,1
6885,reverse genetics,reverse genetics,1
10434,poison gas,poison gas,1
10430,rumors,rumors,1
6889,anticipated epidemic strain,anticipated epidemic strain,1
6890,certain virulence genes,certain virulence genes,1
1150,38 tons,38 tons,1
115,humans,infectious disease france,1
6899,dnabased approaches,dnabased approaches,1
6900,broadly protective vaccines,broadly protective vaccines,1
1147,house,house,1
10428,flanders fields,flanders fields,1
10426,noxious gases,noxious gases,1
6913,success,success,1
6914,e. coli bacteria,taxon,1
1141,exclusively bernard matthews holton problem,exclusively bernard matthews holton problem,1
10419,iodine,chemical element follows tellurium followed xenon,1
6925,e. coli,e. coli,1
1139,lords,lords,1
6929,chicken eggs.the committee,chicken eggs.the committee,1
6241,eastern china,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",1
6150,rapid response,rapid response,1
6236,600 close contacts,600 close contacts,1
1525,pregnant post partum women,pregnant post partum women,1
5383,route transmission,route transmission,1
5386,respiratory tract secretions,respiratory tract secretions,1
5389,clothing,clothing,1
5390,inanimate objects,inanimate objects,1
5392,desiccation,desiccation,1
5393,disinfectants,disinfectants,1
10789,vaniprevir,chemical compound,1
5400,tack,tack,1
5401,proper biosecurity procedures,type security,1
10780,zaire ebolavirus,taxon,1
5412,infected horses,infected horses,1
1518,salicylate products,salicylate products,1
10779,vitro effectiveness,vitro effectiveness,1
10774,interferonproduction,interferonproduction,1
5426,underlying epithelial cells,underlying epithelial cells,1
1515,paracetamol,chemical compound medication essential medicine,1
5428,hemagglutinin spike,group class proteins,1
5430,endocytosis,endocytosis,1
10773,humoral immune response,humoral immune response,1
5433,trachea bronchial tree,trachea bronchial tree,1
5437,desquamation,desquamation,1
5438,focal erosion,focal erosion,1
5440,skeletal cardiac muscle,skeletal cardiac muscle,1
5441,encephalitic signs,encephalitic signs,1
5444,drippy’ nose,drippy’ nose,1
5445,discharge,discharge,1
5378,identification,identification,1
5447,isolation,isolation,1
5373,europeanlike lineage,europeanlike lineage,1
5371,families,families,1
5292,triple reassortants,triple reassortants,1
5296,bivalent siv vaccines,bivalent siv vaccines,1
5297,97 recent h3n2 isolates,subtype,1
5301,protective ability,protective ability,1
1536,substitute,substitute,1
5304,match,match,1
5307,nonreactive h3n2 siv variants,subtype,1
5308,current commercial vaccines,current commercial vaccines,1
5313,h3n2 mutations,subtype,1
5314,207 isolates,207 isolates,1
10800,financial cost,financial cost,1
10799,diagnostic uncertainty,diagnostic uncertainty,1
5328,2005–2006 season,2005–2006 season,1
10798,otherwisehealthy individuals,otherwisehealthy individuals,1
5343,2010–2011 season,2010–2011 season,1
5345,2011–2012 season,2011–2012 season,1
5346,northern hemisphere 2012–2013 season,northern hemisphere 2012–2013 season,1
5348,northern hemisphere 2014–2015 season,northern hemisphere 2014–2015 season,1
5350,northern hemisphere 2015–2016 season,northern hemisphere 2015–2016 season,1
5351,h3n8,h3n8,1
5353,main cause,main cause,1
5357,related animals,related animals,1
10796,glaxo,glaxo,1
5358,donkeys,donkeys,1
5362,miami,miami,1
5368,widespread epidemics,widespread epidemics,1
5369,a/equine/2 strain,a/equine/2 strain,1
5372,americanlike lineage,americanlike lineage,1
1509,immunization practices,immunization practices,1
5455,submandibular lymph nodes,submandibular lymph nodes,1
5456,nasal conjunctival mucosa,nasal conjunctival mucosa,1
5536,wuhan,sub-province-level division big city city millions inhabitants human settlement,1
5537,epicenter,epicenter,1
1491,dose,dose,1
31,east asia,continent continental area surrounding islands,1
5543,sudden death,stock character psychopomp literary character,1
5545,a/chicken/nakornpatom/thailand/cuk2/04,a/chicken/nakornpatom/thailand/cuk2/04,1
5546,genetic structure related subtypes,genetic structure related subtypes,1
5547,genus alphainfluenzavirus,genus alphainfluenzavirus,1
5551,singlestrands,singlestrands,1
5556,na,na,1
5558,ns,ns,1
33,gregor horst,gregor horst,1
5563,segmentation,segmentation,1
5564,genetic recombination,genetic recombination,1
5566,previously uncontagious strain,previously uncontagious strain,1
5574,daniel r. lucey,daniel r. lucey,1
5575,codirector,codirector,1
1484,nhs,nhs,1
5579,preparedness,preparedness,1
1478,twoway street,twoway street,1
5596,future international response measures,future international response measures,1
5597,behalf,behalf,1
5598,white house,white house,1
10743,russian tests,russian tests,1
5612,alveoli,alveoli,1
5613,oxygen,oxygen,1
5615,usual route,usual route,1
5533,shaoyang city,shaoyang city,1
5530,inappropriate focus,inappropriate focus,1
1495,businesses,businesses,1
5526,interview,interview,1
5458,tachycardia,medical finding,1
5460,stiffness,stiffness,1
5462,important concept,important concept,1
5466,culling,culling,1
5473,airborne transmission,airborne transmission,1
5474,concerns,concerns,1
10770,specific antiviral action,specific antiviral action,1
5475,limited humantohuman transmission,limited humantohuman transmission,1
5480,edge,edge,1
1505,clinical workers,clinical workers,1
1504,protective items,protective items,1
29,1%,1%,1
5490,infected persons,infected persons,1
5290,h3n2 subtypes,subtype,1
5492,genetics,genetics,1
1502,disaster response organizations,disaster response organizations,1
10763,peerreviewed studies,peerreviewed studies,1
5500,disposal,disposal,1
5504,killing,killing,1
5506,447 cases,447 cases,1
10760,lobbying attempts,lobbying attempts,1
10758,arbidol,arbidol,1
5509,especially financial political social personal responses,especially financial political social personal responses,1
5510,billions,billions,1
10754,known overdose cases,known overdose cases,1
1497,possible school closures,possible school closures,1
5521,crisis response,crisis response,1
5523,nabarro,nabarro,1
10764,арбидол,арбидол,1
5289,late august,late august,1
1539,available methods,available methods,1
22,early modern europe,continental area surrounding islands continent geographic region,1
1596,fewer fatalities,fewer fatalities,1
10848,license agreement,license agreement,1
5025,wadden sea area,wadden sea area,1
5031,orthomyxovirus,orthomyxovirus,1
5032,h,h,1
5034,metabolic synergy,metabolic synergy,1
5035,red blood cells,biogenic substance type,1
9,charlemagne,charlemagne,1
1591,victims,victims,1
1590,bronchial tubes,bronchial tubes,1
10836,negatively charged zone,negatively charged zone,1
5041,diameter,diameter,1
5045,hormonal changes,hormonal changes,1
5048,growing fetus,growing fetus,1
5050,fever recover,fever recover,1
5053,prescription,prescription,1
5064,fort dix,fort dix,1
5079,genetic elements,genetic elements,1
1585,deadly waves,deadly waves,1
5089,31 974 cases,31 974 cases,1
5097,widespread rumors,widespread rumors,1
5098,entire atoll,entire atoll,1
5099,saudi arabian embassy,saudi arabian embassy,1
10835,catalytic site canyon,catalytic site canyon,1
5101,saudi monarch,saudi monarch,1
5105,30 confirmed cases,30 confirmed cases,1
5106,sports,sports,1
4,europe,continental area surrounding islands continent geographic region,1
5013,wikimedia commons,wikimedia commons,1
5011,bone diseases,bone diseases,1
5010,bone,bone,1
4947,certain strains,certain strains,1
4949,avian adaptation,avian adaptation,1
4957,likelihood,likelihood,1
10858,prophylaxis trials,prophylaxis trials,1
4962,scientific advances,scientific advances,1
1614,mechanical ventilation,mechanical ventilation,1
4964,genetic lethality potential,genetic lethality potential,1
1612,admission,admission,1
4973,possible prepandemic vaccines,possible prepandemic vaccines,1
10857,self reported investigator mediated pneumonia,cause death infectious disease,1
1610,immediate admission,immediate admission,1
4983,available vaccines,available vaccines,1
4985,idx184,idx184,1
5113,gujranwala,city big city city millions inhabitants,1
4987,reasonable effectiveness,reasonable effectiveness,1
4995,chemical substructure,chemical substructure,1
4996,benzodiazepines,benzodiazepines,1
1607,deterioration,deterioration,1
2,asia,continent continental area surrounding islands,1
4999,cyclopyrrones,cyclopyrrones,1
10854,risk ofone sneedtobehospitalizedortheriskof death,stock character psychopomp literary character,1
5001,anxiolytics,anxiolytics,1
5002,hypnotics,hypnotics,1
5004,gerd,gerd,1
5005,gastroprokinetic agents,gastroprokinetic agents,1
10852,affectstheriskofone sneedtobehospitalizedor risk,affectstheriskofone sneedtobehospitalizedor risk,1
5007,nsaids,nsaids,1
5009,antimigraine drugs,antimigraine drugs,1
1609,24 hours,24 hours,1
5617,movements,movements,1
1576,recent genetic analysis,recent genetic analysis,1
5119,30 cases,30 cases,1
5218,diseased pigs,diseased pigs,1
5219,certain mammals,certain mammals,1
1555,scientific journals,scientific journals,1
5229,swine h2n3,swine disease,1
1551,course,course,1
10816,joseph varghese,joseph varghese,1
5237,pathologic changes,pathologic changes,1
5240,significantly higher titers,significantly higher titers,1
1550,british report,british report,1
5242,blood plasma levels,biogenic substance type,1
5244,monocyte,monocyte,1
5245,chemotactic protein1,chemotactic protein1,1
10815,peter colman,peter colman,1
5247,human h2n2 infected animals,organisms known particular common homo sapiens homo sapiens sapiens homowikimedia disambiguation page,1
5248,previously published notion,previously published notion,1
20,variations,variations,1
10807,precautionary information,precautionary information,1
5255,surveillance efforts,surveillance efforts,1
5256,farmed pig populations,farmed pig populations,1
5265,h3n2 coat,subtype,1
5271,separate vaccines,separate vaccines,1
5272,northern southern hemispheres,northern southern hemispheres,1
5273,separate vaccines annual epidemics,separate vaccines annual epidemics,1
10802,bronchospasms,bronchospasms,1
5274,clear seasonality,clear seasonality,1
5278,overlapping epidemics,overlapping epidemics,1
1541,drugs,drugs,1
5215,overview,overview,1
5211,h9n2 candidate vaccines,h9n2 candidate vaccines,1
5210,lessons,lessons,1
10817,australian csiro,australian csiro,1
5125,iran,iran,1
5126,56 fatalities,56 fatalities,1
10830,potent specific inhibitors,potent specific inhibitors,1
5137,essential hallmarks,essential hallmarks,1
5138,ea,ea,1
1572,20th century,20th century,1
5141,implemented.michael ryan,implemented.michael ryan,1
5142,executive director,executive director,1
1570,annual epidemics,annual epidemics,1
10825,zanamivir strategy,chemical compound neuraminidase inhibitor medication,1
18,sicily,autonomous region special statute cultural region region italy,1
10822,biota,biota,1
10821,australian biotechnology company,australian biotechnology company,1
5117,midjanuary,midjanuary,1
5162,reported cases,reported cases,1
5164,alarm,alarm,1
10819,pharmacy,pharmacy,1
5165,h1n2,subtype,1
5170,latvia,sovereign state republic countries bordering baltic sea country,1
5183,1960s,1960s,1
5186,h2 hemagglutinin,group class proteins,1
5189,wild ducks,wild ducks,1
5195,test kits,test kits,1
5196,approximately 3 700 test kits,approximately 3 700 test kits,1
5198,college,college,1
5200,cap,cap,1
5202,unidentified samples,unidentified samples,1
10818,victorian college,victorian college,1
10820,monash university,monash university,1
6237,760 close contacts,760 close contacts,1
5619,fertilizer,fertilizer,1
5621,migrating waterfowl,migrating waterfowl,1
6019,markets,markets,1
1367,8 august,8 august,1
1366,cdc.in september,cdc.in september,1
10642,exogenous endogenous origin,exogenous endogenous origin,1
6032,seasons,seasons,1
6033,possibly combination,possibly combination,1
6037,previous experience,previous experience,1
6039,fall,fall,1
6040,h7n9 transmission,taxon,1
6042,widespread bird migratory patterns,taxon,1
6046,fifth,fifth,1
6049,security,security,1
6054,true distribution,true distribution,1
6055,surveillance artifact,surveillance artifact,1
6058,detected cases,detected cases,1
6063,twothirds,twothirds,1
1360,diabetes,diabetes,1
1356,higher risk,higher risk,1
6077,elderly men,elderly men,1
6080,danuta m. skowronski,danuta m. skowronski,1
10634,commonwealth war graves commission,commonwealth war graves commission,1
1353,diarrhea,diarrhea,1
6087,dengue fever,dengue fever,1
10633,war scientists,war scientists,1
6088,crossreactive antibodies,family protein complexes,1
1352,runny nose,runny nose,1
6091,related nonidentical variants,related nonidentical variants,1
59,constriction,constriction,1
10629,halifax port,halifax port,1
6014,director general,director general,1
6008,wild songbirds environment,wild songbirds environment,1
5934,closing,closing,1
5935,144 cases,144 cases,1
5937,surge,surge,1
5940,spike,spike,1
5945,unofficial number,unofficial number,1
10661,parasitology,parasitology,1
10658,pathogens,pathogens,1
1385,realtime rtpcr,realtime rtpcr,1
1384,patient,patient,1
10651,definition,definition,1
5953,larger group,larger group,1
55,royal courts,royal courts,1
5959,sequences,sequences,1
5962,ha origin,ha origin,1
5965,east asian flyway,east asian flyway,1
5970,health security,health security,1
5971,toronto interview,city single-tier municipality big city city millions inhabitants,1
5973,low path,low path,1
5975,deputy director,deputy director,1
10648,sepsis,sepsis,1
5988,purely human.in august,purely human.in august,1
5993,high security laboratories,high security laboratories,1
5996,organ failure,organ failure,1
6000,multiorgan failure,multiorgan failure,1
6002,75%,75%,1
6006,route,route,1
6007,wild songbirds,wild songbirds,1
6009,intermediate hosts,intermediate hosts,1
6092,quick response,quick response,1
6094,adequate supplies,adequate supplies,1
6099,existing seasonal vaccines,existing seasonal vaccines,1
6165,gisaid,gisaid,1
6180,researcher neil seeman,researcher neil seeman,1
10608,social variability,social variability,1
6182,toronto,city single-tier municipality big city city millions inhabitants,1
6183,internet users,internet users,1
6186,contagion awareness,contagion awareness,1
67,children,children,1
10604,social variation,social variation,1
6189,33%,33%,1
10603,social behavior,social behavior,1
6202,international response,international response,1
6204,reported cases 2013,reported cases 2013,1
6205,chp,chp,1
6208,jiangsu province,province china,1
6212,epidemiologic links,epidemiologic links,1
6214,close contacts,close contacts,1
6215,reported death,stock character psychopomp literary character,1
6216,second man,second man,1
6218,48yearold man,48yearold man,1
6222,death toll,stock character psychopomp literary character,1
6223,18 positive cases,18 positive cases,1
6224,positive cases,positive cases,1
6228,additional laboratoryconfirmed cases,additional laboratoryconfirmed cases,1
6230,85yearold man,85yearold man,1
6232,64yearold man,64yearold man,1
6233,24 cases,24 cases,1
6234,laboratory,laboratory,1
66,valleriola,valleriola,1
1328,terms,terms,1
10613,occupations,occupations,1
6162,j. craig venter institute data,j. craig venter institute data,1
6100,apdm09 vaccines,apdm09 vaccines,1
1350,joint pain,joint pain,1
1348,signs symptoms,signs symptoms,1
10628,male troops,male troops,1
6115,infected patient,infected patient,1
10627,biggest wave,biggest wave,1
10624,young men 20s,young men 20s,1
10623,young men,young men,1
10620,certain regions,certain regions,1
10618,wave men,wave men,1
6130,widespread transmission,widespread transmission,1
6131,nih,nih,1
1336,agricultural surveillance,agricultural surveillance,1
5932,avian populations,avian populations,1
10617,second waves,second waves,1
6139,request,request,1
6140,unprecedented immediate release,unprecedented immediate release,1
1334,pigs,pigs,1
6142,gisaid initiative,gisaid initiative,1
6143,j. craig venter institute,j. craig venter institute,1
6144,synthetic genomics vaccines,branch biology genome omics academic discipline,1
6148,scientific community,scientific community,1
1031,blood samples,biogenic substance type,1
10615,fishing,fishing,1
1330,academics,academics,1
6155,sharing,sharing,1
6157,initial worries,initial worries,1
1329,journalists,journalists,1
6138,dosesparing strategy.in response,dosesparing strategy.in response,1
5926,jager cm,jager cm,1
5925,koopmans m,koopmans m,1
10662,parasite,parasite,1
1443,analyses,analyses,1
10732,active substance,active substance,1
1439,0.3% crossreactive antibody reaction,family protein complexes,1
10731,registration certificate,registration certificate,1
5730,west virginia,west virginia,1
5732,affected flock slaughter,affected flock slaughter,1
5734,chicken turkey farming operations,sovereign state transcontinental country mediterranean country country social state regional power secular state,1
5736,30,30,1
5739,iowa,state united states,1
10730,sarscov2.in august,sarscov2.in august,1
10725,antiinfluenza activity,antiinfluenza activity,1
40,recent pandemics,recent pandemics,1
5746,british columbia,british columbia,1
5748,precautionary measure,precautionary measure,1
5749,st. catharines,st. catharines,1
5750,cfia,cfia,1
5752,compost,compost,1
5753,infected premises,infected premises,1
5754,dominican republic,dominican republic,1
5755,15 roosters,15 roosters,1
10723,bases,bases,1
1430,crossreactive antibody reaction,family protein complexes,1
1428,degree,degree,1
5760,northern province,northern province,1
10718,main principle action,main principle action,1
10717,nonnucleoside antiviral drugs,nonnucleoside antiviral drugs,1
5766,2016,2016,1
5711,sri lanka,sri lanka,1
1444,genetic sequences,genetic sequences,1
1445,isolates,isolates,1
5706,a/ chicken /ibaraki/1/2005,a/ chicken /ibaraki/1/2005,1
5622,diseasespreading hosts,diseasespreading hosts,1
5623,surfaces,surfaces,1
5624,fertilizer dust,fertilizer dust,1
1468,reassortment,reassortment,1
5631,dozens,dozens,1
5633,genetic clades,genetic clades,1
5634,specific isolates,specific isolates,1
1467,report,report,1
5641,severe neurological dysfunction,severe neurological dysfunction,1
1465,hybrid,hybrid,1
5656,37 °c,37 °c,1
36,middle east,middle east,1
5662,rotterdam,rotterdam,1
1424,u.s. centers,u.s. centers,1
5666,infected ferrets,infected ferrets,1
5669,respiratory droplets,respiratory droplets,1
5673,ostrich chicks,ostrich chicks,1
5674,conjunctivitis,conjunctivitis,1
5679,h5n2 humans,infectious disease france,1
5682,257 workers,257 workers,1
5683,35 chicken farms,35 chicken farms,1
1454,americans,americans,1
5697,low quality,low quality,1
10736,republic,republic,1
5698,korea,korea,1
10735,registration procedure,registration procedure,1
5703,40 chicken farms,40 chicken farms,1
5704,chicken farm,chicken farm,1
5668,aerosols,aerosols,1
5620,turn,turn,1
5772,australian test,australian test,1
1422,existing vaccines,existing vaccines,1
1403,researcher paul schreckenberger,researcher paul schreckenberger,1
1399,ridt false negatives,ridt false negatives,1
5865,alkharj,alkharj,1
5874,october–december,october–december,1
1397,2–4 hours,2–4 hours,1
5877,49 chicken poultry farms,organisms known particular common,1
1396,30 minutes,30 minutes,1
5881,15 places,15 places,1
10678,farming practices,farming practices,1
1393,widely available tests,widely available tests,1
1392,mere diagnosis,activity,1
5899,21 january,21 january,1
5900,5400 ducks,5400 ducks,1
49,island,island,1
5901,larger nationwide trend,larger nationwide trend,1
10670,temperature,temperature,1
5906,h7n2,h7n2,1
5907,mind,mind,1
10669,environmental survival,environmental survival,1
10667,infected avian sources,infected avian sources,1
5912,comparative pathobiology,comparative pathobiology,1
10663,fasciola hepatica,fasciola hepatica,1
5920,wild,wild,1
5921,laboratory studies,laboratory studies,1
5922,unusual zoonotic potential,unusual zoonotic potential,1
5923,du ry van beest holle m,du ry van beest holle m,1
5924,meijer,meijer,1
10683,wild water fowl,wild water fowl,1
5854,avian products,avian products,1
5849,zimbabwe,republic sovereign state landlocked country country,1
5848,harare,capital city big city city millions inhabitants,1
1420,tests results,tests results,1
10714,medsintez pharmaceutical,medsintez pharmaceutical,1
5786,intravenous pathogenicity index,intravenous pathogenicity index,1
10711,russian academy,russian academy,1
5790,kawaoka y,kawaoka y,1
5791,importance,importance,1
1417,previous realtime rtpcr diagnostic test,previous realtime rtpcr diagnostic test,1
5793,cleavage site,cleavage site,1
5795,1983,1983,1
5797,usual symptoms,usual symptoms,1
10706,452 fatalities,452 fatalities,1
1414,pdm realtime rtpcr panel,pdm realtime rtpcr panel,1
5806,18 january,18 january,1
10715,novel triazolotriazine core,novel triazolotriazine core,1
5807,duck chicken farms,duck chicken farms,1
5816,november 2016,november 2016,1
5819,israel,israel,1
1411,laboratory confirmation,laboratory confirmation,1
5824,combined death,stock character psychopomp literary character,1
5826,writing,writing,1
5829,symposium,symposium,1
5831,wild duck,wild duck,1
10697,possible mutation,possible mutation,1
5833,lincolnshire,lincolnshire,1
10693,phases,phases,1
1408,regret,regret,1
5841,uganda,uganda,1
1405,rapid tests,rapid tests,1
1412,clinical epidemiological backgrounds,clinical epidemiological backgrounds,1
10328,damaged bronchial tubes,damaged bronchial tubes,1
7463,australian vaccines,australian vaccines,1
7378,1.3 cases,1.3 cases,1
242,entire kingdom,entire kingdom,1
525,blood,biogenic substance type,1
523,wriothesley,wriothesley,1
520,kingdoms england scotland,nation uk cultural area countrynation uk nation,1
9051,royalties,royalties,1
10030,somewhat prolonged death bed,stock character psychopomp literary character,1
9055,generic remdesivir,chemical compound prodrug antiviral drug,1
9057,hetero drugs,hetero drugs,1
9063,expected course,expected course,1
9065,important effect,important effect,1
10028,recent war,recent war,1
9070,covid‑19.in november,covid‑19.in november,1
9074,esterases,esterases,1
9077,bioactivation,bioactivation,1
9078,substantial,substantial,1
509,phlegm,phlegm,1
9088,irreversible chain termination,irreversible chain termination,1
9089,chain terminators,chain terminators,1
244,countryside.coqueluche,countryside.coqueluche,1
9093,merscov,merscov,1
9095,incorporation,incorporation,1
505,shortness,shortness,1
9098,delayed chain terminator,delayed chain terminator,1
9102,activated nucleotide triphosphate form,activated nucleotide triphosphate form,1
10020,possible explanations,possible explanations,1
502,witness,witness,1
9104,pbmc,pbmc,1
9040,poor stability,poor stability,1
10014,historical epidemiological data,historical epidemiological data,1
9038,fresh raw materials,fresh raw materials,1
9031,gilead sciences entire stock,gilead sciences entire stock,1
237,september,september,1
10045,widely,widely,1
238,french poet,french poet,1
550,pain,pain,1
8988,−20 °c,−20 °c,1
8991,reversedphase hplc,reversedphase hplc,1
8992,optically pure compound,optically pure compound,1
8995,pure remdesivir,chemical compound prodrug antiviral drug,1
8996,chiral resolution methods,chiral resolution methods,1
9000,direction,direction,1
9001,scientist tomáš cihlář,scientist tomáš cihlář,1
9003,pneumoviruses,pneumoviruses,1
9005,academic institutions,academic institutions,1
543,span,span,1
542,alkmaar,municipality netherlands start time 1 january 1812gregorian,1
10040,1916 operetta,1916 operetta,1
9014,indication,indication,1
537,guise,guise,1
10038,nickname,nickname,1
9019,70 raw materials,70 raw materials,1
534,impending french assault,impending french assault,1
10036,senegal,senegal,1
9023,raw materials,raw materials,1
531,earl,earl,1
530,sufficient reinforcements,sufficient reinforcements,1
10035,purported origins,purported origins,1
241,epidemic,epidemic,1
9035,la verne,la verne,1
10013,false impression,false impression,1
499,toulouse,commune france follows tolosa big city,1
9111,travis warren,travis warren,1
9192,hospitalized individuals,hospitalized individuals,1
9194,highflow oxygen devices,highflow oxygen devices,1
9195,ecmo,ecmo,1
249,university professors,university professors,1
9987,court,court,1
250,intensity,intensity,1
9983,chris mcguigan team,chris mcguigan team,1
9204,early august,early august,1
251,jean fernel,jean fernel,1
9981,known molecules,known molecules,1
9209,albania,albania,1
9210,bosnia,bosnia,1
465,northern italy,northern italy,1
9213,kosovo,kosovo,1
9214,montenegro,montenegro,1
9976,middleincome countries,middleincome countries,1
9219,reuters,news agency,1
9221,total value,total value,1
9224,participating country,participating country,1
9225,orders,orders,1
9228,remdesivir ampoules,chemical compound prodrug antiviral drug,1
461,entire city,entire city,1
9963,fierce marketing war,fierce marketing war,1
255,1510 epidemic,1510 epidemic,1
9238,lópezgatell,lópezgatell,1
9241,sufficient efficacy,sufficient efficacy,1
458,lower,lower,1
9191,compassionate use recommendations,compassionate use recommendations,1
9188,orphan designation,orphan designation,1
473,spring,spring,1
9989,prodrug design,prodrug design,1
9112,usamriid principal investigator,usamriid principal investigator,1
9117,promising antiviral activity,promising antiviral activity,1
9119,kivu ebola epidemic,infectious disease,1
9122,mab114,monoclonal antibody,1
9123,regneb3,regneb3,1
9125,feline coronavirus,group class strains strain,1
9126,websites,websites,1
9127,social media,social media,1
9128,unregulated black market substance,unregulated black market substance,1
9137,hospitalized participants,hospitalized participants,1
494,intense coughing,intense coughing,1
9139,17 countries,17 countries,1
493,headaches,headaches,1
10049,high morbidity mortality rates,high morbidity mortality rates,1
488,languedoc region,languedoc region,1
9150,second randomized openlabel multicenter clinical trial,second randomized openlabel multicenter clinical trial,1
9151,hospitalized adult participants,hospitalized adult participants,1
10005,censors,censors,1
482,candidate,candidate,1
9162,mortality rates,mortality rates,1
10003,successive waves,successive waves,1
479,graduate studies,graduate studies,1
9999,pipeline update,pipeline update,1
9169,sufficient supply,sufficient supply,1
477,late summer,late summer,1
9178,deal,deal,1
9993,increasing numbers,increasing numbers,1
9183,midnovember,midnovember,1
9149,clinical improvement,clinical improvement,1
9244,compassionate use,compassionate use,1
8978,weakly acidic aqueous solution,weakly acidic aqueous solution,1
8973,−108 °f,−108 °f,1
8767,mengovirus,mengovirus,1
8768,picornavirus family,taxon,1
8769,enteric tract,enteric tract,1
8770,primarily nose,primarily nose,1
8772,33 °c,33 °c,1
8773,lower temperature,lower temperature,1
617,war,war,1
8783,vp0,vp0,1
8785,icosahedral,icosahedral,1
8786,triangulation number,triangulation number,1
8788,60 triangles,60 triangles,1
8790,subunit,subunit,1
8791,corner,corner,1
614,true plague,true plague,1
612,granada,granada,1
609,pestilencia,pestilencia,1
606,sixteenth century spaniards,sixteenth century spaniards,1
8811,poly tail,poly tail,1
8813,ends,ends,1
605,east europe,continental area surrounding islands continent geographic region,1
8815,500–1200 nucleotides,500–1200 nucleotides,1
8817,30–650,30–650,1
604,contagious seasonal pneumonias,contagious seasonal pneumonias,1
10082,albert gitchell,albert gitchell,1
8827,stemloopstructure,stemloopstructure,1
8828,cre,cre,1
8830,3’ end elements,3’ end elements,1
8762,poliovirus infected cells,taxon,1
8832,poly tract,poly tract,1
222,east,east,1
10103,signing,signing,1
8695,mitochondrial cytochrome c release,mitochondrial cytochrome c release,1
8696,cleavage,cleavage,1
10114,deadly second wave late 1918,deadly second wave late 1918,1
8699,initiation,initiation,1
8700,apoptotic cascade,apoptotic cascade,1
8703,mitochondria,mitochondria,1
8706,apoptotic pathway,apoptotic pathway,1
637,epidemic ottoman soldiers,epidemic ottoman soldiers,1
10112,half british forces,half british forces,1
636,territory,territory,1
10110,military operations,military operations,1
632,ottomans,ottomans,1
631,massawa,city port settlement,1
8725,vertebrates,vertebrates,1
8730,family picornaviridae,taxon,1
8731,order picornavirales,order picornavirales,1
8736,genera enterovirus,taxon,1
627,emperor gelawdewos,emperor gelawdewos,1
8743,insensitivity,insensitivity,1
10109,reported quarantines,reported quarantines,1
8746,rhinovirus,taxon,1
218,merchants,merchants,1
8750,measurement,measurement,1
8753,genus aphthovirus,taxon,1
8754,picornaviridae family,taxon,1
623,andrés oviedo,andrés oviedo,1
8758,molecular building blocks,molecular building blocks,1
220,travelers,travelers,1
8834,important element,important element,1
10077,1918 nih interviews,1918 nih interviews,1
8838,poliovirus translation initiation,taxon,1
8925,organ impairment,organ impairment,1
8926,low albumin,low albumin,1
8930,elevated bilirubin,elevated bilirubin,1
8933,elevated transaminase levels,elevated transaminase levels,1
8935,electrocardiogram abnormalities,electrocardiogram abnormalities,1
569,flemish physician rembert dodoens,flemish physician rembert dodoens,1
568,low countries,low countries,1
8941,blood plasma concentrations,biogenic substance type,1
10058,significantly risk,significantly risk,1
566,needy,needy,1
565,food,food,1
10056,reconstruction,reconstruction,1
233,august,august,1
563,higher death toll,stock character psychopomp literary character,1
8948,hydroxychloroquine sulfate,chemical compound medication essential medicine,1
8950,antagonistic effect,antagonistic effect,1
8953,ribose derivatives,ribose derivatives,1
236,entire country,entire country,1
8957,coauthors,coauthors,1
8959,phenyl,phenyl,1
8961,dichloromethane,dichloromethane,1
8962,triple benzylprotected ribose,triple benzylprotected ribose,1
8964,acetic anhydride,acetic anhydride,1
8965,lactone intermediate b,lactone intermediate b,1
8966,pyrrolo,pyrrolo,1
8971,halogenlithium exchange reaction,halogenlithium exchange reaction,1
8972,−78 °c,−78 °c,1
8924,blood biomarkers,biogenic substance type,1
574,madrid,municipality spain city big city city millions inhabitants capital,1
10059,tuberculosis,notifiable disease valid place switzerland endemic disease,1
8914,gs5734,gs5734,1
8841,cap independent initiation,cap independent initiation,1
8843,viral particle binds,viral particle binds,1
10068,bubonic plague,bubonic plague,1
8851,cd155 receptor,cd155 receptor,1
595,pernicious symptoms,pernicious symptoms,1
8853,conformational change,conformational change,1
8856,pore,pore,1
8859,7methylguanosine cap,7methylguanosine cap,1
594,double tertian type,double tertian type,1
8861,minus,minus,1
10067,black death,stock character psychopomp literary character,1
10062,scholars,scholars,1
8872,presatovir,presatovir,1
8977,intermediate c dropwise,intermediate c dropwise,1
8879,97% clearup rate,97% clearup rate,1
8884,assortment,assortment,1
8885,chromosomes,chromosomes,1
8886,chromosomal crossover,chromosomal crossover,1
10061,tuberculosis cases,notifiable disease valid place switzerland endemic disease,1
8891,minichromosomes,minichromosomes,1
585,fatal peripneumony,fatal peripneumony,1
232,heart,heart,1
583,nose,nose,1
8899,hhmi.org,hhmi.org,1
580,weight,weight,1
8909,infusionrelated reaction,infusionrelated reaction,1
8910,low blood pressure,biogenic substance type,1
8912,international nonproprietary,international nonproprietary,1
8880,mixing,mixing,1
9245,fda commissioner stephen hahn,fda commissioner stephen hahn,1
456,epidemic control,epidemic control,1
454,contagious catarrhal fevers,contagious catarrhal fevers,1
9612,janssen pharmaceutica,janssen pharmaceutica,1
9616,1 infected subjects,1 infected subjects,1
9620,rbv,rbv,1
9621,chc,chc,1
359,1559 wave,1559 wave,1
9625,men,men,1
9854,ribavirin fetus,chemical compound medication essential medicine 1 april 1990,1
9628,rash,rash,1
9632,ns3/4a protease inhibitor,ns3/4a protease inhibitor,1
355,red sea,red sea,1
9639,prevalent form,prevalent form,1
9641,cyp2c19 enzymes,cyp2c19 enzymes,1
9853,pregnancy category x,physiological condition,1
9852,pregnancy outcomes,physiological condition,1
9648,peginterferon alfa,peginterferon alfa,1
352,northern eastern parts,northern eastern parts,1
9650,baseline,baseline,1
9651,q80k polymorphism,q80k polymorphism,1
9652,cyp3a4 substrate,cyp3a4 substrate,1
9654,strong cyp3a4 inhibitors,strong cyp3a4 inhibitors,1
9655,strong cyp3a4 inducers,strong cyp3a4 inducers,1
9850,pregnancy breastfeeding,physiological condition,1
9658,randomized doubleblind placebo controlled clinical trials,randomized doubleblind placebo controlled clinical trials,1
9664,racial ethnic minorities,racial ethnic minorities,1
349,newly established trade routes,newly established trade routes,1
9668,pratt vm,pratt vm,1
9670,rubinstein ws,rubinstein ws,1
9603,90s,90s,1
348,wave,wave,1
9602,80s,80s,1
363,humorism,theory,1
380,diet,diet,1
9514,m2 channel pore,m2 channel pore,1
9515,senantiomer,senantiomer,1
9517,electrophysiology studies,electrophysiology studies,1
9524,channel pore,channel pore,1
9527,arboviruses,arboviruses,1
9528,saint louis ecephalitis,saint louis ecephalitis,1
9529,sindbis,sindbis,1
9535,fluzone/fluzone quadrivalent,fluzone/fluzone quadrivalent,1
9540,csl subsidiary,csl subsidiary,1
9544,flulaval,flulaval,1
9546,mylan,pharmaceutical company multinational corporation business,1
9550,abbott laboratoriesin,abbott laboratoriesin,1
9552,solvay pharmaceuticals,solvay pharmaceuticals,1
9553,solvay pharmaceuticals $6.2 billion purchase,solvay pharmaceuticals $6.2 billion purchase,1
9862,accidental pregnancy,physiological condition,1
299,miscarriages,miscarriages,1
374,mulberries,mulberries,1
9561,mylan laboratories,pharmaceutical company multinational corporation business,1
9860,months posttreatment,months posttreatment,1
9563,developed markets,developed markets,1
9858,pregnancy test,physiological condition,1
300,english names,english names,1
369,excess humors physicians,excess humors physicians,1
367,entire communities,entire communities,1
9579,pediatric use,pediatric use,1
9584,8 °c,8 °c,1
9593,vaxigriptetra,vaxigriptetra,1
9672,biotechnology information,biotechnology information,1
9673,bookshelf id,bookshelf id,1
9675,dosing,dosing,1
9826,management,management,1
305,established trade pilgrimage routes,established trade pilgrimage routes,1
9819,similar phosphoramidate prodrug technology,academic discipline,1
325,rest,rest,1
9744,specific contraindications,specific contraindications,1
324,scotland,nation uk nation,1
9746,irritability,irritability,1
9749,3–6%,3–6%,1
9753,abnormally slow heartbeats,abnormally slow heartbeats,1
321,fevers,fevers,1
9758,intestinal epithelium cells,intestinal epithelium cells,1
320,epidemics,epidemics,1
9761,absorption,absorption,1
319,food scarcity,food scarcity,1
9763,antimycobacterials,antimycobacterials,1
9767,ciclosporin,chemical compound medication essential medicine reactant reactant,1
9817,tenofovir alafenamide,tenofovir alafenamide,1
9774,nucleoside analogs,nucleoside analogs,1
9776,relatively low potency,relatively low potency,1
316,death rates,stock character psychopomp literary character,1
9814,low costs,low costs,1
9809,controversies,controversies,1
310,plague,plague,1
9808,sofosbuvi,sofosbuvi,1
9790,scientist,scientist,1
9792,hepc,hepc,1
9806,u.s. market,u.s. market,1
9738,30 97%,30 97%,1
9829,close 100%,close 100%,1
328,contemporary scholars,contemporary scholars,1
9832,genotype costeffectiveness–based perspective,genotype costeffectiveness–based perspective,1
9849,retreatment,retreatment,1
345,gulf area,gulf area,1
9688,monthly pregnancy tests,physiological condition,1
9690,ribavirin pregnancy registry,chemical compound medication essential medicine 1 april 1990physiological condition,1
9848,consideration,consideration,1
9694,h5n1 pandemicthe social impact,subtype,1
9697,financial,financial,1
9841,fourfold reduced duration,fourfold reduced duration,1
9700,danger,danger,1
9838,sofosbuvirbased regimens,sofosbuvirbased regimens,1
9706,valuations,valuations,1
9707,trillions,trillions,1
336,european death rates,stock character psychopomp literary character,1
298,epidemic responses,epidemic responses,1
9710,investors,investors,1
9715,political,political,1
9836,weightbased ribavirin,chemical compound medication essential medicine 1 april 1990,1
9718,social,social,1
9719,personal,personal,1
9720,web sites,web sites,1
9722,advertising space,advertising space,1
9723,personal fear,personal fear,1
9725,dr. david nabarro,dr. david nabarro,1
9728,pop culture,pop culture,1
9729,barenaked ladies,barenaked ladies,1
331,damp weather,damp weather,1
9731,drumstick,drumstick,1
9735,costs,costs,1
9712,accordance,accordance,1
9511,solid state nmr studies,solid state nmr studies,1
9508,flumadine,flumadine,1
9507,rimantadine enantiomers interactions m2,chemical compound medication,1
9910,diana degette,diana degette,1
432,sofia,sofia,1
9319,vivo activity,vivo activity,1
429,bulgaria,bulgaria,1
9324,useful activity,useful activity,1
9325,canine distemper,canine distemper,1
428,balkans,balkans,1
9332,acyclovir,acyclovir,1
9333,possible use,possible use,1
9334,especially acute myeloid leukemia,especially acute myeloid leukemia,1
275,noteworthy murrain,noteworthy murrain,1
426,infected travelers,infected travelers,1
9339,didanosine,didanosine,1
9340,mitochondrial toxicity,mitochondrial toxicity,1
9342,guanosine,"""purine ribonucleoside 5-triphosphate"" product participant cargo reactant",1
9347,international chemical nuclear corporation,international chemical nuclear corporation,1
9348,joseph t. witkovski,joseph t. witkovski,1
9349,roland k. robins,roland k. robins,1
9350,undue toxicity,undue toxicity,1
423,trade shipping routes,trade shipping routes,1
421,ottoman empire east europe,continental area surrounding islands continent geographic region,1
9356,replacement,replacement,1
9359,carbon,carbon,1
9361,imidazole riboside derivatives,imidazole riboside derivatives,1
9363,halide,halide,1
9365,smaller activity,smaller activity,1
418,ages,ages,1
270,epidemiological study,epidemiological study,1
9307,pregnancy results,physiological condition,1
268,fernel,fernel,1
9305,red blood cell breakdown,biogenic substance type,1
9960,licenses,licenses,1
257,heaviness,heaviness,1
9262,seemingly capricious decisionmaking,seemingly capricious decisionmaking,1
9263,frustration,frustration,1
261,1510 peste,1510 peste,1
9270,florida,florida,1
9274,announcements,announcements,1
9947,delhi high court,delhi high court,1
9276,allocation,allocation,1
9278,implications,implications,1
9279,current needs,current needs,1
9280,28 august,28 august,1
9941,successful outcome,successful outcome,1
9371,unacceptable toxicity,unacceptable toxicity,1
9285,remdesivir allocation,chemical compound prodrug antiviral drug,1
263,colleges,colleges,1
9287,amerisourcebergen,business enterprise,1
9931,nhs england,nation uk cultural area country,1
9930,400 mg,400 mg,1
9921,comparable western developed countries,comparable western developed countries,1
267,foreign account,foreign account,1
9919,specialty drugs,specialty drugs,1
9295,ribavirin \ alsoknownas,chemical compound medication essential medicine 1 april 1990,1
437,tripoli,tripoli,1
9299,lassa fever,lassa fever,1
9300,crimean–congo hemorrhagic fever,crimean–congo hemorrhagic fever,1
9303,headache nausea,headache nausea,1
9304,irritable mood,irritable mood,1
443,continental europe,continental area surrounding islands continent geographic region,1
8690,foreign antigen,group class chemical substances,1
276,cattle,organisms known particular common bos taurus bos primigenius taurus bos taurus taurus bos primigenius indicus bos indicus,1
9378,cytosine,chemical compound,1
289,charles creighton,charles creighton,1
9457,tricyclo)decane1methanamine,tricyclo)decane1methanamine,1
9877,chain terminator,chain terminator,1
290,descriptions,descriptions,1
9461,rimant,rimant,1
291,catarrhal fevers,catarrhal fevers,1
9462,.alpha,.alpha,1
9465,maybridge1002066,maybridge1002066,1
9466,schembl2981,schembl2981,1
9468,schembl2619249,schembl2619249,1
9471,ctk6a4437,ctk6a4437,1
9872,nucleophile foranincomingntpasimilarnucleotideanalogue2 deoxy2 αfluoroβcmethylcytidineisproposedtoactasachainterminatorbecausethe2methylgroupofthenucleotideanaloguecausesastericclashwith incoming ntp,nucleophile foranincomingntpasimilarnucleotideanalogue2 deoxy2 αfluoroβcmethylcytidineisproposedtoactasachainterminatorbecausethe2methylgroupofthenucleotideanaloguecausesastericclashwith incoming ntp,1
9479,stk177253,stk177253,1
294,greatest intensity,greatest intensity,1
9481,akos000264537,akos000264537,1
9483,bbv156986,bbv156986,1
9868,gs461203,gs461203,1
9484,ccg236078,ccg236078,1
9485,cs2380,cs2380,1
9487,fch3207896,fch3207896,1
9488,mcule9027470290,mcule9027470290,1
9492,proton transport,proton transport,1
9496,genetic studies,genetic studies,1
9499,virion m2 gene,virion m2 gene,1
9502,certain locations,certain locations,1
9504,m2,m2,1
9505,mutation s31n binding site,mutation s31n binding site,1
9456,ethyl]amine hydrochloride,ethyl]amine hydrochloride,1
9454,tricyclodecane1methanamine,tricyclodecane1methanamine,1
9452,brn,brn,1
9445,alphamethyladamantanemethylamine,alphamethyladamantanemethylamine,1
9380,hypermutation,hypermutation,1
9383,mystery,mystery,1
9384,complete inactivity,complete inactivity,1
9389,ribavirin 5 monophosphateinhibits cellular inosine monophosphate dehydrogenase,chemical compound medication essential medicine 1 april 1990,1
9899,2.5%,2.5%,1
279,iberian peninsula,iberian peninsula,1
9392,gtp,gtp,1
9393,cited paper,cited paper,1
408,rashes,rashes,1
9897,single 400 mg oral dose,single 400 mg oral dose,1
9399,generic forms,generic forms,1
9402,successful ribavirin derivative,chemical compound medication essential medicine 1 april 1990,1
9405,j. t. witkowski,j. t. witkowski,1
9375,base analog,base analog,1
9892,enzyme histidine triad nucleotidebinding protein,enzyme histidine triad nucleotidebinding protein,1
404,19th century,19th century,1
9890,cathepsin,cathepsin,1
9409,property,property,1
9413,second property,second property,1
9415,enzymes,enzymes,1
9885,gs331077,gs331077,1
9418,rimantadine rimantadine,chemical compound medicationchemical compound medication,1
9420,derivates,derivates,1
9426,rimantadine isknowntoreducethebody suptakeofrimantadineby approximately 12%,chemical compound medication,1
395,death,stock character psychopomp literary character,1
9440,rimantadine fromthecorrespondingketoneoximewerebasedonprichard smethodsofsynthesisofrimantadinefrom corresponding ketone oxime,chemical compound medication,1
9442,rimantadine fromthecorrespondingketoneoximewerebasedonprichard smethodsofsynthesisofrimantadinefrom corresponding ketone oxime reduction,chemical compound medication,1
288,lazare rivière,lazare rivière,1
9406,similar spectrum,similar spectrum,1
7374,eggbased techniques,eggbased techniques,1
10115,boston,big city city united states,1
650,modern transport infrastructure,modern transport infrastructure,1
7781,p70s6,p70s6,1
168,sicily italian kingdoms,autonomous region special statute cultural region region italy,1
7786,csn5containing cop9 signalosome,csn5containing cop9 signalosome,1
7791,nfκb,nfκb,1
169,cases,cases,1
7802,dengue,dengue,1
7804,herpesvirus family,herpesvirus family,1
7814,irf9,irf9,1
7815,poxviruses,poxviruses,1
910,680 deaths,680 deaths,1
7817,—that bind,—that bind,1
909,midmay,midmay,1
7824,sigma,sigma,1
171,arrival,arrival,1
10243,lower rates,lower rates,1
7842,lindenmann,lindenmann,1
7844,chicken embryo chorioallantoic membranes,chicken embryo chorioallantoic membranes,1
7848,isaacs,isaacs,1
7849,isaacs lindenmann results,isaacs lindenmann results,1
7851,1957 publication,1957 publication,1
899,response,response,1
897,second wave,second wave,1
7856,tokyo—,tokyo—,1
10240,tissue samples,tissue samples,1
7865,1959 publication,1959 publication,1
7867,somatic cell genetics,somatic cell genetics,1
7875,fibroblast cells,fibroblast cells,1
7780,pi3k,pi3k,1
10237,newfoundland,newfoundland,1
7779,p38 map kinase,p38 map kinase,1
7776,nuclear adaptor,nuclear adaptor,1
940,u.s. death toll,stock character psychopomp literary character,1
163,mecca,tourist attraction city millions inhabitants,1
7730,receptors,receptors,1
7732,specific receptors,specific receptors,1
7734,signal transducer,signal transducer,1
7738,certain immune genes,certain immune genes,1
7741,stat activation,stat activation,1
7742,welldefined cell signaling pathway,welldefined cell signaling pathway,1
7743,pathway,pathway,1
7744,jaks,jaks,1
10268,denial,denial,1
10267,lies,lies,1
7746,receptor engagement,receptor engagement,1
7747,stat1,gene,1
10262,combat chemical attacks susceptibility,combat chemical attacks susceptibility,1
166,egypt,emoji regional indicator sequence,1
10256,massive troop movements,massive troop movements,1
7753,isgf3,isgf3,1
7755,specific regulatory elements,specific regulatory elements,1
7758,interferome,biological database,1
7761,stat homodimers,stat homodimers,1
7765,ifnactivated site elements,ifnactivated site elements,1
7768,isre gas elements,isre gas elements,1
10254,transmission mutation,transmission mutation,1
7771,gas element,gas element,1
10253,original hosts,original hosts,1
7774,crk family,crk family,1
921,pictures,pictures,1
7880,sufficient amounts,sufficient amounts,1
7883,nterminal analyses,nterminal analyses,1
7884,unusually hydrophobic glycoprotein,unusually hydrophobic glycoprotein,1
7961,acip,acip,1
7966,genetic reassortment,genetic reassortment,1
10223,main disseminators,main disseminators,1
7971,centrifuges,centrifuges,1
7972,sucrose gradient,disaccharide chemical compound product reactant reactant reactant reactant reactant reactant cargo cargo cargo cargo cargo cargo reactant sucrose phosphorylase activity,1
7973,sucrose,disaccharide chemical compound product reactant reactant reactant reactant reactant reactant cargo cargo cargo cargo cargo cargo reactant sucrose phosphorylase activity,1
7974,arginine,biological process,1
7978,certain chronic diseases,certain chronic diseases,1
7986,michigan,michigan,1
848,presence,presence,1
7989,mountain view,mountain view,1
7990,sponsorship,sponsorship,1
7991,fdaapproved lots,fdaapproved lots,1
7998,changchun bcht biotechnology,changchun bcht biotechnology,1
8003,candidates,candidates,1
8005,near future,near future,1
8009,serum institute,serum institute,1
8011,bangladesh,bangladesh,1
10216,claude hannoun,claude hannoun,1
8016,modifiability,modifiability,1
8017,light,light,1
835,recombination,recombination,1
8033,kanta subbarao,kanta subbarao,1
8035,base,base,1
8039,virusspecific ctls,virusspecific ctls,1
8040,mucosal serum antibodies,family protein complexes,1
8044,viruses.in september,viruses.in september,1
858,school closures,school closures,1
177,central europe,continental area surrounding islands continent geographic region,1
7956,50% cases,50% cases,1
7954,poor effectiveness,poor effectiveness,1
10236,newfoundland inst.john sbasedhumphriesofthememorialuniversityofnewfoundlandinst.johnconclusionson newly unearthed records,newfoundland inst.john sbasedhumphriesofthememorialuniversityofnewfoundlandinst.johnconclusionson newly unearthed records,1
880,mark a.,mark a.,1
7901,autoimmune disorder,autoimmune disorder,1
7908,chronic myeloid leukemia,chronic myeloid leukemia,1
10235,memorial university,memorial university,1
7910,cutaneous tcell lymphoma,cutaneous tcell lymphoma,1
10234,based humphries,based humphries,1
7911,recurrent melanomas,recurrent melanomas,1
874,lone,lone,1
7916,formulation,formulation,1
7917,interferonalpha2b,interferonalpha2b,1
7920,pegylated drugs,pegylated drugs,1
7924,interferoncontaining regimens,interferoncontaining regimens,1
7723,induction interferons,induction interferons,1
7925,protease inhibitors,protease inhibitors,1
871,chowell,chowell,1
870,readings,readings,1
868,factories,factories,1
10232,newfoundland inst.john sbasedhumphriesofthememorialuniversityofnewfoundlandin st. john,newfoundland inst.john sbasedhumphriesofthememorialuniversityofnewfoundlandin st. john,1
10231,memorial university ofnewfoundlandinst.john sbasedhumphriesofthememorialuniversityof newfoundland,memorial university ofnewfoundlandinst.john sbasedhumphriesofthememorialuniversityof newfoundland,1
865,second half,second half,1
7937,wholly owned subsidiary,wholly owned subsidiary,1
10230,humphries,humphries,1
7938,biota scientific management pty,biota scientific management pty,1
863,15%,15%,1
7943,laiv effectiveness,laiv effectiveness,1
7948,intramuscular injection,intramuscular injection,1
7953,instead type,instead type,1
7926,boceprevir,medication group stereoisomers,1
10214,political scientist andrew pricesmith,political scientist andrew pricesmith,1
7721,beneficial action,beneficial action,1
10277,modern pandemics,modern pandemics,1
1003,village,village,1
7456,nonclinical staff,nonclinical staff,1
7458,laboratory staff,laboratory staff,1
155,timelines,timelines,1
1000,area main source,area main source,1
7462,teaching hospital,teaching hospital,1
9798,interferonbased regimen,interferonbased regimen,1
7464,annual reformulation,annual reformulation,1
7469,coming season,coming season,1
7472,quadrivalent vaccines,quadrivalent vaccines,1
7473,contents,contents,1
7482,2019–2020,2019–2020,1
7483,2020–2021,2020–2021,1
7484,quadrivalent formulation,quadrivalent formulation,1
7487,following,following,1
10307,limbs,limbs,1
7493,ancient art,ancient art,1
7499,success.in,success.in,1
7504,growth,growth,1
7505,thomas francis,thomas francis,1
7506,jonas salk,jonas salk,1
7507,wilson smith,wilson smith,1
7512,approved inactivated vaccines,approved inactivated vaccines,1
7513,second world war,second world war,1
156,sickness,sickness,1
7515,purity,purity,1
7518,systemic reactivity,systemic reactivity,1
153,1510 sudden symptoms,1510 sudden symptoms,1
7520,recombinant proteins,group class chemical substances second-order class,1
7451,high service demand,high service demand,1
10312,peculiar smell,peculiar smell,1
1027,culling operations,culling operations,1
10324,petechial hemorrhages,petechial hemorrhages,1
1026,government response,government response,1
10322,intestine,intestine,1
10321,mucous membranes,mucous membranes,1
1023,spot,spot,1
7391,thiomersal,chemical compound excipient,1
10320,hemorrhage,hemorrhage,1
10318,impaired color vision,impaired color vision,1
7408,financial logistics burden,financial logistics burden,1
10315,hearing,hearing,1
7411,sufficient antibodies,family protein complexes,1
7413,australian government,australian government,1
7415,inactivated vaccines,inactivated vaccines,1
1015,overreaction,overreaction,1
7424,patient reminders,patient reminders,1
1013,unnecessary panic,unnecessary panic,1
7426,letters,letters,1
1012,media,media,1
7431,free vaccinations,free vaccinations,1
7434,physician competition,physician competition,1
7437,2010 survey,2010 survey,1
7439,63.5%,63.5%,1
1009,reason,reason,1
7442,previous season,previous season,1
10314,hair,hair,1
7448,main reason,main reason,1
7450,staff absence,staff absence,1
7523,primary method,primary method,1
10304,cheekbones,cheekbones,1
988,1977 reemergent lineage,1977 reemergent lineage,1
162,jerusalem,city big city capital city council,1
7651,dr. john j. treanor,dr. john j. treanor,1
7656,microgram,microgram,1
7657,dr. david e. swayne,dr. david e. swayne,1
7658,dinosaurs.\ researchers,dinosaurs.\ researchers,1
10281,copenhagen,copenhagen,1
7674,scheringplough,scheringplough,1
7675,alfa r.it,alfa r.it,1
7676,indications,indications,1
7677,cancers,cancers,1
10279,social upheaval,social upheaval,1
7684,carcinoid tumor,carcinoid tumor,1
955,laboratory accident,laboratory accident,1
7686,malignant melanoma,rare disease,1
7687,peerreviewed scientific literature,peerreviewed scientific literature,1
7689,galveston,galveston,1
953,unusual characteristics,unusual characteristics,1
7692,novel coronavirus,group class strains strain,1
7693,vitro,vitro,1
7697,second study,second study,1
7699,77 moderate covid19 subjects,77 moderate covid19 subjects,1
7702,inflammatory cytokine,inflammatory cytokine,1
7703,offlabel,offlabel,1
946,northern china,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",1
7709,introna summary,introna summary,1
7710,product characteristics,product characteristics,1
10278,deadlier strains,deadlier strains,1
961,students,students,1
962,areas,areas,1
7637,chicken vaccines,chicken vaccines,1
10284,lesslethal wave,lesslethal wave,1
987,certain reanalysis,certain reanalysis,1
7540,400 excess hospitalizations,400 excess hospitalizations,1
7545,significantly enhanced immune response,significantly enhanced immune response,1
7557,fluzone highdose quadrivalent,fluzone highdose quadrivalent,1
982,deliberate release,deliberate release,1
7564,novel technologies,novel technologies,1
981,origin theories,origin theories,1
980,laboratory leak,laboratory leak,1
7574,active immunization,active immunization,1
10300,player,player,1
7578,design,design,1
10299,fatal cases,fatal cases,1
7582,broadly neutralizing antibodies,family protein complexes,1
7720,tumor growth,tumor growth,1
7583,annual seasonal vaccines,annual seasonal vaccines,1
7592,projects,projects,1
973,u.s,u.s,1
7595,tcell response,tcell response,1
10286,lethal second wave,lethal second wave,1
7596,strong early tcell response,strong early tcell response,1
971,solely students,solely students,1
7607,seven m001 trials,seven m001 trials,1
7609,m001,m001,1
7611,12 400 participants,12 400 participants,1
7625,primary course,primary course,1
7626,boosters,boosters,1
965,following months,following months,1
7629,bits,bits,1
10289,rapid decline,rapid decline,1
8047,deoxycytidine analog,deoxycytidine analog,1
8050,enzyme inosine monophosphate dehydrogenase,enzyme inosine monophosphate dehydrogenase,1
830,h3n2,subtype,1
8480,policymakers,policymakers,1
711,total death toll,stock character psychopomp literary character,1
8487,communityacquired pneumonia,cause death infectious disease,1
8490,otitis media,otitis media,1
8491,18 hours,18 hours,1
706,thomas smith,thomas smith,1
207,northern europe,continental area surrounding islands continent geographic region,1
8499,increased rates,increased rates,1
8501,sufficient numbers,sufficient numbers,1
703,east coast,east coast,1
8505,widespread use,widespread use,1
10148,11 november,11 november,1
209,west,west,1
697,birmingham,association football club,1
8520,antiviral resistance inability,antiviral resistance inability,1
10146,celebrations,celebrations,1
8522,surveillance studies,surveillance studies,1
8524,proportion,proportion,1
8526,99.4%,99.4%,1
10145,russian civil war,russian civil war,1
8528,99.1%,99.1%,1
10144,russia intervention,empire start time 22 october 1721julian end time 1 september 1917julian 1 september 1917julian,1
696,london,london,1
8530,h3n,h3n,1
8534,0%,0%,1
8535,3.3%,3.3%,1
8537,weakened immune response,weakened immune response,1
8478,healthcare policymakers,healthcare policymakers,1
8539,japanese investigators,japanese investigators,1
713,buenos aires,buenos aires,1
8469,– m2 inhibitors,– m2 inhibitors,1
10169,detroit,detroit,1
8406,drugattributable adverse events,drugattributable adverse events,1
8407,pregnancy category c,physiological condition,1
8408,category b,category b,1
740,contagious quick action,contagious quick action,1
739,66 fatalities,66 fatalities,1
8414,15 studies,15 studies,1
10165,scandinavia,scandinavia,1
10164,isolated areas,isolated areas,1
8419,substantial number,substantial number,1
736,hold,hold,1
8422,prolonged shedding,prolonged shedding,1
8425,firstpass,firstpass,1
10163,fourth wave,fourth wave,1
8429,6–10 hours,6–10 hours,1
8435,doubleblinded randomized placebocontrolled clinical trials,doubleblinded randomized placebocontrolled clinical trials,1
10162,fourth wave 1920,fourth wave 1920,1
8443,high demand,high demand,1
728,northern hemisphere,northern hemisphere,1
8446,congress,congress,1
10161,tens thousands,tens thousands,1
10160,overall american mortality rates,overall american mortality rates,1
10159,st. louis,st. louis,1
8454,oseltamivir low effectiveness,chemical compound neuraminidase inhibitor medication essential medicine,1
10157,memphis,memphis,1
203,austria father,sovereign state start time 12 november 1918gregorian republic rechtsstaat landlocked country country state,1
204,holy roman emperor maximilian,holy roman emperor maximilian,1
8472,pediatrics,pediatrics,1
210,england,nation uk cultural area country,1
694,lyon,commune france big city,1
211,infected sailors,infected sailors,1
10128,coast,coast,1
8629,use adjuvant,use adjuvant,1
666,transcaspian,transcaspian,1
8634,ribavirin cure rates,chemical compound medication essential medicine 1 april 1990,1
8635,24 92%,24 92%,1
8637,blood clots,biogenic substance type,1
8640,alfa2a,alfa2a,1
8641,neovascular agerelated macular degeneration,neovascular agerelated macular degeneration,1
10127,west africa,continent,1
662,transsiberian railway,transsiberian railway,1
661,bukhara,city local administrative unit nuts big city,1
10125,troop movements,troop movements,1
657,sea,sea,1
8653,sustained virological response,sustained virological response,1
8654,genetic variants,genetic variants,1
10122,boston navy yard,big city city united states,1
8657,middle east respiratory syndrome,middle east respiratory syndrome,1
8659,melanoma melanoma,rare diseaserare disease,1
8660,melanoma,rare disease,1
8665,peginterferon alpha2b,peginterferon alpha2b,1
655,railroads,railroads,1
8668,peginterferon alpha2b receptor,peginterferon alpha2b receptor,1
654,202 887,202 887,1
8674,basic mechanism signal transduction,basic mechanism signal transduction,1
8675,jak,jak,1
8676,tyk2,tyk2,1
217,shipyards,shipyards,1
8625,mpa press release,mpa press release,1
668,volga trade routes,volga trade routes,1
8622,152 cases,152 cases,1
8620,probability,probability,1
8545,pandemrix,influenza vaccine,1
8554,active antigen,group class chemical substances,1
693,toulon,commune france big city,1
692,grenoble,commune france big city,1
8560,twodose schedule,twodose schedule,1
8563,availability,availability,1
8565,marketing authorisation,marketing authorisation,1
8568,demand,demand,1
8569,emea,emea,1
10139,28 september,28 september,1
683,60%,60%,1
8580,adverse event report data,adverse event report data,1
8584,td clare daly,td clare daly,1
8405,cited published treatment trials,cited published treatment trials,1
8586,multiple legal cases,multiple legal cases,1
678,baltic shipping trade,baltic shipping trade,1
677,st. petersburg,st. petersburg,1
8594,mpa,mpa,1
8595,thl,thl,1
675,sakhalin,island time discovery invention 1808 1928,1
10133,zambezi,zambezi,1
8606,pandemrix vaccinations,influenza vaccine,1
10130,colonial railways,colonial railways,1
8610,6 cases,6 cases,1
8613,27 august,27 august,1
8615,limited number,limited number,1
670,saint petersburg,saint petersburg,1
8619,narcolepsy epidemic,narcolepsy epidemic,1
8588,clack job,clack job,1
8404,doseresponse effect,doseresponse effect,1
741,pervasiveness,pervasiveness,1
8401,postmarketing surveillance,postmarketing surveillance,1
10207,home,home,1
186,aargua,aargua,1
8148,license,license,1
10201,etaples,etaples,1
10200,overcrowded camp,overcrowded camp,1
799,likely cause,likely cause,1
8159,pharmaceutical factory,pharmaceutical factory,1
8160,russian city,russian city,1
8166,longlasting activity,longlasting activity,1
796,reanalysis,reanalysis,1
4944,simultaneous change,simultaneous change,1
8172,universal implementation,universal implementation,1
8173,nais,nais,1
8176,abnormal behaviors,abnormal behaviors,1
8182,broad spectrum antiviral activity,broad spectrum antiviral activity,1
793,cause,cause,1
8199,serine protease,chemical compound medication dl-serine l-amino acid dispensable amino acids cargo cargo cdp-diacylglycerol-serine o-phosphatidyltransferase activity,1
8201,helicase,helicase,1
791,confirmation,confirmation,1
191,deadly epidemic,deadly epidemic,1
8206,cofactor domains,cofactor domains,1
8207,ns2 protein,ns2 protein,1
8208,telaprevir drugs,chemical compound medication,1
787,1898–1900 epidemic,1898–1900 epidemic,1
8218,ns5a inhibitors,ns5a inhibitors,1
8220,seven genera,seven genera,1
8226,genera,genera,1
8140,i.g. bakulin,i.g. bakulin,1
807,bovine coronavirus,group class strains strain,1
10208,piggery,piggery,1
809,introduction,introduction,1
829,number,number,1
826,h2n2,wikimedia disambiguation page,1
8063,promising results,promising results,1
8068,continuing lack,continuing lack,1
821,pneumonia heart attack,cause death infectious disease,1
8080,miamibased company ridgeback biotherapeutics,miamibased company ridgeback biotherapeutics,1
819,patterns mortality,patterns mortality,1
818,anders gorm pedersen research,anders gorm pedersen research,1
8093,toxicity studies,toxicity studies,1
8094,regulators,regulators,1
8095,safety studies,safety studies,1
8096,ridgeback biotherapeutics,ridgeback biotherapeutics,1
8097,future safety studies,future safety studies,1
8228,salmon,salmon,1
8099,tolerability,tolerability,1
814,calculation,calculation,1
8104,late stage trials,late stage trials,1
813,anders gorm pedersen,anders gorm pedersen,1
8108,moroxydine,chemical compound,1
8109,potential applications,potential applications,1
8111,structurally moroxydine,chemical compound,1
8112,heterocyclic biguanidine,heterocyclic biguanidine,1
8113,ns3/4a serine protease,chemical compound medication dl-serine l-amino acid dispensable amino acids cargo cargo cdp-diacylglycerol-serine o-phosphatidyltransferase activity,1
8121,reversible covalent binding,reversible covalent binding,1
8125,efficacy studies,efficacy studies,1
8128,dual combination,dual combination,1
8132,sustained virologic response,sustained virologic response,1
8134,treatmentnaïve,treatmentnaïve,1
10209,surrounding villages,surrounding villages,1
10117,sierra leone,sierra leone,1
8229,thogotoviruses,thogotoviruses,1
782,antibodies,family protein complexes,1
8305,bleach,bleach,1
8308,133 °f,133 °f,1
199,24 august,24 august,1
10173,late wave,late wave,1
8310,60 minutes,60 minutes,1
8311,low ph,low ph,1
8313,inactivated live attenuated virions,inactivated live attenuated virions,1
8318,n subtypes,n subtypes,1
757,quinine,chemical compound medication essential medicine,1
8330,local epidemics,local epidemics,1
8333,genus,genus,1
8335,main hosts,main hosts,1
8338,pill,pill,1
10171,kansas city,state united states,1
8349,dose adjustment,dose adjustment,1
751,bäumler,bäumler,1
8360,core,core,1
8371,magnitude,magnitude,1
8376,pharmacological management,pharmacological management,1
200,margaret,margaret,1
8383,oseltamivir experienced vomiting,chemical compound neuraminidase inhibitor medication essential medicine,1
745,patterns,patterns,1
8386,psychiatric events,psychiatric events,1
8389,arrhythmias,arrhythmias,1
8393,toxic epidermal necrolysis,toxic epidermal necrolysis,1
8394,abnormal heart rhythms,abnormal heart rhythms,1
742,climates,climates,1
8304,cages,cages,1
761,whiskey,whiskey,1
8301,17 °c,17 °c,1
762,brandy,brandy,1
193,mankind,mankind,1
779,1918 epidemics,1918 epidemics,1
8238,glycoprotein spikes,glycoprotein spikes,1
778,subtypes,subtypes,1
8243,13.5 kilobases,13.5 kilobases,1
777,researchers,researchers,1
8248,sugars,sugars,1
8249,mature viral particles,mature viral particles,1
8251,key targets,key targets,1
8253,contaminated surfaces,contaminated surfaces,1
8255,cell hemagglutinin glycoprotein,group class proteins,1
8258,acidic endosome,acidic endosome,1
8261,complex,complex,1
8230,influenzavirus virion,influenzavirus virion,1
8263,crna,crna,1
8268,vrna,vrna,1
8272,released nucleotides,released nucleotides,1
8273,vrna synthesis,vrna synthesis,1
772,miasma theory,miasma theory,1
8279,bulge,bulge,1
194,mira,mira,1
10187,haemagglutinin glycoproteins,structural class chemical compounds,1
195,epidemia mortales,epidemia mortales,1
10182,tissue slides,tissue slides,1
10181,2018 study,2018 study,1
8288,phylogeneticbased taxonomy,phylogeneticbased taxonomy,1
10177,geographic origin,geographic origin,1
198,paucissimis ad gorcum,paucissimis ad gorcum,1
775,result,result,1
2302,attractive candidate,attractive candidate,1
1227,general workers union thencalledfor,general workers union thencalledfor,1
0,summary,summary,1
4192,mixed cryoglobulinemia,mixed cryoglobulinemia,1
4193,inflammation,inflammation,1
2705,baloxavir recipients,baloxavir recipients,1
2702,tablet form,tablet form,1
2701,available forms,available forms,1
2698,covid19,covid19,1
4198,low platelet count,low platelet count,1
2695,switzerlandbased roche ag,switzerlandbased roche ag,1
2187,entropy changes,entropy changes,1
2694,japanese pharmaceutical company,japanese pharmaceutical company,1
2692,market,market,1
4208,pancreatic cancer,constellation zodiacal constellation,1
4213,conventional testing,conventional testing,1
4214,ultrasensitive tests,ultrasensitive tests,1
2689,bxm,bxm,1
4223,persistently moderately elevated serum liver enzymes,organ type,1
2688,compound numbers,compound numbers,1
4228,highest absolute totals,highest absolute totals,1
4205,cardiomyopathy,cardiomyopathy,1
1819,workplace,workplace,1
4188,cognitive impairment,cognitive impairment,1
4187,syndrome,syndrome,1
4158,females,females,1
2726,recent metaanalysis,recent metaanalysis,1
2719,daclatasvir,scholarly article review article,1
4163,7–53%,7–53%,1
2717,beclabuvir,chemical compound,1
4165,apparent cure,apparent cure,1
4166,reinfection,reinfection,1
4168,change,change,1
2715,i38f mutations,i38f mutations,1
4170,cirrhosis cases,cirrhosis cases,1
1826,updated guidance,updated guidance,1
4175,alcoholics,alcoholics,1
4176,male sex,male sex,1
2710,variants,variants,1
1825,homeland security,homeland security,1
2186,1.08 1.18 g/cm3,1.08 1.18 g/cm3,1
4180,transformation,transformation,1
4183,portal hypertension,portal hypertension,1
4184,ascites,ascites,1
4229,prison inmates,prison inmates,1
2728,high response rates,high response rates,1
4232,prisons,prisons,1
4238,blood transfusion,biogenic substance type,1
4292,dyes,dyes,1
2651,updated indication,updated indication,1
4293,tattoos,tattoos,1
4294,piercings,piercings,1
1785,line,line,1
1784,pharmaceutical industry,pharmaceutical industry,1
4298,settings,settings,1
4299,larger tattoos,larger tattoos,1
2201,covalent lattice,covalent lattice,1
4300,nearly half,nearly half,1
2646,bronchitis,bronchitis,1
4304,shared personal items,shared personal items,1
4305,personalcare items,personalcare items,1
4306,razors,razors,1
4308,manicuring,manicuring,1
2642,cap snatching,cap snatching,1
4310,items,items,1
2636,baloxavir marboxil metabolism,baloxavir marboxil metabolism,1
2647,sinusitis,sinusitis,1
2657,laxatives,laxatives,1
1788,clearly defined virological epidemiological criteria,clearly defined virological epidemiological criteria,1
4280,hiv genital ulceration,organisms known particular common,1
4239,blood products,biogenic substance type,1
4240,organ transplants,organ transplants,1
2193,principal value,principal value,1
2195,c11,c11,1
4243,universal screening,universal screening,1
4247,potential blood donor,biogenic substance type,1
4250,1.8% chance,1.8% chance,1
4254,blood exposure,biogenic substance type,1
4257,reuse,reuse,1
1795,visitors,visitors,1
2670,polymerasecatalyzed synthesis,polymerasecatalyzed synthesis,1
2667,baloxavir,baloxavir,1
1794,restricting,restricting,1
4263,implementation,implementation,1
4264,enforcement,enforcement,1
4267,primary cause,primary cause,1
4270,sexual transmission,sexual transmission,1
4273,low risks,low risks,1
2198,crystalline diamond,crystalline diamond,1
4233,idu,idu,1
2635,prodrug strategy,prodrug strategy,1
2730,ribavirin use,chemical compound medication essential medicine 1 april 1990,1
2732,restriction,restriction,1
4024,lower dosages,lower dosages,1
2800,bms,bms,1
2798,brand daklinza,brand daklinza,1
4032,rates,rates,1
4035,subsaharan africa,continent,1
4038,caribbean,caribbean,1
4039,oceania,oceania,1
4040,australasia,australasia,1
1856,21 u.s. students,21 u.s. students,1
1854,foreign visitors,foreign visitors,1
2781,chimerix,chimerix,1
2779,new macrocyclic inhibitors,new macrocyclic inhibitors,1
4053,percentage,percentage,1
4055,half,half,1
4057,bid,bid,1
4058,2025 nhs england,nation uk cultural area country,1
1848,exceptions,exceptions,1
4063,contracts,contracts,1
2167,carbon–carbon bond lengths,carbon–carbon bond lengths,1
1859,state department,state department,1
2803,ribavirin,chemical compound medication essential medicine 1 april 1990,1
4017,sustained response,sustained response,1
3999,ultrasound surveillance,ultrasound surveillance,1
4000,hepatocellular carcinoma,hepatocellular carcinoma,1
4002,coffee consumption,coffee consumption,1
2830,pgp,pgp,1
2828,dose modifications,dose modifications,1
4004,prognosis,prognosis,1
4005,sustained viral response,sustained viral response,1
2825,inhibitors,inhibitors,1
4008,24 weeks,24 weeks,1
4009,rapid virological response,rapid virological response,1
2823,phenytoin,chemical compound medication essential medicine carcinogen,1
2822,inducers,inducers,1
4013,75%.prior 2012 sustained response,75%.prior 2012 sustained response,1
2818,concomitant use,concomitant use,1
4014,40–50%,40–50%,1
2159,extreme toxicity,extreme toxicity,1
2811,sofusbivir/ribavirin,sofusbivir/ribavirin,1
2807,bradycardia,medical finding,1
2806,breastmilk,breastmilk,1
2773,good selectivity,good selectivity,1
2731,prior interferonbased therapy,prior interferonbased therapy,1
1845,nonhealth care settings,nonhealth care settings,1
4073,numbers,numbers,1
4123,insurance coverage,insurance coverage,1
4128,spanish anaesthetist juan maeso,spanish anaesthetist juan maeso,1
1834,workforce,workforce,1
2753,pharmacology,pharmacology,1
4132,immunomodulators,immunomodulators,1
4133,cyclophilin inhibitors,cyclophilin inhibitors,1
1832,staff,staff,1
1831,employers objectives,employers objectives,1
2755,hepatocytes,hepatocytes,1
4137,cure rates,cure rates,1
4145,weight loss,weight loss,1
4146,jaundice,clinical sign,1
4147,claycoloured stools,claycoloured stools,1
1828,employers,employers,1
2735,resistanceassociated variants,resistanceassociated variants,1
2179,phase transition,phase transition,1
4151,elevated liver enzymes,organ type,1
2180,order,order,1
4142,20–30%,20–30%,1
4116,economic costs,economic costs,1
4111,charles m. rice,charles m. rice,1
4110,houghton,houghton,1
4074,higher cure rates,higher cure rates,1
4076,track,track,1
2771,ns3/4a protease,ns3/4a protease,1
4080,mid1970s,mid1970s,1
4082,posttransfusion hepatitis cases,posttransfusion hepatitis cases,1
4085,michael houghton,michael houghton,1
4088,chiron corporation,chiron corporation,1
4089,daniel w. bradley,daniel w. bradley,1
4090,novel molecular cloning approach,novel molecular cloning approach,1
1842,general guidance,general guidance,1
2169,diamond,diamond,1
2170,carbon–hydrogen distances,carbon–hydrogen distances,1
4096,nanbh specimens,nanbh specimens,1
2762,ciluprevir,chemical compound,1
4102,competing patent application,competing patent application,1
4106,damages,damages,1
2758,myrcludex b,myrcludex b,1
4108,suit,suit,1
4109,appeals court,appeals court,1
4069,extremely effective medication,extremely effective medication,1
3997,nonsteroidal antiinflammatory drugs,nonsteroidal antiinflammatory drugs,1
1779,readers,readers,1
4315,casual contact,casual contact,1
2238,molecular bromine,molecular bromine,1
2514,timelimited window,timelimited window,1
2512,prolonged doc,prolonged doc,1
4561,27kda largehdag,27kda largehdag,1
4562,smallhdag,smallhdag,1
2510,neurology,neurology,1
4565,cterminal,cterminal,1
2507,subarachnoid hemorrhage,subarachnoid hemorrhage,1
4559,viroids,viroids,1
2505,nontraumatic cases,nontraumatic cases,1
1710,usual federal requirements,usual federal requirements,1
2241,reaction products,reaction products,1
2499,functional objective use,functional objective use,1
4574,90% identical sequences,90% identical sequences,1
4575,roles,roles,1
4576,hdags,hdags,1
4577,hdagl,hdagl,1
4578,contrast,contrast,1
2504,significantly improved consciousness,significantly improved consciousness,1
4557,delta antigens,delta antigens,1
2237,brominating agents,brominating agents,1
2517,neurons,neurons,1
2532,disability,disability,1
4516,3.18 x 10×10−3 substitutions,3.18 x 10×10−3 substitutions,1
2529,norepinephrine pathway,chemical compound medication neurotransmitter,1
2528,stimulants,stimulants,1
4520,slave trade,slave trade,1
1725,century,century,1
2526,dopamine norepinephrine pathways,chemical compound medication neurotransmitterchemical compound medication neurotransmitter,1
1724,greatest medicine scandals,greatest medicine scandals,1
4526,36 nm diameter,36 nm diameter,1
1722,wodarg,wodarg,1
1721,wolfgang wodarg,wolfgang wodarg,1
4534,hdag,hdag,1
4538,partially doublestranded rodlike hdv structure,partially doublestranded rodlike hdv structure,1
2519,impairments,impairments,1
4540,ntcp bile transporter,ntcp bile transporter,1
4544,mutagenesis,mutagenesis,1
2518,physiatrists,physiatrists,1
4546,receptorbinding site,receptorbinding site,1
4550,signal,signal,1
2497,consistent demonstration,consistent demonstration,1
2534,psychosocial stressors,psychosocial stressors,1
2242,reaction conditions,reaction conditions,1
2493,vegetative state,vegetative state,1
4619,peru,sovereign state republic country,1
4626,neurological symptoms,neurological symptoms,1
4628,hemorrhagic coma,hemorrhagic coma,1
2464,combination therapy,combination therapy,1
1693,similar crisis,similar crisis,1
1692,steps,steps,1
2460,laboratory testing,laboratory testing,1
4635,survivors,survivors,1
2471,ms,ms,1
2458,m2 inhibitors,m2 inhibitors,1
4639,gilberta bensabath,gilberta bensabath,1
4640,instituto evandro chagas,instituto evandro chagas,1
2457,current guidelines,current guidelines,1
2253,carbon tetrachloride,carbon tetrachloride,1
1687,burden,burden,1
4650,inflammatory cells,inflammatory cells,1
1685,authorisation number,authorisation number,1
2449,100%,100%,1
4637,main discovery,main discovery,1
1696,stock,stock,1
4613,brazilian amazon basin,brazilian amazon basin,1
2473,amantadineinduced improvement,amantadineinduced improvement,1
4583,balance,balance,1
4584,virion assembly,virion assembly,1
2492,coma,coma,1
2491,consciousness,consciousness,1
1704,state,state,1
2487,gmss guidelines,gmss guidelines,1
4590,subviral particles,subviral particles,1
4591,hdv antigen proteins,group class chemical substancesgroup class chemical substances second-order class,1
2247,formation,formation,1
2248,fluorinated nucleophiles,fluorinated nucleophiles,1
1703,coordination,coordination,1
2482,moderate improvement,moderate improvement,1
4593,virallike particles,virallike particles,1
4594,determinant,determinant,1
2249,gaseous fluorine,gaseous fluorine,1
4598,mediator,mediator,1
4601,camille sureau,camille sureau,1
2478,effectiveness,effectiveness,1
2476,subjective objective ratings,subjective objective ratings,1
2243,especially presence,especially presence,1
4314,sores,sores,1
2535,neurological,neurological,1
4508,phylogenetic studies,phylogenetic studies,1
4353,blood tests,biogenic substance type,1
2608,200 mg,200 mg,1
2607,maximum daily dose,maximum daily dose,1
4360,blood transfusions,biogenic substance type,1
2602,1969 trial,1969 trial,1
4368,highest complication risk,highest complication risk,1
1765,uncertainties,uncertainties,1
4376,surgery,medical specialty academic discipline,1
4351,changes,changes,1
1763,failure,failure,1
4388,spontaneous resolution,spontaneous resolution,1
4389,15–45%,15–45%,1
4392,children pregnancy,physiological condition,1
4400,vertical transmission,vertical transmission,1
4401,developed countries transmission,developed countries transmission,1
1755,preliminary report,preliminary report,1
4406,procedures,procedures,1
4407,nipples,nipples,1
2219,specific rotation,specific rotation,1
4350,portal triad,portal triad,1
4349,lymphoid follicles,lymphoid follicles,1
2613,neurological drugs,neurological drugs,1
2205,spectrum,spectrum,1
4317,kissing,kissing,1
4318,mothertochild transmission,mothertochild transmission,1
4319,fewer 10%,fewer 10%,1
4320,pregnancies,pregnancies,1
4321,gestation,gestation,1
4324,infected mother nipples,infected mother nipples,1
4325,infected mother viral loads,infected mother viral loads,1
2627,baloxavir marboxil,baloxavir marboxil,1
4328,blood testing,biogenic substance type,1
4329,enzyme immunoassay,enzyme immunoassay,1
4330,confirmatory test,confirmatory test,1
2208,1h,1h,1
2619,adverse effect,adverse effect,1
2617,ldopa anticholinergic drugs,ldopa anticholinergic drugs,1
2211,37.85 ppm,37.85 ppm,1
4346,procedure,procedure,1
4347,typical changes,typical changes,1
4348,parenchyma,parenchyma,1
4413,hypogammaglobulinemia,hypogammaglobulinemia,1
2536,drowsiness,drowsiness,1
4414,unusually rapid progression,unusually rapid progression,1
4421,mouse,mouse,1
2554,peripheral edema,peripheral edema,1
1738,existing definition,existing definition,1
1736,statement,statement,1
1735,statement scientists,statement scientists,1
4484,hbsag,hbsag,1
2547,suicidal ideation,suicidal ideation,1
2546,psychosis,psychosis,1
4487,low income regions,low income regions,1
1740,independent advice,independent advice,1
4490,currently amazon basin,currently amazon basin,1
4492,nuclear antigen,group class chemical substances,1
2543,neuroleptic malignant syndrome,neuroleptic malignant syndrome,1
4500,entire genome genus,scientific model natural environment,1
2540,agents,agents,1
2539,combination,combination,1
4505,genomes,genomes,1
2538,dizziness,dizziness,1
4507,8 genotypes,8 genotypes,1
1733,big pharmaceutical companies,big pharmaceutical companies,1
4470,current established treatments,current established treatments,1
4469,rare instances,rare instances,1
2559,rare cases,rare cases,1
4423,available living,available living,1
4424,ethical concerns,ethical concerns,1
2577,investigations,investigations,1
2575,mother,mother,1
2222,1fluoroadamantane,1fluoroadamantane,1
2223,sbf5,sbf5,1
2224,dication,dication,1
1747,chance,chance,1
2225,solutions,solutions,1
2565,pregnancy,physiological condition,1
4440,3d architectural design,3d architectural design,1
4443,susceptibility,susceptibility,1
4446,small spherical enveloped particle,small spherical enveloped particle,1
4447,viroid,viroid,1
2227,stability,stability,1
2563,pregnancy lactation,physiological condition,1
1742,outside interests,outside interests,1
4459,clotting factor concentrates,clotting factor concentrates,1
4460,developed countries,developed countries,1
4418,moderate success,moderate success,1
3995,acetaminophen,acetaminophen,1
2837,narcotic analgesics,chebi ontology term,1
1862,entire hotel,entire hotel,1
3091,season,season,1
3089,hemisphere,hemisphere,1
3507,open letter,open letter,1
3086,annually recurring time period,annually recurring time period,1
3510,covid19covid19,covid19covid19,1
3511,financial motives,financial motives,1
3513,direct efficacy,direct efficacy,1
3515,preclinical efficacy,preclinical efficacy,1
3502,lower kidney,lower kidney,1
2081,samsara,religious concept,1
3526,supreme court decision,supreme court decision,1
3527,fda regulations,fda regulations,1
3528,chemicals,chemicals,1
3529,chemicals manufacture,chemicals manufacture,1
3530,fda cgmp certified conditions,fda cgmp certified conditions,1
1978,3.7%,3.7%,1
3534,structurally similar ribavirin,chemical compound medication essential medicine 1 april 1990,1
3535,nucleosidediphosphate kinase,nucleosidediphosphate kinase,1
3522,medchemexpress,scholarly article erratum,1
3500,specific advantages,specific advantages,1
3097,main infective agents,main infective agents,1
3498,field trials,field trials,1
3455,hans seitinger,hans seitinger,1
3458,styria,state austria,1
3126,growing number,growing number,1
3460,august 2006,august 2006,1
1994,saudi arabia,saudi arabia,1
3463,january 24 2007,january 24 2007,1
3465,airlangga university,airlangga university,1
3124,northern,northern,1
3474,gs441524,gs441524,1
3485,fip,fip,1
3116,variability,variability,1
3115,subtropics,geographic region,1
3111,junejuly,junejuly,1
3107,complex seasonality component,complex seasonality component,1
3105,paraguay,paraguay,1
3491,approved treatments,approved treatments,1
3102,manifestations,manifestations,1
3497,multiple trials,multiple trials,1
3099,cooler temperature,cooler temperature,1
3538,prodrug remdesivir,chemical compound prodrug antiviral drug,1
1997,saudi arabian government,saudi arabian government,1
3071,ketolike form,ketolike form,1
3541,rapid hydrolysis,rapid hydrolysis,1
3042,fruit bats,fruit bats,1
3040,raw date palm sap,raw date palm sap,1
3039,consumption,consumption,1
3038,bangladesh outbreaks,bangladesh outbreaks,1
3584,immunization,immunization,1
3588,candidate vaccines,candidate vaccines,1
3031,historical controls,historical controls,1
3601,pharmaceutical company,pharmaceutical company,1
3579,intestines,intestines,1
3602,rockville,rockville,1
3029,lowtomoderate levels,lowtomoderate levels,1
3609,adjuvanted vaccines,adjuvanted vaccines,1
1956,clinical examination,clinical examination,1
3028,decrease,decrease,1
3616,gregory glenn,gregory glenn,1
2096,humantohuman transmission,humantohuman transmission,1
3024,preliminary results,preliminary results,1
1954,second case,second case,1
3603,md.,md.,1
3578,low variable absorption,low variable absorption,1
3044,syrian hamster model,syrian hamster model,1
1966,total number,total number,1
3543,utility,utility,1
3544,advantages,advantages,1
3545,letter,letter,1
2083,68 800strong flock,68 800strong flock,1
3548,ncats,ncats,1
3064,limited efficacy,limited efficacy,1
3549,ind,ind,1
1973,perceived severity,perceived severity,1
3551,pk,pk,1
3060,control cases,control cases,1
3058,obvious morbidity,obvious morbidity,1
3057,100% survival,100% survival,1
3055,peroral route,peroral route,1
3555,prediction,prediction,1
3558,art,art,1
3054,previous studies,previous studies,1
3560,modeling data,modeling data,1
1968,wisconsin study,wisconsin study,1
3567,bit half molecular weight,bit half molecular weight,1
3540,serum,serum,1
3625,lower dose,lower dose,1
3131,employee,employee,1
3135,standard antiviral drugs amantadine,chemical compound medication,1
3277,4 deaths,4 deaths,1
3215,hiv/aids,endemic disease location west africa benin rep syndrome,1
2039,south korea,south korea,1
3284,hong kong sar,hong kong sar,1
3211,chemotherapy,chemotherapy,1
3302,mammals general,mammals general,1
3208,nasal spray vaccines,nasal spray vaccines,1
3313,stone,stone,1
3276,4 cases,4 cases,1
3315,bbc,television station,1
3320,novel route,novel route,1
3194,severe shortness,severe shortness,1
3322,mammals,mammals,1
3323,onethousandth,onethousandth,1
3325,felines,felines,1
3326,carnivores,carnivores,1
3332,apparent symptoms.h5n1,apparent symptoms.h5n1,1
3189,acute bronchitis,acute bronchitis,1
3316,stray dog,stray dog,1
2049,norwegian food safety authority,norwegian food safety authority,1
3274,17 cases,17 cases,1
3272,37 deaths,37 deaths,1
3238,paramyxoviruses,paramyxoviruses,1
3239,coronaviruses,coronaviruses,1
3240,flaviviruses,flaviviruses,1
3243,monkeys,monkeys,1
3244,bcx4430 galidesivir,chemical compound,1
3229,funding,funding,1
3227,immucillina,immucillina,1
3247,viremia,viremia,1
3249,vietnam,war proxy war,1
3253,surveillance,surveillance,1
3255,thailand,constitutional monarchy sovereign state country,1
3256,isolated cases,isolated cases,1
3257,caregivers,caregivers,1
3224,galidesivir,chemical compound,1
2043,wild swans,wild swans,1
2048,sandnes municipality,sandnes municipality,1
3268,97 cases,97 cases,1
3269,53 deaths,53 deaths,1
3271,76 cases,76 cases,1
3188,pneumonias,pneumonias,1
3132,free service,free service,1
2028,toyama prefecture,toyama prefecture,1
3338,1959–1997,1959–1997,1
3394,northern vietnam,war proxy war,1
2066,barwala,barwala,1
2014,chicken farms,chicken farms,1
3401,sham shui po,sham shui po,1
3406,8pm,8pm,1
2008,northern western europe,continental area surrounding islands continent geographic region,1
2007,waterbirds,waterbirds,1
3148,total economic burden,total economic burden,1
3393,school teacher,school teacher,1
3413,fine,fine,1
3417,endemic areas,endemic areas,1
3144,2007 study,2007 study,1
3421,23yearold woman,23yearold woman,1
3424,10yearold girl,10yearold girl,1
3426,joint statement,joint statement,1
3140,cost,cost,1
3432,tigers,tigers,1
3435,140 tigers,140 tigers,1
2005,western russia,empire start time 22 october 1721julian end time 1 september 1917julian 1 september 1917julian,1
3387,afghanistan,emoji regional indicator sequence,1
3386,pakistan,sovereign state country,1
3384,2007,2007,1
3182,hospitalization,hospitalization,1
2026,awaji island,awaji island,1
3351,2003,2003,1
3353,fujian province,fujian province,1
2058,indian state,indian state,1
2059,kerala,state india start time 1 november 1956,1
3178,elevated blood sugars,biogenic substance type,1
3357,regions,regions,1
3358,waterfowl,waterfowl,1
3359,especially ducks,especially ducks,1
3362,strategy,strategy,1
2023,kyushu island,kyushu island,1
3175,blood sugars,biogenic substance type,1
2022,shikoku island,shikoku island,1
3174,healtheu portal eu response,healtheu portal eu response,1
3371,david nabarro,david nabarro,1
2063,unknown subtypes,unknown subtypes,1
2019,fisheries,fisheries,1
3383,decades,decades,1
3337,seroconversion,seroconversion,1
3628,immune response,immune response,1
3630,accompanying commentary,accompanying commentary,1
3631,obstacles,obstacles,1
3867,possible paths,possible paths,1
2906,cure,cure,1
2904,tradename,tradename,1
3870,related information,related information,1
2900,array biopharma,array biopharma,1
3873,matrix proteins,group class chemical substances second-order class,1
2898,ic50,ic50,1
3881,nucleoprotein,group class proteins,1
3866,pig,pig,1
2892,ns3/4a hcv protease,ns3/4a hcv protease,1
2134,water,water,1
2889,twelveweek course,twelveweek course,1
2135,nonpolar organic solvents,nonpolar organic solvents,1
1892,argentina,argentina,1
1891,northern ireland,emoji regional indicator sequence éire (irish),1
3896,subbarao k,subbarao k,1
2140,hydrocarbons,hydrocarbons,1
2880,iv dose,iv dose,1
2891,orally available 15membered macrocyclic peptidomimetic inhibitor,orally available 15membered macrocyclic peptidomimetic inhibitor,1
2130,cyclohexanone,chemical compound class ii combustible liquid,1
2129,derivatives,derivatives,1
3858,conformation,conformation,1
3825,signature,signature,1
3826,avian receptor binding,avian receptor binding,1
3828,a/hk/213/03 isolates,a/hk/213/03 isolates,1
2931,viekira pak,viekira pak,1
2930,following criteria,following criteria,1
3830,closely related a/gs,closely related a/gs,1
3832,avian type receptors,avian type receptors,1
1907,lightheadedness,lightheadedness,1
2924,compensated cirrhosis,compensated cirrhosis,1
2125,d. bottger,d. bottger,1
3845,infected cells,infected cells,1
3846,relenza,relenza,1
1902,examination,examination,1
2917,ombitasvir/paritaprevir/ritonavir,medication chemical substance mixture essential medicine,1
3850,n1 form,n1 form,1
1901,entire americas,entire americas,1
3855,existing drugs,existing drugs,1
3856,n1 protein,n1 protein,1
2914,dasabuvir,scholarly article,1
3897,golding h,golding h,1
2934,subjects,subjects,1
2879,60 mg,60 mg,1
3900,monoclonal antibodies,family protein complexes,1
3957,lymphocytes,lymphocytes,1
1873,prescreening outbound passengers,prescreening outbound passengers,1
3962,primary route,primary route,1
3966,immunoassay,immunoassay,1
3971,challenge,challenge,1
1869,mecca return,tourist attraction city millions inhabitants,1
2846,phenotypic screening,phenotypic screening,1
2845,precursor,precursor,1
2854,combination regimens,combination regimens,1
3974,transition,transition,1
1868,annual pilgrimage,annual pilgrimage,1
3983,maternal antibodies,family protein complexes,1
3984,18 months,18 months,1
1864,cruise ship,cruise ship,1
3986,blood donors,biogenic substance type,1
3988,universal precautions,universal precautions,1
2840,cardiovascular agents,cardiovascular agents,1
2839,sedatives,sedatives,1
2844,daklinza,daklinza,1
1874,pigs food safety,pigs food safety,1
3950,genotypes,genotypes,1
3948,genus hepacivirus,genus hepacivirus,1
1887,widespread media use,widespread media use,1
3908,abdominal pain,abdominal pain,1
3909,yellow tinged skin,yellow tinged skin,1
2875,dose strength,dose strength,1
2874,99%,99%,1
3915,dilated blood vessels,biogenic substance type,1
3918,blood screening,biogenic substance type,1
3919,transfusion,transfusion,1
3920,infected mother,infected mother,1
3921,infected mother baby,infected mother baby,1
1883,industry groups,industry groups,1
2871,liver enzyme cyp3a4,organ type,1
2869,bioavailability,bioavailability,1
3929,peginterferon,peginterferon,1
2144,water vapor,water vapor,1
3938,transplantation,transplantation,1
2862,steady state,steady state,1
3941,low middleincome countries,low middleincome countries,1
3946,chimpanzees,chimpanzees,1
3899,convalescent sera,convalescent sera,1
1908,nausea,nausea,1
2936,liver enzymes,organ type,1
2937,ast,ast,1
3670,acceptable response,acceptable response,1
1940,trade,trade,1
3673,inactivated strain,inactivated strain,1
2994,favipiravir efficacy,chemical compound medication,1
3675,allergy,allergy,1
3681,volunteer,volunteer,1
3684,nih institutes,nih institutes,1
2990,prodrug,prodrug,1
2996,defense,defense,1
3691,dnabased vaccines,dnabased vaccines,1
2983,favipiravir,chemical compound medication,1
2982,zhejiang hisun pharmaceutical co. ofchinatoproduceanantiviralmedicationusedtotreatinfluenzainjapaninthepeople srepublicof china,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",1
3696,vrc director gary nabel,vrc director gary nabel,1
3697,m.d.,m.d.,1
3699,vrc,vrc,1
3702,reliability,reliability,1
2980,zhejiang hisun pharmaceutical co.,zhejiang hisun pharmaceutical co.,1
3704,dr. nabel,dr. nabel,1
2985,baby,baby,1
1941,calls,calls,1
3004,6 14 hours,6 14 hours,1
1942,border,border,1
3020,mouse models,mouse models,1
3636,inactivated splitvirion strain,inactivated splitvirion strain,1
3637,vietnam/1194/2004.cidrap article glaxo,vietnam/1194/2004.cidrap article glaxo,1
3639,low dose,low dose,1
3019,ebola,infectious disease,1
3642,good immune response,good immune response,1
2101,fusion,fusion,1
3645,typical dose,typical dose,1
2103,stable isomer,stable isomer,1
3650,news release,news release,1
1946,silent epidemic,silent epidemic,1
3652,antigen,group class chemical substances,1
3653,meaning,meaning,1
3008,toyama chemical,toyama chemical,1
3657,bbc radio,television station,1
3658,agence francepresse,agence francepresse,1
3006,usa,usa,1
1944,nonlethal cases,nonlethal cases,1
3663,adequate immune response,adequate immune response,1
3710,investigational vaccines,investigational vaccines,1
3713,west nile,west nile,1
3727,omninvest,omninvest,1
2975,reovirus,reovirus,1
2953,morning,morning,1
3772,h5 elderly august 2006,h5 elderly august 2006,1
3774,expected completion,expected completion,1
3780,terminology,terminology,1
3781,orthomyxovirus family,orthomyxovirus family,1
2116,attempted laboratory synthesis,attempted laboratory synthesis,1
1918,99.6%,99.6%,1
3789,microscopic parasite,microscopic parasite,1
1916,314 samples,314 samples,1
3796,hemagglutinin forms spikes,group class proteins,1
2947,regimen,regimen,1
3798,efficient transfer,efficient transfer,1
2118,reaction,reaction,1
3806,mutation,mutation,1
3807,substitution,substitution,1
1912,half drugs,half drugs,1
3813,father,father,1
2941,ns5b palm polymerase,group class enzymes,1
2938,alt,alt,1
3769,study completion,study completion,1
4653,epidemiological survey,epidemiological survey,1
2954,dasabuvir tablet,scholarly article,1
2956,combination pack,combination pack,1
3730,results trials,results trials,1
3732,poor immunogenicity,poor immunogenicity,1
3735,unacceptable results,unacceptable results,1
3738,acceptable levels,acceptable levels,1
2971,activity,activity,1
3741,high dose level.adjuvanted vaccines,high dose level.adjuvanted vaccines,1
3742,greatest promise,greatest promise,1
2968,leukemia,leukemia,1
2965,enzyme imp dehydrogenase,enzyme imp dehydrogenase,1
3747,twodose regimen,twodose regimen,1
2114,h. decker,h. decker,1
3753,acceptable immune response,acceptable immune response,1
2115,existence,existence,1
3756,adjuvanted 3.8microgram subjects,adjuvanted 3.8microgram subjects,1
3758,prepandemic vaccines,prepandemic vaccines,1
3759,right dose,right dose,1
3760,dose interval,dose interval,1
2957,monthly package,monthly package,1
3762,puzzle,puzzle,1
2955,meal,meal,1
4656,asymptomatic hbv carriers,asymptomatic hbv carriers,1
2767,ns3/4a,ns3/4a,1
4717,excessive number,excessive number,1
4749,casefatality rates,casefatality rates,1
2396,western countries,western countries,1
4679,direct transmission,direct transmission,1
4692,maximum intensity,maximum intensity,1
1624,second important cause,second important cause,1
4751,0.6%,0.6%,1
4927,reliable prediction,reliable prediction,1
4706,little improvement,little improvement,1
2310,adamantanebased polymers,adamantanebased polymers,1
2419,dopamine release,chemical compound medication neurotransmitter,1
4796,graphic exhibiting total cases,graphic exhibiting total cases,1
1623,streptococcus,streptococcus,1
2436,exocytosis,exocytosis,1
4868,familial genetics,familial genetics,1
2324,noncompetitive nmda antagonist,noncompetitive nmda antagonist,1
2420,dopamine reuptake,chemical compound medication neurotransmitter,1
2323,dopamine agonist,chemical compound medication neurotransmitter,1
4866,impairment,impairment,1
4893,date,date,1
2322,nicotinic antagonist,nicotinic antagonist,1
2421,monoamine,monoamine,1
2269,difficult reaction,difficult reaction,1
2384,contraindications,contraindications,1
4841,opposite,opposite,1
2258,acetone,chemical compound excipient polar aprotic solvent class ib flammable liquid mutagen ketone oxygenated hydrocarbons organic compound ketone bodies reactant product product product acetone carboxylase activity,1
2397,international livestock regulations,international livestock regulations,1
2341,offlabel uses,offlabel uses,1
4803,18 humans,infectious disease france,1
2400,amantadineresistant strains,amantadineresistant strains,1
2416,antiparkinsonian effect,antiparkinsonian effect,1
2380,antidopaminergic drugs,antidopaminergic drugs,1
4801,moderate number,moderate number,1
2267,catalyst,catalyst,1
4873,unrelated maladies,unrelated maladies,1
4665,genetic process,genetic process,1
2274,nitroester,nitroester,1
4677,hosts,hosts,1
4666,multiple subtypes,multiple subtypes,1
4798,countryspecific information,countryspecific information,1
2417,weak antagonist,weak antagonist,1
2438,mechanistically identical fashion,mechanistically identical fashion,1
2268,nitration,nitration,1
4671,late 19th century,late 19th century,1
2342,improvement,improvement,1
4673,new subtypes,new subtypes,1
1629,poor outcome,poor outcome,1
4676,divergent subtypes,divergent subtypes,1
4747,southeast east asia,continent continental area surrounding islands,1
4711,vietnam war,war proxy war,1
4682,accumulated antibodies,family protein complexes,1
4864,harvard school,harvard school,1
1634,13%,13%,1
2314,prospects,prospects,1
2387,enlarged prostate,enlarged prostate,1
2424,dopamine,chemical compound medication neurotransmitter,1
4696,june–december,june–december,1
2285,dopamantine,chemical compound,1
4857,attempt,attempt,1
1653,transmission,transmission,1
1657,2009 novel,2009 novel,1
2351,methyne positions,methyne positions,1
2428,similar pharmaceutical memantine,chemical compound medication,1
2392,administered vaccines,administered vaccines,1
2427,anticholinergic,anticholinergic,1
1656,basic reproduction number,basic reproduction number,1
2425,norepinephrine,chemical compound medication neurotransmitter,1
4769,solid number,solid number,1
2389,live attenuated vaccines,live attenuated vaccines,1
4691,square kilometre,square kilometre,1
2352,similar biological properties,similar biological properties,1
4904,speculation,speculation,1
2426,nerve endings,nerve endings,1
4773,humans.h5n1 vaccines,humans.h5n1 vaccines,1
4906,half million americans,half million americans,1
2319,guest molecules,guest molecules,1
1659,transmissibility,transmissibility,1
4686,recorded instance,recorded instance,1
4763,director,director,1
2296,designer drugs,designer drugs,1
4793,mutants,mutants,1
4920,current lethality,current lethality,1
4792,mouse antibodies,family protein complexes,1
2422,brain,brain,1
2360,toxicity,toxicity,1
4918,ready transmission,ready transmission,1
2423,release,release,1
4846,h2n2 strain,wikimedia disambiguation page,1
4916,lethal avian strain lethality,lethal avian strain lethality,1
2347,brain injury,brain injury,1
4862,familial genetic susceptibility,familial genetic susceptibility,1
4847,opportunity,opportunity,1
4915,lethal avian strain,lethal avian strain,1
4913,1900s,1900s,1
4896,mouse study,mouse study,1
4897,significantly higher levels,significantly higher levels,1
4861,blood relatives,biogenic substance type,1
4898,proinflammatory cytokines,proinflammatory cytokines,1
4762,dr. julie l. gerberding,dr. julie l. gerberding,1
2321,matrix,matrix,1
1622,important cause,important cause,1
1632,55 hospitals,55 hospitals,1
2440,tetrameric m2 channel,tetrameric m2 channel,1
4737,excess deaths,excess deaths,1
2391,efficacy,efficacy,1
2308,working fluid,working fluid,1
4828,demographic characteristics,demographic characteristics,1
2273,bromide,bromide,1
4824,asymptomatic cases,asymptomatic cases,1
4719,subway tunnels,subway tunnels,1
4726,absenteeism,absenteeism,1
2304,hall thrusters,hall thrusters,1
4817,unknown number,unknown number,1
1667,dog,dog,1
4813,mild asymptomatic cases,mild asymptomatic cases,1
1625,primary,primary,1
2291,polymers,polymers,1
4829,patient ages,patient ages,1
4722,undertakers,undertakers,1
1620,staphylococcus aureus,staphylococcus aureus,1
2377,anticholinergic drugs,anticholinergic drugs,1
2376,additional cns stimulants,additional cns stimulants,1
4810,account,account,1
1645,multivariate analyses,multivariate analyses,1
1646,physicianrecorded obesity,scientific journal hybrid open access journal academic journal allegedly,1
2339,extended release formulation,extended release formulation,1
4825,relatively benign korean strain,relatively benign korean strain,1
4819,overlooked genuine cases,overlooked genuine cases,1
4723,total,total,1
4879,possible ranges,possible ranges,1
2287,rimantadine,chemical compound medication,1
2265,anisole proceeds,anisole proceeds,1
2289,tromantadine,chemical compound,1
2444,mutations,mutations,1
2334,a. epidemic resistance frequency,a. epidemic resistance frequency,1
2298,synthetic cannabinoid designer drugs,synthetic cannabinoid designer drugs,1
2372,dopaminergic anticholinergic properties,dopaminergic anticholinergic properties,1
2443,consequence,consequence,1
2378,concurrent use,concurrent use,1
2447,usual way,usual way,1
1665,ferrets,ferrets,1
4732,geographicallydistinct mortality patterns,geographicallydistinct mortality patterns,1
2263,friedel–crafts reaction,friedel–crafts reaction,1
4731,circulation,circulation,1
837,human influenza viruses,organisms known particular common homo sapiens homo sapiens sapiens homoinfectious disease,2
2624,phase iii clinical trials,phase iii clinical trials,2
8020,specific human h5n1 vaccine,organisms known particular common homo sapiens homo sapiens sapiens homosubtype,2
1823,centers,centers,2
6377,influenza virus pleomorphy,infectious disease,2
4884,spanish influenza pandemic virus,infectious disease,2
8297,mammalian influenza viruses,infectious disease,2
5498,stockpile,stockpile,2
3047,human disease,organisms known particular common homo sapiens homo sapiens sapiens homo,2
6726,limited humantohuman transmission influenza,infectious disease,2
2707,10%,10%,2
1822,human services,organisms known particular common homo sapiens homo sapiens sapiens homo,2
3572,human oral use,organisms known particular common homo sapiens homo sapiens sapiens homo,2
3677,avian influenza enters human trial,infectious diseaseorganisms known particular common homo sapiens homo sapiens sapiens homo,2
2992,primary human airway cells,organisms known particular common homo sapiens homo sapiens sapiens homo,2
6673,potential influenza,infectious disease,2
10771,b viruses,b viruses,2
4759,h5n1 infections,subtype,2
8055,phase 2b human clinical trials,organisms known particular common homo sapiens homo sapiens sapiens homo,2
8054,antiviral immunosuppressive effects,antiviral immunosuppressive effects,2
8287,new influenza virus,infectious disease,2
383,identification influenza,infectious disease,2
2626,hepatitis c virus,hepatitis c virus,2
6682,category 5 influenza,infectious disease,2
6683,influenza virus strain,infectious disease,2
6400,viral genomes,viral genomes,2
6399,doublestranded dna,doublestranded dna,2
4761,human transmissions,organisms known particular common homo sapiens homo sapiens sapiens homo,2
1519,flutype symptoms,flutype symptoms,2
9490,influenza activity,infectious disease,2
4327,hepatitis c testing,hepatitis c testing,2
6396,viral proteins,group class chemical substances second-order class,2
4331,viral load,viral load,2
8042,heterologous human influenza,organisms known particular common homo sapiens homo sapiens sapiens homoinfectious disease,2
6695,a/h1n1 influenza,infectious disease,2
8041,broad crossprotection,broad crossprotection,2
9493,influenza s viral replication,infectious disease,2
6698,3,3,2
6701,global influenza preparedness plan,infectious disease,2
8037,emerge.several trials,emerge.several trials,2
3678,2007the human trial,organisms known particular common homo sapiens homo sapiens sapiens homo,2
5417,aerosolized influenza virus,infectious disease,2
3680,h5n1 avian influenza infection,subtypeinfectious disease,2
836,avian influenza,infectious disease,2
8026,h5n1 variants,subtype,2
4860,current h5n1 influenza,subtypeinfectious disease,2
8222,betainfluenzavirus,betainfluenzavirus,2
9500,influenza resistance,infectious disease,2
2727,published clinical trials,published clinical trials,2
2612,different combinations,different combinations,2
8322,influenza b serotype,infectious disease,2
235,summer,summer,2
6361,human toll,organisms known particular common homo sapiens homo sapiens sapiens homo,2
6814,updated pandemic influenza plan,infectious disease,2
5391,equine influenza virus tsurviveoutsideof horse,infectious disease,2
6822,influenza research,infectious disease,2
8329,influenza c,infectious disease,2
4153,hepatitis c infection,hepatitis c infection,2
8331,mild disease,mild disease,2
4770,suspected human,organisms known particular common homo sapiens homo sapiens sapiens homo,2
6804,potential influenza epidemics,infectious disease,2
6827,influenza countermeasures,infectious disease,2
8332,influenza d,infectious disease,2
10043,librettists,librettists,2
10250,deadly 1918 influenza,infectious disease,2
5508,human society,organisms known particular common homo sapiens homo sapiens sapiens homo,2
1163,human consumption,organisms known particular common homo sapiens homo sapiens sapiens homo,2
3724,influenza virus vaccine,infectious disease,2
2738,chronic hepatitis d,chronic hepatitis d,2
10676,whoconfirmed human cases,organisms known particular common homo sapiens homo sapiens sapiens homo,2
7922,hepatitis c genotypes,hepatitis c genotypes,2
3556,human oral bioavailability,organisms known particular common homo sapiens homo sapiens sapiens homo,2
4148,acute hepatitis c,acute hepatitis c,2
7921,antiviral drug ribavirin,chemical compound medication essential medicine 1 april 1990,2
3723,approved human h5n1 vaccines,organisms known particular common homo sapiens homo sapiens sapiens homosubtype,2
1273,chickens,chicken gallus gallus domesticus common,2
2978,viral infections,viral infections,2
9525,effective antiviral,effective antiviral,2
2989,viral rnadependent rna polymerase,structural class chemical compoundsgroup class enzymes,2
844,study,study,2
6738,groups,groups,2
6740,antiviral resistance,antiviral resistance,2
6748,influenza vaccine manufacturers,infectious disease,2
2709,infecting influenza strain,infectious disease,2
2711,polymerase protein,group class enzymes,2
8314,h3n2 human influenza,subtypeorganisms known particular common homo sapiens homo sapiens sapiens homoinfectious disease,2
6756,h5n1 strains,subtype,2
4859,human victims,organisms known particular common homo sapiens homo sapiens sapiens homo,2
3694,human cells,organisms known particular common homo sapiens homo sapiens sapiens homo,2
8315,influenza b viruses,infectious disease,2
7945,20182019 influenza,infectious disease,2
5156,disease prevention,disease prevention,2
6763,seasonal influenza vaccines,infectious disease,2
7979,inactivated virus vaccines,inactivated virus vaccines,2
10071,influenza disease,infectious disease,2
8317,wild viruses,wild viruses,2
9516,antiviral assay,antiviral assay,2
3701,effective vaccines,effective vaccines,2
8319,human pathogen,organisms known particular common homo sapiens homo sapiens sapiens homo,2
2716,continuing research clinical concern,continuing research clinical concern,2
4856,factor,factor,2
10066,comparable disease,comparable disease,2
7960,inactivated recombinant influenza vaccines,infectious disease,2
5397,different surfaces,different surfaces,2
2984,novel influenza,infectious disease,2
5145,influenza surveillance program,infectious disease,2
6413,expression,expression,2
3575,potent antiviral effects,potent antiviral effects,2
8194,nonstructural protein,nonstructural protein,2
8191,human trials,organisms known particular common homo sapiens homo sapiens sapiens homo,2
4285,hepatitis c transmission,hepatitis c transmission,2
6531,b virus,b virus,2
8179,influenza parents,infectious disease,2
10654,viral superinfections,viral superinfections,2
10783,vitro effectivenessatpreventingentryofzaireebolavirustacaribearenavirusandkaposi ssarcomaassociatedherpesvirusinmammaliancellcultureswhileconfirmingumifenovir ssuppressiveeffectinvitroon hepatitis b,vitro effectivenessatpreventingentryofzaireebolavirustacaribearenavirusandkaposi ssarcomaassociatedherpesvirusinmammaliancellcultureswhileconfirmingumifenovir ssuppressiveeffectinvitroon hepatitis b,2
6545,human vaccines,organisms known particular common homo sapiens homo sapiens sapiens homo,2
6455,b. influenza,infectious disease,2
6546,influenza viruses c,infectious disease,2
3622,experimental h5n1 avian influenza vaccine,subtypeinfectious disease,2
3623,adjuvant,adjuvant,2
2664,influenza therapeutic agent,infectious disease,2
1952,clinical specimens,clinical specimens,2
8157,clinical centers,clinical centers,2
6561,influenza evolution,infectious disease,2
9450,rimantadin,rimantadin,2
6452,types c,types c,2
2405,influenza virus particles,infectious disease,2
803,human animal coronaviruses,organisms known particular common homo sapiens homo sapiens sapiens homotaxon,2
4744,10% human fatality ratio,organisms known particular common homo sapiens homo sapiens sapiens homo,2
6449,influenza d virus,infectious disease,2
2671,viral mrnas,viral mrnas,2
3021,ebola virus disease,infectious disease,2
6577,> 100 influenza genomes,infectious disease,2
5446,equine influenza virus infection,infectious disease,2
4248,hepatitis c andtheblood stestingpositivedependingon method,hepatitis c andtheblood stestingpositivedependingon method,2
4739,human fatality,organisms known particular common homo sapiens homo sapiens sapiens homo,2
6447,c virus,c virus,2
6519,human health,organisms known particular common homo sapiens homo sapiens sapiens homo,2
8198,hepatitis c virus polyprotein,hepatitis c virus polyprotein,2
3604,phase 1 clinical trials,phase 1 clinical trials,2
3605,h5n1 avian influenza vaccine candidate,subtypeinfectious disease,2
3606,h5n1 avian influenza vaccine candidate contract,subtypeinfectious disease,2
8227,isaviruses,isaviruses,2
1247,highly pathogenic avian influenza virus,infectious disease,2
786,influenza subtype,infectious disease,2
5470,861 confirmed human cases,organisms known particular common homo sapiens homo sapiens sapiens homo,2
2649,influenza medication,infectious disease,2
2650,antiviral,antiviral,2
8214,viral life cycle,viral life cycle,2
2403,viral neuraminidase enzyme,group class enzymes,2
6477,influenza virus c.,infectious disease,2
1243,h5n1,subtype,2
8211,hepatitis c. odalasvir,chemical compound,2
6501,influenza virus c growth requirements,infectious disease,2
2643,virus polymerase complex,group class enzymes,2
4738,human mortality,organisms known particular common homo sapiens homo sapiens sapiens homo,2
5465,tens millions,tens millions,2
8236,10 1.the viral envelope,10 1.the viral envelope,2
6467,influenza virus c,infectious disease,2
2094,known human cases,organisms known particular common homo sapiens homo sapiens sapiens homo,2
2652,uncomplicated influenza,infectious disease,2
2641,influenza virus capdependent endonuclease activity,infectious disease,2
10790,macrocyclic hepatitis c virus,macrocyclic hepatitis c virus,2
6459,viruses b,viruses b,2
3615,different h5n1 strain,subtype,2
2653,influenza complications,infectious disease,2
8196,viral nonstructural protein,viral nonstructural protein,2
6443,influenza c virus,infectious disease,2
402,influenza epidemics,infectious disease,2
3640,h5n1 avian influenza vaccine,subtypeinfectious disease,2
6631,new influenza,infectious disease,2
4216,viral genome,scientific model natural environment,2
6419,human influenza virus,organisms known particular common homo sapiens homo sapiens sapiens homoinfectious disease,2
6634,common human vaccine,organisms known particular common homo sapiens homo sapiens sapiens homo,2
6635,trivalent influenza vaccine,infectious disease,2
3581,viral diseases,viral diseases,2
6636,viral strains,viral strains,2
8276,future viruses,future viruses,2
6638,influenza virus subtypes,infectious disease,2
6639,influenza b virus strain,infectious disease,2
1810,influenza symptoms,infectious disease,2
6641,new influenza pandemic changes,infectious disease,2
816,different strains,different strains,2
6643,isolate,isolate,2
1630,pandemic a/h1n1 influenza,infectious disease,2
387,flulike symptoms,flulike symptoms,2
2408,influenza strains,infectious disease,2
4863,human infection,organisms known particular common homo sapiens homo sapiens sapiens homo,2
6655,human selfishness,organisms known particular common homo sapiens homo sapiens sapiens homo,2
6482,influenza virus infections,infectious disease,2
1660,h1n1 influenza virus,virusinfectious disease,2
8075,sarscov2.the drug,sarscov2.the drug,2
8072,antiviral action,antiviral action,2
1263,nadia,nadia,2
2999,broadspectrum antiviral,broadspectrum antiviral,2
8064,antiviral research,antiviral research,2
3667,wholevirus h5n1 avian influenza vaccine,subtypeinfectious disease,2
6420,known influenza,infectious disease,2
8274,hostcell mrnas,hostcell mrnas,2
8098,preliminary human study,organisms known particular common homo sapiens homo sapiens sapiens homo,2
3582,h5n1 clinical trials,subtype,2
776,influenza virus,infectious disease,2
1224,drop,drop,2
10791,clinical testing,clinical testing,2
8127,antiviral activity,antiviral activity,2
3587,current status h5n1 candidate vaccines,subtype,2
10778,hepatitis c.more recent studies,hepatitis c.more recent studies,2
4236,risk factor,risk factor,2
8124,malignancies,malignancies,2
6602,influenza infection,infectious disease,2
6435,polymerase complex,group class enzymes,2
3643,human volunteers,organisms known particular common homo sapiens homo sapiens sapiens homo,2
8117,chronic hepatitis c.,chronic hepatitis c.,2
4750,23%,23%,2
6669,known influenza virus subtypes,infectious disease,2
811,human population,organisms known particular common homo sapiens homo sapiens sapiens homo,2
6430,influenza b virus capsid,infectious diseasecellular component,2
5130,swine influenza virus strain,swine diseaseinfectious disease,2
10777,candidate drug,candidate drug,2
6428,genus betainfluenzavirus,genus betainfluenzavirus,2
6616,low temperatures,low temperatures,2
4226,major risk factor,major risk factor,2
6427,influenza b virus,infectious disease,2
10776,clinical application,clinical application,2
2092,human transmission confirmed,organisms known particular common homo sapiens homo sapiens sapiens homo,2
4221,viral particles,viral particles,2
3583,h5n1 vaccines,subtype,2
6623,severe influenza illness,infectious disease,2
3009,new influenza medication,infectious disease,2
1512,methods,methods,2
8122,human proteases,organisms known particular common homo sapiens homo sapiens sapiens homo,2
5281,influenza a/h3n2 virus,infectious disease,2
9534,seasonal influenza vaccine brands,infectious disease,2
2910,kidney disease,kidney disease,2
3994,hepatitis,hepatitis,2
7236,inactivated influenza vaccine information statement,infectious disease,2
3860,internal viral protein,internal viral protein,2
7232,veterinary influenza vaccination,infectious disease,2
2128,phloroglucinol,chemical compound benzenetriol medication,2
5233,human h2n2 virus,organisms known particular common homo sapiens homo sapiens sapiens homowikimedia disambiguation page,2
5232,human influenza infection,organisms known particular common homo sapiens homo sapiens sapiens homoinfectious disease,2
7594,universal vaccines,universal vaccines,2
9851,adequate human data,organisms known particular common homo sapiens homo sapiens sapiens homo,2
1648,chronic obstructive pulmonary disease,chronic obstructive pulmonary disease,2
4799,h5n1 killed chickens,subtypechicken gallus gallus domesticus common,2
972,military bases,military bases,2
9687,effective birth control methods,effective birth control methods,2
7215,disease burden,disease burden,2
3864,h5n1 viruses,subtype,2
7213,influenza costeffectiveness models,infectious disease,2
5302,influenza vaccines,infectious disease,2
7568,70 known clinical trials,70 known clinical trials,2
7551,quadrivalent influenza vaccines,infectious disease,2
7269,disease research,disease research,2
7552,20182019 influenza season,infectious disease,2
7556,recombinant influenza vaccine,infectious disease,2
3869,influenza genomic sequences,infectious disease,2
7262,placebocontrolled randomized clinical trials,placebocontrolled randomized clinical trials,2
7558,20202021 influenza season,infectious disease,2
7260,clinical evidence,clinical evidence,2
7559,2020–2021 influenza season,infectious disease,2
9705,h5n1 threat,subtype,2
7257,annual influenza vaccination,infectious disease,2
7562,pandemic influenza vaccines,infectious disease,2
3868,influenza research database – database,infectious disease,2
5300,commercial siv vaccines,commercial siv vaccines,2
5238,chronic pneumonia,cause death infectious disease,2
7250,certain influenza subtypes,infectious disease,2
7273,seasonal influenza vaccine,infectious disease,2
7604,universal vaccines vaccines,universal vaccines vaccines,2
7207,different groups,different groups,2
1552,drug,drug,2
7175,viral forms,viral forms,2
44,influenza,infectious disease,2
2814,hepatitis b c viruses,hepatitis b c viruses,2
2813,hepatitis b,hepatitis b,2
7628,poultry vaccines,organisms known particular common,2
7169,increase,increase,2
7631,human poultry vaccines,organisms known particular common homo sapiens homo sapiens sapiens homoorganisms known particular common,2
2925,antiviral medicine,antiviral medicine,2
3840,h5n1 influenza virus,subtypeinfectious disease,2
10702,highly pathogenic h5n1 avian influenza,subtypeinfectious disease,2
10701,human incubation period,organisms known particular common homo sapiens homo sapiens sapiens homo,2
7647,onlyneedtoprotecthumanvaccines].chickensforsixweeksbecausethat showlonghumanvaccines].chickenslivetillyoueat human vaccines]. chickens],organisms known particular common homo sapiens homo sapiens sapiens homo,2
7648,human vaccines]. chickens,organisms known particular common homo sapiens homo sapiens sapiens homochicken gallus gallus domesticus common,2
2801,hepatitis c genotype,hepatitis c genotype,2
2816,hepatitis c,hepatitis c,2
2826,enzyme,enzyme,2
7178,2019–2020 influenza seasons,infectious disease,2
9870,viral rna polymerase,structural class chemical compoundsgroup class enzymes,2
7206,seasonal influenza vaccination,infectious disease,2
7606,m001 h1ssf3928 universal influenza vaccine candidates,infectious disease,2
10739,viral entry,viral entry,2
7203,human vaccine,organisms known particular common homo sapiens homo sapiens sapiens homo,2
5227,big concern,big concern,2
5315,influenza genome sequencing project,infectious diseasescientific model natural environment,2
43,1510 influenza,infectious disease,2
7610,3 study,3 study,2
7194,yearly influenza vaccination,infectious disease,2
7616,oral influenza vaccine,infectious disease,2
2918,chronic hepatitis c infection,chronic hepatitis c infection,2
4012,future risk,future risk,2
7618,clinical research,clinical research,2
9867,active antiviral agent,active antiviral agent,2
10708,broadspectrum antiviral drug,broadspectrum antiviral drug,2
2817,hepatitis b reactivation,hepatitis b reactivation,2
1538,experimental antiviral drug,experimental antiviral drug,2
2841,amiodarone,chemical compound medication essential medicine,2
7277,chronic illnesses,chronic illnesses,2
7466,global influenza surveillance,infectious disease,2
5277,seasonal influenza viruses,infectious disease,2
7368,modern influenza vaccines,infectious disease,2
7366,annual influenza epidemic,infectious disease,2
7468,significant human suffering,organisms known particular common homo sapiens homo sapiens sapiens homo,2
2860,hcv viral transcription,hcv viral transcription,2
7470,2012–2013 northern hemisphere influenza season,infectious disease,2
7475,2017–2018 northern hemisphere influenza season,infectious disease,2
7477,2018 southern hemisphere influenza season,infectious disease,2
1875,swine influenza,swine diseaseinfectious disease,2
7478,2018–2019 northern hemisphere influenza season,infectious disease,2
7479,2019 southern hemisphere influenza season,infectious disease,2
7480,2019–2020 northern hemisphere influenza season,infectious disease,2
7353,randomized clinical trials,randomized clinical trials,2
2856,directacting antiviral agents,directacting antiviral agents,2
9780,triphosphate,triphosphate,2
7481,2020–2021 northern hemisphere influenza season,infectious disease,2
9779,phosphate groups,phosphate groups,2
5258,epidemic pandemic influenza preparedness,infectious disease,2
10728,lethal influenza infection,infectious disease,2
7417,risk groups,risk groups,2
2873,protein,protein,2
5267,influenza subtypes,infectious disease,2
9755,pglycoprotein,pglycoprotein,2
3925,hepatitis c. prevention,hepatitis c. prevention,2
3917,injection drug use,injection drug use,2
7405,human influenza sickness,organisms known particular common homo sapiens homo sapiens sapiens homoinfectious disease,2
7404,influenza circulation,infectious disease,2
7402,influenza vaccination strategy,infectious disease,2
5264,viral genus influenzavirus,viral genus influenzavirus,2
3912,liver disease,organ type,2
3905,infectious disease,infectious disease,2
9772,rilpivirine,chemical compound medication,2
9775,antihepatitis c treatments,antihepatitis c treatments,2
2863,human subjects,organisms known particular common homo sapiens homo sapiens sapiens homo,2
7350,influenza outbreaks,infectious disease,2
3953,3 hours,3 hours,2
5663,influenza conference,infectious disease,2
5286,s global influenza surveillance network],infectious disease,2
7521,plantbased influenza vaccines,infectious disease,2
992,typical seasonal influenza,infectious disease,2
7309,virologically confirmed influenza,infectious disease,2
2849,bovine viral diarrhea virus,bovine viral diarrhea virus,2
9815,hill,hill,2
3973,mild nonspecific flulike symptoms,mild nonspecific flulike symptoms,2
990,estimated influenza mortality rate,infectious disease,2
7528,influenza vaccination levels,infectious disease,2
1052,compensation,compensation,2
9717,alarmist,film,2
3975,chronic,chronic,2
3976,chronic hepatitis c,chronic hepatitis c,2
5293,human swine avian lineages,organisms known particular common homo sapiens homo sapiens sapiens homoswine disease,2
4830,h5n1 attacks,subtype,2
3880,np codes,np codes,2
7511,military,military,2
2894,clinical candidate,clinical candidate,2
7509,experimental influenza vaccines,infectious disease,2
1546,antiviral medications,antiviral medications,2
9796,hepatitis c treatments,hepatitis c treatments,2
7485,eggbased influenza vaccines,infectious disease,2
7486,influenza season,infectious disease,2
5251,severe influenza infections,infectious disease,2
10720,viral ribonucleic acid,viral ribonucleic acid,2
7488,2020 southern hemisphere influenza season,infectious disease,2
7649,human vaccines]. chickens forsixweeksbecausethat showlonghumanvaccines].chickenslivetill,organisms known particular common homo sapiens homo sapiens sapiens homochicken gallus gallus domesticus common,2
7489,2020 southern hemisphere influenza season influenza season,infectious diseaseinfectious disease,2
3887,influenza vaccine,infectious disease,2
9802,anticipation,anticipation,2
7329,laboratoryconfirmed influenza,infectious disease,2
996,h5n1 virus,subtype,2
3886,viral polymerase,group class enzymes,2
2149,uses,uses,2
7500,viral growth,viral growth,2
2885,different countries,different countries,2
5167,19 influenza h1n2 virus isolates,infectious diseasesubtype,2
10700,widespread seasonal influenza vaccination,infectious disease,2
10699,influenza virus type,infectious disease,2
7839,viral interference,viral interference,2
6939,2 clinical trials,2 clinical trials,2
10684,avian influenza cycle,infectious disease,2
10000,1918 influenza,infectious disease,2
6936,individual viral proteins,group class chemical substances second-order class,2
7843,live influenza virus,infectious disease,2
6933,clinical studies,clinical studies,2
10001,unusually deadly influenza,infectious disease,2
2757,hepatitis b virus surface,hepatitis b virus surface,2
7845,heatinactivated influenza virus,infectious disease,2
2756,hepatitis b virus,hepatitis b virus,2
4114,world hepatitis day,world hepatitis day,2
4115,world hepatitis alliance,world hepatitis alliance,2
6919,dowpharma,dowpharma,2
6917,harmful,harmful,2
901,chinese national influenza center,infectious disease,2
7857,viral inhibitory factor,viral inhibitory factor,2
9994,hepatitis c. similarly,hepatitis c. similarly,2
7831,antiviral activities,antiviral activities,2
912,taiwan,island disputed territory,2
6981,reservations,reservations,2
4849,human form,organisms known particular common homo sapiens homo sapiens sapiens homo,2
9591,splitvirion influenza vaccines,infectious disease,2
7805,human cytomegalovirus,organisms known particular common homo sapiens homo sapiens sapiens homotaxon,2
2763,hepatitis c. ciluprevir,chemical compound,2
7810,human papillomavirus,organisms known particular common homo sapiens homo sapiens sapiens homo,2
10750,russian antiviral market,russian antiviral market,2
6964,injection site,injection site,2
2761,hepatitis b virus infection,hepatitis b virus infection,2
2760,hepatitis d,hepatitis d,2
2280,antiviral drug,antiviral drug,2
906,influenza epidemic,infectious disease,2
4101,clinical medical research,clinical medical research,2
6954,h5n1 influenza vaccine,subtypeinfectious disease,2
1137,rodents,rodents,2
3233,human trial,organisms known particular common homo sapiens homo sapiens sapiens homo,2
2961,hepatitis c. deleobuvir,chemical compound,2
7864,specific antiviral effect,specific antiviral effect,2
884,1957 influenza,infectious disease,2
6875,h5n1 speed,subtype,2
6871,h5n1 vaccination effectiveness,subtype,2
4775,h5n1 prepandemic vaccines,subtype,2
10027,previous influenza strains,infectious disease,2
2749,hdv,hdv,2
4852,human h1n1,organisms known particular common homo sapiens homo sapiens sapiens homovirus,2
2390,viral replication,viral replication,2
875,fuentes,fuentes,2
2744,hepatitis b viruses,hepatitis b viruses,2
2743,hepatitis delta,hepatitis delta,2
7914,different types,different types,2
3728,h5n1 influenza strain,subtypeinfectious disease,2
1160,concern,concern,2
5384,different routes,different routes,2
10022,disease vectors,disease vectors,2
2962,nonnucleoside hepatitis c virus ns5b polymerase inhibitor,group class enzymes,2
6879,live attenuated influenza vaccine,infectious disease,2
6882,intranasal influenza vaccine candidate,infectious disease,2
7866,responsible factor viral inhibitory factor,responsible factor viral inhibitory factor,2
4119,antiviral treatment,antiviral treatment,2
7870,human beta interferon,organisms known particular common homo sapiens homo sapiens sapiens homogroup class proteins,2
6901,influenza virus proteins,infectious diseasegroup class chemical substances second-order class,2
7873,radiolabeled human beta,organisms known particular common homo sapiens homo sapiens sapiens homo,2
2967,antiviral effects,antiviral effects,2
3744,pandemic influenza vaccine development,infectious disease,2
6894,influenza coat protein,infectious disease,2
5176,disease control prevention document,disease control prevention document,2
6891,highly pathogenic influenza viruses,infectious disease,2
6349,human influenza pandemics,organisms known particular common homo sapiens homo sapiens sapiens homoinfectious disease,2
2969,human clinical trials,organisms known particular common homo sapiens homo sapiens sapiens homo,2
2970,broad spectrum antiviral effects,broad spectrum antiviral effects,2
9551,vaccines subunit,vaccines subunit,2
5376,influenza infections,infectious disease,2
6881,phase 1 h5n1 study,subtype,2
9596,recombinant influenza vaccines,infectious disease,2
6991,viral m2 protein,viral m2 protein,2
4783,pandemic vaccines,pandemic vaccines,2
5335,influenza virus vaccines,infectious disease,2
2787,adenoviruses,adenoviruses,2
3827,human a/hk/212/03,organisms known particular common homo sapiens homo sapiens sapiens homo,2
4839,h5n1 influenza attacks,subtypeinfectious disease,2
7100,antiviral drugs ribavirin,chemical compound medication essential medicine 1 april 1990,2
5336,2007–2008 northern hemisphere influenza season,infectious disease,2
2783,related viral diarrheas,related viral diarrheas,2
4043,~1–4%,~1–4%,2
10695,new influenza virus subtypes,infectious disease,2
5214,h2n3 viruses,h2n3 viruses,2
5338,virus vaccines,virus vaccines,2
5213,h2n3 coat,h2n3 coat,2
5212,h2n3,h2n3,2
3817,human receptors,organisms known particular common homo sapiens homo sapiens sapiens homo,2
1558,annual influenza epidemics,infectious disease,2
271,past influenza pandemics,infectious disease,2
9635,4 chronic hepatitis c,4 chronic hepatitis c,2
2122,compound,compound,2
7112,influenza strain,infectious disease,2
2365,acetylation,acetylation,2
4028,hepatitis crelated diseases,hepatitis crelated diseases,2
351,influenza territories,infectious disease,2
7665,filtered purified influenza vaccine,infectious disease,2
7667,swine influenza vaccines,swine diseaseinfectious disease,2
4033,intravenous drug abuse,intravenous drug abuse,2
2928,chronic hepatitis c virus,chronic hepatitis c virus,2
7669,canine influenza,infectious disease,2
7671,antiviral antineoplastic drug,chebi ontology term drug class,2
9657,clinical study,clinical study,2
3834,human type receptors,organisms known particular common homo sapiens homo sapiens sapiens homo,2
9656,hepatitis c. simeprevir,chemical compound medication essential medicine,2
4837,h5n1 attack,subtype,2
2789,viral rnadependant rna polymerase,structural class chemical compoundsgroup class enzymes,2
7113,primary viral pneumonia,cause death infectious disease,2
1532,outcomes,outcomes,2
5339,2008–2009 northern hemisphere influenza season,infectious disease,2
7077,initial trials,initial trials,2
9633,viral maturation,viral maturation,2
2949,genotype 1 chronic hepatitis c infection,genotype 1 chronic hepatitis c infection,2
929,trials,trials,2
3784,influenzavirus c,influenzavirus c,2
3783,influenzavirus b,influenzavirus b,2
2769,human,organisms known particular common homo sapiens homo sapiens sapiens homo,2
254,1557 influenza,infectious disease,2
5354,equine influenza,infectious disease,2
9609,ribavirin active disease,chemical compound medication essential medicine 1 april 1990,2
3778,h5n1 genetic structure,subtype,2
5355,equine influenza virus,infectious disease,2
9607,active disease,active disease,2
7005,additional antiviral drugs,additional antiviral drugs,2
9606,previous hepatitis b infection,previous hepatitis b infection,2
5194,influenza outbreak,infectious disease,2
4785,h5n1 clinical trials stage,subtype,2
45,continents,continents,2
4844,additional factor,additional factor,2
10691,human human transmission,organisms known particular common homo sapiens homo sapiens sapiens homoorganisms known particular common homo sapiens homo sapiens sapiens homo,2
4790,human cellular receptors,organisms known particular common homo sapiens homo sapiens sapiens homo,2
7716,human interferons,organisms known particular common homo sapiens homo sapiens sapiens homo,2
7718,antiviral agents antiviral agents modulate functions,antiviral agents antiviral agents modulate functions,2
9631,hepatitis c virus protease inhibitor,hepatitis c virus protease inhibitor,2
7722,human tumors,organisms known particular common homo sapiens homo sapiens sapiens homo,2
5206,deadly avian influenza virus subtypes,infectious disease,2
7724,microbes,microbes,2
941,1968 influenza,infectious disease,2
2926,chronic hepatitis c virus genotype,chronic hepatitis c virus genotype,2
2776,human leukocyte elastase,organisms known particular common homo sapiens homo sapiens sapiens homo,2
7062,viral infection,viral infection,2
7726,viral glycoproteins,structural class chemical compounds,2
2944,polymerase,group class enzymes,2
7055,alternative influenza treatments,infectious disease,2
3801,genetic factor,genetic factor,2
7735,activator,activator,2
1115,antiviral drugs,antiviral drugs,2
7063,combat influenza,infectious disease,2
7881,human beta,organisms known particular common homo sapiens homo sapiens sapiens homo,2
4741,confirmed human deaths,organisms known particular common homo sapiens homo sapiens sapiens homo,2
5270,influenza b,infectious disease,2
5051,influenza vaccination,infectious disease,2
3100,influenza cases,infectious disease,2
5052,influenza doctor,infectious disease,2
4693,clinical symptoms,clinical symptoms,2
8650,genotype 1 hepatitis c patients,genotype 1 hepatitis c patients,2
4494,hepatitis b antigen,group class chemical substances,2
6035,human seasonal influenza viruses,organisms known particular common homo sapiens homo sapiens sapiens homoinfectious disease,2
5636,avian influenza virus,infectious disease,2
2325,antiviral mechanism,antiviral mechanism,2
3418,avian influenza disease situation,infectious disease,2
1750,fake,fake,2
8656,genotype 1 hepatitis c virus,genotype 1 hepatitis c virus,2
8481,annual influenza,infectious disease,2
6206,confirmed human cases,organisms known particular common homo sapiens homo sapiens sapiens homo,2
5783,virus symptoms,virus symptoms,2
3306,h5n1 effects,subtype,2
6034,seasonal pattern,seasonal pattern,2
1320,direct viral pneumonia,cause death infectious disease,2
8905,covid19.remdesivir,covid19.remdesivir,2
9298,viral hemorrhagic fevers,viral hemorrhagic fevers,2
9097,directacting antiviral agent,directacting antiviral agent,2
8509,symptomatic disease,symptomatic disease,2
5913,low,low,2
8780,vp,vp,2
10509,major pattern,major pattern,2
4667,clinical data,clinical data,2
2076,transit,transit,2
5915,h7n3 chilean avian influenza viruses,infectious disease,2
5794,virulent avian influenza,infectious disease,2
4903,things,things,2
4431,hepatitis research,hepatitis research,2
4597,large protein,large protein,2
5534,hunan,hunan,2
8645,1 hepatitis c,1 hepatitis c,2
10605,different results,different results,2
1702,second influenza vaccination program,infectious disease,2
8647,human il28b gene,organisms known particular common homo sapiens homo sapiens sapiens homo,2
1421,hours,hours,2
4498,complete viral particle,complete viral particle,2
3096,c,c,2
6030,new human h7n9 cases,organisms known particular common homo sapiens homo sapiens sapiens homotaxon,2
4503,yakutia,republic russia,2
5928,influenza research database—database,infectious disease,2
5640,h5n1 caused acute disease,subtype,2
3291,confirmed human fatality,organisms known particular common homo sapiens homo sapiens sapiens homo,2
5567,avian h5n1 varieties,subtype,2
3288,human infections,organisms known particular common homo sapiens homo sapiens sapiens homo,2
3287,human clinical specimens,organisms known particular common homo sapiens homo sapiens sapiens homo,2
5643,lethal influenza virus infection,infectious disease,2
3286,avian influenza viruses,infectious disease,2
4411,human immunodeficiency virus infection,organisms known particular common homo sapiens homo sapiens sapiens homoorganisms known particular common,2
8453,routine seasonal influenza,infectious disease,2
4621,superinfection,superinfection,2
5060,human history,organisms known particular common homo sapiens homo sapiens sapiens homo,2
2292,antiviral agents,antiviral agents,2
6013,visible disease,visible disease,2
5747,36 sites,36 sites,2
10622,influenza pandemic canadian soldiers,infectious disease,2
8663,melanoma hepatitis c,rare disease,2
5628,virus isolate,virus isolate,2
6022,human animal infections,organisms known particular common homo sapiens homo sapiens sapiens homotaxon,2
1370,associated influenza symptoms,infectious disease,2
4932,future influenza,infectious disease,2
8658,hepatitis e.,hepatitis e.,2
3416,h5n1 pathogenicity,subtype,2
3095,b,b,2
3298,fastmutating highly pathogenic avian influenza virus,infectious disease,2
5591,avian influenza occurrences,infectious disease,2
1425,disease control,disease control,2
5767,h5n6 avian influenza,infectious disease,2
4543,large hepatitis b surface antigen,group class chemical substances,2
8928,low count,low count,2
2474,multiple control trials,multiple control trials,2
2584,parkinson s disease cogwheel rigidity,parkinson s disease cogwheel rigidity,2
6220,farmer,farmer,2
3293,h5n1 influenza,subtypeinfectious disease,2
4611,lethal tropical viral infection,lethal tropical viral infection,2
4416,lack,lack,2
2052,pathogenic h5n8 avian influenza,infectious disease,2
9315,hepatitis ribavirin,chemical compound medication essential medicine 1 april 1990,2
8511,symptomatic influenza,infectious disease,2
586,risk,risk,2
6169,decade mighthavemadetheh5n1avianinfluenzavirusharderforchineseveterinarytechnicianstospottherecentspreadoftheh7n9viruschina sagricultureministrydefendedchina sagricultureministrypolicyoflargescalevaccinationofpoultryagainsttheearlierbirdflustrainsayingthatchina sagricultureministrywasnotinterferingwithchina sagricultureministryeffortsnowtoidentify h5n1 avian influenza virus,subtypeinfectious disease,2
489,disease,disease,2
4465,hepatitis d virus,hepatitis d virus,2
4464,hepatitis b protects,hepatitis b protects,2
1489,clinical trials,clinical trials,2
4894,human h5n1 infection,organisms known particular common homo sapiens homo sapiens sapiens homosubtype,2
110,influenza pandemics,infectious disease,2
8548,h1n1 influenza,virusinfectious disease,2
1471,influenza division,infectious disease,2
8543,h5n1 avian influenza bird flu,subtypeinfectious diseasetaxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,2
4979,human pandemic lethality,organisms known particular common homo sapiens homo sapiens sapiens homo,2
8542,oseltamivirresistant influenza,infectious disease,2
8540,neuraminidaseresistant influenza,infectious disease,2
1990,human transmission,organisms known particular common homo sapiens homo sapiens sapiens homo,2
4674,avian human viruses,organisms known particular common homo sapiens homo sapiens sapiens homo,2
10491,pandemic influenza deaths,infectious disease,2
1410,octors,octors,2
6132,investigational h7n9 influenza vaccine,taxoninfectious disease,2
4895,h5n1 pandemic,subtype,2
6133,phase ii trials,phase ii trials,2
608,deadly disease,deadly disease,2
8858,viral protein,viral protein,2
496,languedoc influenza,infectious disease,2
2320,human body,organisms known particular common homo sapiens homo sapiens sapiens homo,2
9134,randomized controlled clinical trials,randomized controlled clinical trials,2
4481,human use,organisms known particular common homo sapiens homo sapiens sapiens homo,2
2501,randomized control trials,randomized control trials,2
4482,antiviral hepcludex,antiviral hepcludex,2
10461,nauru,nauru,2
3344,turkeysh5n1 h5n1,subtype,2
2057,h5n8 avian influenza,infectious disease,2
2549,control,control,2
4989,emerging viral diseases,emerging viral diseases,2
1474,human viruses,organisms known particular common homo sapiens homo sapiens sapiens homo,2
2555,gastrointestinal,gastrointestinal,2
3348,highly pathogenic h5n1,subtype,2
3444,clinical manifestations,clinical manifestations,2
97,symptoms,symptoms,2
8857,viral protein (vpg),viral protein (vpg),2
107,origin 1510 influenza,infectious disease,2
2329,influenza a.,infectious disease,2
6134,different vaccine dosages,different vaccine dosages,2
4456,hepatitis b. infection,hepatitis b. infection,2
4444,viral hepatitis,viral hepatitis,2
9105,mouse hepatitis virus rna replicase,structural class chemical compounds,2
8882,different individuals,different individuals,2
8633,hepatitis c hepatitis c,hepatitis c hepatitis c,2
3480,human patients,organisms known particular common homo sapiens homo sapiens sapiens homo,2
4975,human pandemic eventual emergence,organisms known particular common homo sapiens homo sapiens sapiens homo,2
4552,rna polymerase,structural class chemical compoundsgroup class enzymes,2
9282,countries disease,countries disease,2
8521,viral loads,viral loads,2
4441,antiviral compounds,antiviral compounds,2
6161,usage,usage,2
4974,human pandemic,organisms known particular common homo sapiens homo sapiens sapiens homo,2
8784,different capsid components,cellular component,2
3361,avian influenza experts,infectious disease,2
6167,poultry againsttheh5n1avianinfluenzavirusoverthelastdecademighthavemadetheh5n1avianinfluenzavirusharderforchineseveterinarytechnicianstospottherecentspreadoftheh7n9viruschina sagricultureministrydefendedchina sagricultureministrypolicyoflargescalevaccinationofpoultryagainsttheearlierbirdflustrainsayingthatchina sagricultureministrywasnotinterferingwithchina sagricultureministryeffortsnowtoidentify h5n1 avian influenza virus,organisms known particular common namesubtypeinfectious disease,2
6168,h5n1 avian influenza virus,subtypeinfectious disease,2
5027,influenza research database database,infectious disease,2
6152,h7n9 avian influenza,taxoninfectious disease,2
4457,hepatitis b infection,hepatitis b infection,2
4445,hepatitis delta virus,hepatitis delta virus,2
3478,antiviral prodrug remdesivir,chemical compound prodrug antiviral drug,2
1394,rapid influenza diagnostic tests,infectious disease,2
1362,heart disease,heart disease,2
4930,h5n1 virus genetic offspring,subtype,2
4453,hepatitis b carrier state,hepatitis b carrier state,2
4452,chronic hepatitis b,chronic hepatitis b,2
4586,hdv envelope protein,hdv envelope protein,2
4449,known hepatitis viruses,known hepatitis viruses,2
5042,respiratory disease,respiratory disease,2
3321,influenza transmission,infectious disease,2
5559,low pathogenic h5n1,subtype,2
8874,phase ii clinical trials,phase ii clinical trials,2
111,influenza viruses,infectious disease,2
1332,different cases,different cases,2
2311,application,application,2
8628,narcolepsy following pandemrix influenza vaccination,influenza vaccineinfectious disease,2
5028,influenza sequences,infectious disease,2
8796,viral particle,viral particle,2
9152,clinical status,clinical status,2
4622,hepatitis d.lábrea fever,hepatitis d.lábrea fever,2
1711,vaccines,vaccines,2
1451,north american avian influenza,infectious disease,2
4660,chronic hepatitis b cases,chronic hepatitis b cases,2
1760,influenza expert,infectious disease,2
8702,cytochrome c,cytochrome c,2
8722,confirmed acute uncomplicated influenza infection,infectious disease,2
4386,silver,silver,2
5985,human virus,organisms known particular common homo sapiens homo sapiens sapiens homo,2
2316,nanotechnology,branch science,2
415,pandemic influenza,infectious disease,2
1602,disease pattern,disease pattern,2
2450,seasonal h3n2,subtype,2
8357,confirmed suspected influenza virus infection,infectious disease,2
10548,human behavioral responses,organisms known particular common homo sapiens homo sapiens sapiens homo,2
4937,different genes,different genes,2
3258,h5n1 patients,subtype,2
6289,h9n2 influenza strain,infectious disease,2
10263,large factor,large factor,2
10546,human behavioral changes,organisms known particular common homo sapiens homo sapiens sapiens homo,2
6326,different distribution,different distribution,2
4390,develop chronic infection,develop chronic infection,2
5990,lethal human pandemic,organisms known particular common homo sapiens homo sapiens sapiens homo,2
3260,additional human cases,organisms known particular common homo sapiens homo sapiens sapiens homo,2
5074,viral rna,structural class chemical compounds,2
4636,chronic disease,chronic disease,2
5713,bingiriya,bingiriya,2
4393,hepatitis c virus infection,hepatitis c virus infection,2
3169,cdc u.s. influenza season summary,infectious disease,2
3261,h5n1 avian influenza,subtypeinfectious disease,2
3156,2009 pandemic influenza,infectious disease,2
2215,different substituents,different substituents,2
4659,fulminant hepatitis b cases,fulminant hepatitis b cases,2
5075,influenza a/ussr/90/77,infectious disease,2
8388,cardiac symptoms,cardiac symptoms,2
1450,north american swine influenza,swine diseaseinfectious disease,2
2062,avian influenza outbreaks,infectious disease,2
9187,condition,condition,2
4948,avianadapted h5n1 influenza virus,subtypeinfectious disease,2
4371,previous hepatitis c treatment,previous hepatitis c treatment,2
6311,h9n2 influenza virus,infectious disease,2
9013,authorizations deployment,authorizations deployment,2
6310,transmission chicken human,organisms known particular common homo sapiens homo sapiens sapiens homo,2
5976,cdc s influenza division,infectious disease,2
8369,seasonal pandemic influenza,infectious disease,2
417,severe respiratory disease,severe respiratory disease,2
2601,clinical trial,clinical trial,2
8372,relevant clinical outcomes,relevant clinical outcomes,2
8710,influenza neuraminidase,infectious diseasegroup class enzymes,2
416,pandemic influenza fastmoving unrestricted epidemics,infectious disease,2
4527,viral envelope,viral envelope,2
1378,laboratoryconfirmed 2009 influenza,infectious disease,2
4950,human adaptation,organisms known particular common homo sapiens homo sapiens sapiens homo,2
1686,antiviral medication,antiviral medication,2
4888,virulent transmissible human form,organisms known particular common homo sapiens homo sapiens sapiens homo,2
1452,human influenza,organisms known particular common homo sapiens homo sapiens sapiens homoinfectious disease,2
5080,swine influenza virus,swine diseaseinfectious disease,2
1762,confusion,confusion,2
1618,primary influenza pneumonia,infectious diseasecause death infectious disease,2
6298,recent human infections,organisms known particular common homo sapiens homo sapiens sapiens homo,2
4959,human contagion,organisms known particular common homo sapiens homo sapiens sapiens homo,2
1453,swine influenza viruses,swine diseaseinfectious disease,2
8377,pandemic seasonal influenza,infectious disease,2
1289,influenza pandemic,infectious disease,2
2454,influenza treatment,infectious disease,2
4367,chronic cases,chronic cases,2
4532,hepatitis d antigen,group class chemical substances,2
1603,seasonal influenza,infectious disease,2
10554,viral waves,viral waves,2
5720,highly pathogenic avian influenza,infectious disease,2
5512,potential avian influenza,infectious disease,2
5581,facilities,facilities,2
3234,broadspectrum antiviral effectiveness,broadspectrum antiviral effectiveness,2
4961,lethal humanadapted influenza,infectious disease,2
8437,randomised clinical trials,randomised clinical trials,2
1436,similar seasonal influenza viruses,infectious disease,2
1616,obesity respiratory disease,scientific journal hybrid open access journal academic journal allegedly,2
754,influenza von,infectious disease,2
9331,antiviral effect,antiviral effect,2
4657,acute nonfulminant hepatitis b cases,acute nonfulminant hepatitis b cases,2
559,influenza s symptoms cameonsuddenlyandattacked,infectious disease,2
10811,influenza virus replication,infectious disease,2
6341,viral surface proteins,group class chemical substances second-order class,2
2333,amantadineresistant influenza viruses,infectious disease,2
651,1889 influenza,infectious disease,2
2330,antiviral properties,antiviral properties,2
8346,psychiatric symptoms,psychiatric symptoms,2
4629,fulminant hepatitis,fulminant hepatitis,2
3076,ns5b viral polymerase,group class enzymes,2
3521,selleckchem,selleckchem,2
1728,normal reported influenza cases,infectious disease,2
5733,low pathogenic avian influenza,infectious disease,2
6259,human human transfer virus,organisms known particular common homo sapiens homo sapiens sapiens homoorganisms known particular common homo sapiens homo sapiens sapiens homo,2
3074,hepatitis c.,hepatitis c.,2
2448,influenza b infections,infectious disease,2
10810,influenza virus host cell,infectious disease,2
4969,human preparation,organisms known particular common homo sapiens homo sapiens sapiens homo,2
8410,influenza s neuraminidase enzyme cleaves,infectious diseasegroup class enzymes,2
5070,strain influenza a/ussr/90/77,infectious disease,2
3061,severe disease,severe disease,2
4364,chronic hepatitis,chronic hepatitis,2
8441,h5n1 avian influenza epidemic,subtypeinfectious disease,2
3266,human cases,organisms known particular common homo sapiens homo sapiens sapiens homo,2
2431,newly formed viral proteins,group class chemical substances second-order class,2
9343,viral mrna,transcript,2
4967,human lives,organisms known particular common homo sapiens homo sapiens sapiens homo,2
8975,intermediate b,intermediate b,2
6265,pandemic influenza viruses,infectious disease,2
5957,human beings,organisms known particular common homo sapiens homo sapiens sapiens homo,2
3154,clinical infectious diseases,clinical infectious diseases,2
8689,b cells,b cells,2
3373,avian human influenza,organisms known particular common homo sapiens homo sapiens sapiens homoinfectious disease,2
6254,460 human infections,organisms known particular common homo sapiens homo sapiens sapiens homo,2
5209,pandemic preparedness,pandemic preparedness,3
3341,significant spread,significant spread,3
3339,highly pathogenic strain,highly pathogenic strain,3
613,pathological records,pathological records,3
9130,similar potency,similar potency,3
3815,fatal case,fatal case,3
9135,mildtosevere covid‑19,mildtosevere covid‑19,3
8821,5 end mayalsohave,5 end mayalsohave,3
8829,virus types,virus types,3
628,portuguese attaché,portuguese attaché,3
3831,recent research,recent research,3
7670,natural immunity,natural immunity,3
9132,covid‑19 treatment,covid‑19 treatment,3
7803,2 virus,2 virus,3
490,french,french,3
5008,analgesics,chebi ontology term,3
9589,standard vaccine,standard vaccine,3
8732,riboviria,riboviria,3
8804,5’ end,5’ end,3
3823,ha,ha,3
7801,japanese encephalitis virus,japanese encephalitis virus,3
954,public,public,3
9143,ongoing medical care,ongoing medical care,3
3349,entire world,entire world,3
9590,standarddose vaccine,standarddose vaccine,3
3352,family,family,3
2121,piperidine,chemical compound piperidine,3
35,trade routes,trade routes,3
951,virus strain,virus strain,3
7696,quantity,quantity,3
9653,simeprevir plasma concentration,chemical compound medication essential medicine,3
7811,b18r protein,b18r protein,3
7807,large t antigen,group class chemical substances,3
7812,vaccinia virus,infectious disease,3
10745,similar efficiency,similar efficiency,3
3766,public discussion,public discussion,3
364,cosmos,cosmos,3
3385,nations,nations,3
5217,triple reassortant h2n3 virus,triple reassortant h2n3 virus,3
8801,3’ end,3’ end,3
3763,primed immunity,primed immunity,3
4991,imidazopyridine,structural class chemical compounds,3
7806,epsteinbarr virus,epsteinbarr virus,3
9181,alberta health services,alberta health services,3
7681,chronic myelogenous leukemia,chronic myelogenous leukemia,3
9136,revised eua,revised eua,3
1608,respiratory failure,respiratory failure,3
3354,2004,2004,3
5197,1957 h2n2 virus,wikimedia disambiguation page,3
7712,virusinfected cell,virusinfected cell,3
1633,confirmed infection,confirmed infection,3
9610,hcv protease inhibitor,hcv protease inhibitor,3
3793,ha codes,ha codes,3
2948,ombitasvirparitaprevirritonavir,ombitasvirparitaprevirritonavir,3
5201,accuracy,accuracy,3
3375,turkey,sovereign state transcontinental country mediterranean country country social state regional power secular state,3
9161,recovery rates,recovery rates,3
4925,basis,basis,3
1621,methicillinresistant strains,methicillinresistant strains,3
8771,rhinoviruses,rhinoviruses,3
9623,rbv therapy,rbv therapy,3
7775,adaptor proteins,group class chemical substances second-order class,3
936,vaccine rapid deployment,vaccine rapid deployment,3
3365,unprecedented dieoff,unprecedented dieoff,3
9608,significant liver problems,organ type,3
9624,simeprevir pegifn combination therapy,chemical compound medication essential medicine,3
8755,plaque assay,plaque assay,3
3800,hemagglutinin proteins,group class proteinsgroup class chemical substances second-order class,3
8757,infection virus,infection virus,3
9619,pegifn,pegifn,3
7763,dimers,dimers,3
927,vaccine manufacturers,vaccine manufacturers,3
9165,eua,eua,3
8760,internal ribosome entry sites,internal ribosome entry sites,3
926,virus cultures,virus cultures,3
360,medicine treatments,medicine treatments,3
925,public health service,public health service,3
5003,peptic ulcer disease,peptic ulcer disease,3
3171,dozen charts,dozen charts,3
9614,chronic hepatic c infection,chronic hepatic c infection,3
7757,known isgs,armed organization,3
9615,triple antiviral treatment regimen,triple antiviral treatment regimen,3
2117,german chemist hans meerwein,german chemist hans meerwein,3
923,samples,samples,3
3788,virusa virus,virusa virus,3
5199,american pathologists,american pathologists,3
8765,animal virus,taxon,3
5190,preexisting human strain,organisms known particular common homo sapiens homo sapiens sapiens homo,3
9170,australia national stockpile,continent,3
9171,requests,requests,3
485,french physician medical historian lazare rivière,french physician medical historian lazare rivière,3
915,navy personnel,navy personnel,3
9174,confirmed covid‑19,confirmed covid‑19,3
2024,kanto region,kanto region,3
7794,virus resistance interferons,virus resistance interferons,3
615,area,area,3
9597,recombinant virus technology,academic discipline,3
5191,worldwide deaths,worldwide deaths,3
626,deaths,deaths,3
2060,early january,early january,3
1911,online sources,online sources,3
9595,flublok/flublok quadrivalent,flublok/flublok quadrivalent,3
9594,b strain,b strain,3
6,medical historians,medical historians,3
7714,virusinfected cell antiviral defenses,virusinfected cell antiviral defenses,3
9177,public services,public services,3
8793,group iv viruses,group iv viruses,3
8751,small rna viruses,structural class chemical compounds,3
8745,orphan virus,orphan virus,3
5205,1957 strain,1957 strain,3
3379,2006,2006,3
362,theory,theory,3
10746,clinical setting,clinical setting,3
4919,initial outbreaks,initial outbreaks,3
919,vaccine aftermath,vaccine aftermath,3
8776,icosahedral capsid,cellular component,3
9627,sensitivity,sensitivity,3
7727,bacterial flagella,bacterial flagella,3
8777,60 protomers,60 protomers,3
9156,care,care,3
5192,pandemic varies,pandemic varies,3
9601,peginterferonalfa,peginterferonalfa,3
1913,online pharmacies,online pharmacies,3
7789,deubiquitination,deubiquitination,3
9598,egggrown vaccine virus,egggrown vaccine virus,3
4914,early projections,early projections,3
7784,ribosomal protein s6,ribosomal protein s6,3
2278,medical applications known derivatives,medical applications known derivatives,3
3319,respiratory tract,respiratory tract,3
3187,common cold viruses,common cold viruses,3
3280,widespread infection,widespread infection,3
3278,international experts,international experts,3
3876,virus encodes,virus encodes,3
7519,growing virus,growing virus,3
2895,favorable potency profile,favorable potency profile,3
517,judiciary meetings,judiciary meetings,3
4933,higher pandemic severity index level,higher pandemic severity index level,3
8963,dimethyl sulfoxide,dimethyl sulfoxide,3
1893,leading health agencies,leading health agencies,3
4826,remaining strains,remaining strains,3
3281,communityacquired infection,communityacquired infection,3
9062,private health insurance companies,private health insurance companies,3
558,pregnant women,pregnant women,3
9059,29 june,29 june,3
556,place,place,3
1548,fight,fight,3
7496,therapeutic measure,therapeutic measure,3
1547,drugresistant strains,drugresistant strains,3
3265,details,details,3
2137,hydrocarbon,hydrocarbon,3
3889,suguitan al,suguitan al,3
3263,ha tay provinces,ha tay provinces,3
4934,category 5 pandemic,category 5 pandemic,3
518,spread,spread,3
3875,capsid,cellular component,3
2899,danaoprevir,danaoprevir,3
3295,recent highly pathogenic emergent strain,recent highly pathogenic emergent strain,3
984,soviet scientists,soviet scientists,3
9711,assets,assets,3
571,cold winter,cold winter,3
2902,commercialization,commercialization,3
7546,2009 pandemic h1n1,virus,3
9072,updated world health organization treatment guidelines,updated world health organization treatment guidelines,3
7544,2010 study,2010 study,3
7543,maligned 1976 vaccine,maligned 1976 vaccine,3
9713,fears,fears,3
8946,coadministration,coadministration,3
7541,potential swine,swine disease,3
1896,properly cooked pork,properly cooked pork,3
985,vaccine trial,vaccine trial,3
986,hand,hand,3
7536,public relations problems,public relations problems,3
7535,delays,delays,3
2036,samples fromwildbirdsinthecentralwestofsouthkorea sandissuedthehighlypathogenich5n8strainofbirdfluinsamplesfrom wild birds,samples fromwildbirdsinthecentralwestofsouthkorea sandissuedthehighlypathogenich5n8strainofbirdfluinsamplesfrom wild birds,3
3872,m codes,m codes,3
9071,world health organization guideline,world health organization guideline,3
7529,vaccine coverage levels,vaccine coverage levels,3
989,detection,detection,3
3292,global spread,global spread,3
551,chest,chest,3
548,sudden fits,sudden fits,3
2138,270 °c,270 °c,3
9751,neutropenia,abnormally low value absolute neutrophil count,3
7445,higher vaccination uptake,higher vaccination uptake,3
3910,initial infection,initial infection,3
7443,health professionals,health professionals,3
3911,chronic infection,chronic infection,3
1886,canadian pork council,canadian pork council,3
5263,classification,classification,3
1885,american meat institute,american meat institute,3
3242,ebola marburg viruses,infectious diseaselocation identifier q28791882 masculine plural 8 november 1919gregorian,3
7435,2009 pandemic low uptake,2009 pandemic low uptake,3
5262,h3n2 viruses,subtype,3
3241,phleboviruses,phleboviruses,3
2046,highly pathogenic h5n8 strain,highly pathogenic h5n8 strain,3
7433,physician reminders,physician reminders,3
7432,physician payment,physician payment,3
5266,internal proteins,group class chemical substances second-order class,3
2045,norway case,emoji regional indicator sequence,3
7429,vaccine home visits,vaccine home visits,3
7428,client outreach programs,client outreach programs,3
3236,bunyaviruses,bunyaviruses,3
3235,rna virus families,structural class chemical compounds,3
10727,potential application,potential application,3
1,acute respiratory disease,acute respiratory disease,3
1888,world health organization designation,world health organization designation,3
7454,public hospitals,public hospitals,3
4938,highvirulence alleles,highvirulence alleles,3
3893,sallusto f,sallusto f,3
9050,licensees,licensees,3
4956,areas research,areas research,3
4955,h5n1 genes,subtype,3
10856,middle ear infection,middle ear infection,3
8997,rsv,rsv,3
7476,trivalent virus vaccines,trivalent virus vaccines,3
522,contemporary writer,contemporary writer,3
7474,likely strains,likely strains,3
3895,king lr,king lr,3
4953,virus replication,virus replication,3
524,18th century physician thomas short,18th century physician thomas short,3
3226,bcx4430,bcx4430,3
1639,underlying condition,underlying condition,3
4821,h5n1 infection,subtype,3
5257,integral,integral,3
9042,captisol,captisol,3
3248,provinces,provinces,3
9007,mintz levin law firm,mintz levin law firm,3
2141,molecular weight,molecular weight,3
3901,potential vaccine,potential vaccine,3
3902,diagnostic targets,diagnostic targets,3
3903,e1000049,e1000049,3
3296,hitherto unprecedented global spread,hitherto unprecedented global spread,3
4831,preadults,preadults,3
5239,swine h2n3 virus,swine disease,3
4971,vaccine development,vaccine development,3
7639,h5n2 strain,h5n2 strain,3
5223,avian virus,avian virus,3
1904,slaughter,slaughter,3
7636,thumbs,thumbs,3
2923,1 mixed infection,1 mixed infection,3
7634,abscesses,abscesses,3
1553,medication,medication,3
4982,examples research,examples research,3
347,native american cherokee,native american cherokee,3
3844,progeny viruses,progeny viruses,3
7640,vaccine sonly85percentrelated,vaccine sonly85percentrelated,3
4981,pandemic mortality,pandemic mortality,3
5225,significant prerequisite,significant prerequisite,3
8863,uridylylation,uridylylation,3
4929,future pandemic strain,future pandemic strain,3
8866,additional virus groups,additional virus groups,3
8868,virus rna viruses,structural class chemical compounds,3
2919,following hcv subtypes,following hcv subtypes,3
9676,triple therapy,triple therapy,3
7621,licensed injectable vaccine,licensed injectable vaccine,3
7620,similar immunity,similar immunity,3
9109,ebola virus,infectious disease,3
3324,large numbers,large numbers,3
9669,mcleod hl,mcleod hl,3
8854,viral capsid proteins,cellular componentgroup class chemical substances second-order class,3
7644,vaccine s99.99percentrelatedwon tprotect,vaccine s99.99percentrelatedwon tprotect,3
9659,chronic hcv gt1,chronic hcv gt1,3
8839,internal ribosome entry site,internal ribosome entry site,3
9661,presentation,presentation,3
7662,90 percent,90 percent,3
4984,increasing vaccine manufacturing capacity,increasing vaccine manufacturing capacity,3
7661,95 percent,95 percent,3
9663,postmarketing studies,postmarketing studies,3
598,negligent medical care,negligent medical care,3
1906,medications,medications,3
2927,copackaged dasabuvir,scholarly article,3
7655,experimental vaccine,experimental vaccine,3
9666,simeprevir therapy,chemical compound medication essential medicine,3
7652,vaccine expert,vaccine expert,3
3838,pathogenicity,pathogenicity,3
4928,herd immunity,herd immunity,3
9121,monoclonal antibody treatments,family protein complexes,3
9120,congolese health officials,congolese health officials,3
8847,cd155,cd155,3
8848,special receptor,special receptor,3
9118,west african ebola virus epidemic,infectious disease,3
1905,29 april,29 april,3
3330,virus infection,virus infection,3
7645,vaccine s99.99percentrelatedareweaker.chickensaresmallerandyouonlyneedtoprotecthumanvaccines].chickensforsixweeksbecausethat showlonghumanvaccines].chickenslivetillyoueathumanvaccines].,vaccine s99.99percentrelatedareweaker.chickensaresmallerandyouonlyneedtoprotecthumanvaccines].chickensforsixweeksbecausethat showlonghumanvaccines].chickenslivetillyoueathumanvaccines].,3
7619,oral vaccine candidate,oral vaccine candidate,3
10847,zanamivir patent rights,chemical compound neuraminidase inhibitor medication,3
8873,fusion inhibitor,fusion inhibitor,3
9681,endstage kidney disease,endstage kidney disease,3
5234,mild pneumonia,cause death infectious disease,3
3307,purposely mutated strain,purposely mutated strain,3
3206,nasal spray vaccine,nasal spray vaccine,3
7579,escape,escape,3
8906,marburg virus infections,location identifier q28791882 masculine plural 8 november 1919gregorian,3
3863,rna viruses,structural class chemical compounds,3
7576,supply,supply,3
7575,universal vaccine,universal vaccine,3
8907,postinfection treatment,postinfection treatment,3
5236,entire respiratory tract,entire respiratory tract,3
341,spanish ships,spanish ships,3
979,scientists,scientists,3
338,spanish portuguese empires,spanish portuguese empires,3
579,breast,breast,3
7565,vaccine production,vaccine production,3
3207,inactivated viruses,inactivated viruses,3
9087,respiratory syncytial virus predominant effect,respiratory syncytial virus predominant effect,3
3301,recent highly pathogenic strain,recent highly pathogenic strain,3
8918,revision,revision,3
3209,live viruses,live viruses,3
3210,cancer treatment,constellation zodiacal constellation,3
3297,h5n1 strain,subtype,3
7570,initial vaccine lots,initial vaccine lots,3
8901,covid‑19,covid‑19,3
7586,challenges,challenges,3
581,stomach,stomach,3
3195,asthmatics,asthmatics,3
9682,simprevir,simprevir,3
3848,n2,n2,3
4977,veryeffective prepandemic vaccine,veryeffective prepandemic vaccine,3
8877,investigational ns5a inhibitor,investigational ns5a inhibitor,3
8878,combination treatment,combination treatment,3
12,communication advances,communication advances,3
500,italian physician francisco vallerioli,italian physician francisco vallerioli,3
5228,pathogenic potential,pathogenic potential,3
3201,potent immunosuppressive medications,potent immunosuppressive medications,3
4976,nonevent,nonevent,3
2033,south korea s agriculture ministry saidsouthkorea sagricultureministryhadconfirmedthehighlypathogenich5n8strainofbirdfluinsamplesfromwildbirdsinthecentralwestofsouthkorea sandissued highly pathogenic h5n8 strain,south korea s agriculture ministry saidsouthkorea sagricultureministryhadconfirmedthehighlypathogenich5n8strainofbirdfluinsamplesfromwildbirdsinthecentralwestofsouthkorea sandissued highly pathogenic h5n8 strain,3
9684,fetal deaths,fetal deaths,3
7603,vaccine adjuvants,vaccine adjuvants,3
7602,vaccine field,vaccine field,3
8892,copy,copy,3
9685,abortions,abortions,3
4834,frequent development,frequent development,3
3310,scientific research,scientific research,3
9689,medication regimen,medication regimen,3
2034,highly pathogenic h5n8 strain ofbirdfluinsamplesfromwildbirdsinthecentralwestofsouthkorea sandissuedthehighlypathogenich5n8strainofbirdfluinsamplesfromwildbirdsinthecentralwestofthecountry bird flu,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,3
3308,notable international policy debate,notable international policy debate,3
974,h3n2 strain,subtype,3
966,h1n1 strain,virus,3
8729,paralysis,paralysis,3
9381,dna viruses,dna viruses,3
5187,n2 neuraminidase genes,group class enzymes,3
9443,synonyms,synonyms,3
8168,early treatment,early treatment,3
8167,recent years,recent years,3
8165,longlasting antiinfluenza virus activity,longlasting antiinfluenza virus activity,3
9444,alphamethyl1adamantanemethylamine,alphamethyl1adamantanemethylamine,3
3626,similar h5n1 vaccine,subtype,3
27,nearuniversal infection,nearuniversal infection,3
3504,oral delivery,oral delivery,3
8156,scheringplough research institute,scheringplough research institute,3
9449,1adamantan1ylethylamine,1adamantan1ylethylamine,3
8471,public health england,nation uk cultural area country,3
9311,generic medication,generic medication,3
3503,hepatotoxicity,hepatotoxicity,3
8473,significant health problems,significant health problems,3
5056,2009 h1n1 pandemic,virus,3
3093,virus families,virus families,3
5123,11 deaths,11 deaths,3
8477,plos,plos,3
3632,effective vaccine,effective vaccine,3
8147,rpharm,rpharm,3
805,virus strains,virus strains,3
8145,regulatory approval,regulatory approval,3
8142,moscow clinical research center,moscow clinical research center,3
1949,skewed initial estimate,skewed initial estimate,3
8152,russian federation,russian federation,3
9312,oral form,oral form,3
8464,canine parvovirus infection,canine parvovirus infection,3
4871,health care,health care,3
1955,nearby imperial county,nearby imperial county,3
8445,president george w. bush,president george w. bush,3
5062,severe respiratory illness,severe respiratory illness,3
397,case,case,3
26,society,society,3
10784,poliovirus infection,taxon,3
9435,left,left,3
5059,unusually severe deadly strain,unusually severe deadly strain,3
8189,omsk hemorrhagic fever virus,omsk hemorrhagic fever virus,3
3506,public citizen,public citizen,3
8188,kyasanur forest disease virus,kyasanur forest disease virus,3
8187,powassan virus,powassan virus,3
8186,yellow fever virus,yellow fever virus,3
3505,public health advocacy group,public health advocacy group,3
8185,west nile virus,west nile virus,3
8184,dengue virus,dengue virus,3
8183,related viruses,related viruses,3
9437,new chemical compound u.s. patent,new chemical compound u.s. patent,3
9316,known treatment,known treatment,3
717,durban,city port settlement big city,3
4872,medical care,medical care,3
8177,extension,extension,3
8175,oseltamavir treatment,oseltamavir treatment,3
8174,oseltamivirresistant viruses,oseltamivirresistant viruses,3
1014,incident,incident,3
8479,nis,nis,3
3613,seroprotection,seroprotection,3
5124,2019 iran outbreak,2019 iran outbreak,3
5055,virus samples,virus samples,3
8507,long term care facilities,long term care facilities,3
5136,g4 ea h1n1 viruses,virus,3
701,american soil,american soil,3
3655,effective pandemic vaccine,effective pandemic vaccine,3
2345,functional recovery,functional recovery,3
3659,inactivated h5n1 virus,subtype,3
3660,jennifer armstrong,jennifer armstrong,3
8516,sporadic cases,sporadic cases,3
5043,h1n1 infection,virus,3
3484,effective treatment,effective treatment,3
3481,remdesivir,chemical compound prodrug antiviral drug,3
1984,h5n8,h5n8,3
3118,early spring,early spring,3
8090,george painter,george painter,3
9470,dtxsid2023561,dtxsid2023561,3
3007,current antivirals,chebi ontology term,3
8084,similar drugs,similar drugs,3
386,fast onset,fast onset,3
8081,safety controversy,safety controversy,3
446,sicilian social life,sicilian social life,3
385,worldwide highlycontagious respiratory disease,worldwide highlycontagious respiratory disease,3
5143,world health organization health emergencies program,world health organization health emergencies program,3
1989,h5n1 outbreak,subtype,3
9478,s1964,s1964,3
817,oc43,oc43,3
3490,use research,use research,3
9464,rimantidin,rimantidin,3
3647,15 mcg,15 mcg,3
4869,aids,endemic disease location west africa benin rep syndrome,3
3638,vietnam/1194/2004.cidrap article glaxo h5n1 vaccine,subtype,3
8133,89%,89%,3
4890,10% 20%,10% 20%,3
810,strain,strain,3
8130,hcv mutations,hcv mutations,3
5128,g4 virus,g4 virus,3
3017,rigorous studies,rigorous studies,3
3098,periods,periods,3
9301,hantavirus infection,hantavirus infection,3
707,massachusetts,massachusetts,3
8123,overexpression,overexpression,3
3496,purpose,purpose,3
3101,higher incidence,higher incidence,3
8119,oral ns3 serine protease inhibitor,chemical compound medication dl-serine l-amino acid dispensable amino acids cargo cargo cdp-diacylglycerol-serine o-phosphatidyltransferase activity,3
8494,german clinical practice guideline,german clinical practice guideline,3
8495,german clinical practice guideline use,german clinical practice guideline use,3
8116,russian tableted medication,russian tableted medication,3
705,kansas,state united states,3
8114,genotype 1 virus,genotype 1 virus,3
1983,ongoing outbreak,ongoing outbreak,3
1575,significant immunity,significant immunity,3
9297,rsv infection,rsv infection,3
8110,rna dna viruses,structural class chemical compounds,3
5049,center,center,3
9455,alphamethyl,alphamethyl,3
1981,h3n2 virus,subtype,3
19,pandemic,pandemic,3
9326,herpes simplex virus,herpes simplex virus,3
9400,copegus ribasphere rebetol,copegus ribasphere rebetol,3
3062,enteroviruses,enteroviruses,3
3063,rift valley fever virus,rift valley fever virus,3
8290,subcategory negativesense ssrna virus,subcategory negativesense ssrna virus,3
5084,20 deaths,20 deaths,3
8289,category rna virus,structural class chemical compounds,3
8370,earlier estimates,earlier estimates,3
3043,scientific reports,scientific reports,3
8285,viral proteins neuraminidase,group class chemical substances second-order classgroup class enzymes,3
8373,listing,listing,3
3576,early testing,early testing,3
8292,serotypes,serotypes,3
8374,medicine use,medicine use,3
23,significant disruption,significant disruption,3
10794,european committee,european committee,3
9362,5 hydrogen,5 hydrogen,3
3065,zika virus,zika virus,3
8379,seasonal pandemic outbreaks,seasonal pandemic outbreaks,3
3066,animal studies,taxon,3
10808,bronchospasm,bronchospasm,3
8385,kidney,kidney,3
9355,structural resemblance,structural resemblance,3
4876,predicting pandemic mortality rate,predicting pandemic mortality rate,3
774,public health,public health,3
4882,currently circulating h5n1 strains,subtype,3
8293,orthomyxoviridae,taxon,3
3045,nipah virus infection,nipah virus infection,3
8361,complementary list,complementary list,3
1584,mild cases,mild cases,3
2335,early 2000s,early 2000s,3
8334,extant strains,extant strains,3
3553,oral bioavailability,oral bioavailability,3
752,christian,christian,3
5088,indian health ministry,indian health ministry,3
8328,limited host range,limited host range,3
5093,maldives,maldives,3
8350,kidney problems,kidney problems,3
8325,lasting immunity,lasting immunity,3
414,early stages,early stages,3
8352,complementary status,complementary status,3
8354,commonly prescribed medication,commonly prescribed medication,3
8320,b infection,b infection,3
8356,world health organization use,world health organization use,3
1970,american medical association,american medical association,3
8316,antigenicities,antigenicities,3
10797,b.,b.,3
9370,pyrazofurin,scholarly article,3
410,1557 pandemic s observers,1557 pandemic s observers,3
2086,h5n8 type birdflu,h5n8 type birdflu,3
10804,initial approval,initial approval,3
8302,manure,manure,3
9394,dna virus,dna virus,3
407,striking features,striking features,3
9411,drug entry,drug entry,3
8265,newly synthesised viral proteins,group class chemical substances second-order class,3
3585,virus subtype,virus subtype,3
8262,complementary positivesense crna,complementary positivesense crna,3
781,seroarcheology—the detection,seroarcheology—the detection,3
3600,oct,oct,3
783,sera,sera,3
5069,novel virus,novel virus,3
10787,valopicitabine,chemical compound,3
8225,quaranjavirus,taxon,3
8223,deltainfluenzavirus,deltainfluenzavirus,3
3525,patent infringements,patent infringements,3
3524,research purposes,research purposes,3
785,1889–1890 pandemic,1889–1890 pandemic,3
1979,seasonal strain,seasonal strain,3
8219,negativesense rna viruses,structural class chemical compounds,3
10812,vivo,vivo,3
8216,treatment failure,treatment failure,3
8423,resistant virus,resistant virus,3
3078,potent selective inhibitor,potent selective inhibitor,3
3081,filibuvirresistant mutations,filibuvirresistant mutations,3
8212,ns5a inhibitor,ns5a inhibitor,3
3517,research chemical,research chemical,3
9328,ribavirin treatment,chemical compound medication essential medicine 1 april 1990,3
9428,approximately 6%,approximately 6%,3
3607,biomedical advanced research development authority,biomedical advanced research development authority,3
3516,wuhan institute,sub-province-level division big city city millions inhabitants human settlement,3
4874,accustomed care,accustomed care,3
789,1918 pandemic,1918 pandemic,3
3599,h5n1 vaccine,subtype,3
695,ajaccio,commune france ajaccio seen west (english),3
8409,competitive inhibitor,competitive inhibitor,3
5071,similar strain,similar strain,3
1974,seasonal strains,seasonal strains,3
8390,postmarketing reports,postmarketing reports,3
10809,neuraminidase protein,group class enzymes,3
5077,2009 a(h1n1) pandemic,2009 a(h1n1) pandemic,3
8259,accessory proteins,group class chemical substances second-order class,3
5076,approximately year,approximately year,3
3072,ns5b inhibitor,ns5b inhibitor,3
8399,warning,warning,3
3073,pfizer,pfizer,3
3034,enveloped rna virus,structural class chemical compounds,3
8254,detergents.flu viruses,detergents.flu viruses,3
3590,2003 strain,2003 strain,3
3033,nipah virus,nipah virus,3
3591,little use,little use,3
424,constantinople,constantinople,3
8250,neuraminidase proteins,group class enzymesgroup class chemical substances second-order class,3
3592,h5n1 prototype seed strain,subtype,3
3032,nipah,nipah,3
8247,progeny virus,progeny virus,3
3594,prototype strains,prototype strains,3
5073,striking similarity,striking similarity,3
8245,large glycoproteins,structural class chemical compounds,3
8244,influenzavirus proteins,group class chemical substances second-order class,3
3595,new prototype strains,new prototype strains,3
5072,substantial immunity,substantial immunity,3
9419,similar drug amantadine,chemical compound medication,3
8069,treatment options,treatment options,3
8533,h1n1 viruses,virus,3
825,global pandemic,global pandemic,3
10829,catalytic site,catalytic site,3
9536,vaxigrip/vaxigriptetra,vaxigrip/vaxigriptetra,3
8661,liver problems,organ type,3
3737,90 mcg,90 mcg,3
877,flores,flores,3
9538,csl limited,csl limited,3
2974,junin virus,junin virus,3
9541,biocsl,biocsl,3
10759,russian media,russian media,3
2973,semliki forest virus,semliki forest virus,3
881,viboud,viboud,3
4907,moderately severe strain,moderately severe strain,3
7898,mass cultivation,mass cultivation,3
9216,serbia,serbia,3
882,cécile,cécile,3
7895,related genes,related genes,3
3145,medical costs,medical costs,3
377,infection,infection,3
3147,life,life,3
5020,indistinguishable viruses,indistinguishable viruses,3
7892,early 1980s,early 1980s,3
2006,kazakhstan,sovereign state unitary state landlocked country transcontinental country country,3
755,medical treatment,medical treatment,3
8669,interferonalpha receptor,interferonalpha receptor,3
2972,pox viruses,pox viruses,3
3731,early results,early results,3
7915,pegylated interferonalpha,pegylated interferonalpha,3
10761,tatyana golikova,tatyana golikova,3
5029,known outbreaks,known outbreaks,3
8626,swedish registry based cohort study,swedish registry based cohort study,3
3716,investigational vaccine,investigational vaccine,3
9230,mohme,mohme,3
9530,respiratory synctial parainfluenza viruses,respiratory synctial parainfluenza viruses,3
8631,potency,potency,3
3719,vrc vaccine pilot plant,vrc vaccine pilot plant,3
2002,h5n8 spreads russia central asia,empire start time 22 october 1721julian end time 1 september 1917julian 1 september 1917juliancontinent continental area surrounding islands,3
867,sickness benefit,sickness benefit,3
3720,vrc candidate vaccine,vrc candidate vaccine,3
378,medical techniques,medical techniques,3
7930,longacting neuraminidase inhibitor,group class enzymes,3
3141,medical expenses,medical expenses,3
664,tomsk,tomsk,3
3721,research bench,research bench,3
7928,neuraminidase inhibitor,group class enzymes,3
3427,cambodian health ministry,cambodian health ministry,3
9533,highly potent selective inhibitor,highly potent selective inhibitor,3
3142,world health organisation,world health organisation,3
3726,hungarian prime minister ferenc gyurcsány,hungarian prime minister ferenc gyurcsány,3
7923,interferon treatment,group class proteins,3
659,eurasia,supercontinent,3
8649,significant differences,significant differences,3
658,region,region,3
4905,eventual h5n1 pandemic,subtype,3
8671,tyk2 protein,tyk2 protein,3
653,russian empire,russian empire,3
7885,large loss,large loss,3
5174,references,references,3
8704,followup research,followup research,3
8705,upstream activators,upstream activators,3
5182,early coronaviruses,early coronaviruses,3
8711,new viruses,new viruses,3
3757,clade 1 vietnam virus,war proxy war,3
634,conquest,conquest,3
8717,peramiflu,peramiflu,3
7841,heatinactivated virus,heatinactivated virus,3
7840,virus growth,virus growth,3
8719,intramuscular peramivir phase ii study,scholarly article review article,3
7838,alick isaacs jean lindenmann studies,alick isaacs jean lindenmann studies,3
7837,medical research,medical research,3
2017,countermeasures,countermeasures,3
7835,alick isaacs,alick isaacs,3
7834,confers immunity,confers immunity,3
3167,source,source,3
902,manual,manual,3
8724,related nonenveloped rna viruses,structural class chemical compounds,3
2295,prevalent strains,prevalent strains,3
10752,potential combination treatment,potential combination treatment,3
8726,large family,large family,3
7826,p25,p25,3
7825,virus e3l gene,virus e3l gene,3
5185,h2n2 virus,wikimedia disambiguation page,3
8727,poliomyelitis,poliomyelitis,3
7846,isaacs lindenmann experiments,isaacs lindenmann experiments,3
864,dow jones industrial average value,dow jones industrial average value,3
366,health,health,3
5180,detailed records,detailed records,3
8673,ifnar2,ifnar2,3
1600,curlie,curlie,3
2009,international spread late 2020 early 2021,international spread late 2020 early 2021,3
10833,functional groups,functional groups,3
649,outbreak spread,outbreak spread,3
648,winter,winter,3
9558,latin american markets,latin american markets,3
9559,sales revenue,sales revenue,3
891,early march,early march,3
7871,y.h. tan,y.h. tan,3
1601,clinical picture,clinical picture,3
892,middle,middle,3
10755,hypersensitivity,biological process,3
1927,20 studies,20 studies,3
641,great pandemic,great pandemic,3
3155,estimated health burden,estimated health burden,3
372,rose water,rose water,3
9198,severe covid‑19,severe covid‑19,3
9196,niaidactt study,niaidactt study,3
3749,inactivated vaccine,inactivated vaccine,3
10753,sensitization,sensitization,3
9570,guaranteed vaccine purchases,guaranteed vaccine purchases,3
8698,important role,important role,3
7852,efficient vaccine,efficient vaccine,3
9574,splitvirus vaccine,splitvirus vaccine,3
5181,speculations,speculations,3
8728,meningitis,meningitis,3
7940,clinical evaluations,clinical evaluations,3
2977,respiratory syncytial virus,respiratory syncytial virus,3
8557,inactivated virus,inactivated virus,3
689,rome,rome,3
8024,certain h5n1 variants,subtype,3
8023,flumist vaccine,brand,3
8022,vaccine technology,academic discipline,3
9497,virus m2 protein,virus m2 protein,3
3462,literature,literature,3
838,novel strain,novel strain,3
839,minimal immunity,minimal immunity,3
9264,health care providers,health care providers,3
3683,vaccine research center,vaccine research center,3
8028,attenuated live viruses,attenuated live viruses,3
9261,2020.the initial distribution,2020.the initial distribution,3
686,german empire,german empire,3
685,denmark,denmark,3
841,world health organization,world health organization,3
1995,early outbreak saudi arabia,early outbreak saudi arabia,3
682,sweden,sovereign state start time 6 june 1523 country unitary state countries bordering baltic sea,3
681,stockholm,capital sweden start time 1436 big city hanseatic city port settlement,3
680,early november,early november,3
3687,h5n1 vaccine developedbysanofipasteurinhenseggsandthenadministeredasaweakenedorkilledformofanh5n1vaccinedevelopedbysanofipasteurdnabasedvaccinescontainonlyportionsofanh5n1vaccinedevelopedby sanofi pasteur,subtype,3
452,healthcare,healthcare,3
8004,prequalification,prequalification,3
2988,selective inhibition,selective inhibition,3
8574,observational studies,observational studies,3
3466,surabaya,city indonesia big city city millions inhabitants,3
8031,looming h5n1 threat,subtype,3
3679,dna vaccine,dna vaccine,3
8066,recently zika virus,recently zika virus,3
8065,tickborne encephalitis virus,tickborne encephalitis virus,3
3473,original cat populations,original cat populations,3
2109,similarity,similarity,3
827,guizhou,province china,3
384,1557 pandemic s nature asaworldwidehighlycontagiousrespiratorydiseasewithfastonsetofflulikesymptomshasledmanyphysiciansfrommedicalhistorianslikecharlescreightontomodernepidemiologiststoconsider,1557 pandemic s nature asaworldwidehighlycontagiousrespiratorydiseasewithfastonsetofflulikesymptomshasledmanyphysiciansfrommedicalhistorianslikecharlescreightontomodernepidemiologiststoconsider,3
8058,foot mouth disease virus,foot mouth disease virus,3
3123,vaccine formulations,vaccine formulations,3
3472,20%,20%,3
8052,guanine,chemical compound,3
5147,early identification,early identification,3
5148,g4 variant,g4 variant,3
8538,higher earlier dosing,higher earlier dosing,3
3672,beijing,capital city direct-controlled municipality national central city big city city millions inhabitants,3
3469,java,multi-paradigm programming language jvm language programming language,3
5151,predominant strain,predominant strain,3
8043,mediated immunity,mediated immunity,3
1993,early outbreak,early outbreak,3
8546,september 2006.the vaccine,september 2006.the vaccine,3
8549,pandemic mockup vaccine,pandemic mockup vaccine,3
8550,stanford university studies,stanford university studies,3
2993,doubt,doubt,3
8552,upper airway respiratory infections,upper airway respiratory infections,3
8036,flumist core virus,brand,3
8034,known strains,known strains,3
8585,health service executive,health service executive,3
8002,seasonal intranasal vaccine,seasonal intranasal vaccine,3
3453,dead cat,dead cat,3
8001,trivalent laiv vaccine,trivalent laiv vaccine,3
3700,new vaccine technology,academic discipline,3
852,improved health care,improved health care,3
7968,resulting viruses,resulting viruses,3
3133,dominant strain,dominant strain,3
3443,initial oie report,initial oie report,3
2000,central sudair region,central sudair region,3
9239,cofepris,cofepris,3
7962,live attenuated vaccine,live attenuated vaccine,3
3703,supply manufacturing capacity,supply manufacturing capacity,3
3136,associated health complications,associated health complications,3
3137,medical conditions,medical conditions,3
9520,acids,acids,3
9521,enantiomers,enantiomers,3
3706,dna vaccine approach,dna vaccine approach,3
9522,similar binding affinity,similar binding affinity,3
9523,similar ability,similar ability,3
3708,highly pathogenic viruses,highly pathogenic viruses,3
3439,h5n1 virus infection,subtype,3
7951,medication uses,medication uses,3
3709,deadly 1918 pandemic,deadly 1918 pandemic,3
3437,effort,effort,3
7947,attenuated vaccine,attenuated vaccine,3
9526,rnacontaining viruses,rnacontaining viruses,3
8623,ninety percent,ninety percent,3
3711,promise,promise,3
8605,similar reports,similar reports,3
2976,measles virus,infectious disease france,3
10768,virus target host cells,virus target host cells,3
4858,eventual pandemic strain,eventual pandemic strain,3
9506,image,image,3
7999,public rights,public rights,3
2110,greek adamantinos,greek adamantinos,3
7996,rights,rights,3
846,approximately 0.67%,approximately 0.67%,3
3450,clinical signs,clinical signs,3
3449,antibiotic treatment,antibiotic treatment,3
7994,laiv vaccine rights,laiv vaccine rights,3
847,pneumonia,cause death infectious disease,3
7992,laiv intranasal vaccine,laiv intranasal vaccine,3
1937,u.s. world health organization,u.s. world health organization,3
455,early detection,early detection,3
3448,respiratory distress,respiratory distress,3
3447,lethargy,lethargy,3
676,end,end,3
3693,h5n1 vaccine developedbysanofipasteurinhenseggsandthenadministeredasaweakenedorkilledformofanh5n1vaccinedevelopedbysanofipasteurdnabasedvaccinescontainonlyportionsofanh5n1vaccinedevelopedby sanofi pasteur genetic material,subtype,3
1998,highly pathogenic h5n8 virus,highly pathogenic h5n8 virus,3
849,secondary bacterial infection,secondary bacterial infection,3
674,siberia,geographic region russia,3
851,vaccine,vaccine,3
5157,pandemic potential,pandemic potential,3
7980,live infection,live infection,3
9247,use requests,use requests,3
3695,proteins,group class chemical substances second-order class,3
7977,living virus,living virus,3
2111,camphorlike odor,camphorlike odor,3
886,respiratory viruses,respiratory viruses,3
5664,h5n1 virus genome,subtypescientific model natural environment,3
1663,symptoms.the h1n1 virus,virus,3
6425,hemagglutinin protein,group class proteins,3
10640,earlier,earlier,3
10639,second infection,second infection,3
2630,medical use,medical use,3
6418,undamaged copy,undamaged copy,3
181,mellingen chronicler anton tegenfeld,mellingen chronicler anton tegenfeld,3
6416,viable progeny viruses,viable progeny viruses,3
6415,damaged viruses,damaged viruses,3
6412,damage,damage,3
10219,precursor virus,precursor virus,3
2207,sites,sites,3
5493,known strain,known strain,3
6402,virus genome,scientific model natural environment,3
5495,highly effective treatment,highly effective treatment,3
6426,known antibody,family protein complexes,3
2625,inhibitor,inhibitor,3
4337,previous infection,previous infection,3
6379,lab strains,lab strains,3
6378,filaments,filaments,3
6374,tens,tens,3
4340,initial,initial,3
10239,chinese health officials,chinese health officials,3
4343,disease severity,disease severity,3
5502,hassan albushra,hassan albushra,3
6367,virus particle,virus particle,3
6358,2013.each virus subtype,2013.each virus subtype,3
4352,bile ducts,bile ducts,3
2609,additional studies,additional studies,3
1669,public health response,public health response,3
10252,detectable spread,detectable spread,3
6385,large proteins,group class chemical substances second-order class,3
6348,virus family,virus family,3
5486,progression,progression,3
6432,envelope,envelope,3
2648,medical uses,medical uses,3
6489,virus assembly,virus assembly,3
1783,profits,profits,3
5472,highly contagious strain,highly contagious strain,3
10191,virologist john oxford study,virologist john oxford study,3
6485,family orthomyxoviridae,taxon,3
6479,underlying health problems,underlying health problems,3
7422,chronic illness,chronic illness,3
10195,similar outbreak,similar outbreak,3
6473,achiness,achiness,3
10199,early outbreaks,early outbreaks,3
5477,asian strain,asian strain,3
6468,mild upper respiratory infections,mild upper respiratory infections,3
6466,18–72 hours,18–72 hours,3
6431,capsid virion,cellular component,3
5478,efficient humantohuman transmission,efficient humantohuman transmission,3
6462,ad.this virus,ad.this virus,3
10203,respiratory virus,respiratory virus,3
2640,enzyme inhibitor,enzyme inhibitor,3
6457,482 ad.influenza virus,482 ad.influenza virus,3
1780,impression,impression,3
6453,d,d,3
4733,pandemic season,pandemic season,3
6445,virus family orthomyxoviridae,taxon,3
4312,medical condition,medical condition,3
5481,large fraction,large fraction,3
184,respiratory illness,respiratory illness,3
5482,american scientist,american scientist,3
10213,possibly years,possibly years,3
6433,matrix protein,matrix protein,3
6463,fomites,fomites,3
1283,quick spread,quick spread,3
6344,favor,favor,3
6343,avian h9n2 viruses,avian h9n2 viruses,3
6267,humantohuman infection,humantohuman infection,3
6266,viruses ability,viruses ability,3
6264,features,features,3
6263,h7n9 strains,taxon,3
2590,published case report,published case report,3
10285,trenches – adults,trenches – adults,3
4397,3–5%,3–5%,3
1306,labconfirmed deaths,labconfirmed deaths,3
4399,higher rates,higher rates,3
1671,european union health commissioner,european union health commissioner,3
6251,h7n9 infection,taxon,3
2261,benzene,chemical compound class ib flammable liquid occupational carcinogen male reproductive toxicant developmental toxicant carcinogen,3
10291,2004 book,2004 book,3
10294,lethal strain,lethal strain,3
4395,0.05–5%,0.05–5%,3
5524,world health organization role,world health organization role,3
10297,pathogenic viruses,pathogenic viruses,3
6238,ongoing humantohuman transmission,ongoing humantohuman transmission,3
10298,dangerous strains,dangerous strains,3
6235,jiangsu,province china,3
1753,influence,influence,3
1311,strains,strains,3
6227,chinese national health family planning commission,chinese national health family planning commission,3
1312,pandemic h1n1/09 virus,pandemic h1n1/09 virus,3
6225,24 death case,stock character psychopomp literary character,3
157,recovery,recovery,3
1313,60 years,60 years,3
6217,5 deaths,5 deaths,3
1751,council,council,3
10306,extremities,extremities,3
10296,tendency,tendency,3
2591,instances,instances,3
1304,world population,world population,3
2592,medical literature,medical literature,3
10255,close quarters,close quarters,3
1286,deadly virus,deadly virus,3
10630,soldier,soldier,3
6334,h9n2 genes,h9n2 genes,3
6333,contribution,contribution,3
1766,new virus,new virus,3
6329,ha protein,ha protein,3
6324,amino acids,amino acids,3
10264,worldwide occurrence,worldwide occurrence,3
4366,approximately 90%,approximately 90%,3
2412,potential,potential,3
4370,initial recommended treatment,initial recommended treatment,3
4372,directacting antivirals,chebi ontology term,3
4373,prior treatment,prior treatment,3
1291,new strain,new strain,3
4715,scientific medical journals,scientific medical journals,3
2262,lewis acids,lewis acids,3
6273,family cluster,family cluster,3
4714,public health warnings virus descriptions,public health warnings virus descriptions,3
6280,haemagglutination inhibition antibodies,family protein complexes,3
6281,daughter,daughter,3
4387,alternative therapy,alternative therapy,3
6283,efforts prevent spread disease,efforts prevent spread disease,3
10186,north american origin,north american origin,3
6286,pigeon samples,pigeon samples,3
4382,alternative medicine,alternative medicine,3
1298,flu.some studies,flu.some studies,3
10274,trenches,trenches,3
10272,mild strain,mild strain,3
6301,h9n2 viruses,h9n2 viruses,3
5516,international health officials,international health officials,3
6292,infection birds,infection birds,3
6502,virus isolation,virus isolation,3
6503,diagnostic purposes,diagnostic purposes,3
4295,mid1980s,mid1980s,3
1520,fever medication,fever medication,3
5419,respiratory mucosa,respiratory mucosa,3
5420,upper lower respiratory tract,upper lower respiratory tract,3
6697,20 confirmed cases,20 confirmed cases,3
4195,autoimmune disorders,autoimmune disorders,3
10106,russian prisoners,russian prisoners,3
6690,h1n1 virus strain,virus,3
2188,significant,significant,3
4760,estimate,estimate,3
10116,freetown,city port settlement capital big city,3
2697,shionogi research reporting,pharmaceutical company,3
6676,– health – eu portal,– health – eu portal,3
10119,american troops,american troops,3
6672,government preparations potential h5n1 pandemic (2003–2009),subtype,3
10096,american expeditionary forces,american expeditionary forces,3
6671,strategies,strategies,3
6668,pandemic threat subtypes,pandemic threat subtypes,3
1202,consequences,consequences,3
1814,infection control,infection control,3
6663,authority,authority,3
4202,antibody,family protein complexes,3
2693,shionogi co.,pharmaceutical company,3
1206,russia,empire start time 22 october 1721julian end time 1 september 1917julian 1 september 1917julian,3
4756,public health officials,public health officials,3
2691,patent literature,patent literature,3
5429,nacetylneuraminic acid receptor,nacetylneuraminic acid receptor,3
4209,issues,issues,3
6650,medical supplies,medical supplies,3
4210,salivary duct stones,salivary duct stones,3
4212,occult infection,occult infection,3
10121,naval training,naval training,3
5416,pathophysiology,pathophysiology,3
1192,coverup,coverup,3
6711,pandemic phases,pandemic phases,3
10074,life expectancy,life expectancy,3
6767,90 µg h5,90 µg h5,3
2714,i38m,i38m,3
2713,isoleucine38 specifically i38t,isoleucine38 specifically i38t,3
6762,technical problems,technical problems,3
1178,viruses,viruses,3
6760,usa h1n1 vaccine supply,virus,3
5406,vaccine strains,vaccine strains,3
6753,canadian health authorities,canadian health authorities,3
2393,vaccine administration,vaccine administration,3
1182,gallfoods delivery wrapper,gallfoods delivery wrapper,3
6746,potential virus,potential virus,3
6745,population infection,population infection,3
5409,horse,horse,3
6741,possible pandemic,possible pandemic,3
1824,department,department,3
6733,behaviour,behaviour,3
10666,ns5b polymerase inhibitor,group class enzymes,3
10095,major training ground,major training ground,3
1821,u.s. department,u.s. department,3
6716,pandemic wave,pandemic wave,3
6717,post pandemic recovery activities,post pandemic recovery activities,3
6718,pandemic severity assessment framework,pandemic severity assessment framework,3
10131,remote communities,remote communities,3
6719,pandemic severity,pandemic severity,3
6721,pandemic response,pandemic response,3
10094,world war,world war,3
223,virus,virus,3
6730,good public health communication strategy,good public health communication strategy,3
6731,public concerns,public concerns,3
1186,middle man,middle man,3
6720,adequate measure,adequate measure,3
4422,poorer communities,poorer communities,3
214,marseille,association football club,3
4754,official world health organization,official world health organization,3
4266,public private medical dental facilities,public private medical dental facilities,3
10655,original infection,original infection,3
2665,specifically enzyme inhibitor,specifically enzyme inhibitor,3
4742,confirmed cases,confirmed cases,3
4271,hcv transmission,hcv transmission,3
5457,tachypnea,medical finding,3
4275,higher levels,higher levels,3
10166,south american islands,south american islands,3
10167,6 374 deaths,6 374 deaths,3
6547,inactivated influenzavirus d vaccine,inactivated influenzavirus d vaccine,3
1790,7,7,3
6541,d virus,d virus,3
4279,concurrent sexually transmitted infection,concurrent sexually transmitted infection,3
6538,type c virus,type c virus,3
10656,recent metagenomic analyses,recent metagenomic analyses,3
6536,37°c,37°c,3
2659,oral supplements,oral supplements,3
6532,humans.influenza d virus,humans.influenza d virus,3
1787,pandemic alert,pandemic alert,3
6526,influenzavirus d,influenzavirus d,3
6525,virus genus deltainfluenzavirus,virus genus deltainfluenzavirus,3
10652,different strain,different strain,3
10175,january–april,january–april,3
197,v ad summum,v ad summum,3
6518,significant concern,significant concern,3
6514,known subtypes,known subtypes,3
6512,type c,type c,3
5463,highly pathogenic causative agent,highly pathogenic causative agent,3
10183,medical reports,medical reports,3
6506,higher sensitivity,higher sensitivity,3
6535,virus ability,virus ability,3
6560,pathogenesis,biological process,3
6562,public data,public data,3
5452,clinical findings,clinical findings,3
6633,industrialized countries,industrialized countries,3
1809,studies,studies,3
4218,newer methods,newer methods,3
4219,antibody test,family protein complexes,3
4220,virus core protein,virus core protein,3
4753,1968 pandemic,1968 pandemic,3
4752,1957 pandemic,1957 pandemic,3
4224,cryptogenic occult infection,cryptogenic occult infection,3
1215,onset,onset,3
5435,edema,edema,3
2685,japanese patent literature,japanese patent literature,3
2684,shionogi reports,pharmaceutical company,3
6607,coughs,coughs,3
4235,shared intranasal drug use,shared intranasal drug use,3
6603,muscle pains,muscle pains,3
2682,shionogi,pharmaceutical company,3
6600,blast,blast,3
2668,short capped primers,short capped primers,3
6568,genomic research,genomic research,3
5449,antibody titer,family protein complexes,3
2196,6.17 gpa,6.17 gpa,3
4745,pandemic threat,pandemic threat,3
6578,research goals,research goals,3
4755,approximately 60%,approximately 60%,3
4253,mucosal exposures,mucosal exposures,3
6588,large region,large region,3
6589,large proportion,large proportion,3
2679,polycyclic family,polycyclic family,3
5442,limb edema,limb edema,3
4748,pandemic planning,pandemic planning,3
4237,healthcare exposure,healthcare exposure,3
206,king,king,3
154,explosive spread,explosive spread,3
4709,northern australia,continent,3
4708,new possible pandemic,new possible pandemic,3
2509,american academy,american academy,3
4564,19 amino acids,19 amino acids,3
10462,fiji,fiji,3
2506,doc,doc,3
10469,neighboring american samoa,neighboring american samoa,3
4566,large hdag,large hdag,3
5606,usgs national wildlife health center,usgs national wildlife health center,3
4567,isoforms,isoforms,3
4680,avian viruses,avian viruses,3
2240,ratio,ratio,3
1401,use,use,3
4569,codon,codon,3
5608,potential global spread,potential global spread,3
5610,galactose receptors,galactose receptors,3
105,pectoral troches,pectoral troches,3
1404,loyola university health,loyola university health,3
10479,pacific,pacific,3
4678,similar coinfection,similar coinfection,3
1406,dangerous public health risk,dangerous public health risk,3
10483,effective quarantines,effective quarantines,3
5838,nigeria,nigeria,3
95,purgation,purgation,3
1682,national health service,national health service,3
10497,thirteen studies,thirteen studies,3
2490,disorders,disorders,3
1705,private health providers,private health providers,3
5817,zoo,zoo,3
5813,h5n8 case,h5n8 case,3
10580,2006 study,2006 study,3
5810,h5n8 outbreak,h5n8 outbreak,3
5611,avian respiratory tract,avian respiratory tract,3
1475,resident viruses,resident viruses,3
5883,h5n8 strain,h5n8 strain,3
73,records,records,3
4535,coiledcoil region,coiledcoil region,3
2520,case reports,case reports,3
4536,animal viruses,taxon,3
1719,seasonal vaccine,seasonal vaccine,3
5933,h7n9 virus,taxon,3
5587,world organization,world organization,3
5931,h7 viruses,h7 viruses,3
1480,h1n1 vaccine,virus,3
10431,germans,germans,3
10433,bayer,bayer,3
10595,fiction,fiction,3
4542,nterminal domain,nterminal domain,3
10593,fiction literature,fiction literature,3
5919,low pathogenic strains,low pathogenic strains,3
5918,highly pathogenic strains,highly pathogenic strains,3
5917,h7n7,h7n7,3
114,water sources,water sources,3
10450,coffins,coffins,3
10449,gravediggers,gravediggers,3
4681,internal genes,internal genes,3
5893,lake area,lake area,3
10446,everyday life,everyday life,3
4683,neuraminidase internal proteins,group class enzymesgroup class chemical substances second-order class,3
5809,2016–17,2016–17,3
10443,american journal,american journal,3
5594,significant numbers,significant numbers,3
10437,early estimate,early estimate,3
5908,h5,h5,3
5909,research update,research update,3
5911,sources,sources,3
4548,nucleocapsid,nucleocapsid,3
2432,extracellular space,extracellular space,3
2521,improved functional recovery,improved functional recovery,3
5626,differing pathogenic profiles,differing pathogenic profiles,3
2246,initial compounds,initial compounds,3
5646,earlier highly pathogenic genotypes,earlier highly pathogenic genotypes,3
5728,lowpathogenic strain,lowpathogenic strain,3
5647,clades,clades,3
87,medicine treatment,medicine treatment,3
85,early 1500s,early 1500s,3
4633,amazon,amazon,3
5649,genotype pathogenicity,genotype pathogenicity,3
10543,simple epidemic model,simple epidemic model,3
5715,50006000 chicken,50006000 chicken,3
5714,health ministry,health ministry,3
4661,amazon region,amazon region,3
4641,belém,municipality brazil capital big city city millions inhabitants,3
5701,h5n2 virus,h5n2 virus,3
5700,suspected low pathogenic h5n2 strain,suspected low pathogenic h5n2 strain,3
4630,young adults,young adults,3
2456,2011 world health organization virology report,2011 world health organization virology report,3
5687,highly pathogenic h5n2,highly pathogenic h5n2,3
2254,solvent,solvent,3
5685,h5n2 antibody titers,family protein complexes,3
5658,h5n1 transmission studies ferrets (2011),subtype,3
1457,fewer deaths,fewer deaths,3
5659,contagious strains,contagious strains,3
5678,poultry vaccine,organisms known particular common,3
5675,humantohuman spread,humantohuman spread,3
5661,erasmus medical center,erasmus medical center,3
5672,highly pathogenic h5n2 variety,highly pathogenic h5n2 variety,3
5670,h5n2,h5n2,3
4654,delta virus infection,delta virus infection,3
1683,website,website,3
4658,74%,74%,3
1448,genes,genes,3
10573,medical doctors,medical doctors,3
5735,midwestern region,midwestern region,3
1466,pandemic h1n1 virus,virus,3
5629,specific case,specific case,3
75,spain,spain,3
5632,highly pathogenic varieties,highly pathogenic varieties,3
1416,specifically 2009 h1n1 virus,virus,3
4596,nterminal pres1 domain,nterminal pres1 domain,3
2480,german multiple sclerosis society,german multiple sclerosis society,3
91,treatment,treatment,3
1700,early autumn,early autumn,3
5784,h5n8 virus,h5n8 virus,3
4603,hdv envelope proteins,group class chemical substances second-order class,3
10516,higher mortality,higher mortality,3
10517,immigrant communities,immigrant communities,3
1699,public health safety net,public health safety net,3
5776,new coronavirus pandemic,group class strains strain,3
5637,significant disease,significant disease,3
2250,carboxylation,carboxylation,3
4607,important factor,important factor,3
2468,commonly medications,commonly medications,3
4625,hematemesis,hematemesis,3
1434,partial immunity,partial immunity,3
1433,findings,findings,3
1431,6–9%,6–9%,3
4620,coinfection,coinfection,3
1469,pandemic virus,pandemic virus,3
10575,women patient care,women patient care,3
5758,dominican department,dominican department,3
10525,women,women,3
1427,preexisting immunity,preexisting immunity,3
5764,haiti,sovereign state island nation country,3
5765,h5n6,h5n6,3
4608,hdv entry,hdv entry,3
1429,immunity,immunity,3
10072,pandemic tuberculosis,notifiable disease valid place switzerland endemic disease,3
1481,short supply,short supply,3
4533,central region,central region,3
6127,new transgenic virus,new transgenic virus,3
5548,rna virus,structural class chemical compounds,3
2228,phenomenon,phenomenon,3
6124,284 adults,284 adults,3
1339,way,way,3
6122,matrix 1 protein,matrix 1 protein,3
6119,a/anhui/1/13 viruslike particle vaccine,a/anhui/1/13 viruslike particle vaccine,3
1344,mount sinai school,mount sinai school,3
1345,medicine,medicine,3
6111,medical sciences,medical sciences,3
10351,mass gatherings,mass gatherings,3
4467,specific vaccine,specific vaccine,3
4468,delta virus,delta virus,3
6103,h7n9 vaccine,taxon,3
6128,candidate virus,candidate virus,3
6102,65 years.on,65 years.on,3
1676,public health agency,public health agency,3
6098,yettobedeveloped pandemic vaccine,yettobedeveloped pandemic vaccine,3
6097,effective vaccine response,effective vaccine response,3
6096,global public health community,global public health community,3
6095,additional vaccine manufacturing capacity,additional vaccine manufacturing capacity,3
5552,pb2,pb2,3
10355,extended periods,extended periods,3
5553,pb1,pb1,3
6090,uptake,uptake,3
2230,pair,pair,3
4478,therapy,therapy,3
2552,orthostatic hypotension,orthostatic hypotension,3
137,loss,loss,3
4479,committee,committee,3
6101,vaccine efficacy,vaccine efficacy,3
6129,vaccine manufacturing,vaccine manufacturing,3
4455,routes,routes,3
4454,genome,scientific model natural environment,3
152,experts,experts,3
1749,description,description,3
1493,health officials,health officials,3
6197,sense,sense,3
1319,initial onset,initial onset,3
10316,smell,smell,3
6193,28%,28%,3
6192,ürümqi,ürümqi,3
1321,secondary bacterial pneumonia,cause death infectious disease,3
1492,limited vaccine supplies,limited vaccine supplies,3
1748,real pandemic,real pandemic,3
10323,ears,ears,3
10326,common secondary infection,common secondary infection,3
5538,coronavirus pandemic,group class strains strain,3
2226,superacids,superacids,3
2567,animal reproduction studies,taxon,3
147,adults,adults,3
4450,simultaneous infection,simultaneous infection,3
1333,research,research,3
6147,new viral strain,new viral strain,3
1674,confirmed case,confirmed case,3
1490,new vaccine,new vaccine,3
6154,reporting,reporting,3
10361,highly detailed mortality records,highly detailed mortality records,3
1672,europeans,europeans,3
6158,novel h7n9 virus,taxon,3
6159,usfunded h7n9 vaccine,taxon,3
10333,rapidly progressive respiratory failure,rapidly progressive respiratory failure,3
1326,controversy,controversy,3
1325,bacterial pneumonia,cause death infectious disease,3
6171,recent spread,recent spread,3
10336,middleaged adults,middleaged adults,3
5942,19 deaths,19 deaths,3
5557,mp,mp,3
1358,underlying medical conditions,underlying medical conditions,3
5998,h7n9 virus infection,taxon,3
1485,vaccine priority,vaccine priority,3
5994,symptoms treatment,symptoms treatment,3
4514,1.07×10−3 substitutions,1.07×10−3 substitutions,3
10398,american samoa,american samoa,3
2533,lessens health care costs,lessens health care costs,3
2430,intracellular virus,intracellular virus,3
10402,actual virus,actual virus,3
10404,large extent,large extent,3
1681,u.k.,u.k.,3
5982,h5 virus,h5 virus,3
10598,covid19 pandemic,covid19 pandemic,3
120,little immunity,little immunity,3
1726,false pandemic campaign,false pandemic campaign,3
5999,approximately 20%,approximately 20%,3
5578,pandemic vaccine,pandemic vaccine,3
118,new strains,new strains,3
4523,hepadnaviridae virus,hepadnaviridae virus,3
5964,h9n2 chicken viruses,h9n2 chicken viruses,3
10418,castor oil,castor oil,3
4525,small spherical virus,small spherical virus,3
5958,parent viruses,parent viruses,3
5583,large amounts,large amounts,3
5955,h7n9 viruses,taxon,3
10420,traditional medicine,traditional medicine,3
2523,initial brain injury,initial brain injury,3
5951,mild upper respiratory symptoms,mild upper respiratory symptoms,3
5584,new pandemic strain,new pandemic strain,3
1387,pandemic h1n1,virus,3
5946,virus designation,virus designation,3
5580,vaccine manufacturing companies,vaccine manufacturing companies,3
6001,early infection,early infection,3
4511,recent common ancestor,recent common ancestor,3
10394,public health authorities,public health authorities,3
6071,yuzo arima,yuzo arima,3
4485,packaging,packaging,3
1361,obesity,scientific journal hybrid open access journal academic journal allegedly,3
10367,significant increase,significant increase,3
10371,explanations,explanations,3
131,contemporaries,contemporaries,3
4489,hbv infection,hbv infection,3
6053,widespread mild disease,widespread mild disease,3
6051,early,early,3
6050,...an unusually dangerous virus,...an unusually dangerous virus,3
1487,compromised immunity,compromised immunity,3
10378,pandemic victims,pandemic victims,3
6045,new infection,new infection,3
10381,eyewitness accounts,eyewitness accounts,3
6041,colder weather,colder weather,3
6038,limited humantohuman spread,limited humantohuman spread,3
4496,structural,structural,3
1374,nerve muscle problems,nerve muscle problems,3
4510,36 strains,36 strains,3
10392,public health management,public health management,3
5569,limited use,limited use,3
6012,virush5n1,virush5n1,3
5568,continual mutation,continual mutation,3
1357,neurodevelopmental conditions,neurodevelopmental conditions,3
6015,world organisation,world organisation,3
1730,threatening new pandemic,threatening new pandemic,3
1371,state local health authorities,state local health authorities,3
1369,paediatric deaths,paediatric deaths,3
1368,36 reports,36 reports,3
4499,entire genome,scientific model natural environment,3
127,suggestions,suggestions,3
6017,advice,advice,3
10070,comorbidities,comorbidities,3
3231,potential treatment,potential treatment,3
2810,sofusbivir triple therapy,sofusbivir triple therapy,3
6957,interim measure,interim measure,3
10685,initial source,initial source,3
4103,chiron,chiron,3
1853,quarantines,quarantines,3
5306,epidemic virus,epidemic virus,3
7088,nacetylcysteine,nacetylcysteine,3
7222,associated health benefits,associated health benefits,3
6953,h5n1 vaccine approval stockpiling,subtype,3
1044,antiflu medication,antiflu medication,3
6952,problems,problems,3
6951,h5n1 vaccine research,subtype,3
1043,cipla,business enterprise,3
2168,1.54 å,1.54 å,3
9924,national healthcare,national healthcare,3
4811,press reports,press reports,3
9923,health insurers,health insurers,3
4104,bradley,bradley,3
6946,trivalent vaccine,trivalent vaccine,3
9926,rebates,rebates,3
3963,developed world,developed world,3
7225,future pandemic,future pandemic,3
7321,allcause deaths,allcause deaths,3
3964,diagnostic tests,diagnostic tests,3
10687,resident water fowl,resident water fowl,3
1841,health safety executive,health safety executive,3
6975,against.the vaccine,against.the vaccine,3
6974,strains antigen protects,group class chemical substances,3
4782,general public,general public,3
1104,h5n1 causation,subtype,3
4097,articles,articles,3
1134,turkeyhouse,turkeyhouse,3
7227,basic research,basic research,3
9927,treatment failures,treatment failures,3
4098,significant improvements,significant improvements,3
307,portuguese goa,portuguese goa,3
10686,ai viruses,ai viruses,3
4099,improved antiviral treatment,improved antiviral treatment,3
6961,sanofi vaccine,sanofi vaccine,3
1852,fear,fear,3
1101,surrey,ceremonial county england,3
5305,vaccine virus,vaccine virus,3
7094,lethal infection,lethal infection,3
2765,research code,research code,3
248,prelates,prelates,3
2784,rotovirus,scholarly article,3
6916,vaccine ingredients,vaccine ingredients,3
10713,biopharma technologies,biopharma technologies,3
7341,highdose vaccine,highdose vaccine,3
6915,sometimesfatal infection,sometimesfatal infection,3
7342,regulardose vaccine,regulardose vaccine,3
1091,initial signs,initial signs,3
247,bishops,bishops,3
6911,vaxinnate,business,3
6918,bacterium,bacterium,3
10009,neutral spain,neutral spain,3
301,higher burial rates,higher burial rates,3
2790,virus type,virus type,3
9794,viral ns5a inhibitor,viral ns5a inhibitor,3
3952,virus particles,virus particles,3
4006,absence,absence,3
273,reports,reports,3
7204,livestock vaccine,livestock vaccine,3
5279,global health officials,global health officials,3
7346,significant benefit,significant benefit,3
10696,pandemic period,pandemic period,3
3956,1012 virus particles,1012 virus particles,3
2381,metoclopramide,chemical compound medication essential medicine,3
6943,novartis vaccine,business multinational corporation,3
9918,medicine cost,medicine cost,3
5365,h3n8 virus,h3n8 virus,3
1041,similar restrictions,similar restrictions,3
2829,cyp3a,gene,3
7217,circulating strains,circulating strains,3
9916,government health programs,government health programs,3
6935,subunit vaccine,subunit vaccine,3
1840,symptoms end,symptoms end,3
7334,frailty,frailty,3
269,world,world,3
7106,rantes production,rantes production,3
9800,sofosbuvir clinical development,chemical compound medication active ingredient essential medicine,3
4779,prepandemic vaccine,prepandemic vaccine,3
10681,mass slaughter,mass slaughter,3
6774,90 μg,90 μg,3
1650,radiologically confirmed pneumonia,cause death infectious disease,3
1542,oseltamivir treatment,chemical compound neuraminidase inhibitor medication essential medicine,3
10006,early reports,early reports,3
2853,society culture,society culture,3
4777,emerging pandemic,emerging pandemic,3
4094,virus presence,virus presence,3
1529,bacterial infection,bacterial infection,3
7065,early studies leukocytes,early studies leukocytes,3
1120,mild respiratory illness evening,mild respiratory illness evening,3
9958,approximately double party estimate,approximately double party estimate,3
2772,hcv genotype 1a,hcv genotype 1a,3
7027,vitamin d,vitamin d,3
2777,cathepsin b,cathepsin b,3
3992,active infection,active infection,3
7026,vitamin c,vitamin c,3
5294,present vaccination strategies,present vaccination strategies,3
4787,humancommunicable strain,humancommunicable strain,3
3993,effective preventive measure,effective preventive measure,3
5352,horses,horses,3
4077,hcv elimination,hcv elimination,3
9824,american association,american association,3
9823,initial hcv treatment,initial hcv treatment,3
7243,virus prevalence,virus prevalence,3
2770,potent competitive reversible inhibitor,potent competitive reversible inhibitor,3
7290,35 months,35 months,3
7246,mismatched vaccine,mismatched vaccine,3
4075,new infection rates,new infection rates,3
4788,laboratorygenerated h5n1,subtype,3
9942,patent,patent,3
2774,representative serine,chemical compound medication dl-serine l-amino acid dispensable amino acids cargo cargo cdp-diacylglycerol-serine o-phosphatidyltransferase activity,3
3990,insufficient supply,insufficient supply,3
1847,public places,public places,3
7255,yearly vaccine,yearly vaccine,3
9948,appeal,appeal,3
3989,healthcare facilities,healthcare facilities,3
9949,meantime,meantime,3
260,height,height,3
304,garotillo,garotillo,3
7040,adjunctive vitamin d therapy,adjunctive vitamin d therapy,3
9945,indian patent office,indian patent office,3
1844,respirators,respirators,3
4804,known case,known case,3
9833,viral ns5a inhibitor ledipasvir,chemical compound carbocyclic compound heterocyclic compound essential medicine medication,3
7270,policy,policy,3
9944,exclusive rights,exclusive rights,3
10689,newly mutated virus,newly mutated virus,3
7271,vaccine promotion,vaccine promotion,3
7272,sales job,sales job,3
7242,real world,real world,3
3965,hcv antibody,family protein complexes,3
9822,nbk409960,nbk409960,3
1850,value,value,3
9813,previous treatment options,previous treatment options,3
9973,algeria,emoji regional indicator sequence,3
9811,2017 range,2017 range,3
9847,initial treatment,initial treatment,3
4086,quilim choo,quilim choo,3
4087,george kuo,george kuo,3
9810,considerable controversy,considerable controversy,3
7231,current vaccine methods,current vaccine methods,3
5287,virus subtypes,virus subtypes,3
5356,highly contagious respiratory disease,highly contagious respiratory disease,3
4092,diagnostic test,diagnostic test,3
6988,clade 2 h5n1 vaccine,subtype,3
9977,patent challenges,patent challenges,3
7082,grippferon,grippferon,3
7316,vaccine uptake,vaccine uptake,3
7228,library,library,3
9980,european patent office,european patent office,3
6982,2006 article,2006 article,3
6993,symptomatic treatment,symptomatic treatment,3
9972,jennifer cohn,jennifer cohn,3
7078,oral dosing,oral dosing,3
1644,bacterial coinfection,bacterial coinfection,3
2768,clinical development,clinical development,3
4081,alter transfusion medicine,alter transfusion medicine,3
7013,prescriptiononly medication,prescriptiononly medication,3
7012,overthecounter medication,overthecounter medication,3
7011,seasonal h1n1 strains,virus,3
9933,care excellence,care excellence,3
9821,ifnl4 genotype,ifnl4 genotype,3
7293,canadian national advisory committee,canadian national advisory committee,3
7240,antibody production,family protein complexes,3
9820,sofosbuvir therapy,chemical compound medication active ingredient essential medicine,3
4083,international research efforts,international research efforts,3
9967,medicine indexrankedgileadfirstamongtheworld s20largestpharmaceuticalcountriesinthepricingmanufacturinganddistributioncategoryinboth2013and2014citing gilead,medicine indexrankedgileadfirstamongtheworld s20largestpharmaceuticalcountriesinthepricingmanufacturinganddistributioncategoryinboth2013and2014citing gilead,3
5291,h3n2 virus isolates,subtype,3
1051,nawapur,nawapur,3
7006,evaluation,evaluation,3
252,physician,physician,3
7301,vaccinated adults,vaccinated adults,3
9845,prior failed treatment,prior failed treatment,3
7304,working adults,working adults,3
1651,raised creactive protein,raised creactive protein,3
3947,small enveloped singlestranded positivesense rna virus,structural class chemical compounds,3
6924,higher volume,higher volume,3
10015,certainty thepandemic sgeographicoriginwithvaryingviewsasto pandemic s geographic origin],certainty thepandemic sgeographicoriginwithvaryingviewsasto pandemic s geographic origin],3
7183,best way,best way,3
5382,certainty,certainty,3
10703,prophylaxis treatment,prophylaxis treatment,3
10063,males life expectancy,males life expectancy,3
7406,high herd immunity strategies,high herd immunity strategies,3
4144,pains,pains,3
9771,methadone,group stereoisomers,3
9895,0.4 hours,0.4 hours,3
5398,pets,pets,3
6841,current vaccine research,current vaccine research,3
6837,american,american,3
7176,live weakened vaccine,live weakened vaccine,3
6835,$3.8 billion pandemic preparedness,$3.8 billion pandemic preparedness,3
1524,antivirals,chebi ontology term,3
5399,horse equipment,horse equipment,3
7143,medical experiments,medical experiments,3
50,melite,melite,3
1018,initial reaction,initial reaction,3
6784,lead health official,lead health official,3
1156,recent hungarian h5n1 outbreak,subtype,3
10726,forestspring encephalitis virus,forestspring encephalitis virus,3
7163,certain health problems,certain health problems,3
5379,1889 pandemic,1889 pandemic,3
10052,2000s,2000s,3
7387,aso3adjuvanted h1n1 vaccine,virus,3
4794,premutated viruses,premutated viruses,3
4138,preventive antiviral medication,preventive antiviral medication,3
1880,mass media,mass media,3
4765,atlanta,atlanta,3
4140,acute infection,acute infection,3
7386,aso3adjuvanted vaccine,aso3adjuvanted vaccine,3
4023,24 weeks treatment,24 weeks treatment,3
1654,h1n1 virus,virus,3
280,highly interconnected trade pilgrimage routes,highly interconnected trade pilgrimage routes,3
2802,sofosbuvir,chemical compound medication active ingredient essential medicine,3
6829,diagnostic tools,diagnostic tools,3
282,italian kingdoms,italian kingdoms,3
7152,new versions,new versions,3
6819,malaysian health ministry,malaysian health ministry,3
6801,early use,early use,3
6818,nipah virus outbreak,nipah virus outbreak,3
7157,vaccine effectiveness,vaccine effectiveness,3
6800,initial vaccine,initial vaccine,3
2725,hcv,hcv,3
284,pandemic strain,pandemic strain,3
9887,plasma protein,plasma protein,3
5396,upper respiratory tract,upper respiratory tract,3
2868,oral tablet,oral tablet,3
5394,virus multiplies,virus multiplies,3
7395,vaccine safety,vaccine safety,3
10050,public awareness,public awareness,3
9768,darunavir/ritonavir,darunavir/ritonavir,3
4160,experience,experience,3
2805,virus genotype,virus genotype,3
6903,inhibition,inhibition,3
7401,chronic medical conditions,chronic medical conditions,3
4771,earlier later instances,earlier later instances,3
9764,hiv protease inhibitor tipranavir,organisms known particular common,3
318,communities,communities,3
6794,u.s. vaccine production,u.s. vaccine production,3
9883,initial dose,initial dose,3
4162,mild cognitive problems,mild cognitive problems,3
3930,earlier generation treatments,earlier generation treatments,3
3928,simeprevir,chemical compound medication essential medicine,3
4795,h5n1 cases humans,subtypeinfectious disease france,3
6796,pilot vaccine lots,pilot vaccine lots,3
4152,laboratory findings,laboratory findings,3
1021,bird deaths,taxon,3
6797,h5n1 vaccine production,subtype,3
6860,hpai strain,hpai strain,3
1077,h5n1 subtype,subtype,3
2746,entry,entry,3
7187,hivpositive adults,hivpositive adults,3
5402,subclinical infection,subclinical infection,3
7193,public health organizations,public health organizations,3
6782,vaccine research,vaccine research,3
2156,ions,ions,3
4125,english national health service treatment rates,english national health service treatment rates,3
4126,wealthier groups,wealthier groups,3
6895,recent niaidsupported phase ii clinical trial,recent niaidsupported phase ii clinical trial,3
4015,hcv genotype,hcv genotype,3
2861,translation,translation,3
6887,seed viruses,seed viruses,3
9773,tacrolimus,chemical compound medication immunosuppressive drug polyketide,3
1526,respiratory problems,respiratory problems,3
2796,hcv protein,hcv protein,3
9902,12week treatment,12week treatment,3
6888,vaccine candidates,vaccine candidates,3
3940,health burden,health burden,3
4034,reused poorly sterilized medical equipment,reused poorly sterilized medical equipment,3
7123,rantes secretion,rantes secretion,3
2824,cyp3a pglycoprotein substrate,gene,3
1175,european commission,european commission,3
1016,tamiflu vaccine,chemical compound neuraminidase inhibitor medication essential medicine,3
1837,ill family member,ill family member,3
9757,substances,substances,3
2858,protein translation,protein translation,3
7195,manufacturing,manufacturing,3
7197,manufacturing process,manufacturing process,3
5404,vaccinated horses,vaccinated horses,3
1086,precautions,precautions,3
1085,range,range,3
5403,virus shedding,virus shedding,3
6897,clinical evaluation,clinical evaluation,3
2859,ns5a,ns5a,3
9759,gut,gut,3
9784,additional groups,additional groups,3
5374,1997 study,1997 study,3
3924,hcv infection,hcv infection,3
10029,bacterial superinfection,bacterial superinfection,3
7139,alternative,alternative,3
6864,low pathogenic strain,low pathogenic strain,3
6865,future avian flu pandemic current high pathogenic set,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,3
6868,pandemic mitigation funds,pandemic mitigation funds,3
9896,27 hours,27 hours,3
9880,similar way,similar way,3
314,advantage,advantage,3
10026,medical journals,medical journals,3
2146,rules,rules,3
6783,clade 1 viruses,clade 1 viruses,3
4011,successful treatment,successful treatment,3
243,towns,towns,3
5330,vaccine composition,vaccine composition,3
2752,compensated liver disease,organ type,3
7136,enhancement,enhancement,3
6813,canadian public health agency,canadian public health agency,3
4131,special populations,special populations,3
7412,live attenuated virus,live attenuated virus,3
315,trade pilgrimage routes,trade pilgrimage routes,3
1882,animal health,taxon,3
6876,extent,extent,3
9901,media sources,media sources,3
9777,low potency,low potency,3
133,high fever,high fever,4
295,governments,governments,4
9703,twoday international pledging conference,twoday international pledging conference,4
9175,19 june,19 june,4
2368,adverse effects,adverse effects,4
10704,international law,international law,4
474,new illness,new illness,4
302,economic turmoil,economic turmoil,4
3168,particularly heavy prevalence,particularly heavy prevalence,4
2524,insufficient evidence,insufficient evidence,4
9839,higher cure rate,higher cure rate,4
2907,90%,90%,4
10413,varying degrees,varying degrees,4
9843,key component,key component,4
9242,20 march,20 march,4
69,10 people,10 people,4
2069,437 000 birds,437 000 birds,4
2235,concentrated sulfuric acid,concentrated sulfuric acid,4
9179,150 000 vials,150 000 vials,4
2548,inhibited actions,inhibited actions,4
9180,8 october,8 october,4
476,citizens,citizens,4
2131,natural occurrence,natural occurrence,4
10828,amino acid residues,amino acid residues,4
2383,dopaminergic mechanisms,dopaminergic mechanisms,4
2812,common adverse events,common adverse events,4
2838,antidepressants,antidepressants,4
9240,agency s view,agency s view,4
10414,arsenics,arsenics,4
9840,fewer effects,fewer effects,4
470,german medical historian justus hecker,german medical historian justus hecker,4
10365,severe climate anomaly,severe climate anomaly,4
3149,200 000 hospitalizations,200 000 hospitalizations,4
296,possibly time,possibly time,4
2317,example,example,4
10377,large percentage,large percentage,4
10393,systems,systems,4
9226,barakat,barakat,4
9227,productions,productions,4
2832,induction,induction,4
10707,53% fatality rate,53% fatality rate,4
3150,41 000 deaths,41 000 deaths,4
10376,pneumococcal comorbid infections,pneumococcal comorbid infections,4
9208,27 european union member states,27 european union member states,4
9206,500 000 remdesivir treatment courses,chemical compound prodrug antiviral drug,4
3153,article,article,4
10375,inclement weather,inclement weather,4
297,bureaucratic organization,bureaucratic organization,4
9680,moderate severe liver impairment,organ type,4
9223,new contract,new contract,4
2915,inhibitor class,inhibitor class,4
2541,excessive alcohol usage,excessive alcohol usage,4
2542,rare severe adverse effects,rare severe adverse effects,4
2382,typical antipsychotics,typical antipsychotics,4
9217,treatment course,treatment course,4
42,,,4
9218,13 october,13 october,4
10384,anzac troops,anzac troops,4
9229,20 000 150 000 ampoules,20 000 150 000 ampoules,4
10383,gallipoli campaign,gallipoli campaign,4
41,africa,continent,4
9863,high barrier,high barrier,4
2127,derivative,derivative,4
128,whooping cough,whooping cough,4
463,complications,complications,4
129,adult sufferers,adult sufferers,4
2233,reactions,reactions,4
9855,sofosbuvir/ribarivin combinations,sofosbuvir/ribarivin combinations,4
9203,€63 million contract,€63 million contract,4
130,precipitous symptoms,precipitous symptoms,4
9202,conditional marketing authorization,conditional marketing authorization,4
9233,labour,labour,4
3139,risks,risks,4
10405,new york city health commissioner,new york city health commissioner,4
122,chronicled biological evidence,chronicled biological evidence,4
10607,socioeconomic status,socioeconomic status,4
2065,160 000 birds,160 000 birds,4
472,dual outbreak,dual outbreak,4
9696,million birds,million birds,4
2367,renal excretion,renal excretion,4
9189,gilead sciences international,gilead sciences international,4
3163,majority,majority,4
9846,possible steps,possible steps,4
10411,secondary bacterial infections,secondary bacterial infections,4
3164,high rates,high rates,4
3138,immune,immune,4
9185,17 march,17 march,4
10408,later study,later study,4
9236,23 october,23 october,4
9193,noninvasive ventilation,noninvasive ventilation,4
2531,amantadineinduced acceleration,amantadineinduced acceleration,4
124,debunking suggestions whooping cough,debunking suggestions whooping cough,4
10372,lower temperatures,lower temperatures,4
9678,patient s liver function,organ type,4
2429,m2 protein s function istoallow,m2 protein s function istoallow,4
9231,japan s ministry],sovereign state island nation country,4
2545,convulsions,convulsions,4
9232,japan s ministry,sovereign state island nation country,4
2836,immunosuppressants,immunosuppressants,4
10369,mortality figures,mortality figures,4
342,new spain,new spain,4
10600,2.56 million deaths,2.56 million deaths,4
3157,approximately 60.8 million cases,approximately 60.8 million cases,4
2834,ketoconazole,pair enantiomers medication heterocyclic compound azole,4
2912,birth control pills,birth control pills,4
3159,12 469 deaths,12 469 deaths,4
9677,appropriate dosing,appropriate dosing,4
9691,gilead sciences emailed warnings,gilead sciences emailed warnings,4
116,infections,infections,4
10766,biochemistry,biochemistry,4
9172,additional doses,additional doses,4
2475,improvements,improvements,4
9742,60 000 people,60 000 people,4
9788,viral reproduction cycle,viral reproduction cycle,4
10733,new active molecule,new active molecule,4
3212,lymphatic form,lymphatic form,4
311,typhus,typhus,4
511,french lawyer étienne pasquier,french lawyer étienne pasquier,4
512,severe pain,severe pain,4
10576,2020 study,2020 study,4
513,12 15hour fever,12 15hour fever,4
2472,2012 cochrane review,2012 cochrane review,4
2442,drug class,drug class,4
2470,overall evidence,overall evidence,4
10530,sick,sick,4
10850,glaxo s sales,glaxo s sales,4
2469,2007 cochrane literature review,2007 cochrane literature review,4
2373,mechanisms,mechanisms,4
2051,outdoor poultry,organisms known particular common,4
514,sufferers noses ranlike,sufferers noses ranlike,4
9068,high price,high price,4
2145,nomenclature,nomenclature,4
10521,disparities,disparities,4
9741,works,works,4
9080,metabolite remaining hours,metabolite remaining hours,4
90,form,form,4
3202,body s ability tofightoff,body s ability tofightoff,4
2486,concentration,concentration,4
9799,severe rash,severe rash,4
9094,sarscov2 arrest,sarscov2 arrest,4
2053,jeongeup,city south korea big city,4
9797,6 12 months treatment,6 12 months treatment,4
9795,breakthrough status,breakthrough status,4
10578,additional adverse economic effects,additional adverse economic effects,4
9092,growing rna chain,structural class chemical compounds,4
10513,poorer people,poorer people,4
516,paris law court,paris law court,4
2857,hcv viral rna replication,structural class chemical compounds,4
9791,new drug application,new drug application,4
507,chills,chills,4
10721,viral genomic fragments,viral genomic fragments,4
2297,key structural subunit,key structural subunit,4
9086,rnadependent rna polymerases,structural class chemical compounds,4
10722,synthetic analogue,synthetic analogue,4
9085,viral rna production,structural class chemical compounds,4
9084,viral exoribonuclease,viral exoribonuclease,4
9083,evades,evades,4
508,expulsion,expulsion,4
2479,consensus guidelines,consensus guidelines,4
323,new acquaintance,new acquaintance,4
3217,body s immune,body s immune,4
2251,formic acid,formic acid,4
10549,significant effects,significant effects,4
9752,interferonfree treatment,interferonfree treatment,4
9766,interaction,interaction,4
10567,revenue,revenue,4
2047,wild geese,wild geese,4
82,1493.amerindian populations sharp decline,1493.amerindian populations sharp decline,4
9043,excipient,excipient,4
9765,sofosbuvir concentration,chemical compound medication active ingredient essential medicine,4
2255,oxidation,oxidation,4
2299,ab001,ab001,4
2446,channel,channel,4
3228,biocryst pharmaceuticals,biocryst pharmaceuticals,4
10559,kahn,kahn,4
9037,new batch,new batch,4
2870,67%,67%,4
10561,model,model,4
9036,filling plant,filling plant,4
10564,economic,economic,4
10860,certain people,certain people,4
2143,room temperature,room temperature,4
9034,gilead sciences filling plant,gilead sciences filling plant,4
9033,powder form,powder form,4
9039,drug\ s poor predicted solubility,drug\ s poor predicted solubility,4
9099,rapid extracellular conversion,rapid extracellular conversion,4
2305,solid form,solid form,4
3222,vaccination,vaccination,4
2466,fatigue multiple sclerosis,symptom,4
10853,s need tobehospitalizedor,s need tobehospitalizedor,4
9748,influenzalike symptoms,influenzalike symptoms,4
2465,levodopa effects,levodopa effects,4
2876,volume,volume,4
9061,vial,vial,4
9060,price,price,4
2374,cns effects,cns effects,4
10572,nursing,nursing,4
2306,heavy pressure tank,heavy pressure tank,4
83,spanishimported diseases,spanishimported diseases,4
2463,extrapyramidal effects,extrapyramidal effects,4
9058,pricing,pricing,4
3219,flurelated complications,flurelated complications,4
2461,priority,priority,4
10729,arvi,arvi,4
9056,gilead sciences licensees,gilead sciences licensees,4
322,new sickness,new sickness,4
2459,continued high rate,continued high rate,4
2375,caution,caution,4
9053,23 june,23 june,4
2445,porelining amino acid residues,porelining amino acid residues,4
10539,transmission rate,transmission rate,4
10424,mass panic,mass panic,4
504,severe headache,severe headache,4
9801,warehouse people,warehouse people,4
10,1357 s outbreak thefirsttobecalledinfluenzabut,1357 s outbreak thefirsttobecalledinfluenzabut,4
10841,conserved glutamic acid,conserved glutamic acid,4
486,anonymous physician s descriptions,anonymous physician s descriptions,4
9153,subject s covid‑19 symptoms improvingwerestatisticallysignificantlyhigherin,subject s covid‑19 symptoms improvingwerestatisticallysignificantlyhigherin,4
10439,1991 states,1991 states,4
10440,25 39 million people,25 39 million people,4
112,asia s migratory water fowl,continent continental area surrounding islands,4
8,influenzalike illnesses,influenzalike illnesses,4
2901,roche,roche,4
10445,devastated communities,devastated communities,4
2151,unfunctionalized hydrocarbon,unfunctionalized hydrocarbon,4
9816,severe acute respiratory syndrome coronavirus,group class strains strain,4
2239,composition,composition,4
10453,indigenous people,indigenous people,4
2433,m2 channel,m2 channel,4
9144,10 days,10 days,4
2511,treatment guidelines,treatment guidelines,4
491,severe outbreak,severe outbreak,4
492,nîmes,nîmes,4
10845,small company,small company,4
2434,impaired replication,impaired replication,4
71,fatality rate,fatality rate,4
334,varying waves,varying waves,4
10719,triazavirin,medication chemical compound,4
10436,onethird,onethird,4
9837,previous treatments,previous treatments,4
2522,amantadine treatment,chemical compound medication,4
10716,new structural class,new structural class,4
10427,mass graves,mass graves,4
9168,severe covid‑19 symptoms,severe covid‑19 symptoms,4
2379,enhanced cns depressant effects,enhanced cns depressant effects,4
9834,2 3 hcv infections,2 3 hcv infections,4
2905,combinations,combinations,4
3172,graphs,graphs,4
335,years,years,4
3183,immune systems,immune systems,4
481,severe fits,severe fits,4
9831,specific circumstances,specific circumstances,4
9830,longer treatment durations,longer treatment durations,4
70,day,day,4
2842,slowing,slowing,4
2061,late december,late december,4
9158,subject s moderate covid‑19 symptoms improvingweresimilarforthosein,subject s moderate covid‑19 symptoms improvingweresimilarforthosein,4
9828,secondline treatments,secondline treatments,4
9827,firstline treatments,firstline treatments,4
484,kingdom france,kingdom france,4
2843,heart rate,heart rate,4
10432,aspirin,aspirin,4
9812,efficacy rate,efficacy rate,4
10587,lower socioeconomic status,lower socioeconomic status,4
10463,western samoa,western samoa,4
9115,initial screening,initial screening,4
497,high mortality rate,high mortality rate,4
10481,new caledonia,new caledonia,4
10482,single death,stock character psychopomp literary character,4
498,200 people,200 people,4
2495,emergence,emergence,4
74,new world,new world,4
10488,brazil s amazon river delta hadnotreported,brazil s amazon river delta hadnotreported,4
330,vapors,vapors,4
3193,emergency room,emergency room,4
2133,physical properties,physical properties,4
10492,half mortality rate,half mortality rate,4
10494,weak individuals,weak individuals,4
9805,new drug,new drug,4
9804,sofosbuvir s u.s. launch wasthefastestof,chemical compound medication active ingredient essential medicine,4
10499,71%,71%,4
10500,oddity,oddity,4
2257,aqueous solution,aqueous solution,4
2245,fluorination,fluorination,4
2888,developing world,developing world,4
93,common treatments,common treatments,4
2055,19 000 ducks,19 000 ducks,4
9110,rhesus monkeys,rhesus monkeys,4
10504,great variation,great variation,4
9116,gilead sciences compound library,gilead sciences compound library,4
332,dryness,dryness,4
9133,agency s analysis,agency s analysis,4
16,coccolucio,coccolucio,4
495,fourth day,fourth day,4
102,medicinal treatments,medicinal treatments,4
101,short,short,4
2897,(gt1b,(gt1b,4
9129,main circulating metabolite,main circulating metabolite,4
9721,cures,cures,4
3185,lung disease,lung disease,4
2896,multiple hcv genotypes,multiple hcv genotypes,4
3192,close 100 000 asthmatics,close 100 000 asthmatics,4
3186,lifethreatening complications,lifethreatening complications,4
9724,intheknow,intheknow,4
2272,bromine nitric acid,bromine nitric acid,4
2502,time period,time period,4
10585,physical disability,physical disability,4
3190,acute respiratory distress syndrome,acute respiratory distress syndrome,4
2851,counterscreen,counterscreen,4
98,sufferers,sufferers,4
2498,interactive communication,interactive communication,4
9726,unanswered questions,unanswered questions,4
3191,related complications,related complications,4
2850,huh7,cell line cancer cell line,4
2508,cerebral hemorrhage,cerebral hemorrhage,4
150,period,period,4
9248,23 march,23 march,4
9572,fluzone,fluzone,4
3027,opportunistic infections,opportunistic infections,4
9438,prichard s methods ofsynthesisofrimantadinefromthecorrespondingketoneoximewerebasedonprichard smethodsof synthesis,prichard s methods ofsynthesisofrimantadinefromthecorrespondingketoneoximewerebasedonprichard smethodsof synthesis,4
368,treatments,treatments,4
10172,minneapolis,minneapolis,4
2658,antacids,antacids,4
54,flu s highly contagious nature enabledeurope sinternationallytraveledcitiesandflu shighlycontagiousnaturespreadthrough european populations,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,4
9436,prichardpatent,prichardpatent,4
10004,morale,morale,4
2386,anticholinergic effects,anticholinergic effects,4
9441,corresponding ketone oxime,corresponding ketone oxime,4
10002,world s population,world s population,4
196,urbes,urbes,4
10180,january 1918 outbreak,january 1918 outbreak,4
9998,achillion,achillion,4
9432,racemic hydroxy acid,racemic hydroxy acid,4
9997,fast track status,fast track status,4
9996,ns3/4a inhibitor,ns3/4a inhibitor,4
398,weather,weather,4
9430,200 mg/d,200 mg/d,4
9429,sideeffects,sideeffects,4
10649,pseudomonas aeruginosa,pseudomonas aeruginosa,4
2656,calciumfortified beverages,calciumfortified beverages,4
2661,adverse events,adverse events,4
2388,glaucoma,glaucoma,4
201,austria,sovereign state start time 12 november 1918gregorian republic rechtsstaat landlocked country country state,4
2675,polymerase s endonuclease activity cleavage,group class enzymes,4
2674,polymerase s endonuclease activity catalyzes polymerase s endonuclease activity cleavage],group class enzymesgroup class enzymes,4
9451,chembl959,chembl959,4
10016,pandemic s geographic origin,pandemic s geographic origin,4
10659,rhinovirus species,taxon,4
2672,host,host,4
2112,simplest diamondoid,simplest diamondoid,4
2669,host cell rna transcripts,structural class chemical compounds,4
2754,sodium/bile acid cotransporter,sodium/bile acid cotransporter,4
392,mercado,mercado,4
53,flu s highly contagious nature enabled europe s internationally traveled cities],influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenzacontinental area surrounding islands continent geographic region,4
245,hospitals,hospitals,4
393,severe coughing,severe coughing,4
10011,king alfonso xiii,king alfonso xiii,4
394,short period,short period,4
2354,pharmacokinetics,pharmacokinetics,4
10782,umifenovir s suppressive effect,chemical compound,4
2098,organic compound,organic compound,4
246,king louis xii s national assembly,king louis xii s national assembly,4
9562,abbott laboratoriesin s generic drugs business,abbott laboratoriesin s generic drugs business,4
2963,interferonfree regimens,interferonfree regimens,4
9567,plan,plan,4
10008,epidemic s effects,epidemic s effects,4
10185,phylogenetic analyses,phylogenetic analyses,4
9427,gastrointestinal central nervous adverse effects,gastrointestinal central nervous adverse effects,4
9992,high cost,high cost,4
10646,endogenous clostridium difficile,endogenous clostridium difficile,4
2093,20 february,20 february,4
9412,rbcs,rbcs,4
9979,gilead s patent,gilead s patent,4
9978,objection,objection,4
9410,taribavirin s basic amidine group whichinhibits,chemical compound,4
60,breathing,breathing,4
10792,brand vanihep,brand vanihep,4
10688,particularly domestic ducks,particularly domestic ducks,4
9975,gilead partners,gilead partners,4
9974,70 000 people,70 000 people,4
9599,setrobuvir,chemical compound,4
10220,europe s battlefields],continental area surrounding islands continent geographic region,4
9403,3carboxamidine derivative,3carboxamidine derivative,4
10221,europe s battlefields,continental area surrounding islands continent geographic region,4
179,switzerland,emoji regional indicator sequence,4
10637,record,record,4
9600,anadys pharmaceuticals,anadys pharmaceuticals,4
405,scarlet fever,scarlet fever,4
175,southern france,southern france,4
2952,ritonavir,chemical compound medication heterocyclic compound essential medicine,4
10228,96 000 chinese laborers,96 000 chinese laborers,4
2409,new antiinfluenza therapies,new antiinfluenza therapies,4
10635,2 million men,2 million men,4
2633,selection,selection,4
9453,riamantadine,riamantadine,4
9985,gilead drug,gilead drug,4
2639,bxa,bxa,4
9577,intradermal injection,intradermal injection,4
9578,0.25 ml syringe,0.25 ml syringe,4
2958,28 days,28 days,4
57,social life,social life,4
10193,new disease,new disease,4
9425,body s uptake,body s uptake,4
10194,high mortality,high mortality,4
10788,rnadependent rna polymerase inhibitor,structural class chemical compoundsgroup class enzymes,4
2645,common effects,common effects,4
9991,medical tourism,medical tourism,4
2644,process,process,4
9424,acetylsalicylic acid whiletakingrimantadineisknowntoreducethebody suptakeof rimantadine,chemical compound medication,4
9580,0.5 ml syringe,0.5 ml syringe,4
9581,0.5 ml vial,0.5 ml vial,4
9582,5 ml vial,5 ml vial,4
9423,acetylsalicylic acid,acetylsalicylic acid,4
399,mass poisoning,mass poisoning,4
9421,fewer symptoms,fewer symptoms,4
9990,specific example,specific example,4
187,june,june,4
9986,developing world countries,developing world countries,4
9588,greater immune response,greater immune response,4
10206,100 000 soldiers,100 000 soldiers,4
2638,baloxavir acid,baloxavir acid,4
2622,hepatitis c. asunaprevir,chemical compound carbocyclic compound heterocyclic compound,4
10017,varying views,varying views,4
10660,moraxella,moraxella,4
10668,documented case,documented case,4
2284,chlodantane,chlodantane,4
2720,combination s safety profile,combination s safety profile,4
2723,asunaprevir/daclatasvir/beclabuvir,asunaprevir/daclatasvir/beclabuvir,4
2270,moderate yields,moderate yields,4
10057,gender mortality gap,gender mortality gap,4
9495,virus s protective shells,virus s protective shells,4
10098,midwest,midwest,4
10099,western,western,4
219,pilgrims,pilgrims,4
9498,ion channel,ion channel,4
9531,samatasvir,chemical compound,4
10104,treaty,treaty,4
10047,epidemiology pathology,branch science,4
10046,spanish flu],spanish flu],4
10107,flurelated deaths,flurelated deaths,4
10108,fewer 1 000 people,fewer 1 000 people,4
9491,m2 transmembrane channel,m2 transmembrane channel,4
10044,play s popular musical number,play s popular musical number,4
10111,french troops,french troops,4
10113,900 000 german soldiers,900 000 german soldiers,4
2700,8 april,8 april,4
10102,odessa,port settlement big city city millions inhabitants amalgamated hromada city \u200b\u200bin ukraine,4
2991,favipiravir active form,chemical compound medication,4
2979,fujifilm,fujifilm,4
9501,amino acid substitutions,amino acid substitutions,4
10073,higher mortality rate,higher mortality rate,4
10069,1300s,1300s,4
10075,videoswe,videoswe,4
10672,northernmost areas,northernmost areas,4
2712,substitutions,substitutions,4
9518,r s enantiomers,r s enantiomers,4
10080,4 march,4 march,4
379,urbino,comune italy city,4
9510,r s states,r s states,4
9509,racemic mixture,racemic mixture,4
229,coqueluchons,coqueluchons,4
228,etymology,etymology,4
10084,camp funston,camp funston,4
10065,death rate,stock character psychopomp literary character,4
10064,tuberculosis mortality rate,notifiable disease valid place switzerland endemic disease,4
2986,teratogenic embryotoxic effects,teratogenic embryotoxic effects,4
10765,阿比朵尔.,阿比朵尔.,4
10088,camp,camp,4
10089,11 march,11 march,4
224,western mediterranean,western mediterranean,4
10091,new york,new york,4
9503,transmembrane region,transmembrane region,4
10769,drug s actions aremoreeffectiveatpreventinginfectionsfromrnavirusesthan,drug s actions aremoreeffectiveatpreventinginfectionsfromrnavirusesthan,4
10675,ortrud werner,ortrud werner,4
10118,brest,brest,4
2995,legal status,legal status,4
52,europe s internationally traveled cities andflu shighlycontagiousnatureenabledeurope sinternationallytraveledcitiesand flu s highly contagious nature],continental area surrounding islands continent geographic regioninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,4
28,mortality rate,mortality rate,4
10137,philadelphia liberty loans parade,philadelphia liberty loans parade,4
3011,ministry,ministry,4
9463,rimantidine,rimantidine,4
10023,bodies,bodies,4
2687,possible industrial synthetic routes,possible industrial synthetic routes,4
9548,latest recommendations,latest recommendations,4
10141,12 000 deaths,12 000 deaths,4
9549,abbott laboratoriesin february,abbott laboratoriesin february,4
2353,m2 proton channel,m2 proton channel,4
10021,severe 6year climate anomaly,severe 6year climate anomaly,4
9460,ncgc0015949102,ncgc0015949102,4
2683,co.,co.,4
3016,limited evidence,limited evidence,4
2681,ways,ways,4
391,dodoens,dodoens,4
10756,ld50,ld50,4
10149,lima,capital city big city city millions inhabitants,4
9554,acquisition,acquisition,4
10019,higherthanexpected mortality rate,higherthanexpected mortality rate,4
2343,multiple sclerosis,multiple sclerosis,4
2676,polymerase s endonuclease activity mechanism isdistinctfrom,group class enzymes,4
10154,initial wave,initial wave,4
10136,new york city fatality,new york city fatality,4
10018,higher survival rate,higher survival rate,4
9467,oprea1602732,oprea1602732,4
10135,new york city,new york city,4
10039,naples soldier,naples soldier,4
2740,bile salts,bile salts,4
10664,fasciola gigantica,fasciola gigantica,4
10123,camp devens,camp devens,4
10762,claims,claims,4
240,king louis xii s royal court,king louis xii s royal court,4
3001,safety,safety,4
9482,api0024288,api0024288,4
216,international crowds,international crowds,4
3002,2 000 patients,2 000 patients,4
9480,methylamine,methylamine,4
2741,injection,injection,4
10772,umifenovir exhibits modulatory effects,chemical compound,4
9477,mfcd00869344,mfcd00869344,4
215,nice,commune france big city,4
10129,rivers,rivers,4
10032,wartime censorship,wartime censorship,4
9537,influvac,influvac,4
2191,large single crystals,large single crystals,4
10031,disease geographic origin,disease geographic origin,4
2748,ability,ability,4
9543,fluarix,fluarix,4
213,ports,ports,4
2344,rate,rate,4
2620,asunaprevir,chemical compound carbocyclic compound heterocyclic compound,4
9396,usan,usan,4
2410,recall,recall,4
9646,simeprevir s prescriber information,chemical compound medication essential medicine,4
2579,woman withparkinson sdiseasewasprescribedamantadinetotreatawomanwithparkinson sdiseaseinfluenzainfectionandreportedawomanwith parkinson s disease],woman withparkinson sdiseasewasprescribedamantadinetotreatawomanwithparkinson sdiseaseinfluenzainfectionandreportedawomanwith parkinson s disease],4
9647,simeprevir s prescriber information efficacy,chemical compound medication essential medicine,4
2578,amantadine s effectiveness fortreating,chemical compound medication,4
151,months,months,4
2260,alcohol,alcohol,4
10317,blurred vision,blurred vision,4
2574,breastfeeding,breastfeeding,4
10319,observer,observer,4
3103,timing,timing,4
9645,pharmacogenomics,pharmacogenomics,4
2570,excretion,excretion,4
2932,severe itching,severe itching,4
9292,drug s active ingredient,drug s active ingredient,4
9912,$84 000 price,$84 000 price,4
2566,teratogenic effects,teratogenic effects,4
2362,endstage renal disease,endstage renal disease,4
10742,umifenovir s efficacy hasmainlyoccurredinchinaandrussiaanditiswellknownin,chemical compound,4
2072,8 january,8 january,4
10741,status,status,4
10334,strong immune reactions,strong immune reactions,4
9284,new guidance,new guidance,4
9293,compounders,compounders,4
2580,parkinson s disease wasprescribedamantadinetotreatawomanwithparkinson sdiseaseinfluenzainfectionandreported woman,parkinson s disease wasprescribedamantadinetotreatawomanwithparkinson sdiseaseinfluenzainfectionandreported woman,4
2581,parkinson s disease wasprescribedamantadinetotreatawomanwithparkinson sdiseaseinfluenza infection,parkinson s disease wasprescribedamantadinetotreatawomanwithparkinson sdiseaseinfluenza infection,4
64,lungs,lungs,4
9929,24 pills,24 pills,4
9636,adult people,adult people,4
3084,m423 investigation,m423 investigation,4
2080,city,city,4
9928,chf,chf,4
3087,prevalence,prevalence,4
2586,parkinson s disease alsoreportedthatawomanwithparkinson sdiseasesymptomsworsenedafter woman,parkinson s disease alsoreportedthatawomanwithparkinson sdiseasesymptomsworsenedafter woman,4
9321,respiratory syncytial virusrelated diseases,respiratory syncytial virusrelated diseases,4
9637,hiv1 coinfection,hiv1 coinfection,4
2585,woman withparkinson sdiseasealsoreportedthatawomanwithparkinson sdiseasesymptomsworsenedafterawomanwith parkinson s disease],woman withparkinson sdiseasealsoreportedthatawomanwithparkinson sdiseasesymptomsworsenedafterawomanwith parkinson s disease],4
9320,aerosol form,aerosol form,4
9318,venezuelan hemorrhagic fever,venezuelan hemorrhagic fever,4
158,outbreak,outbreak,4
2327,influenzavirus m2 proton channel,influenzavirus m2 proton channel,4
9638,previous interferon therapy,group class proteins,4
9640,liver s cyp3a4 enzymes mainlybreakdown,organ type,4
10621,bigger impact,bigger impact,4
9314,combination s efficacy intreating,combination s efficacy intreating,4
2119,formaldehyde,organic compound flammable gas occupational carcinogen aldehydes chemical compound carcinogen,4
9310,safest effective medicines,safest effective medicines,4
2583,woman withparkinson sdiseasewasprescribedamantadinetotreatawomanwithparkinson sdiseaseinfluenzainfectionandreportedawomanwith parkinson s disease cogwheel rigidity],woman withparkinson sdiseasewasprescribedamantadinetotreatawomanwithparkinson sdiseaseinfluenzainfectionandreportedawomanwith parkinson s disease cogwheel rigidity],4
2326,antagonism,antagonism,4
9643,41 hours,41 hours,4
3117,humid subtropical climate,humid subtropical climate,4
10335,weaker immune reactions,weaker immune reactions,4
2792,sofusbivir,sofusbivir,4
9907,12 weeks combination treatment,12 weeks combination treatment,4
10347,severe decline,severe decline,4
9265,607 000 vials,607 000 vials,4
2229,fourcenter twoelectron bond,fourcenter twoelectron bond,4
2556,dry mouth,dry mouth,4
3127,large companies,large companies,4
9260,500 000 courses,500 000 courses,4
9259,140 000 treatment courses,140 000 treatment courses,4
9891,phosphoramidate,phosphoramidate,4
10610,severe underlying condition,severe underlying condition,4
9258,1.5 million vials,1.5 million vials,4
3128,large companies employees,large companies employees,4
283,spanish cities,spanish cities,4
10354,adverse climate conditions,adverse climate conditions,4
9254,heart–lung bypass machine,heart–lung bypass machine,4
286,intense occasionally lethal symptoms,intense occasionally lethal symptoms,4
10609,newfoundland s leading cause,newfoundland s leading cause,4
3130,small cost,small cost,4
9252,room air,room air,4
2126,meerwein s ester,meerwein s ester,4
9250,severe covid‐19 covid‐19,severe covid‐19 covid‐19,4
2550,compulsions,compulsions,4
17,france,france,4
2809,specific effects,specific effects,4
9266,gilead s promised donation,gilead s promised donation,4
2942,rna polymerization,structural class chemical compounds,4
10823,biota s ongoing program todevelop,biota s ongoing program todevelop,4
449,sicilian senate,sicilian senate,4
9906,list price,list price,4
445,palermo,comune italy city big city,4
145,slow recovery,slow recovery,4
3120,individual s risk ofgetting,individual s risk ofgetting,4
10338,microscope,microscope,4
10698,humanized form,humanized form,4
447,economy,economy,4
2793,st. john s wort,st. john s wort,4
10614,day interaction,day interaction,4
2795,carbamazepine,chemical compound medication essential medicine,4
10611,|mortality rate,|mortality rate,4
2797,world health organization s list,world health organization s list,4
9662,johnson,johnson,4
2162,new caledonian marine sponge,new caledonian marine sponge,4
9273,needed refrigeration,needed refrigeration,4
448,large portion,large portion,4
2561,stevens–johnson syndrome,stevens–johnson syndrome,4
2560,skin rashes,skin rashes,4
9271,initial distribution,initial distribution,4
350,spanish colonies,spanish colonies,4
141,cough,cough,4
10346,russia s elite wasthat,empire start time 22 october 1721julian end time 1 september 1917julian 1 september 1917julian,4
9269,distribution rounds,distribution rounds,4
3125,southern hemisphere,southern hemisphere,4
2778,ciluprevir scaffold,chemical compound,4
10694,interpandemic period,interpandemic period,4
159,guillaume baillou s description,guillaume baillou s description,4
9965,discounted price,discounted price,4
412,localized outbreak,localized outbreak,4
256,fever,fever,4
9377,uracil,uracil,4
9376,adenine,adenine,4
2214,optical activity,optical activity,4
2604,parkinson s disease,parkinson s disease,4
10258,people s resistance,people s resistance,4
9373,ribavirin s amide group canmake,chemical compound medication essential medicine 1 april 1990,4
10259,soldiers immune systems wereweakenedby,soldiers immune systems wereweakenedby,4
10803,breathing problems,breathing problems,4
10260,malnourishment,malnourishment,4
258,coughing,coughing,4
165,people,people,4
9617,simeprevir s effectiveness,chemical compound medication essential medicine,4
164,large volumes,large volumes,4
9956,world s hcvinfected population andthat,world s hcvinfected population andthat,4
10805,asthma chronic obstructive pulmonary disease,asthma chronic obstructive pulmonary disease,4
9364,larger substituent,larger substituent,4
2600,parkinson s disease showed,parkinson s disease showed,4
9618,single therapy,single therapy,4
259,1000 parisians,1000 parisians,4
21,popular names,popular names,4
2213,high molecular symmetry,high molecular symmetry,4
10269,circumstances,circumstances,4
361,time,time,4
9382,ribavirin s effect,chemical compound medication essential medicine 1 april 1990,4
2616,monotherapy,monotherapy,4
32,possibly china,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",4
2615,long periods,long periods,4
2288,saxagliptin,medication group stereoisomers,4
3048,widespread vasculitis,widespread vasculitis,4
2088,edible ducks,edible ducks,4
9604,typically 12 weeks,typically 12 weeks,4
9971,equitable pricing,equitable pricing,4
10238,archival evidence,archival evidence,4
3052,104 pfu nivm,104 pfu nivm,4
9388,dna nucleoside mimic,dna nucleoside mimic,4
9387,rna nucleoside mimic,structural class chemical compounds,4
9970,gilead\ s leading performance,gilead\ s leading performance,4
9968,world s 20 largest pharmaceutical countries,world s 20 largest pharmaceutical countries,4
2411,dingo chip twists,dingo chip twists,4
10632,case rate,case rate,4
411,recognized whooping cough epidemic,recognized whooping cough epidemic,4
10631,halifax,halifax,4
9385,ribavirin s 2 deoxyribose analogue,chemical compound medication essential medicine 1 april 1990,4
3053,intraperitoneal,intraperitoneal,4
10245,chinese population s previously acquired immunity,chinese population s previously acquired immunity,4
2336,high level,high level,4
2212,simplicity,simplicity,4
2610,schwab s team followed,schwab s team followed,4
457,naples,naples,4
10270,civilian life,civilian life,4
9954,gilead announcedthatgileadwouldseekgenericlicensingagreementswithmanufacturerstoproducesofosbuvirin91developingcountriescontaining54%oftheworld shcvinfectedpopulationandthat gilead,gilead announcedthatgileadwouldseekgenericlicensingagreementswithmanufacturerstoproducesofosbuvirin91developingcountriescontaining54%oftheworld shcvinfectedpopulationandthat gilead,4
2775,cysteine proteases,cysteine proteases,4
9341,mechanisms action,mechanisms action,4
2589,parkinson s disease alsoreportedthatawomanwithparkinson sdiseasesymptomsworsenedafterawomanwithparkinson sdiseasefinished course,parkinson s disease alsoreportedthatawomanwithparkinson sdiseasesymptomsworsenedafterawomanwithparkinson sdiseasefinished course,4
9938,croatian health insurance fund,croatian health insurance fund,4
10287,4 597 people,4 597 people,4
10288,explanation,explanation,4
9936,essential medications,essential medications,4
9935,run rate,run rate,4
3077,viral rna synthesis,structural class chemical compounds,4
425,asia minor,continent continental area surrounding islands,4
9336,sex,sex,4
3079,0.019 μm,0.019 μm,4
9934,10 000 courses,10 000 courses,4
3082,m423,m423,4
2588,parkinson s disease symptoms worsenedafter,parkinson s disease symptoms worsenedafter,4
9330,placebo treatment,placebo treatment,4
2587,woman withparkinson sdiseasealsoreportedthatawomanwith parkinson s disease symptoms],woman withparkinson sdiseasealsoreportedthatawomanwith parkinson s disease symptoms],4
3083,filibuvir monotherapy,chemical compound,4
2943,replication,replication,4
10292,epic story,epic story,4
9327,small study,small study,4
160,paris,paris,4
9932,22 operational delivery networks,22 operational delivery networks,4
2385,end stage renal disease,end stage renal disease,4
10271,natural selection,natural selection,4
356,shipping routes,shipping routes,4
357,pandemic s memorable effects,pandemic s memorable effects,4
9953,73 million people,73 million people,4
419,widespread infections,widespread infections,4
2598,patients withparkinson sdiseaseandgaveagroupoftenpatientswith parkinson s disease amantadine],patients withparkinson sdiseaseandgaveagroupoftenpatientswith parkinson s disease amantadine],4
9358,triazole,triazole,4
10275,crowded trains,crowded trains,4
9952,indian firms,indian firms,4
10276,crowded field hospitals,crowded field hospitals,4
2597,parkinson s disease andgave,parkinson s disease andgave,4
2596,patients withparkinson sdiseaseandgaveagroupoftenpatientswith parkinson s disease],patients withparkinson sdiseaseandgaveagroupoftenpatientswith parkinson s disease],4
3068,tautomerism,tautomerism,4
9352,national cancer institute s viruscancer program waswidelyconsideredafailureand,constellation zodiacal constellation,4
2414,parkinson s disease hasinfoabout,parkinson s disease hasinfoabout,4
3069,possible tautomerism,possible tautomerism,4
3070,enollike form,enollike form,4
9946,gilead sciences s lawyers moved,gilead sciences s lawyers moved,4
2945,new cells,new cells,4
10626,mobility,mobility,4
10280,firstwave infections,firstwave infections,4
9345,direct indirect mechanisms,direct indirect mechanisms,4
63,cooked humor,cooked humor,4
10692,century s,century s,4
9344,rna metabolism,structural class chemical compounds,4
10282,combined mortality rate,combined mortality rate,4
262,judicial proceedings,judicial proceedings,4
9756,transporter protein,transporter protein,4
4943,haemagglutinin,haemagglutinin,4
9028,gilead sciences manufacturing plant,gilead sciences manufacturing plant,4
6495,enzyme esterase,enzyme esterase,4
1245,animal species,taxon,4
6498,new ha,new ha,4
6509,esterase,esterase,4
6510,situ esterase assays,situ esterase assays,4
4291,contamination,contamination,4
4290,improperly sterilized equipment,improperly sterilized equipment,4
6516,drift,drift,4
6517,capability,capability,4
6520,vaccinations,vaccinations,4
4288,single partner,single partner,4
4287,relationships,relationships,4
4286,multiple partners,multiple partners,4
6524,situ esterase,situ esterase,4
4281,greater risks,greater risks,4
6533,lineages,lineages,4
6534,influenzavirus d natural host,influenzavirus d natural host,4
4278,anal penetrative sex,anal penetrative sex,4
6542,slower mutation rate,slower mutation rate,4
4276,trauma,trauma,4
1237,159 000 culled turkeys,159 000 culled turkeys,4
6494,viral cellular membranes,viral cellular membranes,4
1236,1 march,1 march,4
1782,desire,desire,4
4303,licensed facility,licensed facility,4
6411,rna strands,structural class chemical compounds,4
6417,genomic segments,genomic segments,4
1260,25 january,25 january,4
6438,segments,segments,4
6440,segment,segment,4
6441,separate nucleocapsid,separate nucleocapsid,4
6442,nucleocapsids,nucleocapsids,4
4311,appropriate caution,appropriate caution,4
6448,minor symptoms,minor symptoms,4
6450,amino acid composition,amino acid composition,4
6456,single ancestor,single ancestor,4
6458,natural host,natural host,4
6461,6 lineages,6 lineages,4
6464,short durations,short durations,4
6465,relatively short incubation period,relatively short incubation period,4
6470,dry cough,dry cough,4
1252,exotic birds,exotic birds,4
1781,decision,decision,4
6474,severe infections,severe infections,4
6476,body s main source,body s main source,4
6481,effective immune systems,effective immune systems,4
6486,single stranded genomes,single stranded genomes,4
4268,highest rate,highest rate,4
4261,improperly sterilized surgical equipment,improperly sterilized surgical equipment,4
6565,consortium,consortium,4
1812,2009 h1n1 outbreak,virus,4
4204,possible associations includehyde sprurigonodularisand membranoproliferative glomerulonephritis,possible associations includehyde sprurigonodularisand membranoproliferative glomerulonephritis,4
4203,possible associations,possible associations,4
6666,1921 book,1921 book,4
6674,medicines,medicines,4
1817,young schoolage people,young schoolage people,4
4196,sjögren s syndrome,sjögren s syndrome,4
6686,estimated 1–4 million people,estimated 1–4 million people,4
6687,100 000 deaths,100 000 deaths,4
1199,17 february,17 february,4
6693,march–april,march–april,4
1197,bernard matthews shipments,bernard matthews shipments,4
4194,small mediumsized blood vessels,biogenic substance type,4
1196,bernard matthews bernard matthews,bernard matthews bernard matthews,4
1194,14 february,14 february,4
1818,24 years,24 years,4
6706,new recommendations,new recommendations,4
4190,extrahepatic complications,extrahepatic complications,4
1193,bernard matthews,bernard matthews,4
1820,worstcase scenario,worstcase scenario,4
1188,feed,feed,4
6656,trust,trust,4
6654,great deal,great deal,4
6653,great social disruption,great social disruption,4
6646,isolate a/fujian/411/2002,isolate a/fujian/411/2002,4
6567,institute,institute,4
6569,project,project,4
6573,new technology development,academic discipline,4
1798,continued standing practices,continued standing practices,4
4255,intact skin,intact skin,4
4244,200 units,200 units,4
6585,component,component,4
1805,china southern airlines,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",4
6587,sequencing project home page,sequencing project home page,4
6590,140 years,140 years,4
4322,delivery,delivery,4
6591,50–100 million people,50–100 million people,4
6601,common symptoms,common symptoms,4
4231,highrisk behavior,highrisk behavior,4
6612,healthy individuals,healthy individuals,4
4227,million intravenous drug users,million intravenous drug users,4
4222,ultracentrifugation,ultracentrifugation,4
6624,field hospitals,field hospitals,4
6626,battlefield,battlefield,4
6630,great risk,great risk,4
6637,material,material,4
6645,typical host,typical host,4
6592,million deaths,million deaths,4
4323,long labor,long labor,4
6407,multiplicity reactivation,multiplicity reactivation,4
6405,negativesense rna,structural class chemical compounds,4
1317,pneumonia acute respiratory distress syndrome,cause death infectious disease,4
6207,anhui,province china,4
6209,critical condition,critical condition,4
1316,small percentage,small percentage,4
1315,previously healthy people,previously healthy people,4
6213,h7n9 infections,taxon,4
4417,suitable animal model,taxon,4
1314,unusual characteristic feature,unusual characteristic feature,4
4415,barrier,barrier,4
6229,new patients,new patients,4
4412,recipients,recipients,4
4410,immunosuppressed people,immunosuppressed people,4
1310,250 000 500 000 people,250 000 500 000 people,4
1307,284 000 deaths,284 000 deaths,4
6246,medical professional,medical professional,4
4404,increased rate,increased rate,4
4402,leading cause,leading cause,4
1757,12 april,12 april,4
6257,759 infections,759 infections,4
4396,vertical transmission rate,vertical transmission rate,4
1305,estimated 500 million people,estimated 500 million people,4
6201,average chinese citizens,average chinese citizens,4
4427,questions,questions,4
6199,current disease outbreak,current disease outbreak,4
6198,urgency,urgency,4
1744,s actions,s actions,4
6149,china transparency,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",4
6156,spite,spite,4
4442,inbred mice,inbred mice,4
4438,humanized mice,humanized mice,4
4437,engineering process,engineering process,4
4436,chimeric mice,chimeric mice,4
6172,china s agriculture ministry defended china s agriculture ministry policy],"sovereign state socialist state secular state constitutional republic country ""peoples republic""sovereign state socialist state secular state constitutional republic country ""peoples republic""",4
6173,china s agriculture ministry policy,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",4
6174,largescale vaccination,largescale vaccination,4
6262,world s leading experts onavianflureportedthatwhile,world s leading experts onavianflureportedthatwhile,4
6177,china s agriculture ministry defendedchina sagricultureministrypolicyoflargescalevaccinationofpoultryagainsttheearlierbirdflustrainsayingthatchina sagricultureministrywasnotinterferingwith china s agriculture ministry efforts],"sovereign state socialist state secular state constitutional republic country ""peoples republic""sovereign state socialist state secular state constitutional republic country ""peoples republic""",4
6179,riwi corporation,riwi corporation,4
1746,outbreak cycle,outbreak cycle,4
4434,technique,technique,4
6184,24.08% response rate,24.08% response rate,4
6185,20 hours,20 hours,4
4430,aspect,aspect,4
4429,body s response,body s response,4
4428,questions accuracy,questions accuracy,4
6191,52%,52%,4
6194,zhengzhou,zhengzhou,4
6178,china s agriculture ministry efforts nowtoidentify,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",4
6729,main ways,main ways,4
6269,worldwide outbreak,worldwide outbreak,4
4394,1–8%,1–8%,4
1281,high poultry density,organisms known particular common,4
1280,immediate causes,immediate causes,4
1279,causes,causes,4
6356,h18n11,h18n11,4
6360,approximately 36 000 deaths,approximately 36 000 deaths,4
6364,290 000–645 000 deaths,290 000–645 000 deaths,4
6365,previous estimates,previous estimates,4
4344,biopsy,biopsy,4
1775,directorgeneral,directorgeneral,4
1777,bmj feature,scientific journal open-access journal medical journal,4
1271,howrah,municipal corporation west bengal city millions inhabitants,4
4336,recombinant immunoblot,recombinant immunoblot,4
4335,immunoblot,immunoblot,4
6386,outside,outside,4
4334,rna,structural class chemical compounds,4
4333,hcv rna polymerase chain reaction,structural class chemical compoundsgroup class enzymes,4
4332,recombinant immunoblot assay,recombinant immunoblot assay,4
6393,host s antibodies canbindandtrigger,family protein complexes,4
1778,editorial,editorial,4
6401,different singlestranded nucleic acid,different singlestranded nucleic acid,4
6403,single piece,single piece,4
4354,hepatic fibrosis,hepatic fibrosis,4
1772,performance.in june,performance.in june,4
6347,issue,issue,4
4356,canada status,varies state/province census january 2015 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2016,4
1302,500 million people,500 million people,4
6284,shanghai s health ministry],city direct-controlled municipality national central city big city city millions inhabitants,4
6285,shanghai s health ministry orderedcullingof,city direct-controlled municipality national central city big city city millions inhabitants,4
6290,5 years,5 years,4
1761,declaration,declaration,4
4381,unclear evidence,unclear evidence,4
6296,great economic loss,great economic loss,4
4378,graft,graft,4
6304,breeding ground,breeding ground,4
6306,distinct lineages,distinct lineages,4
6270,protective immune responses,protective immune responses,4
4374,12 weeks,12 weeks,4
4369,liver scarring,organ type,4
6321,distinct antigenic groups,distinct antigenic groups,4
6323,current prevalence,current prevalence,4
6327,antigenic areas,antigenic areas,4
6328,multiple amino acid positions,multiple amino acid positions,4
6332,multiple genotypes,multiple genotypes,4
6336,siddique s,siddique s,4
4359,injection drug users,injection drug users,4
1285,high risk,high risk,4
1770,s handling,s handling,4
6316,secondary infections,secondary infections,4
1185,gallfoods,gallfoods,4
1184,possibility,possibility,4
1183,bernard matthews bin,bernard matthews bin,4
1106,10 surveillance zone,10 surveillance zone,4
4050,single greatest cause,single greatest cause,4
4049,2%,2%,4
1103,3 february,3 february,4
4046,1990s,1990s,4
4045,western world,western world,4
7091,placebo,placebo,4
1098,dead birds,dead birds,4
4044,new infections,new infections,4
7097,kilogram,kilogram,4
4041,20 years,20 years,4
7101,nac,nac,4
7102,cytopathic effects,cytopathic effects,4
1094,1 february,1 february,4
7104,dna fragmentation,dna fragmentation,4
1092,tuesday,tuesday,4
7111,imprudent,imprudent,4
7114,cytokinerelated risks,cytokinerelated risks,4
1090,plant,plant,4
4037,southern latin america,southern latin america,4
1855,contact,contact,4
4051,infectious death,stock character psychopomp literary character,4
7074,8.4 million units,8.4 million units,4
1108,159 000 turkeys,159 000 turkeys,4
7072,256 units,256 units,4
7029,folic acid,folic acid,4
1121,6 february,6 february,4
7032,respiratory infections,respiratory infections,4
4072,1.7 million new infections,1.7 million new infections,4
4071,950 000 people,950 000 people,4
4068,improperly sterilized glass syringes,improperly sterilized glass syringes,4
1846,workplaces,workplaces,4
7045,possible benefit,possible benefit,4
4065,high prevalence,high prevalence,4
7047,high lactoferrin whey protein,high lactoferrin whey protein,4
1087,large cull,large cull,4
3232,deadly filovirus infections,deadly filovirus infections,4
4060,merck sharp,merck sharp,4
1113,action,action,4
4059,large procurement exercise,large procurement exercise,4
7059,shortcomings,shortcomings,4
1110,5 february,5 february,4
7064,14 000 subjects,14 000 subjects,4
7067,high dose,high dose,4
7068,newcastle disease,newcastle disease,4
1109,evening,evening,4
7070,high doses,high doses,4
7050,elenolic acid,elenolic acid,4
7024,ecuador,ecuador,4
7120,andrographis paniculata,andrographis paniculata,4
7128,high dietary intake,high dietary intake,4
7173,severe allergy,severe allergy,4
7174,previous versions,previous versions,4
7177,middle layer,middle layer,4
1076,occurrence,occurrence,4
7180,largescale availability,largescale availability,4
1075,2007 bernard matthews h5n1 outbreak,subtype,4
7188,healthy children,healthy children,4
7192,recommendations,recommendations,4
4010,undetectable levels,undetectable levels,4
7198,announcement,announcement,4
7202,nonhumans,nonhumans,4
7205,costeffectiveness,costeffectiveness,4
4007,detectable rna,structural class chemical compounds,4
7210,key assumptions,key assumptions,4
7211,economic evaluations,economic evaluations,4
4003,slower rate,slower rate,4
7218,healthy working adults,healthy working adults,4
7219,2012 review,2012 review,4
1861,travellers,travellers,4
7224,interventions,interventions,4
3998,advanced liver disease,organ type,4
7172,million doses,million doses,4
7171,older people,older people,4
7168,certain years,certain years,4
7167,tiredness,tiredness,4
4030,acute infections,acute infections,4
7130,high levels,high levels,4
4029,16 000 people,16 000 people,4
4027,400 000 people,400 000 people,4
7134,regular dietary intake,regular dietary intake,4
4026,1.75 million people,1.75 million people,4
7137,tcell function,tcell function,4
4025,71 million people,71 million people,4
1081,holton,holton,4
1080,bernard matthews farms,bernard matthews farms,4
4031,196 000 deaths,196 000 deaths,4
4021,higher rate,higher rate,4
1079,2007 bernard matthews h5n1 outbreak affected poultry,subtypeorganisms known particular common,4
7154,high protection,high protection,4
7155,medical visits,medical visits,4
7158,high quality research,high quality research,4
1078,30 january,30 january,4
7160,yearly vaccination,yearly vaccination,4
7161,nearly people,nearly people,4
7162,high risk groups,high risk groups,4
1860,china s antiflu measures andwarned,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",4
7166,feelings,feelings,4
7147,average casefatality rate,average casefatality rate,4
6136,19 64 years,19 64 years,4
4078,people infection,people infection,4
7019,chloroquine,chemical compound medication essential medicine,4
6805,professionally vetted search engine,professionally vetted search engine,4
4159,detectable viral replication,detectable viral replication,4
6810,canada followsthewho scategoriesbuthasexpanded s categories],varies state/province census january 2015 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2016,4
6811,s categories,s categories,4
4157,young people,young people,4
4156,affected people,affected people,4
1168,connection,connection,4
1167,investigation,investigation,4
4155,10–50%,10–50%,4
6824,host immune responses,host immune responses,4
6826,main goal,main goal,4
6833,technology,academic discipline,4
6834,speedier mass production,speedier mass production,4
6839,speedy mass vaccinations,speedy mass vaccinations,4
4143,4–12 weeks,4–12 weeks,4
4141,acute symptoms,acute symptoms,4
1830,h1n1 outbreak,virus,4
6858,wild bird s lpai wouldmutatein,taxon,4
1155,processing plant,processing plant,4
6863,hope,hope,4
4134,potential new treatments,potential new treatments,4
1171,directions,directions,4
4161,initial decades,initial decades,4
6793,$100 million dhhs initiative,$100 million dhhs initiative,4
6791,fforts,fforts,4
6743,pill form,pill form,4
4177,excess alcohol,excess alcohol,4
6750,750 million doses,750 million doses,4
1180,government s cobra emergency committee indicatedthat,government s cobra emergency committee indicatedthat,4
6752,large quantities,large quantities,4
6754,32 million doses,32 million doses,4
6757,indonesia citizens,sovereign state archipelagic state constitutional republic island nation presidential régime country,4
6759,10 percent,10 percent,4
6764,single injection,single injection,4
6765,weak immune response,weak immune response,4
6867,expenditures,expenditures,4
4174,schistosoma,schistosoma,4
6769,54%,54%,4
6771,900 million doses,900 million doses,4
4173,30 years,30 years,4
4172,10–30%,10–30%,4
6776,as03,immunologic adjuvant,4
4169,27%,27%,4
4167,fatty,fatty,4
6786,5–150 million people,5–150 million people,4
6787,march 2005 plan,march 2005 plan,4
4164,late relapses,late relapses,4
6768,provided protection,provided protection,4
1123,12 february,12 february,4
6874,world s ability tokeeph5n1containedlimiting,world s ability tokeeph5n1containedlimiting,4
4124,insurance people,insurance people,4
6963,age groups,age groups,4
1135,holes,holes,4
6968,informed consent,informed consent,4
6972,45 micrograms,45 micrograms,4
6977,today s approval bythefdafollowsafebruary27recommendationbyan,today s approval bythefdafollowsafebruary27recommendationbyan,4
6978,february 27 recommendation,february 27 recommendation,4
1130,company s attention,company s attention,4
6983,90microgram doses,90microgram doses,4
6984,103 healthy adults,103 healthy adults,4
4093,alter,alter,4
6986,national stockpile,national stockpile,4
1129,holton plant,holton plant,4
6992,classes,classes,4
1126,highly critical report,highly critical report,4
7000,june 2009 issue,june 2009 issue,4
7001,nature biotechnology,nature biotechnology,4
7002,urgent need,urgent need,4
7003,augmentation,augmentation,4
7004,stockpiles,stockpiles,4
7008,scenario,scenario,4
4079,infected people infection,infected people infection,4
6962,6.5 million people,6.5 million people,4
6960,13 million doses,13 million doses,4
4100,lasker award,lasker award,4
6947,new facility,new facility,4
6896,protein sciences corporation,protein sciences corporation,4
6898,new pathways,new pathways,4
1836,healthy adults,healthy adults,4
1148,commons,commons,4
6904,morpholino oligomers,morpholino oligomers,4
4120,30 000 cad,30 000 cad,4
1146,david miliband,david miliband,4
4118,average lifetime cost,average lifetime cost,4
1143,8 february,8 february,4
6910,peptides,peptides,4
6884,medimmune s live attenuated vaccine technology],business,4
6912,new jerseybased biotechnology company,new jerseybased biotechnology company,4
6922,soil,soil,4
1140,22 february,22 february,4
6927,production process,production process,4
6930,27 eu countries,27 eu countries,4
6931,novartis s optaflu vaccine,business multinational corporation,4
6932,3 400 people,3 400 people,4
6937,licensing,licensing,4
6940,$600 million plant,$600 million plant,4
4105,coinventor,coinventor,4
6945,50 million doses,50 million doses,4
4117,individual,individual,4
4462,immediate mediterranean region,immediate mediterranean region,4
6121,recombinant baculovirus,recombinant baculovirus,4
1340,popular assumption,popular assumption,4
5381,1889 1900 outbreak,1889 1900 outbreak,4
5385,ultimate source,ultimate source,4
1655,person,person,4
5388,person s hands,person s hands,4
1658,december 2009 study,december 2009 study,4
5405,mismatch,mismatch,4
5407,field,field,4
5408,incubation period,incubation period,4
5413,appropriate control measures,appropriate control measures,4
5414,diseases,diseases,4
5415,long incubation periods,long incubation periods,4
5425,mucosal layer,mucosal layer,4
4758,true casefatality rate,true casefatality rate,4
5432,new virions,new virions,4
5448,nasopharyngeal large rise,nasopharyngeal large rise,4
1508,cdc s advisory committee,cdc s advisory committee,4
1507,cdc s advisory committee],cdc s advisory committee],4
5454,epiphora,epiphora,4
1661,past pandemics,past pandemics,4
5459,muscle soreness,muscle soreness,4
4740,casefatality rate,casefatality rate,4
5377,possible cause,possible cause,4
4778,6 000 health care workers,6 000 health care workers,4
5370,late 1980s,late 1980s,4
4780,widespread vaccinations,widespread vaccinations,4
1643,evidence,evidence,4
5280,13 000 samples,13 000 samples,4
5282,s global influenza surveillance network showed,infectious disease,4
4806,33% mortality rate,33% mortality rate,4
4805,zero mortality rate,zero mortality rate,4
5299,antiserum,antiserum,4
1647,pulmonary conditions,pulmonary conditions,4
5309,750 000 humans,infectious disease france,4
5311,91%,91%,4
1535,zanamivir,chemical compound neuraminidase inhibitor medication,4
5461,period infectivity,period infectivity,4
1649,severe outcome,severe outcome,4
5318,estimated 500 000 hong kong residents,estimated 500 000 hong kong residents,4
5319,low death rate,stock character psychopomp literary character,4
5332,fda s vaccines,fda s vaccines,4
4789,substantially greater affinity,substantially greater affinity,4
1530,48 hours,48 hours,4
5361,present day lineages,present day lineages,4
4781,preemptive vaccination,preemptive vaccination,4
1527,severe cases,severe cases,4
5366,single lineage,single lineage,4
5367,0.8 amino acid substitutions,0.8 amino acid substitutions,4
5317,estimated million people,estimated million people,4
5275,past years,past years,4
5464,hpai,hpai,4
5469,imperfect disease surveillance systems,imperfect disease surveillance systems,4
1675,6,6,4
1677,canada,varies state/province census january 2015 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2016,4
5554,pa,pa,4
1678,canada national microbiology laboratory,varies state/province census january 2015 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2016,4
5560,minor sickness,minor sickness,4
5562,high mutation rate,high mutation rate,4
4690,6 000 people,6 000 people,4
4688,unconfirmed possibility,unconfirmed possibility,4
1483,priority groups,priority groups,4
5582,rapid production,rapid production,4
1482,initial doses,initial doses,4
1479,exchange,exchange,4
5590,transparency,transparency,4
5592,international partners,international partners,4
4685,origin outbreak hong kong china,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",4
4684,fewer casualties,fewer casualties,4
5599,departments,departments,4
1476,new variants,new variants,4
5603,detailed mutually coordinated onsite surveillance,detailed mutually coordinated onsite surveillance,4
5609,variant forms,variant forms,4
5614,sneezing,sneezing,4
5544,actual hpai example,actual hpai example,4
5540,egg production,egg production,4
5539,mild—decrease,mild—decrease,4
4707,handling,handling,4
5471,455 people,455 people,4
4736,34 000 100 000 people,34 000 100 000 people,4
5476,infected birds,infected birds,4
5479,worldrenowned virologist robert g. webster,worldrenowned virologist robert g. webster,4
5484,5 million 150 million people,5 million 150 million people,4
5488,large,large,4
5489,infected persons immune systems andwhether,infected persons immune systems andwhether,4
4729,9 million doses,9 million doses,4
4725,large disruptions,large disruptions,4
4724,60 000 estimated deaths,60 000 estimated deaths,4
5467,global hpai situation,global hpai situation,4
5499,million treatment courses,million treatment courses,4
5503,panzootic outbreak,panzootic outbreak,4
1500,effects,effects,4
1498,multiple employee absences,multiple employee absences,4
5513,200 million birds,200 million birds,4
5517,unknown questions,unknown questions,4
5520,chief,chief,4
5522,h5n1 s potential impact,subtype,4
5525,150 million people,150 million people,4
4710,troops,troops,4
5529,underestimations,underestimations,4
5501,million courses,million courses,4
4670,h3n1 infections,h3n1 infections,4
4815,s case count isclearlythemostauthoritative,s case count isclearlythemostauthoritative,4
5269,estimated 36 000 people,estimated 36 000 people,4
4899,planning reports,planning reports,4
5039,small fraction,small fraction,4
5044,developing complications,developing complications,4
5046,physical changes,physical changes,4
5047,h1n1 infection immune,virus,4
5054,1 october,1 october,4
5057,short term adverse effects,short term adverse effects,4
4889,overall fatality rate,overall fatality rate,4
5065,new jersey,new jersey,4
5066,19 january,19 january,4
1587,great majority,great majority,4
1586,autumn,autumn,4
5082,2012 india outbreak,dominion british empire sovereign state historical country,4
5083,300 infections,300 infections,4
5085,india s health ministry],dominion british empire sovereign state historical country,4
5086,india s health ministry declared,dominion british empire sovereign state historical country,4
5087,2015 india outbreak,dominion british empire sovereign state historical country,4
4886,highly lethal second waves,highly lethal second waves,4
5090,1 895 people,1 895 people,4
5092,2017 maldives outbreak,2017 maldives outbreak,4
5094,501 people,501 people,4
1593,throat,throat,4
4901,levels,levels,4
5021,healthy mallards,healthy mallards,4
1599,external links,external links,4
4940,haemagglutinin molecule,haemagglutinin molecule,4
4946,exceptionally high virulence,exceptionally high virulence,4
4951,additional virulence factor,additional virulence factor,4
4952,total rate,total rate,4
4954,virulence factors,virulence factors,4
4958,rapid slow evolution,rapid slow evolution,4
1615,previously unhealthy individuals,previously unhealthy individuals,4
4966,ultimate outcome,ultimate outcome,4
1613,immediate respiratory support,immediate respiratory support,4
4970,reverse dna techniques,reverse dna techniques,4
5095,education,education,4
4986,ns5b rna polymerase inhibitor,structural class chemical compoundsgroup class enzymes,4
4990,mers,mers,4
4993,heterocycle,heterocycle,4
4994,class,class,4
4923,prepandemic virulence,prepandemic virulence,4
4922,initial lethality,initial lethality,4
4921,accurate projection,accurate projection,4
4911,severity rate,severity rate,4
4910,assumed contraction rate,assumed contraction rate,4
4909,accurate guess,accurate guess,4
5016,reported h10n7 outbreak,reported h10n7 outbreak,4
4926,far lower 12% lethality rate,far lower 12% lethality rate,4
1640,mainly asthma,mainly asthma,4
4885,50 million 100 million people,50 million 100 million people,4
5102,2017 myanmar outbreak,sovereign state country,4
1563,290 000–650 000 deaths,290 000–650 000 deaths,4
1562,3–5 million people,3–5 million people,4
5173,earliest documented outbreak,earliest documented outbreak,4
5175,public domain material,public domain material,4
1561,severe illness,severe illness,4
5193,overall mortality rate,overall mortality rate,4
5203,private contractor meridian bioscience,private contractor meridian bioscience,4
1557,comparisons pandemics epidemics,comparisons pandemics epidemics,4
1635,high dependency,high dependency,4
1556,2009 outbreak,2009 outbreak,4
4836,50 years,50 years,4
1554,epidemiology,branch science,4
4835,cytokine storm,cytokine storm,4
5231,surrogate model,surrogate model,4
5235,severe pneumonia,cause death infectious disease,4
1637,36%,36%,4
5243,interleukin,group class proteins,4
4827,higher case fatality rate,higher case fatality rate,4
5253,larger outbreak,larger outbreak,4
4820,occasional reports,occasional reports,4
5259,h3n1,h3n1,4
5168,6 cities,6 cities,4
1564,41 400 people,41 400 people,4
5161,close contact,close contact,4
5160,important intervention,important intervention,4
4877,actual rate,actual rate,4
1628,hospitalisation,hospitalisation,4
5109,international assistance,international assistance,4
5110,2017–18 pakistan outbreak,sovereign state country,4
5111,h1n1 cases,virus,4
1577,threequarters,threequarters,4
5115,2019 malta outbreak,religious minority major religious group,4
5116,european union member state,european union member state,4
5118,island s main state hospital overcrowdedwithin,island s main state hospital overcrowdedwithin,4
5120,2019 morocco outbreak,2019 morocco outbreak,4
4881,grim backdrop,grim backdrop,4
5121,morocco,morocco,4
5127,4 000 people,4 000 people,4
5132,2020 peerreviewed paper,2020 peerreviewed paper,4
5133,proceedings,proceedings,4
5135,sciences,sciences,4
4867,needed immune function,needed immune function,4
1571,global pandemics,global pandemics,4
5146,400 000 tests,400 000 tests,4
5149,30 000 swine,swine disease,4
5154,230 people,230 people,4
5159,ecdc,ecdc,4
5122,confirmed fatalities,confirmed fatalities,4
3996,reduced doses,reduced doses,4
4669,serologic evidence,serologic evidence,4
4668,known outbreak,known outbreak,4
5939,chinese new year feasts,chinese new year feasts,4
5941,96 confirmed reports,96 confirmed reports,4
5943,outbreak s overall total],outbreak s overall total],4
5944,outbreak s overall total was419including7in,outbreak s overall total was419including7in,4
5954,2013 outbreak,2013 outbreak,4
5960,zhejiang province,zhejiang province,4
5963,probably wild birds,probably wild birds,4
5966,european lineages,european lineages,4
4522,related species,related species,4
5968,s assistant directorgeneral],s assistant directorgeneral],4
5969,s assistant directorgeneral,s assistant directorgeneral,4
5972,new territory,new territory,4
5974,simplydon tknow,simplydon tknow,4
1727,mexico city,state mexico,4
4517,mutation rate,mutation rate,4
5978,600 people,600 people,4
5979,past 10 years,past 10 years,4
5981,thing sdifferentbetween 600 people,thing sdifferentbetween 600 people,4
5986,stillhasawaystogobeforeitbecomeslikeahumanvirusbutthefactisit ssomewherein middle ground,stillhasawaystogobeforeitbecomeslikeahumanvirusbutthefactisit ssomewherein middle ground,4
5987,middle ground,middle ground,4
4515,overall evolution rate,overall evolution rate,4
5936,winter months,winter months,4
5929,h7n9,taxon,4
5927,outbreak report,outbreak report,4
4539,life cycle,life cycle,4
5879,25 february,25 february,4
5882,kantō region,kantō region,4
5884,migratory species,migratory species,4
5885,himachal pradesh,himachal pradesh,4
5886,rajasthan,rajasthan,4
5887,madhya pradesh,madhya pradesh,4
4560,forms,forms,4
5889,40 000 domestic birds,40 000 domestic birds,4
5890,kuttanad region,kuttanad region,4
5891,2 700 migratory birds,2 700 migratory birds,4
5989,mutant forms,mutant forms,4
5892,barheaded geese,barheaded geese,4
1713,doses,doses,4
4556,hdv replication,hdv replication,4
4554,rna polymerase ii,structural class chemical compoundsgroup class enzymes,4
5902,7 million poultry,organisms known particular common,4
4553,host cellular rna polymerases,structural class chemical compounds,4
5904,february 17th,february 17th,4
1715,2009 review,2009 review,4
5914,high pathogenicity,high pathogenicity,4
1717,2009 h1n1 vaccine,virus,4
4545,9–15,9–15,4
5895,dead edible ducks,dead edible ducks,4
5878,5 november,5 november,4
1376,26 april,26 april,4
5995,blood poisoning,biogenic substance type,4
6064,possible reasons,possible reasons,4
6066,female relationship,female relationship,4
6067,median age,median age,4
6068,584 years,584 years,4
1359,asthma,asthma,4
6075,age distribution,age distribution,4
6078,possible greater biological susceptibility,possible greater biological susceptibility,4
6079,severe outcomes,severe outcomes,4
6085,immune responses,immune responses,4
6086,immune phenomenon,immune phenomenon,4
4476,%,%,4
4474,benefit,benefit,4
4472,latest evidence,latest evidence,4
1351,sore throat,sore throat,4
1349,muscle,muscle,4
6107,china s national institute],"sovereign state socialist state secular state constitutional republic country ""peoples republic""",4
6108,china s national institute,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",4
4466,s dependence,s dependence,4
1346,small region,small region,4
6113,widespread vaccination,widespread vaccination,4
4463,20 million people,20 million people,4
4486,major medical scourge,major medical scourge,4
6062,h7n9infected patients,h7n9infected patients,4
1363,weakened immune,weakened immune,4
6060,unusual prevalence,unusual prevalence,4
4513,substitution rate,substitution rate,4
5997,new england journal,nation uk cultural area country,4
1375,especially high risk,especially high risk,4
6004,pigeons,pigeons,4
4509,african origin,african origin,4
6010,dissemination,dissemination,4
6011,great concern,great concern,4
1731,little scientific evidence,little scientific evidence,4
6029,potential channel,potential channel,4
4497,pathogen,pathogen,4
5992,highly transmissible deadly forms,highly transmissible deadly forms,4
6036,past,past,4
4493,severe liver disease,organ type,4
6043,100 people,100 people,4
6044,unusually high rate,unusually high rate,4
6047,world health organization s assistant directorgeneral],world health organization s assistant directorgeneral],4
6048,world health organization s assistant directorgeneral,world health organization s assistant directorgeneral,4
6052,new cases,new cases,4
1734,redefined pandemics,redefined pandemics,4
6056,reported mortality rate,reported mortality rate,4
6057,city hospitals,city hospitals,4
6059,age/gender distribution,age/gender distribution,4
1732,cooperation,cooperation,4
5625,virulence,virulence,4
1712,19 november,19 november,4
5873,22 700 birds,22 700 birds,4
1691,current h1n1 outbreak,virus,4
1440,previous vaccinations,previous vaccinations,4
5722,41 000 birds,41 000 birds,4
5723,accentuated virulence,accentuated virulence,4
5726,minor outbreak,minor outbreak,4
5729,25 000 turkeys,25 000 turkeys,4
1437,november 2009 study,november 2009 study,4
4627,agitation,agitation,4
5737,43 million birds,43 million birds,4
5740,nation s largest egg producer],nation s largest egg producer],4
4623,sudden onset,sudden onset,4
5751,biological heat treatment,biological heat treatment,4
1695,summer lull,summer lull,4
4617,rondônia,federative unit brazil,4
4616,amazonas,amazonas,4
4612,lábrea,municipality brazil,4
4610,lábrea fever,municipality brazil,4
5771,2017,2017,4
4606,sureau s study provided,sureau s study provided,4
4605,jaoudé,jaoudé,4
5775,2020,2020,4
5717,single farm,single farm,4
5716,h5n2 outbreak,h5n2 outbreak,4
5710,documented occurrence,documented occurrence,4
5707,5.7 million birds,5.7 million birds,4
5635,z,z,4
5638,new isolates,new isolates,4
4664,million people,million people,4
5642,ducks,ducks,4
5645,1961.genotype z,1961.genotype z,4
5651,birds death,stock character psychopomp literary character,4
5652,transmission host range,transmission host range,4
5654,0 °c,0 °c,4
1461,figures,figures,4
5665,noses,noses,4
5778,china s sichuan province.25 000 birds wereculledin,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",4
5671,affected birds,affected birds,4
5680,japan s health ministry saidin,sovereign state island nation country,4
1456,10 000 deaths,10 000 deaths,4
5686,russian ministry,russian ministry,4
5688,660 000 birds,660 000 birds,4
1455,200 000 hospitalisations,200 000 hospitalisations,4
4647,steatosis,steatosis,4
4644,infected patients,infected patients,4
4643,collaborators,collaborators,4
5702,antih5 antibody,family protein complexes,4
4642,pará,federative unit brazil,4
5676,falcon,falcon,4
5875,22 october,22 october,4
5779,philippines poultry outbreak,organisms known particular common,4
1701,preparations,preparations,4
5837,800 000 birds,800 000 birds,4
5839,3.5 million birds,3.5 million birds,4
1407,nikki shindo,nikki shindo,4
5843,february 2017,february 2017,4
5846,16 march,16 march,4
5847,june 2017,june 2017,4
5851,irvine s private limited],irvine s private limited],4
5852,7 000 birds,7 000 birds,4
5853,140 000 birds,140 000 birds,4
4573,largehdag,largehdag,4
5855,separate outbreak,separate outbreak,4
5858,25 000 birds,25 000 birds,4
5860,december 2017,december 2017,4
5861,20 december,20 december,4
5864,alahsa,alahsa,4
1398,high rate,high rate,4
5867,dharma,dharma,4
5868,mazahmiya,mazahmiya,4
5869,cull,cull,4
5870,100 000 birds,100 000 birds,4
5871,12 locations,12 locations,4
5836,january 2017,january 2017,4
5835,800 000 chickens,chicken gallus gallus domesticus common,4
5834,record 18.4 million birds,record 18.4 million birds,4
4581,cellular enzymes,cellular enzymes,4
5788,highly pathogenic h1n1,virus,4
5789,walker ja,walker ja,4
5799,close proximity,close proximity,4
5800,8 000 turkeys,8 000 turkeys,4
5802,270 000 ducks,270 000 ducks,4
1413,new test,new test,4
5804,2014,2014,4
5805,breeding ducks,breeding ducks,4
5808,12 million poultry,organisms known particular common,4
5811,october 2016,october 2016,4
5782,seven people,seven people,4
5812,27 october,27 october,4
4588,s region,s region,4
5818,26 november 190 000 ducks,26 november 190 000 ducks,4
5820,december 2016,december 2016,4
5821,16 december,16 december,4
5822,tetney,tetney,4
1706,24 october,24 october,4
5825,5 000 turkeys,5 000 turkeys,4
5828,december official delegations,december official delegations,4
5830,china s ministry,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",4
4582,virus’ life cycle,virus’ life cycle,4
5814,wild swan,wild swan,4
7234,immunological basis,immunological basis,4
4064,particularly high rates,particularly high rates,4
7239,high efficacy,high efficacy,4
8368,new evidence,new evidence,4
747,english contract law,english contract law,4
3547,nih s drug discovey arm,nih s drug discovey arm,4
8378,new information,new information,4
8380,common adverse drug reactions,common adverse drug reactions,4
3546,nih s drug discovey arm],nih s drug discovey arm],4
8382,22 adult people,22 adult people,4
8387,oseltamivir s effect ontheheartisunclear:,chemical compound neuraminidase inhibitor medication essential medicine,4
744,pathology,pathology,4
743,terrains,terrains,4
8395,seizure,seizure,4
3539,remdesivir s predominant metabolite circulatingin,chemical compound prodrug antiviral drug,4
8397,haemorrhagic colitis,haemorrhagic colitis,4
8398,eu package inserts,eu package inserts,4
8400,psychiatric effects,psychiatric effects,4
3531,pharmacodynamics,pharmacodynamics,4
8412,single amino acid residue substitutions,single amino acid residue substitutions,4
8415,pooled incidence rate,pooled incidence rate,4
8417,especially h1n1,virus,4
8424,active form,active form,4
3520,medkoo,specialty,4
8367,model list,model list,4
8365,eml,eml,4
750,reading,reading,4
8362,oseltamivir s riskbenefit ratio wasmovedfromthecoretothecomplementarylistbasedonoseltamivir sriskbenefitratio lower costeffectiveness,chemical compound neuraminidase inhibitor medication essential medicine,4
8306,70% ethanol,70% ethanol,4
8307,aldehydes,aldehydes,4
3565,high point,high point,4
3562,reference,reference,4
3561,multiple species,multiple species,4
759,small doses,small doses,4
8321,seal,seal,4
758,phenazone,chemical compound medication,4
8324,early age,early age,4
8326,reduced rate,reduced rate,4
1980,3.1%,3.1%,4
756,standard treatment,standard treatment,4
8341,2014 cochrane review,2014 cochrane review,4
8342,metaanalyses,metaanalyses,4
8343,little evidence,little evidence,4
8344,high risk populations,high risk populations,4
8348,small number,small number,4
3552,multiple preclinical species,multiple preclinical species,4
8351,essential medicines,essential medicines,4
8355,8 million prescriptions,8 million prescriptions,4
8358,critically ill people,critically ill people,4
8359,oseltamivir s riskbenefit ratio wasmovedfrom,chemical compound neuraminidase inhibitor medication essential medicine,4
1972,2009 h1n1 infection,virus,4
1965,america,america,4
8427,1–3 hours,1–3 hours,4
3518,high purity,high purity,4
8485,cochrane study,cochrane study,4
8486,intensive care units,intensive care units,4
708,25 december,25 december,4
3495,gilead sciences efficacy,gilead sciences efficacy,4
8492,healthy people,healthy people,4
3494,affected cats,affected cats,4
8498,0.5–1.0 day,0.5–1.0 day,4
3492,black market,black market,4
8500,vomiting.the 2014 cochrane review,vomiting.the 2014 cochrane review,4
8502,small benefit,small benefit,4
702,18 december,18 december,4
8508,exposed people,exposed people,4
700,dublin,capital big city administrative city republic ireland,4
8513,healthy lowrisk persons,healthy lowrisk persons,4
8514,unvaccinated high risk persons,unvaccinated high risk persons,4
3488,gilead sciences s refusal tolicense,gilead sciences s refusal tolicense,4
3486,lethal coronavirus disease,group class strains strain,4
3482,feline infectious peritonitis,feline infectious peritonitis,4
8525,resistant h1n1,virus,4
3476,gilead sciences,gilead sciences,4
8536,18% resistance rate,18% resistance rate,4
709,san francisco,san francisco,4
3499,sarscov2,sarscov2,4
3501,ease,ease,4
712,mexico,state mexico,4
8430,shikimic acid,shikimic acid,4
733,median time,median time,4
8432,chinese star anise,chinese star anise,4
8433,30%,30%,4
8434,gilead sciences relevant patents,gilead sciences relevant patents,4
732,12 january,12 january,4
8438,lower respiratory tract infections,lower respiratory tract infections,4
731,week,week,4
729,1 december,1 december,4
725,china,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",4
8428,active carboxylate metabolite,active carboxylate metabolite,4
3509,gilead,gilead,4
8452,cochrane review,cochrane review,4
3508,dhhs,dhhs,4
8457,india s court allowing,dominion british empire sovereign state historical country,4
720,indonesia,sovereign state archipelagic state constitutional republic island nation presidential régime country,4
8461,antiflu,antiflu,4
8463,hospitalization time,hospitalization time,4
8466,small intestine,small intestine,4
714,2 february,2 february,4
8470,highrisk people,highrisk people,4
8475,infectious disease society,infectious disease society,4
723,new zealand,new zealand,4
8544,h274y n294s mutations,h274y n294s mutations,4
3570,2 hours,2 hours,4
3571,longer half life,longer half life,4
8077,university s drug innovation company,university s drug innovation company,4
822,physical stress,physical stress,4
3664,78%,78%,4
820,underlying conditions,underlying conditions,4
8086,previous company,previous company,4
8087,pharmasset,business,4
8088,drug s active ingredient hadabandoned,drug s active ingredient hadabandoned,4
8089,drug s active ingredient weredeniedby,drug s active ingredient weredeniedby,4
3654,position,position,4
8100,healthy volunteers,healthy volunteers,4
8101,small numbers,small numbers,4
1947,severe signs,severe signs,4
8107,december 3rd,december 3rd,4
3648,strong immune response,strong immune response,4
8118,narlaprevir,chemical compound,4
8120,infected host cells,infected host cells,4
8126,narlaprevir safety,chemical compound,4
3641,glaxosmithkline,public company,4
8129,narlaprevir activity,chemical compound,4
8138,narlaprevir safety profile,chemical compound,4
8139,narlaprevir pharmacokinetics,chemical compound,4
823,primarily elderly people,primarily elderly people,4
8074,viral rna replication,structural class chemical compounds,4
8073,errors,errors,4
8071,molnupiravir,chemical compound,4
1936,18 march,18 march,4
7997,private production,private production,4
3689,weakened killed form,weakened killed form,4
1938,outbreak mexico city,state mexico,4
8007,large domestic market,large domestic market,4
8008,export,export,4
8010,exclusive licenses,exclusive licenses,4
3685,infectious material,infectious material,4
842,case fatality rate,case fatality rate,4
840,mortality estimates,mortality estimates,4
8141,hepatology,hepatology,4
8021,medimmune s live,business,4
3676,infectious diseases,infectious diseases,4
3674,vietnam/1194/2004.national institute,vietnam/1194/2004.national institute,4
832,origin,origin,4
8048,modern treatment regimens,modern treatment regimens,4
8053,dna,dna,4
3669,european union s requirement,european union s requirement,4
8057,existing treatments,existing treatments,4
828,southern china,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",4
8062,merck,merck,4
3666,10microgram doses,10microgram doses,4
8027,mouse ferret models,mouse ferret models,4
763,cheaper treatments,cheaper treatments,4
8143,chief gastroenterologist,chief gastroenterologist,4
8153,700 million rubles,700 million rubles,4
3596,subclades,subclades,4
8242,segmented negativesense rna,structural class chemical compounds,4
1961,houston,houston,4
8252,replication cycle,replication cycle,4
3589,protection,protection,4
8256,sialic acid,sialic acid,4
8260,rnadependent rna polymerase,structural class chemical compoundsgroup class enzymes,4
3586,pharmacological effects,pharmacological effects,4
8266,golgi apparatus,golgi apparatus,4
8269,new viral genome particles,scientific model natural environment,4
8270,multiple actions,multiple actions,4
773,infectious spread,infectious spread,4
8277,rnadependent rna transcriptase,structural class chemical compounds,4
771,doctors,doctors,4
3580,blood levels,biogenic substance type,4
8282,sphere,sphere,4
8286,sialic acid residues,sialic acid residues,4
1964,infectious diseases society,infectious diseases society,4
8291,generaassociated species,generaassociated species,4
766,people alsothoughtthatfastingwouldstarve,people alsothoughtthatfastingwouldstarve,4
8295,single species,single species,4
8240,helical symmetry,helical symmetry,4
8239,ribonuclear proteins,group class chemical substances second-order class,4
1960,texas children s hospital inhoustontexaswasofatoddlerfrommexicocitywhowasvisitingfamilyinbrownsvilletexasbeforebeingairliftedto,state united states,4
8233,varying surface densities,varying surface densities,4
801,2002–2004 sars outbreak,2002–2004 sars outbreak,4
800,coronavirus,group class strains strain,4
3629,30 micrograms,30 micrograms,4
3627,new study,new study,4
8164,activation,activation,4
8169,statistical reports,statistical reports,4
3619,novavax s senior vice president,novavax s senior vice president,4
3618,novavax s senior vice president],novavax s senior vice president],4
8178,hallucinations,hallucinations,4
8181,flavivirus infections,flavivirus infections,4
806,betacoronavirus 1 species,betacoronavirus 1 species,4
3617,md,md,4
8195,p70,p70,4
792,h1n1,virus,4
8200,cterminal thirds,cterminal thirds,4
1957,30 march,30 march,4
3610,strong immune responses,strong immune responses,4
7237,controlled conditions,controlled conditions,4
8210,investigational new drug,investigational new drug,4
8213,multiple functions,multiple functions,4
8217,achillion pharmaceuticals,achillion pharmaceuticals,4
784,elderly people,elderly people,4
8192,improved treatments,improved treatments,4
8547,h1n1 vaccines,virus,4
8551,autoimmune disease,autoimmune disease,4
8553,constituents,constituents,4
8850,transgenic mice,transgenic mice,4
2031,november 10southkorea sagricultureministrysaid south korea s agriculture ministry],november 10southkorea sagricultureministrysaid south korea s agriculture ministry],4
2032,south korea s agriculture ministry said south korea s agriculture ministry],south korea s agriculture ministry said south korea s agriculture ministry],4
8855,myristic acid,myristic acid,4
3327,dogs,dogs,4
8862,picornavirus replication,taxon,4
8867,supergroup,supergroup,4
8869,animal pathogen,taxon,4
8870,foot mouth disease,foot mouth disease,4
591,spanish mainland,spanish mainland,4
8875,radalbuvir,carboxylic acid chemical compound,4
3318,cats,cats,4
8881,new combinations,new combinations,4
3317,indoors,indoors,4
588,spain s capital city,spain s capital city,4
8889,distinct segments,distinct segments,4
8890,rna act,structural class chemical compounds,4
3311,bioterrorism,bioterrorism,4
8903,updated guidelines,updated guidelines,4
8904,conditional recommendation,conditional recommendation,4
3305,mice,mice,4
596,season s poor harvests,season s poor harvests,4
8846,poliovirus receptor,taxon,4
8845,serotype,serotype,4
3333,asymptomatic shedding,asymptomatic shedding,4
8795,rna genomes,structural class chemical compounds,4
8797,rna rna,structural class chemical compoundsstructural class chemical compounds,4
8798,rna rna isunusualbecausernahasaproteinonthe5endthatisusedasaprimerfortranscriptionbyrnapolymerase.aprimerfortranscriptionby rna,structural class chemical compoundsstructural class chemical compoundsstructural class chemical compounds,4
610,plagues,plagues,4
8806,nonsegmented positivesense,nonsegmented positivesense,4
607,mass outbreak,mass outbreak,4
3350,wild domestic birds,wild domestic birds,4
8812,untranslated region,untranslated region,4
2025,western honshu,western honshu,4
8816,3 utr,3 utr,4
578,small cough,small cough,4
8818,5 utr isimportantin,5 utr isimportantin,4
8822,rna elements,structural class chemical compounds,4
8823,genomic rnas,genomic rnas,4
8824,multiple rna elements,structural class chemical compounds,4
602,region s physicians oftendistinguished region s physicians],region s physicians oftendistinguished region s physicians],4
601,flu symptoms couldbesointensethattheregion sphysiciansoftendistinguished region s physicians],influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,4
8831,rna replication,structural class chemical compounds,4
8833,rna synthesis,structural class chemical compounds,4
8837,secondary structural elements,secondary structural elements,4
3334,infected calves,infected calves,4
8840,rna structures,structural class chemical compounds,4
3343,great economic losses,great economic losses,4
8794,single stranded positive sense,single stranded positive sense,4
3304,species,species,4
576,roughness,roughness,4
8976,solution,solution,4
3267,current outbreak,current outbreak,4
2042,south korea s agriculture ministry reportedthath5n8hadbeenfoundinwildswansinshanxiprovincewhilenorwaydetectednorwayfirstcaseofthehighlypathogenic,south korea s agriculture ministry reportedthath5n8hadbeenfoundinwildswansinshanxiprovincewhilenorwaydetectednorwayfirstcaseofthehighlypathogenic,4
8981,10 minutes,10 minutes,4
3262,hung yen,hung yen,4
8989,potassium carbonate,potassium carbonate,4
8990,methanol,methanol,4
547,degrees,degrees,4
8999,new line,new line,4
3252,140 million birds,140 million birds,4
9002,multiple filoviruses,multiple filoviruses,4
3250,forced killing,forced killing,4
544,slight fever,slight fever,4
3246,june 10th,june 10th,4
9010,patents,patents,4
540,october,october,4
539,habsburg netherlands,habsburg netherlands,4
3245,mouse model,mouse model,4
535,january,january,4
9021,ingredients,ingredients,4
9025,production time,production time,4
3270,cambodia,sovereign state start time 9 november 1953 country constitutional monarchy,4
557,9th 14th day,9th 14th day,4
8967,triazin4amine,triazin4amine,4
2041,south korea s agriculture ministry],south korea s agriculture ministry],4
8917,new data,new data,4
3300,timeline,timeline,4
573,highly contagious catarrhal fever,highly contagious catarrhal fever,4
8921,supplemental oxygen,supplemental oxygen,4
8922,baricitinib,chemical compound medication,4
8923,common adverse effects,common adverse effects,4
3299,multiple bird species,taxon,4
8927,low potassium,low potassium,4
8931,reported adverse effects,reported adverse effects,4
8934,infusion site reactions,infusion site reactions,4
3303,laboratories,laboratories,4
8936,infusion‐related reactions,infusion‐related reactions,4
8938,possible effects,possible effects,4
567,severe bread shortage,severe bread shortage,4
8951,intracellular metabolic activation,intracellular metabolic activation,4
8952,multiple steps,multiple steps,4
3279,suggestive evidence,suggestive evidence,4
8954,right,right,4
561,city s residents,city s residents,4
8958,lalanine,lalanine,4
8960,triethylamine,triethylamine,4
3275,12 deaths,12 deaths,4
570,dry hot summer,dry hot summer,4
8792,baltimore s viral classification asgroupivvirusesas,baltimore s viral classification asgroupivvirusesas,4
3355,major new outbreak,major new outbreak,4
3356,thailand s poultry industry,constitutional monarchy sovereign state countryorganisms known particular common,4
8612,12 suspected cases,12 suspected cases,4
8614,agency s committee,agency s committee,4
3440,ingestion,ingestion,4
8616,finland,finland,4
8617,clear connection,clear connection,4
2001,22 000 birds,22 000 birds,4
669,november,november,4
3436,sick tigers,sick tigers,4
3434,thailand zoo tiger outbreak,constitutional monarchy sovereign state country,4
3433,high lethality,high lethality,4
3431,leopards,leopards,4
8632,body s immune response,body s immune response,4
3429,october 2004,october 2004,4
8636,severe effects,severe effects,4
3428,sunday,sunday,4
665,westernmost station,westernmost station,4
3425,southwestern kampong speu province,southwestern kampong speu province,4
2003,summer months,summer months,4
2004,wild birds,wild birds,4
3419,farmed birds,farmed birds,4
8662,irregular heartbeat,irregular heartbeat,4
8611,12 confirmed cases,12 confirmed cases,4
3442,infected cats,infected cats,4
8609,expected average annual occurrence,expected average annual occurrence,4
672,kiev,capital city special status 1991 city/town city millions inhabitants,4
3464,chairul anwar nidom,chairul anwar nidom,4
690,17 december,17 december,4
8561,10 years,10 years,4
8564,31 million people,31 million people,4
8567,renewal,renewal,4
3459,living cats,living cats,4
687,posen,posen,4
8571,glaxosmithkline s patient information leaflet,public company,4
8572,following effects,following effects,4
8573,adverse outcomes,adverse outcomes,4
8664,major mechanisms,major mechanisms,4
1996,4 february,4 february,4
3454,march 6 2006,march 6 2006,4
3452,february 28 2006,february 28 2006,4
8591,finnish national institute,finnish national institute,4
8592,possible effect,possible effect,4
8597,suspected adverse drug reaction,suspected adverse drug reaction,4
8599,reports concern children,reports concern children,4
8601,external experts,external experts,4
8602,possible relationship,possible relationship,4
673,lake baikal region,lake baikal region,4
8604,eu member states,eu member states,4
8579,18 400 doses,18 400 doses,4
3414,hk$50 000 months imprisonment,hk$50 000 months imprisonment,4
8666,jakstat signaling pathway,jakstat signaling pathway,4
3411,government s decision verydifficultfor,government s decision verydifficultfor,4
8738,cardiovirus,taxon,4
8740,picornavirus,taxon,4
625,severe wave,severe wave,4
3382,multiple continents,multiple continents,4
8744,coxsackievirus,coxsackievirus,4
8747,ribonucleic acid,ribonucleic acid,4
8749,small unit,small unit,4
3378,kuwait,city capital big city,4
8752,prototypic member,prototypic member,4
2020,multiple dead chickens,chicken gallus gallus domesticus common,4
629,battle,battle,4
3374,5 150 million people,5 150 million people,4
620,aid,aid,4
8764,infectious dna clone,infectious dna clone,4
8766,rna dependent rna polymerase,structural class chemical compoundsstructural class chemical compoundsgroup class enzymes,4
3369,migratory birds,migratory birds,4
3368,central china,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",4
3366,6 000 migratory birds,6 000 migratory birds,4
8774,acidic conditions,acidic conditions,4
8775,gastric acid,gastric acid,4
618,ottoman expansion,ottoman expansion,4
8782,protomer,protomer,4
3370,mongolia,sovereign state landlocked country country,4
7988,aviron,aviron,4
630,ottoman army s troops occupying,ottoman army s troops occupying,4
8723,picornaviruses,picornaviruses,4
3410,local government s decision makes government s decision],local government s decision makes government s decision],4
8680,p48,p48,4
647,march,march,4
3404,new regulation,new regulation,4
645,december,december,4
644,reported effects,reported effects,4
2011,netherlands,netherlands,4
3402,2 700 birds,2 700 birds,4
640,1 million people,1 million people,4
8694,previous study,previous study,4
8733,110 species,110 species,4
3400,poultry stall,organisms known particular common,4
2013,late october,late october,4
3395,country s 51st death,stock character psychopomp literary character,4
2016,320 000 birds,320 000 birds,4
8709,transitionstate analogue inhibitor,transitionstate analogue inhibitor,4
635,army s hold,army s hold,4
8713,ii,ii,4
8715,19 december,19 december,4
3390,china s health ministry hasconfirmed,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",4
3389,major outbreak,major outbreak,4
8720,primary endpoint,primary endpoint,4
8697,caspase3,caspase3,4
7983,people immune systems,people immune systems,4
1958,28 march,28 march,4
7976,acid,acid,4
7550,fluarix quadrivalent,fluarix quadrivalent,4
983,biological weapon,biological weapon,4
3865,host organism,host organism,4
7569,2009 h1n1,virus,4
7572,audenz,audenz,4
3862,relatively high mutation rate,relatively high mutation rate,4
7580,subject,subject,4
1898,azerbaijan,sovereign state start time 30 august 1991 18 october 1991 landlocked country administrative territorial entity,4
7542,lingering doubts,lingering doubts,4
7584,highly conserved m2 proton channel,highly conserved m2 proton channel,4
7587,single antibodies,family protein complexes,4
7588,target,target,4
1899,ban,ban,4
3851,small segment,small segment,4
7981,small amounts,small amounts,4
970,70%,70%,4
7600,developers,developers,4
969,morbidity rate,morbidity rate,4
7585,potential target,potential target,4
7605,sufficiently powerful enduring immune response,sufficiently powerful enduring immune response,4
7539,normal annual levels,normal annual levels,4
7524,cdc severe complications,cdc severe complications,4
3894,manischewitz j,manischewitz j,4
3891,simmons cp,simmons cp,4
3888,khurana s,khurana s,4
7494,new vaccines,new vaccines,4
7497,new victims,new victims,4
995,list,list,4
7502,ernest william goodpasture,ernest william goodpasture,4
994,700 000 people,700 000 people,4
991,100 000 population,100 000 population,4
3885,critical component,critical component,4
3883,pa codes,pa codes,4
7508,macfarlane burnet,macfarlane burnet,4
993,infected people,infected people,4
7514,hen s eggs continuedtobeusedtoproducevirususedininfluenzavaccinesbutmanufacturersmadeimprovementsinthepurityofinfluenza,hen s eggs continuedtobeusedtoproducevirususedininfluenzavaccinesbutmanufacturersmadeimprovementsinthepurityofinfluenza,4
3878,rna segment,structural class chemical compounds,4
7516,improved processes,improved processes,4
7517,egg proteins,group class chemical substances second-order class,4
3877,different reading frames,different reading frames,4
3884,pa protein,pa protein,4
968,cheyenne,cheyenne,4
967,high school,high school,4
7613,statistical difference,statistical difference,4
1910,selfinjury,selfinjury,4
7695,10 000 fold reduction,10 000 fold reduction,4
7700,interferon alpha2b,group class proteins,4
949,approximately 700 000 deaths,approximately 700 000 deaths,4
7704,crossspecies nature,crossspecies nature,4
7705,ifnα,ifnα,4
948,age,age,4
947,younger 25 26 years,younger 25 26 years,4
3820,unknown effects,unknown effects,4
3814,son,son,4
7711,typical scenario,typical scenario,4
943,70 000 116 000 people,70 000 116 000 people,4
3809,amino acid,amino acid,4
3805,sialic acid receptors,sialic acid receptors,4
7731,downstream signaling,downstream signaling,4
3803,26 sialic acid receptors,26 sialic acid receptors,4
1914,physical address,physical address,4
7736,stats,stats,4
3812,23 sialic acid receptors,23 sialic acid receptors,4
3824,human a/hk/212/03 a/hk/213/03 isolates,organisms known particular common homo sapiens homo sapiens sapiens homo,4
956,history outbreak,history outbreak,4
7682,multiple myeloma,multiple myeloma,4
7623,dry hacking cough,dry hacking cough,4
7624,vaccination schedules,vaccination schedules,4
1903,9 million pigs,9 million pigs,4
7633,strong immune reaction,strong immune reaction,4
963,mainland china,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",4
3841,na codes,na codes,4
7642,dr. cardona,dr. cardona,4
7650,human vaccines]. chickens forsixweeksbecausethat showlonghumanvaccines].chickenslivetillyoueathumanvaccines].chickens said dr. john j. treanor,organisms known particular common homo sapiens homo sapiens sapiens homochicken gallus gallus domesticus common,4
7653,rochester,rochester,4
3837,host range restriction,host range restriction,4
7659,nicholas savill,nicholas savill,4
7660,mathematical models,mathematical models,4
959,tianjin,direct-controlled municipality port settlement national central city big city city millions inhabitants,4
7664,protection levels,protection levels,4
7672,recombinant form,recombinant form,4
3833,low densities,low densities,4
3829,unique amino acid substitution,unique amino acid substitution,4
7679,behçet s disease],behçet s disease],4
7680,behçet s disease,behçet s disease,4
999,navapur,human settlement,4
7467,h1n1 h3n2 typeb strains,virussubtype,4
1890,hogs,hogs,4
7460,adverse reactions,adverse reactions,4
7298,inflammatory bowel disease,inflammatory bowel disease,4
7300,16%,16%,4
1050,main source,main source,4
7307,influenzarelated complications,influenzarelated complications,4
7308,moderate protection,moderate protection,4
1871,hotel,hotel,4
3968,hcv rna,structural class chemical compounds,4
7312,net benefit,net benefit,4
7296,tertiary referral center,tertiary referral center,4
1872,midjune india,dominion british empire sovereign state historical country,4
7319,2014 review,2014 review,4
7320,moderate evidence,moderate evidence,4
7326,highquality evidence,highquality evidence,4
3961,country s geography,country s geography,4
7331,multiple reasons,multiple reasons,4
3959,contaminated blood,biogenic substance type,4
7335,advanced age,advanced age,4
3958,percutaneous contact,percutaneous contact,4
7314,relationship,relationship,4
7294,healthy 5–18yearolds,healthy 5–18yearolds,4
1053,economic impact,economic impact,4
7291,0.25 milliliters,0.25 milliliters,4
7241,vaccinated people,vaccinated people,4
7248,repeated vaccinations,repeated vaccinations,4
7251,relevance,relevance,4
7252,current recommendations,current recommendations,4
7253,yearly vaccinations,yearly vaccinations,4
7254,future vaccination policy,future vaccination policy,4
7258,tom jefferson,tom jefferson,4
7259,cochrane collaboration reviews,cochrane collaboration reviews,4
7264,medical institutions,medical institutions,4
7265,key figures,key figures,4
7268,infectious,infectious,4
1060,rupees,rupees,4
7276,59 months,59 months,4
7278,weakened immune systems,weakened immune systems,4
1865,2 000 passengers,2 000 passengers,4
3981,acute chronic infections,acute chronic infections,4
7285,fluzone quadrivalent,fluzone quadrivalent,4
3977,chronic infections,chronic infections,4
7289,afluria quadrivalent,afluria quadrivalent,4
7340,available evidence,available evidence,4
937,microbiologist maurice hilleman s vaccine isbelievedtohavesaved,microbiologist maurice hilleman s vaccine isbelievedtohavesaved,4
7343,65 years,65 years,4
7349,goal,goal,4
7394,world health organization s global advisory committee,world health organization s global advisory committee,4
7396,grounds,grounds,4
1019,19 february,19 february,4
7400,secondary priority people,secondary priority people,4
7403,vulnerable people,vulnerable people,4
1881,parisbased world organisation,parisbased world organisation,4
7409,annual injection,annual injection,4
3923,superficial contact,superficial contact,4
7393,world health organization s global advisory committee],world health organization s global advisory committee],4
7416,following people,following people,4
7427,postcard reminders,postcard reminders,4
1011,government s destruction,government s destruction,4
1010,residents main source,residents main source,4
1008,residents,residents,4
7446,dentists,dentists,4
1889,u.s. hogs,u.s. hogs,4
7455,34%,34%,4
1002,birds,birds,4
7420,gender,gender,4
7389,trigger,trigger,4
3931,cure rate,cure rate,4
3932,greater effects,greater effects,4
7352,conclusive evidence,conclusive evidence,4
3951,half life,half life,4
7355,tentative evidence,tentative evidence,4
3945,1970s,1970s,4
7362,soreness,soreness,4
3944,326 000 deaths,326 000 deaths,4
3943,167 000 deaths,167 000 deaths,4
7365,severe health effects,severe health effects,4
1876,rise,rise,4
1029,587 000 eggs,587 000 eggs,4
7372,million vaccinations,million vaccinations,4
7373,egg allergy,egg allergy,4
3939,estimated 71 million people,estimated 71 million people,4
7375,egg allergies,egg allergies,4
7376,severe egg allergies,severe egg allergies,4
1028,253 000 birds,253 000 birds,4
7379,severe symptoms,severe symptoms,4
7381,previous anaphylactic reactions,previous anaphylactic reactions,4
3934,newer treatments,newer treatments,4
3955,infected person,infected person,4
7739,ii ifns,ii ifns,4
879,miller,miller,4
7861,john enders s lab,john enders s lab,4
3734,30mcg doses,30mcg doses,4
3743,grave supplydemand imbalance,grave supplydemand imbalance,4
3771,h5 booster doses june 2006,h5 booster doses june 2006,4
3729,country s national pharmaceutical institute,country s national pharmaceutical institute,4
872,gerardo,gerardo,4
7785,rigg,rigg,4
7879,y.h. tan s laboratory isolated,y.h. tan s laboratory isolated,4
1922,8 december,8 december,4
3722,6 months,6 months,4
869,mines,mines,4
3717,2 months,2 months,4
3761,lasts,lasts,4
3768,revaccination january 2006,revaccination january 2006,4
7936,biota pharmaceuticals,biota pharmaceuticals,4
3712,sars,sars,4
7942,laiv,laiv,4
922,new york times,new york times,4
862,dow jones industrial average,dow jones industrial average,4
861,economic effects,economic effects,4
3777,children february 2007,children february 2007,4
7822,doublestranded rna,structural class chemical compounds,4
7827,protein production,protein production,4
903,outbreak areas,outbreak areas,4
7882,sugar composition,sugar composition,4
7773,signaling cascades,signaling cascades,4
888,neighbouring province,neighbouring province,4
878,jose,jose,4
911,extensive outbreak,extensive outbreak,4
1923,cochrane collaboration,cochrane collaboration,4
7808,polyomavirus,polyomavirus,4
7809,e7 protein,e7 protein,4
7813,ifnα activity,ifnα activity,4
3765,answers,answers,4
913,million cases,million cases,4
4942,evolutionary adaptation,evolutionary adaptation,4
883,severe mortality impact,severe mortality impact,4
7797,downstream signaling events,downstream signaling events,4
1924,medical evidence,medical evidence,4
7903,relapsingremitting multiple sclerosis,relapsingremitting multiple sclerosis,4
914,late june,late june,4
7891,alan waldman,alan waldman,4
7904,slowing disease progression,slowing disease progression,4
7890,sidney pestka,sidney pestka,4
7795,interferon activity,group class proteins,4
3770,a/h5n1 adult february 2006,a/h5n1 adult february 2006,4
7819,communication,communication,4
917,newport naval station,newport naval station,4
887,origin outbreak china,"sovereign state socialist state secular state constitutional republic country ""peoples republic""",4
7788,protein deneddylation,protein deneddylation,4
7905,secondary progressive multiple sclerosis,secondary progressive multiple sclerosis,4
918,new military recruits,new military recruits,4
7832,single amino acid change,single amino acid change,4
890,late february,late february,4
7897,recombinant dna technology,academic discipline,4
1925,bmj,scientific journal open-access journal medical journal,4
3751,euaccepted levels,euaccepted levels,4
855,opportunistic bacterial infections,opportunistic bacterial infections,4
3794,hemagglutinin,group class proteins,4
856,lower mortality rate,lower mortality rate,4
1926,previous findings,previous findings,4
7862,poliovirus,taxon,4
930,fort ord,fort ord,4
898,rural areas,rural areas,4
894,member,member,4
893,people s republic,people s republic,4
7872,y.h. tan coworkers,y.h. tan coworkers,4
857,schools,schools,4
3790,biological organisms,biological organisms,4
3745,glaxosmithkline formula,public company,4
3750,company s proprietary formula induced,company s proprietary formula induced,4
896,february 1957.in,february 1957.in,4
3797,attachment,attachment,4
7860,monto ho,monto ho,4
7955,2018 review,2018 review,4
7850,observations,observations,4
7772,jakstat pathway,jakstat pathway,4
3755,fourths,fourths,4
3707,animal models,taxon,4
7762,heterodimers form,heterodimers form,4
928,12,12,4
7756,collection,collection,4
7876,coworkers,coworkers,4
7975,gelatin,mixture,4
7749,complex forms,complex forms,4
3754,adjuvanted 3.8microgram doses,adjuvanted 3.8microgram doses,4
3785,isavirus,monotypic taxon taxon,4
1948,normal flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1544,flu complications,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1341,new swine flu pandemic,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7028,vitamin,vitamin,5
3646,seasonal flu vaccine,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
182,flu nickname,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7383,live attenuated flu vaccine,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1250,h5n1 flu,subtypeinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4316,hugging,hugging,5
3340,h5n1 caused flu outbreaks,subtypeinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7093,resistance flu symptoms,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3363,future avian flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
2030,highly pathogenic h5n8 type flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1006,bird flu,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
600,flu symptoms,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1118,site,site,5
1878,swine flu,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
8180,nitd008,chemical compound,5
373,quinces,quinces,5
5261,typical hostbird flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5327,2005–2006 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3740,pandemic flu vaccine,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5324,fujian bird flu strain,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5329,2006–2007 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5331,15 february,15 february,5
5322,fujian human flu strain,organisms known particular common homo sapiens homo sapiens sapiens homoinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5321,fujian flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5320,fujian flu (2003–2004),influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5334,2007–2008 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5337,2008–2009 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5340,2009–2010 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
487,flu outbreak,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7414,seasonal flu vaccination,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5316,hong kong flu (1968–1969),influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5342,2010–2011 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1253,south america,south america,5
5268,seasonal h3n2 flu,subtypeinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5344,2011–2012 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5347,2014–2015 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5310,annual flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6175,poultry againsttheh5n1avianinfluenzavirusoverthelastdecademighthavemadetheh5n1avianinfluenzavirusharderforchineseveterinarytechnicianstospottherecentspreadoftheh7n9viruschina sagricultureministrydefendedchina sagricultureministrypolicyoflargescalevaccinationofpoultryagainst earlier bird flu strain,organisms known particular common nametaxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6176,earlier bird flu strain,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
10205,casualties,casualties,5
1537,peramivir,scholarly article review article,5
3181,mild flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
9937,croatia croatia cost,sovereign state unitary state mediterranean country countrysovereign state unitary state mediterranean country country,5
3345,bird flu species,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7418,pandemic flu vaccination uptake,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5349,2015–2016 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5325,2004–2005 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7390,injectionbased flu vaccines,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
8163,b. peramivir,scholarly article review article,5
9555,solvay,solvay,5
1543,pandemic flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6670,management flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4843,seasonal flu strains,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7280,2017–18 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4908,pandemic flu virus,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7184,flu spread,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5030,1977 russian flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4902,planning,planning,5
7182,flu vaccine,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1295,human flu viruses,organisms known particular common homo sapiens homo sapiens sapiens homoinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1296,eurasian pig flu virus,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1866,swine flu threat,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
14,flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
10244,flu mortality,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
10242,comparatively mild flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
8029,2009 study,2009 study,5
5058,1918–1919 spanish flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5061,1976 swine flu outbreak,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1588,1918 flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
834,asian flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
860,estimates,estimates,5
1776,question,question,5
5078,2009 flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7952,20162017 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4887,1918 spanish flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1073,2008 bird flu outbreak,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3221,longer flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
850,1918 spanish flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7244,flu vaccine strains,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1768,29 flu experts,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
853,invention,invention,5
1288,2009 swine flu pandemic,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4965,initial flu pandemic strain,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
845,cfr,cfr,5
7963,flu strain,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4931,spanish flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
549,suffocation,suffocation,5
9859,sofosbuvir/ribavirin/peginterferon combination treatment,sofosbuvir/ribavirin/peginterferon combination treatment,5
5,chronicled interregional flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7199,winter flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3254,province,province,5
10248,low flu mortality rate,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4924,potential flu strain,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3223,flu shot,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3686,conventional flu vaccines,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
11,1510 flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4912,lowest severity flu pandemics,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7959,20182019 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4840,1918 spanish pandemic flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7156,flu return,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7151,flu jabs,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
9539,novartis flu vaccine unit in2014andtransferto,business multinational corporationinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3196,flu vaccines,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
178,alps,alps,5
4855,h5n1 bird flu infection,subtypetaxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1122,site wasadmittedintohospitalsufferingfromamildrespiratoryillnessduringtheeveningof6februaryavetfromthesitewasfoundnottobe bird flu,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
9473,hyb0338,hyb0338,5
5169,2001–02 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
9542,biocsl flu vaccine brands,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
389,1557 flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3198,suppressed immune,suppressed immune,5
30,1510 flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5177,asian flu strain,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5178,1889–1890 russian flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5179,earliest flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5184,category 2 flu pandemic outbreak,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4850,annual flu vaccination,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
2786,astroviruses,astroviruses,5
2629,influenza b flu,infectious diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4845,predominant human flu,organisms known particular common homo sapiens homo sapiens sapiens homoinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
9545,flu vaccines brand,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3739,current flu vaccine manufacturing plants,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
2035,bird flu insamplesfromwildbirdsinthecentralwestofsouthkorea sandissuedthehighlypathogenich5n8strainofbirdfluin samples,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
589,flu thenenteredspain scapitalcitywheretheflurapidlyspreadto parts,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1573,spanish flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7150,flu shots,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1583,firstever reported triplehybrid flu virus,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
824,1957–1958 asian flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6247,h7n9 flu,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1580,north american swine flu strains,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1579,2009 flu pandemic strain,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1308,followup study,followup study,5
7330,nonpandemic flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1309,yearly seasonal flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
10302,typical flu symptoms,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6240,h7n9 bird flu,taxontaxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1754,global swine flu campaign,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7339,highdose flu vaccine,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
8896,april2009 flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3204,flu vaccination,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3203,seasonal flu shot,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3312,civet cats,civet cats,5
5129,g4 swine flu virus,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7345,2016–2017 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
503,1557 flu s symptoms asfeaturing,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1268,malda,malda,5
4853,annual flu shot,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1506,flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
51,1510 flu s springboard,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7638,flu strains,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
8515,h1n1 flu swine flu,virusinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenzaswine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3113,flu seasons,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3775,bird flu november 2006,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3110,south latitudes flu peaks,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4595,infectivity,infectivity,5
6599,ground,ground,5
7654,human seasonal flu vaccines,organisms known particular common homo sapiens homo sapiens sapiens homoinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
8503,harms,harms,5
3776,pandemic flu january 2007,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6785,bird flu outbreak,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1220,13 february,13 february,5
10143,arkhangelsk,city/town big city,5
5984,avian bird flu characteristics,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7666,commonly bird flu,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7668,swine flu vaccines,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1176,h5n1 bird flu strains,subtypetaxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1971,2009 h1n1 flu,virusinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1807,aeromexico,airline,5
6803,specific pandemic flu plan,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5773,august 2017 bird flu outbreak,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
2194,elasticity tensor,elasticity tensor,5
8523,2007–08 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1690,h5n1 avian flu,subtypeinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1162,meat,meat,5
6830,current major flu research contracts,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7615,flu illness,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7617,oral flu vaccine,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7622,horse flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5724,flu outbreaks,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
691,flu end,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3847,flu drugs tamiflu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenzachemical compound neuraminidase inhibitor medication essential medicine,5
10495,1889–1890 flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6812,avian flu scare,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1967,followup,followup,5
6809,pandemic flu search,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
8532,seasonal flu samples,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3121,flu seasonandcanloweranindividual sriskofgettingthefluby half,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
8527,2010–11 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3119,flu vaccinations,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5761,lowpathogenic h5n2 avian flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6806,flu related research,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5769,south korea bird flu alert,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7630,human flu vaccines,organisms known particular common homo sapiens homo sapiens sapiens homoinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
8339,liquid,liquid,5
10078,spanish flu survivors,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
119,flu human beings,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenzaorganisms known particular common homo sapiens homo sapiens sapiens homo,5
10459,flu ports,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
2704,2.2%,2.2%,5
1388,regular seasonal flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6691,h1n1/09 flu pandemic (2009–2010),influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6689,relatively benign flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6688,russian flu (1977–1979),influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1976,h1n1 swine flu strain,virusswine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
8402,frequency,frequency,5
5930,bird flu strain,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
749,putative flu remedy,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1917,2009 pandemic h1n1 flu,virusinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6684,asian flu (1957–1958),influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6681,spanish flu (1918–1920),influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5896,h5n8 type bird flu,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
422,flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6678,flu pandemics,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1816,h1n1 flu virus,virusinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
420,mortalities,mortalities,5
5905,called bird flu virus,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3799,flu virus genes,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6685,category 2 flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6016,oie experts,oie experts,5
944,1977 russian flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3811,flu virus,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6619,existing flu virus,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
715,south africa,continent,5
4580,assembly,assembly,5
3090,major flu activity,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
716,india,dominion british empire sovereign state historical country,5
1920,circulating flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
718,february,february,5
2079,highly pathogenic h5n8 bird flu,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3818,flu virus affinity,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5872,highly pathogenic h5n8 bird flu virus,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
950,h1n1 flu strain,virusinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3816,flu virus s ability tobindto,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6734,flu telephone survey template,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1919,h1n1 flu strains,virusinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6722,strategies prevent flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
10421,ayurveda,healing knowledge cure alternative medical treatment,5
1723,false pandemic flu campaign,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
221,south,south,5
6647,nature flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
10425,misinformation,misinformation,5
1381,pandemic h1n1 flu,virusinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
10673,avian flu birds,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6842,spanish flu research,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3129,seasonal flu shots,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5491,humanized h5n1 flu,subtypeinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1959,confirmed h1n1/09 pandemic flu death,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenzastock character psychopomp literary character,5
3399,h5n1 bird flu virus,subtypetaxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
639,russian flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5515,possible flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6950,pandemic flu vaccine planning,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5518,chief avian flu coordinator,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
2759,ntcp,ntcp,5
4712,mao flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7531,swine flu scare,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3152,common flu strains,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5528,avian flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7533,potential swine flu,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3151,h1n1 swine flu,virusswine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4705,1957 asian flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6942,cellculture flu vaccines,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
9211,herzegovina,herzegovina,5
7534,potential swine flu pandemic,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4701,flu infection,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
638,asiatic flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6971,conventional flu shot,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6084,h7 avian flu viruses,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5487,avian flu virus,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7465,year s flu vaccination,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3377,croatia,sovereign state unitary state mediterranean country country,5
794,1918 flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7016,potential h5n1 avian flu outbreak,subtypeinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7009,2009 h1n1 swine flu neuraminidase weretoacquire,virusswine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenzagroup class enzymes,5
2557,constipation,constipation,5
1511,flu viruses,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1510,universal flu vaccination,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4746,h5n1 flu cases,subtypeinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4700,flu activity,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7491,worldwide spanish flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6490,np functions,np functions,5
9734,annual flu season deaths,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
9733,compared annual flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3166,available flu vaccine,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
10353,spanish flu victims,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6667,1889–90 flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
2402,avian flu outbreak,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
9571,novartis flu vaccine unit wassoldto,business multinational corporationinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3162,2012–2013 flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7492,pharmacists,pharmacists,5
6938,novartis cellbased flu vaccine,business multinational corporationinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
908,new flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
9583,temperatures,temperatures,5
6877,new flu vaccine manufacturing methods,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4663,1968 flu pandemic,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6873,wild bird avian flu,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4662,hong kong flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1464,new swine flu virus,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6870,new flu vaccine manufacturing factories,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
9404,parent,parent,5
6566,proposal,proposal,5
1462,usual flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6878,universal flu vaccines,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
975,seasonal flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
3854,flu drugs,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1684,national pandemic flu service,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1458,average flu season,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
79,recorded flu outbreak,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
2451,2009 pandemic flu samples,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
8593,pandemrix flu vaccination,influenza vaccineinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6571,flu genomes,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6849,1918 flu strain,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1449,different flu viruses,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
6862,avian flu experts,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4501,deltavirus,deltavirus,5
1833,40%,40%,5
4675,h3n2 pandemic flu,subtypeinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5555,np,np,5
7547,quadrivalent vaccines seasonal flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7548,quadrivalent flu vaccine,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
2132,petroleum,petroleum,5
5565,segment reassortment,segment reassortment,5
3420,check,check,5
5571,related flu strains,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5573,future pandemic flu virus strain,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1680,swine flu virus,swine diseaseinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
4274,sexual practices,sexual practices,5
3143,flu epidemics,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7553,regulardose eggbased flu shots,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7554,recombinant cellgrown flu vaccines,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7555,regulardose flu shots,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7560,rapid response pandemic flu,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
9586,standard flu vaccine,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
9702,combat bird flu,taxoninfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
1473,avian flu viruses,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
5605,h5n1 avian flu outbreaks,subtypeinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
7573,h5n1 flu virus,subtypeinfluenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
462,individuals,individuals,5
6856,flu research,influenza pandemic influenza virus subtype h1n1 pandemic infectious disease zoonosis influenza,5
